UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 20172021
OR
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 1-10258
TREDEGAR CORPORATION
(Exact name of registrant as specified in its charter)
Virginia54-1497771
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
Virginia54-1497771
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
1100 Boulders Parkway,
Richmond, Virginia
23225

Richmond,
Virginia23225
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: 804-330-1000
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Classeach classTrading SymbolName of Each Exchangeeach exchange on Which Registeredwhich registered
Common StockTGNew York Stock Exchange
Preferred Stock Purchase RightsNew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act:
None
(Title of class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨    No  x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days.    Yes  x No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K ¨.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated fileroAccelerated filerxSmaller reporting companyo
Non-accelerated filer
o(Do not check if a smaller reporting company)
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x
Aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 20172021 (the last business day of the registrant’s most recently completed second fiscal quarter): $391,348,943*$365,890,037*
Number of shares of Common Stock outstanding as of January 31, 2018: 33,014,831 (33,030,190 as of June 30, 2017)
March 4, 2022: 33,743,617
*In determining this figure, an aggregate of 7,283,5497,142,062 shares of Common Stock beneficially owned by Floyd D. Gottwald, Jr., John D. Gottwald, William M. Gottwald and the members of their immediate families has been excluded because the shares are deemed to be held by affiliates. The aggregate market value has been computed based on the closing price in the New York Stock Exchange on June 30, 2017.2021.
Documents Incorporated By Reference
Portions of the Tredegar Corporation Proxy Statement for the 20182022 Annual Meeting of Shareholders (the “Proxy Statement”) are incorporated by reference into Part III of this Form 10-K.







Index to Annual Report on Form 10-K
Year Ended December 31, 20172021
 
Page
Page
Part I
Business
1-4
5-9
Properties
1112-13
Selected Financial Data
Part III



*Items11, 13 and 14 and portions of Items 10 and 12 are incorporated by reference from the Proxy Statement.






PART I
Item 1.BUSINESS
Item 1.    BUSINESS
Description of Business
Tredegar Corporation (“Tredegar”), a Virginia corporation incorporated in 1988, is engaged, through its subsidiaries, in the manufacture of aluminum extrusions, polyethylene (“PE”) plastic films and polyester (“PET”) films and aluminum extrusions. The financial information related to Tredegar’s polyethylene plastic films, polyester films and aluminum extrusions segments and related geographical areas included in Note 5 of the Notes to Financial Statements is incorporated herein by reference.films. Unless the context requires otherwise, all references herein to “Tredegar,” “the Company,” “we,” “us” or “our” are to Tredegar Corporation and its consolidated subsidiaries.
The Company's reportable business segments are Aluminum Extrusions, PE Films and Flexible Packaging Films.
On October 30, 2020, the Company completed the sale of its personal care films business (“Personal Care Films”). The transaction excluded the packaging film lines and related operations located at the Pottsville, Pennsylvania manufacturing site (“Pottsville Packaging”), which are now being reported within the Surface Protection component of PE Films. Commencing in the third quarter of 2020, all historical results for Personal Care Films have been presented as discontinued operations.
In December 2020, the Company entered into a definitive agreement and Aluminum Extrusions.
PE Films
completed the sale of Bright View Technologies (“Bright View”). The sale did not represent a strategic shift nor did it have a major effect on the Company’s historical and ongoing operations, thus all financial information for Bright View has been presented as continuing operations within the PE Films manufactures plastic films, elasticssegment.
For more information on these transactions, see Note 15 “Discontinued Operations” to the Consolidated Financial Statements included in Item 15. “Exhibits and laminate materials primarily utilized in personal care materials, surface protection films,Financial Statement Schedules” (“Item 15”) of this Annual Report on Form 10-K for the year ended December 31, 2021 (“Form 10-K”).
Aluminum Extrusions
Aluminum Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft and specialtymedium-strength alloyed aluminum extrusions, custom fabricated and optical lighting applications. These products are manufactured atfinished for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets. Bonnell Aluminum has manufacturing facilities located in the United States (“U.S.”).
Aluminum Extrusions manufactures mill (unfinished), The Netherlands, Hungary, China, Brazilmachined, anodized and India. PE Filmspainted (finished) and fabricated aluminum extrusions for sale directly to fabricators and distributors. It also sells branded aluminum flooring trims under its Futura TransitionsTM line and aluminum framing systems under its TSLOTSTM line. Aluminum Extrusions competes in all of its marketsprimarily on the basis of product innovation, quality, service and price. Sales are made predominantly in the U.S. The end-use markets for Aluminum Extrusions are cyclical and seasonal in nature.

Personal Care. Tredegar’s Personal Care unit is a global supplierThe end-uses in each of apertured, elastic and embossed films, laminate materials, and polyethylene and polypropylene overwrap films for personal care markets, including:
Aluminum Extrusions’ primary market segments include:
Major Markets
Apertured film and laminate materials for use as topsheet in feminine hygiene products, baby diapers and adult incontinence products (including materials sold under the ComfortAire, ComfortFeel and FreshFeel brand names);
End-Uses
Building & construction nonresidential
Elastic materials for use as components for baby diapers, adult incontinence productsCommercial windows and feminine hygiene products (including components sold under the ExtraFlexdoors, curtain walls, storefronts and FlexAire brand names);entrances, automatic entry doors, walkway covers, ducts, louvers and vents, office wall panels, partitions and interior enclosures, acoustical walls and ceilings, point of purchase displays, pre-engineered structures, and flooring trims (Futura TransitionsTM)
Building & construction - residentialResidential windows and doors, shower and tub enclosures, railing and support systems, venetian blinds, and swimming pools
Automotive and transportationAutomotive and light truck structural components, spare parts, after-market automotive accessories, grills for heavy trucks, travel trailers and recreation vehicles
Consumer durablesOffice furniture, pleasure boats, refrigerators and freezers, appliances and sporting goods
Machinery & equipment
Three-dimensional apertured film transfer layers for baby diapersMaterial handling equipment, conveyors and adult incontinence products sold under the AquiDry®conveying systems, medical equipment, industrial fans and AquiDry Plus brand names;aluminum framing systems (TSLOTSTM)
Distribution (metal service centers specializing in stock and release programs and custom fabrications to small manufacturers)Various custom profiles including storm shutters, pleasure boat accessories, theater set structures and various standard profiles (including rod, bar, tube and pipe)
Electrical and renewable energyLighting fixtures, electronic apparatus, solar panel brackets and rigid and flexible conduits
Thin-gauge films that are readily printable
1


Aluminum Extrusions’ net sales (sales less freight) by market segment for the years ended December 31, 2021, 2020 and convertible on conventional processing equipment for overwrap for bathroom tissue and paper towels; and
Polypropylene films for various industrial applications, including tape and automotive protection.2019 is shown below:
% of Aluminum Extrusions Net Sales by Market Segment
 202120202019
Building and construction:
Nonresidential50%56%51%
Residential10%9%8%
Automotive8%8%9%
Specialty:
Consumer durables10%10%11%
Machinery & equipment8%7%7%
Electrical6%4%7%
Distribution8%6%7%
Total100%100%100%
In 2017, 20162021, 2020 and 2015, personal care materials2019, Aluminum Extrusions net sales accounted for approximately 27%67%, 30%63% and 33%66% of Tredegar’s consolidated net sales, (sales less freight)respectively.
Backlog. Overall backlog in Aluminum Extrusions was approximately $306.4 million at December 31, 2021 compared to approximately $74.2 million at December 31, 2020, an increase of $232.2 million, or approximately 313%. The increased backlog in 2021 compared to 2020 is primarily due to increased demand (33% increase in bookings), while experiencing a shortage of labor to meet existing demand and desired shipment levels. Net sales for Aluminum Extrusions, which the Company believes are cyclical in nature due to the seasonal nature of end-use markets, were $539.3 million in 2021, $455.7 million in 2020 and $529.6 million in 2019.
Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from continuing operations, respectively.domestic and foreign producers in open-market purchases and under annual contracts. Refer to Quantitative and Qualitative Disclosures About Market Risk in Item 7. "Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Form 10-K (“Item 7”) for additional information on aluminum price trends. Aluminum Extrusions believes that it has adequate supply agreements for aluminum raw materials in 2022 and is in the process of securing supply sources to meet expected needs in 2023. Aluminum Extrusions continues to navigate through supply chain issues for paint and other non-aluminum raw materials.
Surface Protection.PE Films
PE Films produces surface protection films, polyethylene overwrap films and films for other markets. Tredegar’s Surface Protection unit produces single- and multi-layer surface protection films sold under the UltraMask®UltraMask®, ForceField™, ForceField PEARL® and ForceField PEARLPearl A™ brand names. These films, which are manufactured at facilities in the U.S. and China, support manufacturers of optical and other specialty substrates used in high-technology applications, most notably protecting high-value components of flat panel and flexible displays used in televisions, monitors, notebooks, smart phones,smartphones, tablets, e-readers, automobiles and digital signage, during the manufacturing and transportation process. In 2017, 20162021, 2020 and 2015, surface protection films2019, PE Films accounted for approximately 11%15%, 11%19% and 10%, respectively,17% of Tredegar’s consolidated net sales, from continuing operations.respectively.
Bright View Technologies. Tredegar’s Bright ViewIn October 2020, the Surface Protection unit designsassumed responsibility for Pottsville Packaging, which was previously reported within the Personal Care component of PE Films. Pottsville Packaging produces thin-gauge films as overwrap for bathroom tissue and manufactures a range of specialty film-based components that provide tailored functionality for the global engineered optics market.  By leveraging multiple technology platforms, including film capabilities and its patented microstructure technology, Bright View offers high performance optical management solutions for a wide range of applications including LED illumination. paper towels.



PE Films’ net sales by market segment over the last three years is shown below:
% of PE Films Net Sales by Market Segment *
 2017 2016 2015
Personal Care70% 72% 75%
Surface Protection28% 25% 23%
Bright View2% 3% 2%
Total100% 100% 100%
      
* See previous discussion by market segment for comparison of net sales to the Company’s consolidated net sales for significant market segments for each of the years presented.
Raw Materials. The primary raw materials used by PE Films in polyethylene and polypropylene films are low density, linear low density and high density polyethylene and polypropylene resins. These raw materials are obtained from domestic and foreign suppliers at competitive prices. Refer to Quantitative and Qualitative Disclosures About Market Risk in Item 7 for additional information on resin price trends. PE Films believes that there will be an adequate supply of polyethylene and polypropylene resins in the foreseeable future.
Research and Development. Tredegar’s spending for research and development (“R&D”) activities in 2021, 2020 and 2019 was primarily related to PE Films. R&D spending by the PE Films also buys polypropylene-based nonwoven fabrics based on the resins previously notedwas approximately $5.7 million, $7.7 million and styrenic block copolymers,$7.0 million in 2021, 2020 and it believes there will be an adequate supply of these raw materials2019, respectively.
Customers. PE Films’ products are sold primarily in the foreseeable future.
Customers. PE Films sells to many branded product producers throughout the world,U.S. and Asia, with the top fivefour customers, collectively, comprising 68%88%, 69%84% and 73%86% of its net sales in 2017, 20162021, 2020 and 2015,2019, respectively. Its largestNo single PE Films customer is The Procter & Gamble Company (“P&G”). Net sales to P&G totaled $122 million in 2017, $129 million in 2016 and $164 million in 2015 (these amounts include film sold to third parties that converted the film into materials used with products manufactured by P&G).exceeds 10% of Tredegar’s consolidated net sales. For additional information, see “ItemItem 1A. Risk“Risk Factors” of this Form 10-K (“Item 1A”).
2


Flexible Packaging Films
Flexible Packaging Films is comprised of Terphane Holdings LLC (“Terphane”). Flexible Packaging Films produces PET-based films for use in packaging applications that have specialized properties, such as heat resistance, strength, barrier protection and the ability to accept high-quality print graphics. These differentiated, high-value films are primarily manufactured in Brazil and sold in Latin America and the U.S. under the Terphane®, Sealphane® and SealphaneEcophane® brand names. Major end uses include food packaging and industrial applications. In 2017, 2016 and 2015, Flexible Packaging Films accounted for approximately 12%, 14% and 12%, respectively, of Tredegar’s consolidated net sales from continuing operations. Flexible Packaging Films competes in all of its markets on the basis of product quality, service and price. In 2021, 2020 and 2019, Terphane accounted for approximately 18%, 18% and 17% of Tredegar’s consolidated net sales, respectively.
Raw Materials. The primary raw materials used by Flexible Packaging Films to produce polyester resins are purified terephthalic acid (“PTA”) and monoethylene glycol (“MEG”). Flexible Packaging Films also purchases additional polyester resins directly from suppliers. All of theseThese raw materials are obtained from domestic Brazilian suppliers and foreign suppliers at competitive prices. Terphane continues to monitor cost escalations to adjust selling prices as market dynamics permit and Flexible Packaging Films believes that there will be an adequate supply of polyester resins, as well as PTA and MEG in the foreseeable future.
Aluminum Extrusions
The William L. Bonnell Company, Inc., known in the industry as Bonnell Aluminum, and its operating divisions, AACOA, Inc. and Futura Industries Corporation (“Futura”) (together, “Aluminum Extrusions”), produce high-quality, soft-alloy and medium-strength aluminum extrusions primarily for building and construction, automotive, consumer durables, machinery and equipment, electrical and distribution markets. Aluminum Extrusions manufactures mill (unfinished), anodized and painted (coated) and fabricated aluminum extrusions for sale directly to fabricators and distributors, and it competes primarily on the basis of product quality, service and price. Futura designs and manufactures a wide range of extruded aluminum products for a number of industries and end markets, including branded flooring trims and aluminum framing systems (TSLOTSTM), as well as OEM (original equipment manufacturer) components for electronics, store fixture, transportation, medical, marine, retail, solar and other applications. Sales are made predominantly in the U.S.
On February 15, 2017, Bonnell Aluminum acquired Futura on a net debt-free basis for approximately $92 million ($87 million net of a $5 million refund expected in 2018 from an earnout price adjustment mechanism). The acquisition was funded using Tredegar’s revolving credit agreement and treated as an asset purchase for U.S. federal income tax purposes. Futura, located in Clearfield, Utah, has a national sales presence and particular strength in the western U.S.


The end-uses in each of Aluminum Extrusions’ primary market segments include:
Major MarketsEnd-Uses
Building & construction - nonresidentialCommercial windows and doors, curtain walls, storefronts and entrances, walkway covers, ducts, louvers and vents, office wall panels, partitions and interior enclosures, acoustical walls and ceilings, point of purchase displays, pre-engineered structures, and flooring trims
Building & construction - residentialShower and tub enclosures, railing and support systems, venetian blinds, swimming pools and storm shutters
AutomotiveAutomotive and light truck structural components, spare parts, after-market automotive accessories, grills for heavy trucks, travel trailers and recreation vehicles
Consumer durablesFurniture, pleasure boats, refrigerators and freezers, appliances and sporting goods
Machinery & equipment
Material handling equipment, conveyors and conveying systems, medical equipment, and aluminum framing systems (TSLOTSTM)
Distribution (metal service centers specializing in stock and release programs and custom fabrications to small manufacturers)Various custom profiles including storm shutters, pleasure boat accessories, theater set structures and various standard profiles (including rod, bar, tube and pipe)
ElectricalLighting fixtures, solar panels, electronic apparatus and rigid and flexible conduits
Aluminum Extrusions’ net sales by market segment over the last three years is shown below:
% of Aluminum Extrusions Net Sales by Market Segment*
 2017 2016 2015
Building and construction:     
Nonresidential51% 59% 59%
Residential9% 6% 6%
Automotive8% 9% 8%
Specialty:     
Consumer durables12% 11% 11%
Machinery & equipment7% 6% 5%
Electrical7% 3% 6%
Distribution6% 6% 5%
      
Total100% 100% 100%
*Includes Futura as of its acquisition date of February 15, 2017.
In 2017, 2016 and 2015, nonresidential building and construction accounted for approximately 26%, 27% and 26% of Tredegar’s consolidated net sales from continuing operations, respectively.
Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from domestic and foreign producers in open-market purchases and under short-term contracts. Aluminum Extrusions believes that it has adequate long-term supply agreements for aluminum and other required raw materials and supplies in the foreseeable future.


General
Intellectual Property. Tredegar considers patents, licenses and trademarks to be significantmaterial to PE Films. As ofOn December 31, 2017,2021, PE Films held 266 issued40 patents (63 of which are issued in the(including 5 U.S.) patents), and 10879 registered trademarks (9 of which are issued in the(including 4 U.S.) registered trademarks). Flexible Packaging Films held 1 U.S. patent which was issued in the U.S. and 1317 registered trademarks (2 of which are(including 4 U.S. registered in the U.S.)trademarks). Aluminum Extrusions held no U.S. patents and 34 U.S. registered trademarks (alltrademarks. As of which are registered in the U.S.). TheseDecember 31, 2021, these patents havehad remaining terms ranging from 1of 2.5 to 2017.5 years. Tredegar also has licenses under patents owned by third parties.
Research and Development. Tredegar’s spending for research and development (“R&D”) activities in 2017, 2016 and 2015 was primarily related to PE Films. PE Films has technical centers in Durham, North Carolina; Richmond, Virginia; and Terre Haute, Indiana. Flexible Packaging has a technical center in Bloomfield, New York. R&D spending by the Company was approximately $18.3 million, $19.1 million and $16.2 million in 2017, 2016 and 2015, respectively.
Backlog. Backlogs are not material to the operations in PE Films or Flexible Packaging Films. Overall backlog for continuing operations in Aluminum Extrusions was approximately $46.2 million at December 31, 2017 compared to approximately $27.1 million at December 31, 2016, an increase of $19.1 million, or approximately 70%. Backlog at December 31, 2017 included $5.7 million for Futura. Net sales for Aluminum Extrusions, which the Company believes is cyclical in nature, was $466.8 million in 2017, $360.1 million in 2016 and $375.5 million in 2015. Net sales for Futura since it was acquired on February 15, 2017 were $71.0 million.
Government Regulation.The Company’s operations are subject to various local, state, federal and foreign government regulations, including environmental, privacy and anti-corruption and anti-bribery laws and regulations.
U.S. laws concerning the environment to which the Company’s domestic operations are or may be subject to include among others, the Clean Water Act, the Clean Air Act, the Resource Conservation and Recovery Act, the Occupational Safety and Health Act, the National Environmental Policy Act, the Toxic Substances Control Act, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), regulations promulgated under these acts, and other federal, state or local laws or regulations governing environmental matters. Compliance with these laws is an important consideration because Tredegar uses hazardous materials in some of its operations, is a generator of hazardous waste, and wastewater from the Company’s operations is discharged to various types of wastewater management systems. Under CERCLA and other laws, Tredegar may be subject to financial exposure for costs associated with waste management and disposal, even if the Company fully complies with applicable environmental laws.
The U.S. Environmental Protection Agency has adopted regulations under the Clean Air Act relating to emissions of carbon dioxide and other greenhouse gases (“GHG”), including mandatory reporting and permitting requirements. Several of the Company’s manufacturing operations result in emissions of carbon dioxide or GHG and are subject to the current GHG regulations. The Company’s compliance with theseenvironmental regulations has yet to require significant expenditures. The cost of compliance with any future GHG legislation or regulations is not presently determinable, but Tredegar does not anticipate compliance to have a material adverse effect on its consolidated financial condition, results of operations and cash flows based on information currently available.
Tredegar is also subject to the governmental regulations in the countries where it conducts business.
At December 31, 2017, the Company believes that it was in substantial compliance with all applicablecapital expenditures; however, environmental laws, regulations and permits in the U.S. and other countries where it conducts business. Environmental standards tend to become more stringent over time. InTherefore, in order to maintain substantial compliancecomply with such standards,current or future environmental legislation or regulations, the Company may be requiredsubject to incur additional capital expenditures, operating expenses or other compliance costs, the amounts and timing of which are not presently determinable but which could be significant, inincluding constructing new facilities or in modifying existing facilities. Furthermore,
Like environmental regulations, current or future privacy and anti-corruption and anti-bribery legislation or regulations may subject the Company to additional capital expenditures, operating expenses or other compliance costs, the amounts and timing of which are not presently determinable but could be significant. Any failure to comply with current or future laws and regulations, including environmental, privacy and anti-corruption and anti-bribery laws and regulations, could subject Tredegar to substantial penalties, fines, costs and expenses. For further discussion regarding certain environmental, privacy and anti-corruption and anti-bribery laws and regulations to which the Company is subject, see Item 1A below.
Employees. Human Capital Management.
Overview
Tredegar employed approximately 3,2002,400 people at December 31, 2017.2021 located in the U.S., Brazil, and Asia, of which 80% are located in the U.S. Approximately 15% of the Company’s employees are represented by labor unions located in the U.S. under various collective bargaining agreements with varying durations and expiration dates, none of which expire before 2025. All of Tredegar’s Brazilian employees are represented by a national labor union. Generally, the total number of employees of Tredegar does not significantly fluctuate throughout the year. However, acquisition or divestiture activity, or changes in the level of business activity may impact employee levels.
3


Health and Safety
Tredegar has continuously exceeded the industry standards for safety. The Company uses various forms of employee safety metrics to assess the health and safety performance of its Aluminum Extrusions, PE Films and Flexible Packaging operations, including employee safety data which is available on the Company’s website at https://tredegar.com/about-tredegar/committed-to-our-employees. Tredegar has also instituted additional safety precautions during the ongoing COVID-19 pandemic as described in "The Impact of COVID-19" included in Item 7.
Additionally, Aluminum Extrusions has on-site health clinics at its Carthage and Clearfield facilities. These clinics allow Aluminum Extrusions to invest in its people, provide more personal and more thorough healthcare to employees, and enhance the employer-employee relationship. The Carthage and Clearfield clinics serve over 540 and 380 employees, respectively.
Talent and Development
The Company believes its employees are its most valuable asset and are critical to the success of the Company. The Company seeks to retain employees by offering competitive wages, benefits and training opportunities. To assess and monitor employee retention and engagement, the Company surveys employees and takes actions to address areas of employee concern. The annual employee engagement survey results are presented to Tredegar’s Board of Directors (“Board”). Additionally, the objectives of our executive compensation programs are to attract, motivate and retain highly qualified executive officers. To accomplish these objectives, the Company relies on a pay strategy that emphasizes performance-based compensation through annual and long-term incentives. The Company believes that this pay strategy creates a strong link between pay and performance and aligns with our business strategy of generating strong operating results and shareholder value creation while controlling fixed costs.
The Company is committed to holistically supporting our employees both at work and in their communities by:
Strictly following all applicable health, safety and non-discrimination laws in each country;
Promoting the highest standards for employee health and safety through innovative programs; and
Providing opportunities for community outreach and supporting programs that enhance the lives of children and families.
Inclusion and Diversity
Tredegar strictly complies with all applicable state, local and international laws governing nondiscrimination in employment in every location where Tredegar and its businesses have facilities to ensure healthy and positive working conditions. This applies to all terms and conditions of employment, including recruiting, hiring, job assignments, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. All applicants and employees are treated with the same high level of respect regardless of their race, creed, color, religion, sex, sexual orientation, gender identity, age, pregnancy, national origin, ethnicity, political affiliation, union membership, marital status, citizenship status, veteran status, disability or other protected category. Employees who experience or witness discriminatory behavior are encouraged to report such behavior to their supervisor, Human Resources or Tredegar’s toll-free anonymous reporting hotline. Additionally, the Company spends significant resources in developing its employees. Among the five core principles of the “The Tredegar Way” that the Company uses to guide its organization, the “Leadership” principle is focused on building a team of motivated and engaged leaders at every level of the Company. Each business unit has identified specific action plans to promote the Leadership principle among its employees. Action plans include talent development, skills training, reinforcement of strong cultural values, and robust systems to ensure a safe working environment.
Information About Our Executive Officers. See Item 10. “Directors, Executive Officers and Corporate Governance” of this Form 10-K.
Available Information and Corporate Governance Documents. Tredegar’s Internetwebsite address is www.tredegar.com. The Company makes available, free of charge through its website, its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practicable after such documents are electronically filed with, or furnished to, the Securities and Exchange Commission (“SEC”). Information filed electronically with the SEC can be accessed on its website at www.sec.gov. In addition, the Company’s Corporate Governance Guidelines, Code of Conduct, and the charters of the Audit, Executive Compensation, and Nominating and Governance Committees and Climate Change Risk Assessment and many other corporate policies are available on Tredegar’s website and are available in print without charge, to any shareholder upon request by contacting Tredegar’s Corporate Secretary at 1100 Boulders Parkway, Richmond, Virginia 23225. The information on or that can be accessed through the Company’s website is not, and shall not be deemed to be, a part of this Annual Report on Form 10-K for the year ended December 31, 2017 (“Form 10-K”) or incorporated into other filings it makes with the SEC.


4
Item 1A.RISK FACTORS


Item 1A.    RISK FACTORS
There are a number of risks and uncertainties that could have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The following risk factors should be considered, in addition to the other information included in this Form 10-K, when evaluating Tredegar and its businesses.
PE FilmsRisks Related to all Tredegar Businesses
Our results of operations, financial condition and cash flows could be adversely affected by pandemics, epidemics or other public health emergencies, such as coronavirus (“COVID-19”) and emerging variants. Our business, results of operations, financial condition, and cash flows have been, and may continue to be, adversely affected by pandemics, epidemics or other public health emergencies, such as the global outbreak of COVID-19 and emerging variants. In March 2020, the World Health Organization characterized COVID-19 as a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The outbreak resulted in governments around the world implementing increasingly stringent measures to help control the spread of the virus, including quarantines, “shelter in place” and “stay at home” orders, travel restrictions, business curtailments, school closures, and other measures. However, there have been increases in COVID-19 cases in many areas caused by a combination of the potentially more contagious variants of the virus, as well as vaccine hesitancy and low vaccination rates in many areas of the U.S.
PE FilmsThe extent to which the COVID-19 pandemic will ultimately impact our business, results of operations, financial condition and cash flows depends on future developments that are highly uncertain, rapidly evolving and difficult to predict at this time, including:
the duration, spread and intensity of the pandemic;
the availability, usage and effectiveness of vaccines, low vaccination rates in many areas of the U.S., and employee hesitancy to get vaccinated;
increasing costs of labor, raw materials, and global transportation and logistics resources;
a sustained labor shortage due to excessive absenteeism as a result of COVID-19 cases and/or exposures and increased turnover rates within our employee base impacting our ability to meet desired shipping levels;
the ability of our suppliers, contractors and third-party logistics providers to meet their obligations to us (including supplying us with essential raw materials or shipping finished goods to our customers) on a timely basis and at previously anticipated costs without significant disruption, and our ability to identify alternative sources of materials and services, if necessary;
our ability to continue to meet our customers’ needs in the event of the suspension or interruption of essential elements of our manufacturing and supply arrangements and activities such as, the continued availability of raw materials, transportation, labor and production capacity at previously anticipated costs;
the effect of the COVID-19 pandemic on our customers, including their ability to remain in operation and pay for the products purchased from us on a timely basis; and
the impact of the COVID-19 pandemic on the financial and credit markets and economic activity generally, including our ability to maintain compliance with financial covenants, access lending, capital markets, and other sources of liquidity when needed on reasonable terms or at all.
While it is highly dependent on sales associated with its top five customers,not possible at this time to estimate the largest of which is P&G. PE Films’ top five customers comprised approximately 26%, 29% and 32% of Tredegar’s consolidated net sales, in 2017, 2016 and 2015, respectively, with net sales to P&G alone comprising approximately 13%, 16% and 19% in 2017, 2016 and 2015, respectively. The loss or significant reduction of sales associated with one or more of these customers without replacement by new businessimpact that any particular epidemic, including COVID-19, could have a material adverse effect on the Company. OtherCompany’s business, the extent of that impact would likely be affected by factors thatoutside of our control such as the severity, duration and spread of such an epidemic, the measures taken by the governments of countries affected and the ability of our customers and consumers to access government programs providing liquidity and support during the crisis. The impact of an epidemic on our employees, our customers, our supply chains, demand for our products, our ability to supply customers, our operating costs and our other business activities, could adversely affect the business include, by way of example, (i) failure by a key customer to achieve success or maintain share in markets in which they sell products containing PE Films’ materials, (ii) key customers using products developed by others that replace PE Films’ business with such customer, (iii) delays in a key customer rolling out products utilizing new technologies developed by PE Films and (iv) operational decisions by a key customer that result in component substitution, inventory reductions and similar changes. While PE Films is undertaking efforts to expand its customer base, there can be no assurance that such efforts will be successful, or that they will offset any delay or loss of sales and profits associated with these large customers.
In recent years, PE Films lost substantial sales volume due to product transitions and incurred other sales losses associated with various customers. PE Films anticipates a significant product transition after 2018 in the personal care operating segment of the PE Films reporting segment. PE Films currently estimates that this will adversely impact the annual sales of the business unit by $70 million sometime between 2019 and 2021. PE Films has been increasing its R&D spending (an increase of $6 million in 2017 versus 2014), expects to invest capital, and is accelerating sales and marketing efforts to capture growth and diversify its customer base and product offerings in personal care products, but there can be no assurance that such efforts will be successful or that they will offset any loss of business due to product transitions. The overall timing and net change in personal care’s revenues and profits and capital expenditures needed to support growth during this transition period are uncertain at this time.
PE Films also anticipates that, over the next few years, there is an increased risk that a portion of its film used in surface protection applications will be made obsolete by possible customer product transitions to less costly alternative processes or materials. PE Films estimates on a preliminary basis that the annual adverse impact on ongoing operating profit from customer shifts to alternative processes or materials in surface protection is in the range of $5 to $10 million. Given the technological and commercial complexity involved in bringing these alternative processes or materials to market, PE Films is very uncertain as to the timing and ultimate amount of the possible transitions. In response, the Company is aggressively pursuing new surface protection products, applications and customers, but there can be no assurance that such efforts will be successful or that they will offset any loss of business due to product transitions.
PE Films and its customers operate in highly competitive markets. PE Films competes on product innovation, quality, price and service, and its businesses and their customers operate in highly competitive markets. Global market conditions continue to exacerbate the Company’s exposure to margin compression due to competitive forces, especially as certain products move into the later stages of their product life cycles. In addition, the changing dynamics of consumer products retailing, including the impact of on-line retailers such as Amazon, is creating price and margin pressure on the customers of PE Films’ personal care business. While PE Films continually works to identify new business opportunities with new and existing customers, primarily through the development of new products with improved performance and/or cost characteristics, there can be no assurances that such efforts will be successful or that they will offset business lost from competitive dynamics or customer product transitions.
Failure of PE Films’ customers, who are subject to cyclical downturns, to achieve success or maintain market share could adversely impact PE Films’ sales and operating margins. PE Films’ plastic films serve as components for, or are used in the production of, various consumer products sold worldwide. A customer’s ability to successfully develop, manufacture and market those products is integral to PE Films’ success. Also, consumers of premium products made with or using PE Films’ components may shift to less premium or less expensive products, reducing the demand for PE Films’ plastic films. Cyclical downturns may negatively affect businesses that use PE Films’ plastic film products, which could adversely affect sales and operating margins.
The Company’s inability to protect its intellectual property rights or its infringement of the intellectual property rights of others could have a material adverse impact on PE Films. PE Films operates in an industry where its significant customers and competitors have substantial intellectual property portfolios. The continued success of PE Films’ business depends on its ability not only to protect its own technologies and trade secrets, but also to develop and sell new products


that do not infringe upon existing patents or threaten existing customer relationships. Intellectual property litigation is very costly and could result in substantial expense and diversions of Company resources, both of which could adversely affect its consolidatedour financial condition, results of operations and cash flows. In addition, there may be no effective legal recourse against infringementFor more information on the effect of the Company’s intellectual property by third parties, whether due to limitationsCOVID-19 on enforcement of rights in foreign jurisdictions or as a result of other factors.
An unstable economic environment could have a disruptive impact on PE Films’ supply chain. Certain raw materials used in manufacturing PE Films’ products are sourced from single suppliers,our business and PE Films may not be able to quickly or inexpensively re-source from other suppliers.  The risk of damage or disruption to its supply chain may increase if and when different suppliers consolidate their product portfolios, experience financial distress or disruption of manufacturing operations. Failure to take adequate steps to effectively manage such events, which are intensified when a product is procured from a single supplier or location, could adversely affect PE Films’ consolidated financial condition, resultsrefer to “The Impact of operations and cash flows, as well as require additional resources to restore its supply chain.
COVID-19 in Item 7.
Our cost saving initiatives may not achieve the results we anticipate. PE Films has undertaken and will continue to undertake cost reduction initiatives to consolidate certain production, improve operating efficiencies and generate cost savings. PE Films cannot be certain that it will be able to complete these initiatives as planned or that the estimated operating efficiencies or cost savings from such activities will be fully realized or maintained over time. In addition, PE Films may not be successful in moving production to other facilities or timely qualifying new production equipment. Failure to complete these initiatives could adversely affect PE Films’ financial condition, results of operations and cash flows.
Flexible Packaging Films
Overcapacity in Latin American polyester film production and a history of uncertain economic conditions in Brazil could adversely impact the financial condition, results of operations and cash flows of Flexible Packaging Films. Competition in Brazil, Terphane’s primary market, has been exacerbated by global overcapacity in the polyester industry generally, and by particularly acute overcapacity in Latin America. Additional PET capacity from a competitor in Latin America came on line in September 2017.  These factors, plus a recent period of unfavorable economic and political conditions in Brazil, have resulted in significant competitive pricing pressures and U.S. Dollar equivalent margin compression.
For flexible packaging films produced in Brazil, variable conversion, fixed conversion and sales, general and administrative costs for operations in Brazil have been adversely impacted by inflation in Brazil that is higher than in the U.S.  Flexible Packaging Films is exposed to additional foreign exchange translation risk because almost 90% of Flexible Packaging Films’ Brazilian sales are quoted or priced in U.S. Dollars while a large part of its Brazilian costs are quoted or priced in Brazilian Real.  This mismatch, together with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively impact operating profit for Flexible Packaging Films.
Tredegar has attempted to mitigate these impacts through new product offerings, cost saving measures, a currency hedge entered into in 2017, and manufacturing efficiency initiatives, but these efforts to-date have not been sufficient to prevent a significant decline in the operating profit for Flexible Packaging Films since the acquisition of Terphane in October 2011 and continuing efforts may not be successful, which could further adversely impact Flexible Packaging Films’ financial condition, results of operations and cash flows.
Governmental failure to extend anti-dumping duties in Brazil on imported products or prevent competitors from circumventing such duties could adversely impact Flexible Packaging Films. In recent years, excess global capacity in the industry has led to increased competitive pressures from imports into Brazil.  The Company believes that these conditions have shifted the competitive environment from a regional to a global landscape and have driven price convergence and lower product margins for Flexible Packaging Films. Favorable anti-dumping rulings are in effect for products imported from China, Egypt, India, Mexico, UAE and Turkey.  In January 2018, the Brazilian government opened new anti-dumping investigations for products imported from Peru and Bahrain. Competitors not currently subject to anti-dumping duties may choose to utilize their excess capacity by selling product in Brazil, which may result in pricing pressures that Flexible Packaging Films may not be able to offset with cost savings measures and/or manufacturing efficiency initiatives.  There can be no assurance that efforts to impose anti-dumping constraints on products imported to Brazil from Peru and Bahrain, or to extend duties beyond 2018 on products imported from certain other countries, will be successful.


Aluminum Extrusions
Sales volume and profitability of Aluminum Extrusions is cyclical and seasonal and highly dependent on economic conditions of end-use markets in the U.S., particularly in the construction sector. Aluminum Extrusions’ end-use markets can be cyclical and subject to seasonal swings in volume. Because of the capital intensive nature and level of fixed costs inherent in the aluminum extrusions business, the percentage drop in operating profits in a cyclical downturn will likely exceed the percentage drop in volume. In addition, during an economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as competitors protect their position with key customers. Any benefits associated with cost reductions and productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts (including a greater chance of loss associated with customers defaulting on fixed-price forward sales contracts) that usually accompany a downturn. In addition, higher energy costs can further reduce profits unless offset by price increases or cost reductions and productivity improvements.
Failure to prevent competitors from circumventing anti-dumping and countervailing duties, or a reduction in such duties, could adversely impact Aluminum Extrusions. As of April 2017, the antidumping duty and countervailing duty orders on aluminum extrusions from China will remain in place until the next five-year review of the orders. Chinese and other overseas manufacturers continue to try to circumvent the antidumping and countervailing orders to avoid duties. A failure by, or the inability of, U.S. trade officials to curtail efforts to circumvent these duties, or the potential reduction of applicable duties pursuant to annual reviews of the orders, could have a material adverse effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.
The imposition of tariffs or duties on imported aluminum products could significantly increase the price of Aluminum Extrusions’ main raw material, which could adversely impact demand for its products. On April 27, 2017, President Trump directed the U.S. Department of Commerce (“DOC”) to begin an investigation under Section 232 of the Trade Expansion Act regarding the effects on U.S. economic and national security of aluminum imports into the U.S. On January 19, 2018, the DOC formally submitted to President Trump the results of its investigation, which included recommendations from the DOC that the President impose tariffs or quotas, or both, on imports into the U.S. of primary aluminum and semi-fabricated aluminum products. The President has 90 days to decide on any potential action based on the findings of the investigation. It is unknown at this time if the President will take any action as a result of the Section 232 investigation, and, if action is taken, what the impact of that action would be on Bonnell Aluminum. However, the President could impose tariffs or quotas on aluminum imports to the U.S. Bonnell Aluminum and other major U.S. aluminum extruders are net importers of aluminum raw materials. If high tariffs are imposed on imported aluminum ingots purchased by Bonnell, then the aggregate cost of aluminum extrusions produced by Bonnell could rise significantly. Bonnell would expect to be able to pass through the higher aluminum costs to its customers. However, a higher cost for aluminum extrusions could result in product substitutions in place of aluminum extrusions, which could materially and negatively affect Bonnell and other U.S. aluminum extrusion businesses and their results of operations. If tariffs were imposed on all primary aluminum imports into the U.S., then aluminum extruders located outside the U.S. who were not subject to similar tariffs in the country where they produced extrusions, could have a price advantage relative to U.S.-based aluminum extruders.
Competition from China could increase significantly if China is granted market economy status by the World Trade Organization. China has launched a formal complaint at the World Trade Organization challenging its non-market economy status, claiming that as of December 11, 2016, China’s transition period as a non-market economy under its Accession Protocol to the World Trade Organization ended. China believes with respect to all Chinese-made products that it should receive market economy status and the rights attendant to that status under World Trade Organization rules.  The U.S. and the European Union have each rejected that interpretation.  If China is granted market economy status, the extent to which the U.S. antidumping laws will be able to limit unfair trade practices from China will likely be limited because the U.S. government will be forced to utilize Chinese prices and costs that do not reflect market principles in antidumping duty investigations involving China, which would ultimately limit the level of antidumping duties applied to unfairly traded Chinese imports. The volume of unfairly traded imports of Chinese aluminum extrusions would likely increase as a result and this, in turn, would likely create substantial pricing pressure on Aluminum Extrusions’ products and could have a material adverse effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.


The markets for Aluminum Extrusions’ products are highly competitive with product quality, service, delivery performance and price being the principal competitive factors. Aluminum Extrusions has approximately 1,700 customers that are in a variety of end-use markets within the broad categories of building and construction, distribution, automotive and other transportation, machinery and equipment, electrical and consumer durables. No single customer exceeds 4% of Aluminum Extrusions’ net sales. Future success and prospects depend on Aluminum Extrusions’ ability to provide superior service, high quality products, timely delivery and competitive pricing to retain existing customers and participate in overall industry cross-cycle growth. Failure in any of these areas could lead to a loss of customers, which could have an adverse material effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.
Aluminum Extrusions may not have sufficient capacity to meet its growth targets and service all of its customers. Aluminum Extrusions’ ability to grow and service existing customers is closely tied to having sufficient capacity. In recent years, increased demand, primarily from the nonresidential building and construction sector, has substantially increased Aluminum Extrusions’ average capacity utilization.
General
Tredegar has an underfunded defined benefit (pension) plan. Tredegar sponsors a pension plan that covers certain hourly and salaried employees in the U.S. The plan was substantially frozen to new participants in 2007, and frozen to benefit accruals for active participants in 2014. As of December 31, 2017, the plan was underfunded under U.S. generally accepted accounting principles (“GAAP”) measures by $91.8 million. Tredegar expects that it will be required to make a cash contribution of approximately $5.3 million to its underfunded pension plan in 2018, and may be required to make higher cash contributions in future periods depending on the level of interest rates and investment returns on plan assets.
An impairment of our identifiable intangible assets could have a material non-cash adverse impact on our results of operations. As of December 31, 2017, reporting units in PE Films and Aluminum Extrusions carried goodwill balances of $104 million and $24 million, respectively. PE Films’ goodwill balance was carried by its operating units, Personal Care Films and Surface Protection Films, at $47 million and $57 million, respectively. The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis. The valuation of goodwill depends on a variety of factors, including the success in achieving the Company’s business goals, global market and economic conditions, earnings growth and expected cash flows, and goodwill impairment valuations can be sensitive to assumptions associated with such factors. Failure to successfully achieve projections could result in future impairments. Impairments to goodwill and identifiable intangible assets may also be caused by factors outside the Company’s control, such as increasing competitive pricing pressures, changes in foreign exchange rates, lower than expected sales and profit growth rates, and various other factors. Significant and unanticipated changes could require a non-cash charge for impairment in a future period, which may significantly affect the Company’s results of operations in the period of such charge.
Noncompliance with any of the covenants in the Company’s $400 million revolving credit facility, which matures in March of 2021, could result in all debt under the agreement outstanding at such time becoming due and limiting its borrowing capacity, which could have a material adverse effect on consolidated financial condition and liquidity. The credit agreement governing Tredegar’s revolving credit facility contains restrictions and financial covenants that, if violated, could restrict the Company’s operational and financial flexibility. Failure to comply with these covenants could result in an event of default, which if not cured or waived, would result in all outstanding debt under the credit facility at such time becoming due, which could have a material adverse effect on the Company’s consolidated financial condition and liquidity.
Tredegar’s performance is influenced by costs incurred by its operating companies, including, for example, the cost of raw materials and energy. These costs include without limitation, the cost of aluminum (the raw material on which Aluminum Extrusions primarily depends), resin (the raw material on which PE Films primarily depends), PTA and MEG (the raw materials on which Flexible Packaging Films primarily depends), aluminum (the raw material on which Aluminum Extrusions primarily depends), natural gas (the principal fuel necessary for Aluminum Extrusions’ plants to operate), electricity, diesel fuel and diesel fuel. Resin, aluminumpaint. Aluminum, resin and natural gas prices are extremely volatile as shown in the charts in the Quantitative and Qualitative Disclosuressection. in Item 7. The Company continues to face inflationary pressures stemming from the COVID-19 operating environment, including notable increases in costs for raw materials, labor and freight. Additionally, geopolitical tensions, including deteriorating relations between the United States and Russia
5


resulting from the current situation involving Russia and Ukraine, could result in economic sanctions, tariffs, import-export restrictions and retaliatory actions that all have the potential to adversely impact the cost of raw materials and energy. The Company attempts to mitigate the effects of increased costs through price increases and contractual pass-through provisions, but there are no assurances that higher prices can effectively be passed through to customers or that Tredegar will be able to offset fully or on a timely basis the effects of higher raw material and energy costs through price increases or pass-through arrangements. Further, the Company’s cost control efforts may not be sufficient to offset any increases in raw material, energy or other costs.
Material disruptions at one of the Company’s major manufacturing facilities could negatively impact financial results. Tredegar believes it has implemented measures to minimize the risks of disruption at its facilities. However, a disruption could occur as a result of any number of events: an equipment failure with repairs requiring long lead times, labor stoppages or shortages, cybersecurity attacks, utility disruptions, constraints on the supply or delivery of critical raw materials, and severe weather conditions, including potential flooding at the Aluminum Extrusions facility located in Carthage, TN. A material disruption in one of the Company’s operating locations could negatively impact production and the Company’s consolidated financial condition, results of operations and cash flows.
Tredegar has an underfunded defined benefit (pension) plan. Tredegar sponsors a pension plan that covers certain hourly and salaried employees in the U.S. The plan was closed to new participants in 2007, and substantially frozen to benefit accruals for active participants in 2014. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan. On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete. In connection therewith, on February 9, 2022, the Company borrowed funds under its revolving credit agreement to contribute $50 million to the pension plan (the “Special Contribution”) to reduce its underfunding and as part of a program within the pension plan to hedge or fix the expected future contributions that will be needed by the Company through the settlement process. As of December 31, 2021 (and before the Special Contribution), the plan was underfunded under U.S. generally accepted accounting principles (“GAAP”) measures by $69.5 million. The Company estimates that, with the Special Contribution, there will be no required minimum contributions to the pension plan until final settlement. The ultimate settlement benefit obligation may differ from the projected benefit obligation (“PBO”) of $314 million as of December 31, 2021, depending on market factors for buyers of pension obligations at the time of settlement. Additionally, factors that could cause actual future contributions by the Company to settle the pension plan to differ from expectations include, without limitation, the change in the values of pension plan assets and liabilities up through initiating hedging activities to fix underfunding amounts and assumptions thereafter relating to differences between the ultimate settlement benefit obligation and the PBO, census data, administrative costs, the effectiveness of hedging activities and discounts required to liquidate non-public securities held by the plan.
Noncompliance with any of the covenants in the Company’s $375 million revolving credit facility, as amended on December 1, 2020, which matures in June 2024, could result in all debt under the agreement outstanding at such time becoming due and limiting the Company’s borrowing capacity, which could have a material adverse effect on its consolidated financial condition and liquidity. The credit agreement governing Tredegar’s revolving credit facility contains restrictions and financial covenants that, if violated, could restrict the Company’s operational and financial flexibility. Failure to comply with these covenants could result in an event of default, which if not cured or waived, would result in all outstanding debt under the credit facility at such time becoming due, which could have a material adverse effect on the Company’s consolidated financial condition and liquidity.
A failure in the Company’s information technology systems as a result of cybersecurity attacks or other causes could negatively affect Tredegar’s business. The Company depends on information technology (“IT”) to record and process customers’ orders, manufacture and ship products in a timely manner, secure its production processes and know-how, maintain the financial accuracy of its business records and maintain personally identified information of its employees. An IT system failure due to computer viruses, internal or external security breaches, cybersecurity attacks or other malicious causes could disrupt our operations and prevent us from being able to process transactions with our customers, operate our manufacturing facilities and properly report transactions in a timely manner. Increased global IT security threats and cyber-crime pose a potential risk to the security and availability of the Company’s IT systems, networks and services, including those that are managed, hosted, provided or used by third parties, as well as to the confidentiality, availability and integrity of the Company’s data. Additionally, increased cybersecurity risk arises due to certain employees working remotely during the COVID-19 pandemic. To date, interruptions of the Company’s IT systems have been infrequent and have not had a material impact on the Company’s operations. A significant protracted failure of or security breach of the IT systems, networks or service providers the Company relies upon, or a loss or disclosure of business or other sensitive information, or personally identified information, as a result of a cybersecurity incident or other cause, could result in substantial costs to the Company, damage to the Company’s reputation, regulatory enforcement actions and lawsuits and could adversely affect the Company’s results of operations, financial condition or cash flows.
6



The Company has identified material weaknesses in its internal control over financial reporting. The Company’s failure to establish and maintain effective internal control over financial reporting and to maintain effective disclosure controls and procedures increases the risk of a material misstatement in its consolidated financial statements, and its failure to meet its reporting and financial obligations, could, in turn, have a negative impact on its financial condition. Maintaining effective internal control over financial reporting is an integral part of producing reliable financial statements. As discussed in Item 9A. “Controls and Procedures” of this Form 10-K (“Item 9A”), the Company’s management concluded that the Company’s internal control over financial reporting was not effective for the periods referred to therein as a result of certain deficiencies that were determined to constitute material weaknesses in the Company’s internal control over financial reporting.

Tredegar mayUnder standards established by the Public Company Accounting Oversight Board, a material weakness is defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be ableprevented or detected on a timely basis. Under the criteria set forth in Internal Control - Integrated Framework 2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission, a material weakness in the design of monitoring controls indicates that the Company has not sufficiently developed and/or documented internal controls by which management can review and oversee the Company’s financial information to successfully integrate strategic acquisitions. Acquisitions, including our recent acquisitiondetect and correct material errors or that the personnel responsible for performing the review did not have the sufficient skill set or knowledge of Futura, involve special risks, including, without limitation, meeting revenue, margin, working capitalthe subject matter to perform a proper assessment.
The Company is in the process of making certain changes in its internal control over financial reporting to remediate the material weaknesses as described in Item 9A. The implementation of the material aspects of this plan began in the second quarter of 2019 with the continuous significant assistance and capital expenditure expectationssupport of a well-known outside consultant, and, while meaningful progress has been made, completion has been delayed by the COVID-19 pandemic, turnover in positions relevant to internal controls and the need for additional training. As the Company continues to evaluate and work to improve its internal control over financial reporting and disclosure controls and procedures, management may determine to take additional measures to address control deficiencies or modify the remediation plan. The Company cannot provide assurance, however, as to when it will remediate all such weaknesses, nor can it be certain of whether additional actions will be required or the costs of any such actions. Moreover, the Company cannot provide assurance that substantially drive valuation, diversionadditional material weaknesses will not arise in the future.
See Item 9A for details regarding the numerous activities in the remediation plan that were completed through the fourth quarter of 2021 and the remaining activities that are scheduled for completion in the first half of 2022, in anticipation of conducting management’s testing beginning in the first half of 2022. The material weaknesses cannot be considered remediated until the applicable controls have operated for a sufficient period of time and attention from existing businesses,management has concluded, through testing, that these controls are operating effectively.
The material weaknesses discussed in Item 9A did not result in material misstatements of the potential assumptionCompany’s financial statements as of unanticipated liabilities and contingenciesfor the years ended December 31, 2021, 2020 and potential difficulties2019 or in integrating acquired businessesthe intervening interim periods during those respective years. Any failure to remediate the material weaknesses, or the development of new material weaknesses in its internal control over financial reporting, could result in material misstatements in the Company’s consolidated financial statements and achieving anticipated operational improvements.  Acquired businesses may not achieve expected results.
cause it to fail to meet its reporting and financial obligations, which in turn could have a negative impact on its financial condition.
Tredegar is subject to variouscurrent and future governmental regulation, including environmental laws and regulations, and could become exposed to material liabilities and costs associated with such laws.regulation. The Company is subject to various environmental obligationsregulation by local, state, federal and could become subject to additional obligations in the future. Changes in environmentalforeign governmental authorities.  New laws and regulations, or their application,changes to existing laws, including but not limited to, those relating to environmental matters (including global climate change and plastic products), and privacy matters, could subject Tredegar to significant additional capital expenditures, and operating expenses.expenses or other compliance costs. Moreover, future developments in federal, state, local and international environmental laws and regulations, including environmental laws, are difficult to predict. Environmental laws and privacy restrictions have become and are expected to continue to become increasingly strict. As a result, Tredegar expects to be subject to new environmental and privacy laws and regulations. However, any such changes are uncertain and, therefore, it is not possible for the Company to predict with certainty the amount of additional capital expenditures or operating expenses that could be necessary for compliance with respect to any such changes.
The Company is subject to the U.S. Foreign Corrupt Practices Act, Brazilian anti-corruption laws and similar anti-bribery laws in other jurisdictions, which generally prohibit companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or retaining business. Although we have policies and procedures designed to facilitate compliance with these laws and regulations, our employees, contractors and agents may take actions in violation of our policies. Any such violation, even if prohibited by our policies, could adversely affect our business and/or our reputation. See Government Regulationin “ItemItem 1. Business”“Business” of this Form 10-K for a further discussion of this risk factor.
7


Material disruptions at oneThe transition away from the use of the Company’s major manufacturing facilities couldLondon interbank offered rate ("LIBOR") settings as an interest rate benchmark may negatively impact our debt agreements and financial results. Tredegar believes its facilities are operated in compliance with applicable local lawsposition, results of operations and regulations andliquidity. On March 5, 2021, the United Kingdom’s Financial Conduct Authority published the dates that the Company has implemented measuresuse of LIBOR as an index for commercial loans will be phased out. Foreign currency indices, including the British pound, the Euro, and Swiss franc, along with the U.S. dollar 1-week and 2-month settings ceased after December 31, 2021. Also, after June 30, 2023, the remaining U.S. dollar settings will cease. Our most significant exposure to minimizeLIBOR relates to our revolving domestically held credit facility, which may be negatively impacted by renegotiated terms and costs of indebtedness associated with the riskslatter of disruption at its facilities. Such a disruption couldthese transition dates. In addition, the overall financial markets may be disrupted as a result of the replacement of LIBOR, which could have an adverse effect on our cost of capital and our financial position. We continue to monitor the LIBOR transition and will work to minimize any numberimpact.
Risks Related to Aluminum Extrusions
Sales volume and profitability of events, including butAluminum Extrusions is cyclical and seasonal and highly dependent on economic conditions of end-use markets in the U.S., particularly in the construction sector. Aluminum Extrusions’ end-use markets can be cyclical and subject to seasonal swings in volume and have been adversely impacted during the COVID-19 pandemic. Because of the capital-intensive nature and level of fixed costs inherent in the aluminum extrusions business, the percentage drop in earnings before interest, taxes, depreciation and amortization (“EBITDA”) from ongoing operations in a cyclical downturn will likely exceed the percentage drop in volume. In addition, during an economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as competitors seek to protect their position with key customers. Any benefits associated with cost reductions and productivity improvements may not limited to: an equipmentbe sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts (including a greater chance of loss associated with customers defaulting on fixed-price forward sales contracts) that usually accompany a downturn. In addition, higher energy costs can reduce profits unless offset by price increases or cost reductions and productivity improvements.
The failure to successfully implement the new enterprise resource planning and manufacturing execution systems could adversely impact the Aluminum Extrusions business and results of operations. On January 28, 2022, Aluminum Extrusions obtained approval from the Board to engage in the implementation project of a new enterprise resource planning and manufacturing execution systems (“ERP/MES”) across all locations of the Aluminum Extrusions business. The ERP/MES project is expected to cost $28 million over a two-year time span. The implementation of these systems is a major undertaking from a financial, management, and personnel perspective. The implementations may prove to be more difficult, costly, or time consuming than expected, and there can be no assurance that these systems will be beneficial to the extent anticipated. Any disruptions, delays or deficiencies in the design and implementation of the new systems could adversely affect our financial position, results of operations and cash flows; additionally, any disruptions, delays or deficiencies could adversely affect our remediation efforts with repairs requiring long lead times, labor stoppagesrespect to the effectiveness of our internal controls over financial reporting.
Failure to prevent competitors from evading anti-dumping and countervailing duties, or shortages, utility disruptions, constraintsa reduction in such duties, could adversely impact Aluminum Extrusions. Chinese and other overseas manufacturers continue to try to evade the anti-dumping and countervailing orders to avoid duties. Effective April 25, 2017, the anti-dumping duty and countervailing duty orders on aluminum extrusions were extended for a period of five years.  The orders will be reviewed again beginning in March 2022. A failure by, or the inability of, U.S. trade officials to curtail the evasion of these duties, or the potential reduction of applicable duties pursuant to annual administrative reviews of the orders by the Department of Commerce, could have a material adverse effect on the supply or delivery of critical raw materials, and severe weather conditions. A material disruption in one of the Company’s operating locations could negatively impact production and its consolidated financial condition, results of operations and cash flows.
flows of Aluminum Extrusions.
An information technology system failure may adversely affectThe duty-free importation of goods allowed under the business. Tredegar relies on information technology systems to transact its business. An information technology system failure due to computer viruses, internal or external security breaches, cybersecurity attacks, power interruptions, hardware failures, fire, natural disasters, human error,United States-Mexico-Canada Agreement (“USMCA”), or other causesfree trade agreements or duty-preference regimes, could disrupt its operationresult in lower demand for aluminum extrusions made in the U.S., which could materially and prevent itnegatively affect Aluminum Extrusions’ business and results of operations. In March 2018, the U.S. imposed tariffs of 10% on aluminum ingot and semi-finished aluminum imported into the U.S. from beingcertain countries, including countries from which Aluminum Extrusions has historically sourced aluminum products.  In September 2019, the U.S., Canada and Mexico entered into the USMCA.  As a result of the 10% tariffs on aluminum ingot imported to the U.S. and the duty-free importation of goods allowed under USMCA or other trade agreement regimes or duty-preference programs, aluminum extrusions from outside the United States that are able to process transactionstake advantage of duty-preference programs upon importation into the United States made in Canada and Mexico are free of the 10% tariff and can now be imported into and sold in the U.S. at very competitive prices.  This could result in lower demand for aluminum extrusions made in the U.S., which could materially and negatively affect Aluminum Extrusions’ business and results of operations.
The markets for Aluminum Extrusions’ products are highly competitive with its product quality, service, delivery performance and price being the principal competitive factors. Aluminum Extrusions has approximately 1,370
8


customers operate its manufacturing facilities, and properly report transactionsthat are in a variety of end-use markets within the broad categories of building and construction, distribution, automotive and other transportation, machinery and equipment, electrical and consumer durables. No single Aluminum Extrusions’ customer exceeds 4% of consolidated net sales. Future success and prospects depend on Aluminum Extrusions’ ability to provide superior service, high quality products, timely manner. A significant, protracted information technology system failure may adversely affect Tredegar’s resultsdelivery and competitive pricing to retain existing customers and participate in overall industry cross-cycle growth. Failure in any of operations, financial condition, or cash flows.
An inabilitythese areas could lead to renegotiatea loss of customers, which could have an adverse material effect on the Company’s collective bargaining agreements could adversely impact its consolidated financial condition, results of operations and cash flows. Some of Aluminum Extrusions.
Risks Related to PE Films
PE Films is highly dependent on sales associated with relatively few large customers. PE Films’ top four customers comprised approximately 13%, 16% and 14% of Tredegar’s consolidated net sales in 2021, 2020 and 2019, respectively. The loss or significant reduction of sales associated with one or more of these customers without replacement by new business could have a material adverse effect on the Company.
The Company previously reported the risk that a portion of its film products used in surface protection applications would be made obsolete by customer product transitions to less costly alternative processes or materials. The Company estimates that these transitions, which principally relate to one customer, adversely impacted EBITDA from ongoing operations for PE Films by $14.8 million during 2021 versus 2020. A further decline of $7 million in EBITDA from ongoing operations due to the transitions is expected in 2022 versus 2021, at which time the transitions are expected to be complete.
The Surface Protection business is also experiencing competitive pricing pressures, unrelated to the customer product transitions, that are expected to adversely impact EBITDA from ongoing operations by approximately $6 million in 2022 versus 2021. To offset the expected adverse impact of the customer transitions and pricing pressures, the Company is aggressively pursuing and making progress in generating contribution from sales of new surface protection products, applications and customers and driving production efficiencies and cost savings. Annual contribution to EBITDA from ongoing operations for PE Films from sales of products unrelated to previously disclosed customer product transitions increased $7 million for the two-year period ended December 31, 2021, which excludes the impact of resin pass-through lag but includes the adverse impact of customer inventory corrections, customer production slowdowns associated with COVID-19-related factors, and a slowdown in the television market in the fourth quarter of 2021.
While PE Films is undertaking efforts to expand its customer base, there can be no assurance that such efforts will be successful, or that they will offset any loss of sales and profits associated with customer transitions and other large customer declines.
Failure of PE Films’ customers, who are subject to cyclical downturns, to achieve success or maintain market share could adversely impact PE Films’ sales and operating margins. PE Films’ plastic films are used in the production of various consumer products sold worldwide. A customer’s ability to successfully develop, manufacture and market those products is integral to PE Films’ success. Cyclical downturns and changing consumer preferences may negatively affect businesses that use PE Films’ plastic film products, which could adversely affect sales and operating margins. Other factors that could adversely affect the business include (i) failure by a key customer to achieve success or maintain share in markets in which they sell products containing PE Films’ materials, including as a result of customer preferences for products other than plastics, (ii) key customers using products developed by others that replace PE Films’ business with such customers, (iii) delays in a key customer rolling out products utilizing new technologies developed by PE Films, and (iv) operational decisions by a key customer that result in component substitution, inventory reductions and similar changes.
The Company’s employees are represented by labor unions under various collective bargaining agreements with varying durationsinability to protect its intellectual property rights or its infringement of the intellectual property rights of others could have a material adverse impact on PE Films. The continued success of the PE Films’ business depends on its ability not only to protect its own technologies and expiration dates. Tredegar maytrade secrets, but also to develop and sell new products that do not be able to satisfactorily renegotiate collective bargaining agreements when they expire, whichinfringe upon existing patents. Intellectual property litigation is very costly and could result in strikes or work stoppages or higher labor costs. In addition, existing collective bargaining agreements may not prevent a strike or work stoppage at the Company’s facilities in the future. Any such work stoppages (or potential work stoppages)substantial expense and diversions of Company resources, both of which could negatively impact Tredegar’s ability to manufacture its products and adversely affect its consolidated financial condition, results of operations and cash flows.
Tredegar’s valuation of its $7.5 million cost-basis investment in kaléo is volatile and uncertain. Tredegar uses the fair value method to account for its fully-diluted ownership interest of approximately 20% in kaleo, Inc. (“kaléo”), a privately held specialty pharmaceutical company. There is In addition, there may be no active secondary market for buying or selling stock in kaléo. The Company’s fair value estimates can fluctuate materially between reporting periods, primarily due to variances in its performance versus expectations. Additionally, the estimated fair valueeffective legal recourse against infringement of the Company’s investmentintellectual property by third parties, whether due to limitations on enforcement of rights in kaléoforeign jurisdictions or as a result of other factors.
Disruptions to PE Films’ supply chain could decline. Kaléo’s firsthave a material adverse impact on PE Films. Certain raw materials used in manufacturing PE Films’ products are sourced from single suppliers, and PE Films may not be able to quickly or inexpensively re-source from other suppliers.  The risk of damage or disruption to its supply chain may increase if and when different suppliers consolidate their product portfolios, experience financial distress or disruption of manufacturing operations (such as, for example, the impact of hurricanes on petrochemical production). Failure to take adequate steps to effectively manage such events, which are intensified when a product is procured from a single supplier or location, could
9


adversely affect PE Films’ consolidated financial condition, results of operations and cash flows, and also require additional resources to restore its supply chain.
Rising trade tensions could cause an epinephrine auto-injector, was licensed to sanofi-aventis U.S. LLC (“Sanofi”) in 2009. Sanofi commenced commercial salesincrease in the cost of PE Films’ products or otherwise negatively impact the Company. A portion of PE Film’s business involves imports to and from the U.S. and other countries where the Company produces and sells its products. Trade tensions have been rising between the U.S. and other countries, particularly China. An increase in tariffs and other trade barriers between the U.S. and China, or between the U.S. and other countries, could cause an increase in the cost of PE Films’ products or otherwise negatively impact the production and sale of the Company’s products in world markets.
Risks Related to Flexible Packaging Films
A history of uncertain economic conditions in Brazil could adversely impact the financial condition, results of operations and cash flows of Flexible Packaging Films. For flexible packaging films produced in Brazil, selling prices and key raw material costs are principally determined in U.S. Dollars and are impacted by local economic conditions and local and global competitive dynamics. Flexible Packaging Films is exposed to foreign exchange translation risk (its functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films business unit in Brazil (“Terphane Ltda.”) and substantially all of its related raw material costs are quoted or priced in U.S. Dollars while its variable conversion, fixed conversion and sales, general and administrative costs before depreciation & amortization (collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively impact EBITDA from ongoing operations for Flexible Packaging Films. While Flexible Packaging Films hedges this exposure on a short-term basis with foreign exchange forward rate contracts, the exposure continues to exist beyond the hedging periods.
Overcapacity in Latin American polyester film production and governmental failure to extend anti-dumping duties in Brazil on imported products or prevent competitors from circumventing such duties could adversely impact Flexible Packaging Films. In recent years, excess global capacity in the industry has led to increased competitive pressures from imports into Brazil. The Company believes that these conditions have shifted the competitive environment from a regional to a global landscape and have driven price convergence and lower product margins for Flexible Packaging Films. Favorable anti-dumping rulings or countervailing duties are in effect for products imported from China, Egypt, India, Mexico, United Arab Emirates, Turkey, Peru and Bahrain. Competitors not currently subject to anti-dumping duties may choose to utilize their excess capacity by selling product in Brazil, which may result in pricing pressures that Flexible Packaging Films may not be able to offset with cost savings measures and/or manufacturing efficiency initiatives. In May 2021, the Brazilian authorities concluded the sunset review relating to the anti-dumping process for polyester film imported from China, India and Egypt, and decided to extend duties for another five years. However, due to its doubts that films would continue to be imported from China and Egypt, the government immediately suspended the implementation of the tariffs for those countries. If in the future there are volumes imported from China or Egypt which are harming the Brazilian market, authorities may promptly reinstate tariffs. For India, the Brazilian authorities also reviewed measures against countervailing duties and extended those for five years as well. Considering the expiration date for anti-dumping rulings against Mexico, United Arab Emirates and Turkey in first quarter of 2013. Kaléo subsequently developed and commenced commercial sales of its second product,2023, Terphane may request a naloxone auto-injector,sunset review in the third quarter of 2014. In the fourth quarter of 2015, Sanofi announced a voluntary recall2022, if there are indications of continuous dumping practices from those sources into the product and subsequently returned the rights tokaléo in 2016. Kaléo relaunched the epinephrine auto-injector in the U.S. in the first quarter of 2017. See Note 4 to the Notes to Financial Statements for more information.
Brazilian market.



Item 1B.    UNRESOLVED STAFF COMMENTS
Item 1B.UNRESOLVED STAFF COMMENTS
None.
Item 2.PROPERTIES
Item 2.    PROPERTIES
General
Most of the improved real property and the other assets used in the Company’s operations are owned. Certain of the owned property is subject to an encumbrance under the Company’s revolving credit facilityagreement (see Note 117 “Debt and Credit Agreements” to the Consolidated Financial Statements in the Notes to Financial StatementsItem 15 for more information).
Tredegar considers the manufacturing facilities, warehouses and other properties and assets that it owns or leases to be in generally good condition. Capacity utilization at its various manufacturing facilities can vary with product mix and normal fluctuations in sales levels. The Company believes that its Bonnell Aluminum, PE Films and Flexible Packaging Films manufacturing facilities have sufficient capacity to meet its current production requirements. Flexible Packaging Films is operating at capacity but has an idled line that it expects will be restarted in 2018. Bonnell Aluminum is operating at nearly full capacity utilization in its building and construction sector. Tredegar’s corporate headquarters, which is leased, is located at 1100 Boulders Parkway, Richmond, Virginia 23225.
10


The Company’s principal manufacturing plants and facilities as of December 31, 20172021 are listed below:
PE Films
Aluminum Extrusions
Locations in the U.S.Locations Outside the U.S.Principal Operations
Lake Zurich, IllinoisCarthage, Tennessee
Clearfield, Utah (leased)
Elkhart, Indiana
Newnan, Georgia
Niles, Michigan
NoneProduction of aluminum extrusions, fabrication and finishing
PE Films
Durham, North Carolina (technical center and production facility) (leased)
Locations in the U.S.Locations Outside the U.S.Principal Operations
Pottsville, Pennsylvania
Richmond, Virginia (technical center) (leased)
Terre Haute, Indiana (technical center and production facility)
Guangzhou, China
Kerkrade, The Netherlands
Pune, India
Rétság, Hungary
São Paulo, Brazil
Shanghai, China
Production of plastic films and
laminate materials
Flexible Packaging Films
Locations in the U.S.Locations Outside the U.S.Principal Operations
Bloomfield, New York (technical center and production facility)

Cabo de Santo Agostinho, BrazilProduction of polyesterPET-based films
Aluminum Extrusions
Item 3.    LEGAL PROCEEDINGS
The information required by this Item 3 is set forth in Note 18 "Contingencies" to the Consolidated Financial Statements in Item 15 and is hereby incorporated herein by reference.
Item 4.    MINE SAFETY DISCLOSURES
Locations in the U.S.Principal Operations
Carthage, Tennessee
Elkhart, Indiana
Newnan, Georgia
Niles, Michigan
Clearfield, Utah
Production of aluminum extrusions, fabrication and finishing
Item 3.LEGAL PROCEEDINGS
None.
11
Item 4.MINE SAFETY DISCLOSURES
None.






PART II
Item 5.MARKET FOR TREDEGAR’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Prices of Common Stock and Shareholder DataItem 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Tredegar’s common stock is traded on the New York Stock Exchange (“NYSE”) under the ticker symbol “TG”. There were 33,017,42233,743,617 shares of common stock held by 1,9511,677 shareholders of record on December 31, 2017.
The following table shows the reported high and low closing prices of Tredegar’s common stock by quarter for the past two years.
 2017 2016
 High Low High Low
First quarter$25.00
 $16.50
 $16.01
 $11.68
Second quarter17.65
 14.90
 17.37
 14.80
Third quarter18.35
 14.85
 19.39
 16.30
Fourth quarter20.20
 18.20
 25.55
 17.30
The closing price of Tredegar’s common stock on February 16, 2018 was $16.80.March 4, 2022.
Dividend Information
Tredegar has paid a regular cash dividend every quarter since becoming a public company in July 1989. During1989 and expects that comparable regular cash dividends will continue to be paid in the past three years,future. In addition, Tredegar has paid special cash dividends from time to time. On December 1, 2020, the Company paid quarterly dividends as follows:
11 centsBoard declared a special dividend of $200 million, or $5.97 per share, on the Company’s common stock (the “Special Dividend”). The Special Dividend was paid in the last three quarters of 2015 and each of the quarters of 2016 and 2017;December 2020.
9 cents per share in the first quarter of 2015.
All decisions with respect to the declaration and payment of future dividends will be made by the Board of Directors in its sole discretion based upon earnings, financial condition, anticipated cash needs, restrictions in the Company’s revolving credit facility and other such considerations as the Board deems relevant. See Note 11 of7 "Debt and Credit Agreements" to the Notes toConsolidated Financial Statements in Item 15 for the restrictions on the payment of dividends contained in the Company’s revolving credit agreement related to aggregate dividends permitted.
Issuer Purchases of Equity Securities
On January 7, 2008, Tredegar announced that itsthe Board of Directors approved a share repurchase program whereby management is authorized at its discretion to purchase, in the open market or in privately negotiated transactions, up to 5 million shares of the Company’s outstanding common stock. The authorization has no time limit. Tredegar did not repurchase any shares in the open market or otherwise in 2017, 2016 and 20152021, 2020 or 2019 under this standing authorization. The maximum number of shares remaining under this standing authorization was 1,732,003 at December 31, 2017.2021.


Comparative Tredegar Common Stock Performance Graph
The following graph compares cumulative total shareholder returns for Tredegar, the S&P SmallCap 600 Stock Index (an index comprised of companies with market capitalizations similar to Tredegar) and the Russell 2000 Index for the five years ended December 31, 2017.2021. Tredegar is part of both the S&P SmallCap 600 Index and Russell 2000 Index.


COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Tredegar Corporation, the S&P SmallCap 600 Index, and the Russell 2000 Index


tg-20211231_g1.jpg
*$100 invested on 12/31/1215 in stock or index, including reinvestment of dividends.
Fiscal year ending December 31.

Copyright© 2018

Copyright© 2021 Standard & Poor's, a division of S&P Global. All rights reserved.
Copyright© 2018
Copyright© 2021 Russell Investment Group. All rights reserved.



12



InquiriesItem 6.    [RESERVED]
Inquiries concerning stock transfers, dividends, dividend reinvestment, consolidating accounts,
Item 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations focuses on and is intended to clarify the results of our operations, certain changes of address, or lost or stolen stock certificatesin our financial position, liquidity, capital structure and business developments for the periods covered by the consolidated financial statements included in this Form 10-K. This discussion should be directedread in conjunction with, and is qualified by reference to, Computershare Investor Services, the transfer agentother related information including, but not limited to, the audited consolidated financial statements (including the notes thereto) and registrarthe description of our business, all as set forth in this Form 10-K, as well as the risk factors discussed above in Item 1A.
This section provides discussion and a year-to-year comparison for the Company’s common stock:
Computershare Investor Services
P.O. Box 30170
College Station, TX 77842-3170
Phone: 800-622-6757
www.computershare.com/us/contact
All other inquiries should be directed to:
Tredegar Corporation
Investor Relations Department
1100 Boulders Parkway
Richmond, Virginia 23225
Phone: 855-330-1001
E-mail: invest@tredegar.com
Website: www.tredegar.com


Quarterly Information
Tredegar does not generate or distribute quarterly reports to its shareholders. Information on quarterly results can be obtained from the Company’s website. In addition, Tredegar files quarterly, annual and other information electronically with the SEC, which can be accessed on its website at www.sec.gov.


Item 6.SELECTED FINANCIAL DATA
The tables that follow present certain selected financial and segment information for the five years ended December 31, 2017.

FIVE-YEAR SUMMARY
Tredegar Corporation2021 and Subsidiaries
Years Ended December 312017  2016  2015  2014  2013 
(In thousands, except per-share data)              
               
Results of Operations (g):              
Sales$961,330
   $828,341
   $896,177
   $951,826
   $959,346
  
Other income (expense), net51,713
(a)  2,381
(b)  (20,113)(d)  (6,697)(e)  1,776
(f) 
 1,013,043
   830,722
   876,064
   945,129
   961,122
  
Cost of goods sold775,628
(a)  668,626
(b)  725,459
(d)  778,113
(e)  784,675
(f) 
Freight33,683
   29,069
   29,838
   28,793
   28,625
  
Selling, general & administrative expenses85,501
(a)  75,754
(b)  71,911
(d)  69,526
(e)  71,195
(f)
Research and development expenses18,287
   19,122
   16,173
   12,147
   12,669
  
Amortization of identifiable intangibles6,198
   3,978
   4,073
   5,395
   6,744
  
Interest expense6,170
   3,806
   3,502
   2,713
   2,870
  
Asset impairments and costs associated with exit and disposal activities102,488
(a)  2,684
(b)  3,850
(d)  3,026
(e)  1,412
(f) 
Goodwill impairment charge
  
  44,465
(c) 
   
 
 1,027,955
   803,039
   899,271
   899,713
   908,190
  
Income (loss) from continuing operations before income taxes(14,912)   27,683
   (23,207)   45,416
   52,932
  
Income tax expense (benefit)(53,163)(a)  3,217
(b)  8,928
(d)  9,387
(e)  16,995
(f) 
Income (loss) from continuing operations (g)38,251
   24,466
   (32,135)   36,029
  35,937
  
Income (loss) from discontinued operations, net of tax (g)
  
  
  850
(g)  (13,990)(g)
Net income (loss)$38,251
   $24,466
   $(32,135)   $36,879
  $21,947
  
Diluted earnings (loss) per share (g):              
Continuing operations$1.16
   $0.75
   $(0.99)   $1.11
  $1.10
  
Discontinued operations
  
  
  0.02
(g)  (0.43)(g) 
Net income (loss)$1.16
   $0.75
   $(0.99)   $1.13
  $0.67
  
Refer to Notes to Financial Tables that follow these tables.


FIVE-YEAR SUMMARY
Tredegar Corporation2020. Discussion regarding our results of operations for the year ended December 31, 2019 and Subsidiaries
Years Ended December 312017 2016 2015 2014 2013 
(In thousands, except per-share data)          
           
Share Data:          
Equity per share (l)$10.41
 $9.44
 $8.35
 $11.47
 $12.46
 
Cash dividends declared per share$0.44
 $0.44
 $0.42
 $0.34
 $0.28
 
Weighted average common shares outstanding during the period32,946
 32,762
 32,578
 32,302
 32,172
 
Shares used to compute diluted earnings (loss) per share during the period32,951
 32,775
 32,578
 32,554
 32,599
 
Shares outstanding at end of period33,017
 32,934
 32,682
 32,422
 32,305
 
Closing market price per share:          
High$25.00
 $25.55
 $23.76
 $28.45
 $30.73
 
Low$14.85
 $11.68
 $12.63
 $16.76
 $21.06
 
End of year$19.20
 $24.00
 $13.62
 $22.49
 $28.81
 
Total return to shareholders (h)(18.2)% 79.4% (37.6)% (20.8)% 42.5% 
Financial Position:          
Total assets (k)$755,743
 $651,162
 $623,260
 $788,626
 $793,008
 
Cash and cash equivalents$36,491
 $29,511
 $44,156
 $50,056
 $52,617
 
Debt$152,000
 $95,000
 $104,000
 $137,250
 $139,000
 
Shareholders’ equity (net book value)$343,780
 $310,783
 $272,748
 $372,029
 $402,664
 
Equity market capitalization (i)$633,935
 $790,411
 $445,131
 $729,173
 $930,711
 
Refer to Notes to Financial Tables that follow these tables.



SEGMENT TABLES
Tredegar Corporationa year-to-year comparison between the years ended December 31, 2020 and Subsidiaries
Net Sales (j)         
Years Ended December 312017 2016 2015 2014 2013
(In thousands)         
PE Films$352,459
 $331,146
 $385,550
 $464,339
 $495,386
Flexible Packaging Films108,355
 108,028
 105,332
 114,348
 125,853
Aluminum Extrusions466,833
 360,098
 375,457
 344,346
 309,482
Total net sales927,647
 799,272
 866,339
 923,033
 930,721
Add back freight33,683
 29,069
 29,838
 28,793
 28,625
Sales as shown in Consolidated Statements of Income$961,330
 $828,341
 $896,177
 $951,826
 $959,346
          
Identifiable Assets         
As of December 312017 2016 2015 2014 2013
(In thousands)         
PE Films$289,514
 $278,558
 $270,236
 $283,606
 $291,377
Flexible Packaging Films49,915
 156,836
 146,253
 262,604
 265,496
Aluminum Extrusions268,127
 147,639
 136,935
 143,328
 134,928
Subtotal607,556
��583,033
 553,424
 689,538
 691,801
General corporate111,696
 38,618
 25,680
 49,032
 48,590
Cash and cash equivalents36,491
 29,511
 44,156
 50,056
 52,617
Total$755,743
 $651,162
 $623,260
 $788,626
 $793,008
Refer to Notes to Financial Tables that follow these tables.


SEGMENT TABLES
Tredegar Corporation and Subsidiaries
Operating Profit              
Years Ended December 312017  2016  2015  2014  2013 
(In thousands)              
               
PE Films:              
Ongoing operations$41,546
   $26,312
   $48,275
   $60,971
   $61,866
  
Plant shutdowns, asset impairments, restructurings and other(4,905)(a) (4,602)(b)  (4,180)(d)  (12,236)(e)  (671)(f) 
Flexible Packaging Films:              
Ongoing operations(2,626)  1,774
  5,453
  (2,917)  9,100
 
Plant shutdowns, asset impairments, restructurings and other(89,398)(a) (214)(b) (185)(d)  (591)(e)  
 
Goodwill impairment charge
  
  (44,465)(c) 
  
 
Aluminum Extrusions:              
Ongoing operations43,454
   37,794
   30,432
   25,664
  18,291
 
Plant shutdowns, asset impairments, restructurings and other321
(a) (741)(b)  (708)(d)  (976)(e)  (2,748)(f) 
Total(11,608)   60,323
   34,622
   69,915
   85,838
  
Interest income209
   261
   294
   588
   594
  
Interest expense6,170
   3,806
   3,502
   2,713
   2,870
  
Gain (loss) on investment accounted for under the fair value method33,800
(a) 1,600
(b)  (20,500)(d)  2,000
(e)  3,400
(f) 
Gain on sale of investment property
  
  
  1,208
(e)  
 
Unrealized loss on investment property
  1,032
(b)  
  
  1,018
(e) 
Stock option-based compensation expense264
   56
   483
   1,272
   1,155
  
Corporate expenses, net30,879
(a) 29,607
(b)  33,638
(d)  24,310
(e)  31,857
(f) 
Income (loss) from continuing operations before income taxes(14,912)   27,683
   (23,207)   45,416
   52,932
  
Income tax expense (benefit)(53,163)(a) 3,217
(b)  8,928
(d)  9,387
(e)  16,995
(f) 
Income (loss) from continuing operations38,251
   24,466
   (32,135)   36,029
  35,937
  
Income (loss) from discontinued operations, net of tax (g)
  
  
  850
(g) (13,990)(g) 
Net income (loss)$38,251
   $24,466
   $(32,135)   $36,879
  $21,947
  
Refer to Notes to Financial Tables that follow these tables.


SEGMENT TABLES
Tredegar Corporation and Subsidiaries

Depreciation and Amortization
         
Years Ended December 312017 2016 2015 2014 2013
(In thousands)         
PE Films$14,609
 $13,653
 $15,480
 $21,399
 $25,656
Flexible Packaging Films10,443
 9,505
 9,697
 9,331
 9,676
Aluminum Extrusions15,070
 9,173
 9,698
 9,974
 9,202
Subtotal40,122
 32,331
 34,875
 40,704
 44,534
General corporate155
 141
 107
 114
 121
Total depreciation and amortization expense$40,277
 $32,472
 $34,982
 $40,818
 $44,655
          
Capital Expenditures         
Years Ended December 312017 2016 2015 2014 2013
(In thousands)         
PE Films$15,029
 $25,759
 $21,218
 $17,000
 $15,615
Flexible Packaging Films3,619
 3,391
 3,489
 21,806
 49,252
Aluminum Extrusions25,653
 15,918
 8,124
 6,092
 14,742
Subtotal44,301
 45,068
 32,831
 44,898
 79,609
General corporate61
 389
 
 
 52
Total capital expenditures$44,362
 $45,457
 $32,831
 44,898
 79,661
Refer to Notes to Financial Tables that follow these tables.


NOTES TO FINANCIAL TABLES
(a)Plant shutdowns, asset impairments, restructurings and other charges for 2017 include: income of $11.9 million related to the settlement of an escrow arrangement (included in “Other income (expense), net” in the consolidated statements of income); charges related to the impairment of assets of Flexible Packaging in the amount of $101 million; income of $5.6 million related to the explosion that occurred in the second quarter of 2016 at Bonnell’s aluminum extrusions manufacturing facility in Newnan, Georgia, which includes the recognition of a gain of $5.3 million for a portion of the insurance recoveries received from the insurer for the replacement of capital equipment, plus the recovery of excess production costs incurred in 2016 for which recovery from insurance carriers was not previously considered to be reasonably assured, net of other nonrecoverable costs, of $0.3 million ($0.4 million benefit included in “Cost of goods sold” in the consolidated statements of income and $0.1 million charge included in “Selling, general and administrative expenses” in the consolidated statements of income); charges of $4.1 million for estimated excess costs associated with the ramp-up of new product offerings (included in “Cost of goods sold” in the consolidated statements of income); charges of $1.9 million related to expected environmental costs at certain Aluminum Extrusions manufacturing facilities (included in “Cost of goods sold” in the consolidated statements of income); charges of $3.3 million related to the acquisition of Futura Industries Corporation ($1.7 million included in “Cost of goods sold” and $1.6 million included in “Selling, general and administrative expense” in the consolidated statements of income), offset by pretax income of $0.7 million related to the fair valuation of an earnout provision (included in “Other income (expense), net” in the condensed consolidated statements of income); charges of $0.8 million associated with the consolidation of domestic PE Films manufacturing facilities, which includes asset impairments of $0.1 million, accelerated depreciation of $0.3 million and other facility consolidation-related expenses of $0.5 million (included in “Cost of goods sold” in the consolidated statements of income) offset by income of $0.1 million related to a reduction of severance and other employee-related accrued costs; charges of $2.4 million associated with a business development project included in “Selling, general and administrative” in the consolidated statements of income); charge of $0.7 million for severance and other employee-related costs associated with restructurings in PE Films ($0.2 million), Aluminum Extrusions ($0.1 million) and Corporate ($0.4 million); charges of $0.3 million associated with asset impairments in PE Films; charge of $0.2 million associated with the settlement of customer claims and the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana. The unrealized gain of $33.8 million2019 can be found in Item 7 of our Annual Report on the Company’s investment in kaléo is included in “Other income (expense), net” in the consolidated statements of income.
(b)Plant shutdowns, asset impairments, restructurings and other charges for 2016 include income of $0.4 million related to the explosion that occurred in the second quarter of 2016 at Bonnell’s aluminum extrusions manufacturing facility in Newnan, Georgia, which includes the recognition of a gain of $1.9 million for a portion of the insurance recoveries approved by the insurer to begin the replacement of capital equipment, offset by the impairment of equipment damaged by the explosion of $0.3 million (net amount included in “Other income (expense), net” in the consolidated statements of income) and other costs related to the explosion that are not recoverable from insurance of $0.6 million (included in “Selling, general and administrative”) and excess production costs for which recovery from insurance is not assured of $0.6 million (included in “Cost of goods sold” in the consolidated statements of income); charges of $4.3 million associated with the consolidation of domestic PE Films manufacturing facilities, which includes severance and other employee-related costs of $1.2 million, asset impairments of $0.4 million, accelerated depreciation of $0.6 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $2.0 million ($1.6 million is included in “Cost of goods sold” in the consolidated statements of income); charges of $0.4 million associated with a business development project included in “Selling, general and administrative” in the consolidated statements of income); charge of $0.3 million for severance and other employee-related costs associated with restructurings in PE Films ($0.1 million) and Corporate ($0.2 million); charges of $0.6 million associated with the acquisition of Futura Industries Corporation (included in “Selling, general and administrative” in the consolidated statements of income); charges of $0.5 million related to expected future environmental costs at the Company’s aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.3 million related to the settlement of a tax dispute in the Flexible Packaging Films segment (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.2 million associated with asset impairments in PE Films; gain of $0.1 million from the settlement of a Terphane pre-acquisition contingency (included in “Other income (expense), net” in the consolidated statements of income); charge of $0.1 million from the sale of the aluminum extrusions manufacturing facility in Kentland, Indiana at a pretax gain of $0.2 million, offset by pretax charges of $0.3 million associated with the shutdown of this facility. The unrealized gain of $1.6 million on the Company’s investment in kaléo is included in “Other income (expense), net” in the consolidated statements of income.
(c)Results for 2015 included a goodwill impairment charge of $44.5 million ($44.5 million after taxes) recognized in Flexible Packaging Films in the third quarter of 2015 upon completion of an impairment analysis performed as of September 30, 2015.
(d)Plant shutdowns, asset impairments, restructurings and other charges for 2015 include charges of $3.9 million (included in “Selling, general and administrative” in the consolidated statements of income) for severance and other employee-related costs associated with the resignation of the Company’s former chief executive and chief financial officers; charges of $2.2 million associated with the consolidation of domestic PE Films manufacturing facilities, which includes severance and other employee-related costs of $0.8 million, asset impairments of $0.4 million, accelerated depreciation of $0.4 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.6 million ($0.1 million is included in “Cost of goods sold” in the consolidated statements of income); charge of $2.2 million for severance and other employee-related costs associated with restructurings in PE Films ($2.0 million) ($0.4 million included in “Selling, general and administrative expense” in the consolidated statement of income), Flexible Packaging Films ($0.2 million), Aluminum Extrusions ($35,000) and Corporate ($26,000); charges of $1.0 million associated with a non-recurring business development project (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.4 million associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana; and charges of $0.3 million related to expected future environmental costs at the Company’s aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income). The unrealized loss of $20.5 million on the Company’s investment in kaléo is included in “Other income (expense), net” in the consolidated statements of income.
(e)Plant shutdowns, asset impairments, restructurings and other for 2014 include a charge of $10.0 million (included in “Other income (expense), net” in the consolidated statements of income) associated with the one-time, lump sum license payment to 3M Company (“3M”) after the Company settled all litigation issues associated with a patent infringement complaint; charges of $2.3 million for severance and other employee-related costs in connection with restructurings in PE Films ($1.7 million), Flexible Packaging Films ($0.6 million) and Aluminum Extrusions ($31,000); charges of $0.9 million related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statement of income); charges of $0.7 million associated with the shutdown of the film products manufacturing facility in Red Springs, North Carolina, which includes severance and other employee-related costs of $0.4 million and asset impairment and other shutdown-related charges of $0.3 million; gain of $0.1 million related to the sale of previously shutdown film products manufacturing facility in LaGrange, Georgia (included in “Other income (expense), net” in the consolidated statements of income); and charges of $54,000 associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana. The unrealized gain of $2.0 million on the Company’s investment in kaléo; the unrealized loss of $0.8 million on the Company’s investment in Harbinger Capital Partners Special Situations Fund L.P. (“Harbinger”) and the gain of $1.2 million on sale on a portion the Company’s investment property in Alleghany and Bath County, Virginia in 2014 are included in “Other income (expense), net” in the consolidated statements of income. Income taxes from continuing operations in 2014 includes the recognition of a tax benefit for a portion of the Company’s capital loss carryforwards of $4.9 million. These capital loss carryforwards were previously offset by a valuation allowance associated with expected limitations on the utilization of these assumed capital losses. As a result of changes in the underlying basis of certain foreign subsidiaries, income taxes from continuing operations in 2014 also included an adjustment of $2.2 million to reverse previously accrued deferred income tax liabilities arising from foreign currency translation adjustments.
(f)Plant shutdowns, asset impairments, restructurings and other for 2013 include a charge of $1.7 million related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statement of income); charges of $0.6 million associated with the shutdown of the Company’s aluminum extrusions manufacturing facility in Kentland, Indiana; charges of $0.5 million associated with the shutdown of the film products manufacturing facility in Red Springs, North Carolina, which includes severance and other employee-related costs of $0.3 million and asset impairment charges of $0.2 million; charges of $0.4 million for severance and other employee-related costs in connection with restructurings in Aluminum Extrusions ($0.3 million) and PE Films ($0.1 million); charges of $0.2 million for integration-related expenses and other nonrecurring transactions (included in “Selling, general and administrative expenses” in the consolidated statements of income) associated with the acquisition of AACOA, Inc. (“AACOA”) by Aluminum Extrusions; and a loss of $0.1 million related to the sale of previously impaired machinery and equipment at the Company’s film products manufacturing facility in Shanghai, China (included in “Other income (expense), net” in the consolidated statements of income). The unrealized gain of $3.4 million on the Company’s investment in kaléo, the unrealized loss of $0.4 million on the Company’s investment in Harbinger and the unrealized loss of $1.0 million on the Company’s investment property in Alleghany and Bath County, Virginia in 2013 are included in “Other income (expense), net” in the consolidated statements of income. Income taxes for 2013 include the recognition of an additional valuation allowance of $0.4 million related to the expected limitations on the utilization of assumed capital losses on certain investments.
(g)On November 20, 2012, Tredegar sold its membership interests in Falling Springs, LLC. All historical results for this business have been reflected in discontinued operations. On February 12, 2008, Tredegar sold its aluminum extrusions business in Canada. All historical results for this business have been reflected as discontinued operations. In 2014, accruals for indemnifications under the purchase agreement were adjusted, resulting in income from discontinued operations of $0.9 million. In 2013, discontinued operations include after-tax charges of $14.0 million, to accrue for indemnifications under the purchase agreement related to environmental matters.
(h)Total return to shareholders is defined as the change in stock price during the year plus dividends per share, divided by the stock price at the beginning of the year.
(i)Equity market capitalization is the closing market price per share for the period multiplied by the shares outstanding at the end of the period.
(j)Net sales represent gross sales less freight. Net sales is the measure used by the chief operating decision maker of each segment for purposes of assessing performance.
(k)
Total assets in 2015, 2016 and 2017 are not comparable to prior years due to the adoption of new FASB guidance associated with the classification of deferred income tax assets and liabilities. See Note 16 to the Notes to the Financial Statements for additional details.
(l)Equity per share is computed by dividing shareholders’ equity at year end by the shares outstanding at end of period.


Item 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-looking and Cautionary Statements
Some of the information contained in this Form 10-K may constitute “forward-looking statements” withinfor the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When using the words “believe,” “estimate,” “anticipate,” “expect,” “project,” “likely,” “may” and similar expressions, Tredegar does so to identify forward-looking statements. Such statements are based on then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. For risks and important factors that could cause actual results to differ from expectations, refer to the reports that Tredegar files with or furnishes the SEC from time-to-time, including the risks and important factors set forth in “Risk Factors” in Part I, Item 1A of this Form 10-K. Readers are urged to review and consider carefully the disclosures Tredegar makes in the reports Tredegar files with or furnishes to the SEC. Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.year ended December 31, 2020.
Executive Summary
General
Tredegar Corporation is aan industrial manufacturer of polyethylene (“PE”) plasticwith three primary businesses: custom aluminum extrusions for the North American building & construction, automotive and specialty end-use markets through its Aluminum Extrusions segment; surface protection films for high-technology applications in the global electronics industry through its PE Films segment; and specialized polyester films primarily for the Latin American flexible packaging market through its Flexible Packaging Films segment. With approximately 2,400 employees, the Company operates manufacturing facilities in North America, South America, and aluminum extrusions. DescriptionsAsia.
On October 30, 2020, the Company completed the sale of allPersonal Care Films. The transaction excluded the Company’s businessespackaging film lines and related operations located at Pottsville Packaging, which are providednow being reported within the Surface Protection component of PE Films. Commencing in the Business section.third quarter of 2020, all historical results for Personal Care Films have been presented as discontinued operations. For more information on these transactions, see Note 17 to the Consolidated Financial Statements in Item 15.
Sales were $961.3$826.5 million in 20172021 compared to $828.3$755.3 million in 2016.2020. Net income from continuing operations was $38.3$57.9 million ($1.161.72 per diluted share) in 2017,2021, compared with $24.5net loss from continuing operations of $16.8 million ($0.750.51 per diluted share) in 2016. In addition2020.
The 2021 results include:
An after-tax gain of $10.0 million ($0.30 per diluted share) on the sale of the Company’s investment in kaléo on December 27, 2021 resulting in total cash proceeds of $47.1 million (see Note 9 to the results of ongoing operations, the 2017Consolidated Financial Statements in Item 15 for more details).
The 2020 results include:
An unrealized after-tax gainloss on the Company’s investment in kaléo of $24.0$47.6 million ($0.731.42 per diluted share), which iswas accounted for under the fair value method (see Note 4 of9 to the Notes toConsolidated Financial Statements for more details);
An after-tax gain of $11.9 million ($0.36 per share) from the settlement of an escrow agreement related to the Terphane acquisition in 2011 (see Note 17 of the Notes to Financial Statements for more details);
An income tax benefit of $61.4 million ($1.86 per share) associated with the write-off of the stock basis of Terphane Limitada, Terphane’s Brazilian subsidiary, and Terphane’s U.S. subsidiary, Terphane Inc., computed at the 35% U.S. corporate federal income tax rate in effect in 2017 ($56.6 million ($1.72 per share) when reduced for the deductions applicable to the 21% U.S. corporate federal income tax rate effective in 2018 under the Tax Cuts and Jobs Act (the “TCJA”)) (see Note 17 of the Notes to Financial Statements for more details);
An income tax benefit from the adjustment of deferred income tax liabilities as a result of the reduction of U.S. federal corporate income tax rates effective in 2018 and other law changes of $4.4 million ($0.13 per share) (see Note 16 of the Notes to Financial Statements Item 15 for more details); and
An after-tax write-downimpairment of the assetstotal goodwill balance of Flexible Packaging FilmsAluminum Extrusions' reporting unit acquired in the AACOA acquisition in 2012 was recorded in the after-tax amount of $87.2$10.5 million ($2.650.32 per diluted share) (see Note 17 of.
Other losses related to asset impairments and costs associated with exit and disposal activities for continuing operations were not material for the Notes to Financial Statements for more details).
Other lossesyears ended December 31, 2021 and 2020, respectively. Losses associated with plant shutdowns, asset impairments, and restructurings and gains and losses on the sale of assets, and other items are described in Note 17Results of the Notes to Financial Statements. Net sales (sales less freight) and operating profitOperations. EBITDA from ongoing operations areis the measuresmeasure of salesprofit and operating profitloss used by theTredegar’s chief operating decision maker of each segment(“CODM”) for purposes of assessing financial performance. The Company uses net sales from continuing operations as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
Earnings before interest and taxes (“EBIT”) from ongoing operations is a non-GAAP financial measure included in the reconciliation of segment financial information to consolidated results for the Company. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income as defined by GAAP. We believe EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.
13


See the table in Note 513 to the Consolidated Financial Statements in Item 15 for a reconciliation of this non-GAAP measure to GAAP.
THE IMPACT OF COVID-19 AND RELATED FINANCIAL CONSIDERATIONS
Essential Business and Employee Considerations
The Company’s priorities during the COVID-19 pandemic continue to be to protect the health and safety of employees while keeping its manufacturing sites open due to the essential nature of many of its products. The Company has continued to manufacture the full range of products at its facilities.
The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to evolve as the Centers for Disease Control, the Office of the NotesSurgeon General and other state and local health departments learn more about the virus and its variants. Consistent with recommendations and mandates from government agencies and health authorities, the Company has implemented multiple layers of COVID-19 protections and interventions.
The Company has engaged in an education campaign that provides employees with the most accurate and up-to-date information related to COVID-19 vaccines and has offered different monetary and/or time-away-from-work incentives to encourage employees to get vaccinated with the primary dose(s) and to get a booster shot once eligible. The Company will continue to monitor available information to assess safeguards that may be taken to try to prevent a COVID-19 outbreak in the workplace.
Aluminum Extrusions, also known as Bonnell Aluminum, continues to experience higher than normal absenteeism and hiring difficulties, which it attributes to COVID-19-related factors, including high COVID-19 transmission rates in the geographic areas where its plants are located. While the average number of direct labor employees at Bonnell Aluminum facilities increased approximately 9% in the fourth quarter of 2021, compared with the abnormally low levels related to the pandemic in the second and third quarters of 2020, there continues to be a shortage of labor to meet existing demand and desired shipment levels. Moreover, onboarding new employees has resulted in higher hiring and training costs and labor inefficiencies in 2021 versus last year.
All three of the Company's business segments are managing through supply chain disruptions and escalating costs, including raw material cost increases, shortages, transportation cost increases and delays. To offset growing cost pressures, Bonnell Aluminum implemented a selling price increase effective January 3, 2022, which followed two price increases in 2021. In response to unprecedented cost increases and supply issues for polyethylene and polypropylene resin, PE Films implemented a quarterly resin cost pass-through mechanism, effective July 1, 2021, for all products and customers not previously covered by such arrangements. Flexible Packaging Films, which is also known as Terphane, which is headquartered in Brazil, continues to monitor cost escalations to adjust selling prices as market dynamics permit.
Financial Statements Considerations
Approximately 58% of Bonnell Aluminum’s sales volume in 2021 was related to building and construction (“B&C”) markets (non-residential B&C of 51% and residential B&C of 7%). Non-residential B&C volume started to decline in the fourth quarter of 2020 after the fulfillment of contracts that existed at the start of the COVID-19 pandemic. Market demand in this sector has recently been strong but not fully realized in Bonnell Aluminum's fourth quarter and full year 2021 results due to pandemic-related labor shortages and resulting production inefficiencies. Non-residential B&C volume declined 4% versus the fourth quarter of 2020 and 11% versus full year 2020. However, current bookings and backlog remain at record high levels which the Company believes will bode well for future results when production constraints are alleviated.
The Surface Protection component of PE Films had record EBITDA from ongoing operations in 2020 but experienced a presentationdecline in volume in 2021, primarily related to a previously disclosed customer product transition unrelated to the pandemic. In addition, the lag in the pass-through of Tredegar’ssignificant pandemic-related increases in resin costs, and some of such cost increases incurred prior to mid-year that will not be recovered even on a lagging basis, have adversely impacted PE Films’ profitability in 2021.
At Terphane, the Company believes that the pandemic-related surge in demand for flexible packaging films that began in early 2020 returned to lower pre-pandemic levels during the second quarter of 2021.
14


OPERATIONS REVIEW
Segment Analysis. A summary of results for 2021 versus 2020 for each of the Company’s reporting segments is shown below.
Aluminum Extrusions
A summary of results for Aluminum Extrusions is provided below: 
Year EndedFavorable/
(In thousands, except percentages)December 31,(Unfavorable)
20212020% Change
Sales volume (lbs)183,367 186,391 (1.6)%
Net sales$539,325 $455,711 18.3 %
Ongoing operations:
EBITDA$55,948 $55,137 1.5 %
Depreciation & amortization(16,272)(17,403)6.5 %
EBIT$39,676 $37,734 5.1 %
Capital expenditures$18,914 $10,260 
Net sales in 2021 increased by 18.3% versus 2020. The annual increase in net sales was primarily due to an increase in average selling prices to cover significantly higher aluminum raw material costs and higher operating profitcosts, partially offset by segmentlower sales volume. Sales volume in 2021 decreased by 1.6% versus 2020. Increased shipments in the specialty sector were offset by declines in B&C and automotive markets. All end markets served within the specialty sector experienced growth. The Company believes that declines in the non-residential B&C market resulted mainly from COVID-19-related labor shortages, with a portion of the decline in automotive sales volume associated with supply chain issues in the automotive industry.
EBITDA from ongoing operations in 2021 increased by $0.8 million versus 2020 due to higher pricing ($13.6 million net of the pass-through of aluminum raw materials costs), partially offset by higher labor and employee-related costs ($7.2 million) and other inflationary operating costs such as higher supply expenses ($6.4 million), lower labor productivity ($1.6 million), higher freight expenses ($3.2 million) and higher selling, general and administrative costs ($3.2 million). In addition, the timing of the flow through under the first-in first-out method of aluminum raw material costs passed through to customers, previously acquired at lower prices in a quickly rising commodity pricing environment, resulted in a benefit of $6.9 million in 2021 versus a charge of $1.3 million in 2020.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures are projected to be $30 million in 2022, including $15 million for new ERP/MES, $6 million for infrastructure upgrades at the years ended December 31, 2017facilities located in Niles, Michigan, Carthage, Tennessee and 2016.




Newnan, Georgia, and $3 million for other strategic projects. The ERP/MES project is expected to cost $28 million over a two-year time span. In addition to strategic projects, approximately $6 million will be required to support continuity of current operations. Depreciation expense is projected to be $14 million in 2022. Amortization expense is projected to be $3 million in 2022.
PE Films
A summary of operating results for PE Films is provided below: 
Year EndedFavorable/
(In thousands, except percentages)December 31,(Unfavorable)
20212020% Change
Sales volume (lbs)39,429 45,175 (12.7)%
Net sales$118,920 $139,288 (14.6)%
Ongoing operations:
EBITDA$27,694 $45,107 (38.6)%
Depreciation & amortization(6,263)(6,762)7.4 %
EBIT$21,431 $38,345 (44.1)%
Capital expenditures$2,997 $6,024 
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2017 2016 % Change
Sales volume (lbs)138,999
 139,020
  %
Net sales$352,459
 $331,146
 6.4 %
Operating profit from ongoing operations$41,546
 $26,312
 57.9 %
Net sales in 2017 increased2021 decreased by $21.3$20.4 million versus 2016 primarily due to:
Higher sales from surface protection films ($15.1 million),2020, primarily due to higherlower volume and a favorableunfavorable mix associated with the previously disclosed customer product transitions in Surface Protection, partially offset by higher pricing associated with the pass-through of increased resin costs.
15


EBITDA from ongoing operations in 2021 decreased by $17.4 million versus 2020 primarily due to:
A $19.4 million decrease from Surface Protection primarily related to lower sales mix; and
Higher volumeunfavorable mix associated with the customer product transitions ($14.8 million), lower sales and unfavorable mix for acquisition distribution layer materialsproducts unrelated to customer product transitions ($3.4 million), margin erosion associated with higher resin costs that occurred before the resin index pricing plan was fully implemented ($1.4 million), the pass-through lag associated with higher resin costs ($1.4 million), and overwrap products, and a favorable sales mix in personal care materialshigher freight expense ($12.01.0 million), partially offset by volume reductionsproduction efficiencies and cost savings ($1.9 million) and lower research and development spend ($0.4 million);
A $0.1 million increase from Pottsville Packaging; and
A $2.7 million favorable variance associated with the winding downdivestiture of known lost business in personal care that was substantially completed byBright View Technologies at the end of 2016 ($6.2 million).
2020.
Operating profit from ongoing operationsCustomer Product Transitions and Other Factors in 2017 increased by $15.2 million versus 2016 primarily due to:
Higher contribution to profits from surface protection films ($12.3 million), primarily due to higher volume, a favorable sales mix, and production efficiencies;
Higher contribution to profits from personal care materials, primarily due to improved volume, production efficiencies and favorable pricing ($7.3 million), partially offset by known lost business ($2.1 million);
A benefit for inventories accounted for under the LIFO method of $1.1 million in 2017 versus a charge of $0.9 million in 2016; and
Higher net general, selling and plant expenses ($7.3 million), primarily associated with strategic hires and an increase in employee incentive costs, partially offset by realized cost savings of $3.1 million associated with the North American facility consolidation.
Surface Protection
The North American facility consolidation was completed in the third quarter of 2017, with expected annualized savings, excluding depreciation expense, of approximately $6 million. Total pretax cash expenditures for this multi-year project were $16.0 million, which included $11.2 million of capital expenditures.
The surface protection operating segmentSurface Protection component of PE Films supports manufacturers of optical and other specialty substrates used in flat panel display products. These films are primarily used by customers to protect components of displays in the manufacturing and transportation processprocesses and then discarded.
AsThe Company previously discussed,reported the Company believes that over the next few years, there is an increased risk that a portion of its film products used in surface protection applications willwould be made obsolete by possible future customer product transitions to less costly alternative processes or materials. The Company estimates on a preliminary basis that these transitions, which principally relate to one customer, adversely impacted EBITDA from ongoing operations for PE Films by $14.8 million during 2021 versus 2020. A further decline of $7 million in EBITDA from ongoing operations due to the annualtransitions is expected in 2022 versus 2021, at which time the transitions are expected to be complete.
The Surface Protection business is also experiencing competitive pricing pressures, unrelated to the customer product transitions, that are expected to adversely impact EBITDA from ongoing operations by approximately $6 million in 2022 versus 2021. To offset the expected adverse impact on ongoing operating profit from customer shifts to alternative processes or materials in surface protection is in the range of up to $5 to $10 million. Given the technological and commercial complexity involved in bringing these alternative processes or materials to market, the Company is very uncertain as to the timing and ultimate amount of the possible transitions. In response,customer transitions and pricing pressures, the Company is aggressively pursuing and making progress in generating contribution from sales of new surface protection products, applications and customers.
The Company continuescustomers and driving production efficiencies and cost savings. Annual contribution to anticipate a significant product transition after 2018 in the personal care operating segment of PE Films. The Company currently estimates that this will adversely impact the annual sales of the business unit by $70 million sometime between 2019 and 2021. The Company has been increasing its research and development spending (an increase of approximately $6 million in 2017 versus 2014), expects to invest capital, and is accelerating sales and marketing efforts to capture growth and diversify its customer base and product offerings in personal care products. The overall timing and net change in personal care’s revenues and profits and the capital expenditures needed to support growth during this transition period are uncertain at this time. The loss of this business without replacement with new business could trigger impairment of personal care’s long-lived assets and goodwill; see Impairment and Useful Lives of Long-lived Assets and Goodwill in the Critical Accounting Policies section for more information.


Restructuring
In July 2015, the Company began a consolidation of its domestic productionEBITDA from ongoing operations for PE Films by restructuringfrom sales of products unrelated to previously disclosed customer product transitions increased $7 million for the operations in its manufacturing facility in Lake Zurich, Illinois. This restructuring was completedtwo-year period ended December 31, 2021, which excludes the impact of resin pass-through lag but includes the adverse impact of customer inventory corrections, customer production slowdowns associated with COVID-19-related factors, and a slowdown in the thirdtelevision market in the fourth quarter of 2017, with expected annualized savings excluding depreciation expenses of $6.0 million. Total expenses associated with the restructuring were $0.8 million in 2017 (included in “Cost of goods sold” in the consolidated statements of income) and the total expenses for the project since inception were $7.3 million. Cash expenditures for the North American facility consolidation project were $1.9 million in 2017, which includes capital expenditures of $0.1 million. Total cash expenditures for the project since inception were $16.0 million, which includes $11.2 million for capital expenditures. Additional cash payments for remaining accrued costs of approximately $0.5 million are expected to be paid within the next 12 months.2021.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures in PE Films were $15.0 million in 2017 compared to $25.8 million in 2016. Capital expenditures are projected to be $53$5 million in 2018,2022, including: North American capacity expansion for elastics products in personal care ($25 million); new capacity and upgrades for next generation products in surface protection ($9 million); other growth and strategic projects ($9 million); and approximately $10$3 million for routineproductivity projects and $2 million for capital expenditures required to support continuity of current operations. Depreciation expense was $14.5 million in 2017 and $13.5 million in 2016. Depreciation expense is projected to be $16$7 million in 2018.2022. There is no amortization expense for PE Films.
Flexible Packaging Films
A summary of operating results for Flexible Packaging Films is provided below:
Year EndedFavorable/
(Unfavorable)
% Change
(In thousands, except percentages)December 31,
20212020
Sales volume (lbs)104,569 113,115 (7.6)%
Net sales$139,978 $134,605 4.0 %
Ongoing operations:
EBITDA$31,684 $30,645 3.4 %
Depreciation & amortization(1,988)(1,761)(12.9)%
EBIT$29,696 $28,884 2.8 %
Capital expenditures$5,603 $4,959 
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2017 2016 % Change
Sales volume (lbs)89,325
 89,706
 (0.4)%
Net sales$108,355
 $108,028
 0.3 %
Operating profit (loss) from ongoing operations$(2,626) $1,774
 n/a

Sales volume declined by 7.6% in 2021 versus 2020, primarily due to lower demand, resin supply issues, and an equipment failure impacting production. Net sales and sales volume in 2017 were relatively flat2021 increased 4.0% compared to 2016, and adversely impacted by production issues2020, primarily due to intermittent power outages at Terphane’s Cabo de Santo Agostinho, Brazil plant duringhigher selling prices from the third quarter.pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume.
Terphane had an operating lossEBITDA from ongoing operations in 2017 of $2.62021 increased by $1.0 million versus an operating profit from ongoing operations in 2016 of $1.8 million. The resulting unfavorable change of $4.4 million for the period was2020 primarily due to:
Lower production, primarily due to numerous intermittent power outages during
16


Higher selling prices from the third quarterpass-through of higher resin costs ($0.511.2 million), favorable product mix ($2.0 million) and lower average sales priceselling, general, and administration expenses ($1.60.7 million), partially offset by a favorable sales mix ($1.5 million);
Higherhigher raw material costs ($12.8 million), lower sales volume ($4.9 million) and higher variable costs ($1.7 million);
Net favorable currency translation of $1.8 million in 2017 that could not be passed through to customers due to competitive pressures versus a benefit from lower raw materialReal-denominated operating costs of $1.2 million in 2016;
($5.9 million);
Foreign currency transaction losses primarily associated with U.S. Dollar denominated export sales in Brazil of $0.2 million in 2017 versusHigher foreign currency transaction losses of $3.5 million in 2016;
Higher costs and expenses of $3.2 million primarily related to the adverse impact of high inflation in Brazil and the appreciation by approximately 9% of the average exchange rate for the Brazilian Real relative to the U.S. Dollar; and
Higher depreciation and amortization costsgains ($0.9 million).
Terphane Asset Impairment Loss and Worthless Stock Deduction
The Company acquired Terphane in October 2011, and since that time Terphane’s selling prices, margins and overall performance have been adversely impacted by excess industry capacity, particularly in Latin America, and by a period of poor economic conditions in Brazil. Moreover, significant additional capacity came on-line late in the third quarter of 2017 from a competitor in Latin America. As a result, Terphane has struggled with profitability and incurred operating losses from ongoing operations in two of the last five years, including an operating loss of $2.6 million in 2017. Terphane’s quarterly financial results have been volatile, and the Company expects continued uncertainty and volatility until industry capacity utilization and the competitive dynamics in Latin America improve. Furthermore, while industry economics are suffering with excess


capacity, Terphane is currently operating at full capacity utilization and needs to spend approximately $1.8 million (including capital expenditures of $1 million and project expenses of $0.81.2 million) in 2018 to re-start an idled production line to participate2021 versus 2020; and
Lower value-added tax credits received in expected market growth and defend its market share.2021 ($0.5 million) versus 2020.
During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts, the Company determined that the carrying value of Terphane’s remaining long-lived assets were impaired (Terphane’s goodwill was written off in 2015).  Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million. This write-down resulted in a non-cash asset impairment loss recognized during the fourth quarter of 2017 of $101 million ($87 million after non-cash tax benefits).
Also during the fourth quarter of 2017, as a result of the valuation activities referred to above, the Company claimed an ordinary loss for U.S. federal and state income tax purposes of $153 million for the write-off of the stock basis of Terphane Limitada (Terphane’s Brazilian subsidiary). The Terphane Limitada worthless stock deduction resulted in an overall reduction of Tredegar’s U.S. income tax liability of approximately $49 million. Approximately $36 million of the benefit is expected to be realized in cash in 2018 with the balance of $13 million expected to be realized in cash mostly in 2019. The full net tax benefit expected from the Terphane Limitada worthless stock deduction of $49 million was accrued during the fourth quarter of 2017 and reflected as a reduction to Tredegar’s consolidated income tax expense. During the second quarter of 2017, the Company recognized a worthless stock deduction for Terphane, Inc. (Terphane’s U.S. subsidiary), which resulted in an income tax benefit recognized of $8.1 million.
Capital Expenditures, Depreciation & Amortization
Capital expenditures in Flexible Packaging were $3.6 million in 2017 compared to $3.4 million in 2016. Capital expenditures are projected to be $5 million in 2018, including approximately $1 million to re-start the idled production line referred to above and $4 million for routine items required to support operations. Depreciation expense was $7.5 million in 2017 and $6.7 million in 2016. Depreciation expense is projected to be $1 million in 2018. Amortization expense was $3.0 million in 2017 and $2.8 million in 2016, and is projected to be $0.5 million in 2018. Depreciation and amortization expense projections for 2018 are significantly lower than 2017 actual amounts due to the write-down of Terphane’s long-lived assets during the fourth quarter of 2017.
Aluminum Extrusions
A summary of operating results for Aluminum Extrusions, including the results of Futura Industries Corporation (“Futura”) (except sales volume) since its date of acquisition, is provided below:
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2017 2016 % Change
Sales volume (lbs)*176,269
 172,986
 1.9%
Net sales$466,833
 $360,098
 29.6%
Operating profit from ongoing operations$43,454
 $37,794
 15.0%
*Excludes sales volume for Futura, which was acquired on February 15, 2017.
Net sales in 2017 increased versus 2016 primarily due to the addition of Futura. Futura contributed net sales of $71.0 million in 2017. Excluding the impact of Futura, net sales improved due to higher sales volume, improved product mix, and an increase in average selling prices primarily due to the pass-through to customers of higher market-driven raw material costs.
Volume on an organic basis (which excludes the impact of the Futura acquisition) in 2017 increased by 1.9% versus 2016. Higher volume in specialty and automotive & light truck markets were the primary drivers.
Operating profit in 2017 increased by $5.7 million versus 2016. Excluding the favorable profit impact of Futura ($8.2 million), operating profit decreased $2.5 million, primarily due to:
Higher volume and inflation-related sales prices ($7.3 million benefit);
Increased operating costs, including utilities and employee-related expenses and higher depreciation ($3.9 million);
Higher costs associated with the startup of the new press at the Niles, Michigan plant, resulting from disruptions to normal plant production ($4.3 million); and


A charge for inventories accounted for under the LIFO method of $1.3 million in 2017 versus a benefit of $0.5 million in 2016.
Cast House Explosion
On June 29, 2016, the Bonnell Aluminum plant in Newnan, Georgia suffered an explosion in the casting department, causing significant damage to the cast house and related equipment. The Company completed the process of replacing the damaged casting equipment, and the cast house resumed production in the third quarter of 2017. Bonnell Aluminum has various forms of insurance to cover losses associated with this type of event.
During 2017, Bonnell incurred $5.6 million of additional operational expenses as a result of the explosion; $5.5 million of this amount has been fully offset by insurance recoveries. Also, $0.6 million of additional operational expenses incurred in 2016 that were previously considered not reasonably assured of being covered by insurance recoveries were recovered. Each of these amounts is recorded in “Plant shutdowns, asset impairments, restructurings and other” in the Operating Profit table in Note 5 of the Notes to Financial Statements and in “Cost of goods sold” in the Consolidated Statements of Income. In the fourth quarter of 2017, all remaining insurance claims associated with this matter were settled, and a gain on involuntary conversion of the old cast house of $5.3 million was recorded in “Other income (expense), net” in the Consolidated Statements of Income and in “Plant shutdowns, asset impairments, restructurings and other” in the Operating Profit table in Note 5 of the Notes to Financial Statements.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Aluminum Extrusions were $25.7are projected to be $8 million in 2017 compared to $15.9 million in 2016. Capital expenditures in 2017 included: $8 million to complete the extrusions capacity expansion project at the Niles, Michigan, manufacturing facility; expenditures to repair the damage caused by the cast house explosion net of related insurance recoveries (facility upgrades of $2 million); $52022, including $4 million for routinenew capacity for value-added products and productivity projects and $4 million for capital expenditures required to support legacy operations; and $2 million to support the operationscontinuity of Futura. Projections of capital expenditures for Bonnell Aluminum of $15 million in 2018 include approximately $7 million for infrastructure upgrades and to expand fabrication and machining capabilities, and approximately $8 million for routine items required to supportcurrent operations. Depreciation expense was $11.9 million in 2017, which included $2.9 million from the addition of Futura, compared to $8.1 million in 2016, and is projected to be $13$2 million in 2018.2022. Amortization expense was $3.1 million in 2017, which included $2.1 million from the addition of Futura, and $1.0 million in 2016, and is projected to be $3$0.4 million in 2018.
Futura Acquisition
On February 15, 2017, Bonnell Aluminum acquired Futura on a net debt-free basis for approximately $92 million. The amount actually funded in cash at the transaction date was approximately $87 million, which was net of preliminary closing adjustments for working capital and seller transaction-related obligations assumed and subsequently paid by Bonnell Aluminum. In addition, the Company will be refunded $5 million in the first half of 2018 since Futura did not meet certain performance requirements for the 2017 fiscal year. The acquisition, which was funded using Tredegar’s revolving credit facility, is being treated as an asset purchase for U.S. federal income tax purposes. For more information, see “Aluminum Extrusions” in the Business section.2022.
Corporate Expenses, Interest and Income Taxes
Corporate expenses, net, decreased $1.1 million in 2021 versus 2020, primarily due to higher transition service fees, net of corporate costs associated with the 2020 divestiture of the Personal Care Films business ($1.1 million).
Interest expense increased to $3.4 million in 2021 from $2.6 million in 2020, primarily due to higher average debt levels.
The effective tax rate used to compute income taxes for continuing operations in 2021 was 13.8% compared to 32.8% in 2020. The differences between the U.S. federal statutory rate and the effective tax rate for 2021 and 2020 are shown in Note 12 to the Consolidated Financial Statements in Item 15.
Pension expense was $10.1$14.1 million in 2017,2021, a favorable change of $0.8$0.5 million from 2016. Most of the2020. The impact on earnings from lower pension expense is reflected in “Corporate expenses, net” in the Operating Profit tablenet sales and operating profit by segment statements in Note 513 to the Consolidated Financial Statements in Item 15. On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete. In connection therewith, the NotesCompany borrowed funds under its revolving credit agreement and made a $50 million Special Contribution to Financial Statements.reduce its underfunding and as part of a program within the pension plan to hedge or fix the expected future contributions that will be needed by the Company through the settlement process. The Company expects to realize income tax benefits on the Special Contribution of approximately $11 million. Administrative costs for the pension plan through the settlement process are estimated at $4 to $5 million.
As of December 31, 2021 (and before the Special Contribution), the estimated pension plan underfunding under GAAP was $69 million, comprised of investments at fair value of $245 million and a projected benefit obligation (“PBO”) of $314 million. The ultimate settlement benefit obligation may differ from the PBO, depending on market factors for buyers of pension obligations at the time of settlement. Pension expense is projected to be $10.2approximately $14 million under GAAP in 2018. Corporate expenses, net,2022 and zero for ongoing operations increasedcalculating earnings before interest, taxes, depreciation and amortization as defined in 2017 versus 2016 primarily due to higher stock-based employee benefit costs and incentive accruals, partially offset by lower pension expense. In addition, corporate expenses included aggregate charges for business development, environmental, severance, and other special items of $3.9 million in 2017 and $1.6 million in 2016.
Interest expense increased to $6.2 million in 2017 from $3.8 million in 2016, primarily due to higher average debt levels from the acquisition of Futura. Interest expense in 2016 included the write off of $0.2 million in unamortized loan fees from the Company’s revolving credit agreement that was refinanced in the first quarter of 2016.
During 2017, the Company recognized a consolidated income tax benefit of $53.2 million based on a pretax loss of $14.9 million. During 2016, the Company recognized a consolidated income tax expense of $3.2 million based on pretax income of $27.7 million. Information on the significant differences between the effective tax rate for income and the U.S. federal statutory rate for 2017 and 2016 are further detailed in the effective income tax rate reconciliation provided in Note 16 of the Notes(“Credit EBITDA”), which is used to Financial Statements.


The U.S. government enacted the TCJA in December 2017, which, among other impacts, reduces the U.S. federal corporate income tax rate from 35% to 21% beginning in 2018. In the fourth quarter of 2017, the Company recognized a non-cash deferred income tax benefit of $4.4 million for the decrease of its net deferred income tax liabilities, resulting from the 14% tax rate reduction and other applicable tax law changes. No deemed repatriation tax was recorded on unrepatriated earnings of the Company’s foreign subsidiaries as the Company’s foreign subsidiaries have no net cumulative unremitted earnings due to historical repatriation.compute certain borrowing ratios. The Company expectsestimates that, its effective tax rate for ongoing operations in 2018with the Special Contribution, there will dropbe no required minimum contributions to 22% as a result of the TCJA, but how the TCJA will impact the overall competitive dynamics for the Company’s businesses and markets is uncertain.pension plan until final settlement.
Total debt was $152.0$73.0 million at December 31, 2017,2021, compared to $95.0$134.0 million at December 31, 2016.2020. Net debt (debt in excess of cash and cash equivalents), a non-GAAP financial measure, was $115.5$42.5 million at December 31, 2017,2021, compared to $65.5$122.2 million at December 31, 2016.2020. The increaseyear-over-year decline in net debt during 2017of $79.7 million includes proceeds of $47.1 million from the acquisitionsale of Futurathe Company’s investment in kaleo, Inc (“kaléo”). on February 15, 2017. Net debt is calculated as follows:
(In millions) December 31, 2017 December 31, 2016
Debt $152.0
 $95.0
Less: Cash and cash equivalents 36.5
 29.5
Net debt $115.5
 $65.5
Net debt, a financial measure that is not calculated or presentedDecember 27, 2021. The Company’s revolving credit agreement allows borrowings of up to $375 million and matures in accordance with GAAP, is not intended to represent debt as defined by GAAP, but is utilized by management in evaluating financial leverage and equity valuation.June 2024. The Company believes that investors also may find net debt helpful forits most restrictive covenant (computed quarterly) is the same purposes. Consolidated netleverage ratio, which permits maximum borrowings of up to 4x Credit EBITDA. The Company had Credit EBITDA and a leverage ratio (calculated in the “Liquidity and Capital Resources” below) of $90.0 million and 0.81x, respectively, at December 31, 2021.
Net capitalization and other credit measures are provided in Liquidity and Capital Resources, below.
Forward-looking and Cautionary Statements
Some of the Financial Condition section.information contained in this Form 10-K may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When using the words “believe,” “estimate,” “anticipate,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, Tredegar does so to identify forward-looking statements. Such statements are based on Tredegar’s then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that Tredegar’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of the COVID-19 pandemic. As a consequence, the Company's results could differ significantly from its projections, depending on, among other
17


things, the ultimate impact of the pandemic on employees, supply chains, customers and the U.S. and world economies. Accordingly, you should not place undue reliance on these forward-looking statements. For risks and important factors that could cause actual results to differ from expectations, refer to the reports that Tredegar files with or furnishes the SEC from time-to-time, including the risks and important factors set forth in Item 1A. Readers are urged to review and consider carefully the disclosures Tredegar makes in the reports Tredegar files with or furnishes to the SEC. Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
Critical Accounting Policies and Estimates
In the ordinary course of business, the Company makes a number of estimates and assumptions relating to the reporting of results of operations and financial position in theThe preparation of financial statements in conformityaccordance with GAAP.GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Certain accounting policies, as described below, are considered "critical accounting policies" because they are particularly dependent on estimates made by management about matters that are inherently uncertain and could have a material impact on the Company’s consolidated financial statements. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that management believes are reasonable under the circumstances. Actual results could differ significantly from those estimates under different assumptions and conditions. The Company believes the following discussion addresses its criticalA summary of all of our significant accounting policies. These policies require management to exercise judgments that are often difficult, subjective and complex dueis included in Note 1 to the necessity of estimating the effect of matters that are inherently uncertain.Consolidated Financial Statements in Item 15.
Impairment and Useful Lives of Long-lived Identifiable Assets and Goodwill
The Company assesses its long-lived identifiable assets for impairment when events or circumstances indicate that their carrying value may not be recoverable from future cash flows. Any necessary impairment charges are recorded when the Company does not believe the carrying value of the long-lived asset(s) will be recoverable. Tredegar also reassesses the useful lives of its long-lived assets based on changes in the business and technologies.
The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). When assessing goodwill for impairment, accounting guidance allows the Company to first perform a qualitative assessment about the likelihood of the carrying value of a reporting unit exceeding its fair value, referred to as the Step 0 assessment. The Step 0 assessment requires the evaluation of certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well as company and reporting unit factors. If the Company's Step 0 analysis indicates that it is more likely than not that the fair value of a reporting unit is less than the carrying amount, then the Company would perform a quantitative impairment test.
As of December 31, 2017,1, 2021, the Company’s reporting units with goodwill were Surface Protection in PE Films and Futura in Aluminum Extrusions carriedExtrusions. Both of these reporting units have separately identifiable operating net assets (operating assets including goodwill balances. Goodwilland identifiable intangible assets net of operating liabilities). In addition, 2021 the PE Films operating units, Personal Care andCompany applied the Step 0 goodwill assessment to Surface Protection and Futura; both had fair values significantly in excess of their carrying amounts when last tested using the quantitative impairment test. The Company's Step 0 analyses in 2021 of these reporting units concluded that it is not more likely than not that the fair values of each reporting unit was less than its carrying amount. Therefore, the quantitative goodwill impairment tests for these reporting units were not necessary in 2021. The Surface Protection and Futura reporting units had goodwill in the amounts of $46.8$57.3 million and $57.3 million, respectively, was tested for impairment at the annual testing date, with the estimated fair value of these reporting units exceeding the carrying value of their net assets by approximately 15% and +100%, respectively, at December 1, 2017.
All goodwill associated with Flexible Packaging Films was impaired in the third quarter of 2015. In 2017, Flexible Packaging Films’ recorded a charge for the impairment of assets in the amount of $101 million. As part of this write-down, trade names, customer relationships and proprietary technology were impaired by $4.0 million, $9.4 million and $4.1 million, respectively, reducing their values to $2.4 million, $0.8 million and $0.4 million, respectively. The remaining part of the write-down was related to property, plant and equipment. See Terphane Asset Impairment Loss and Worthless Stock Deduction in Flexible Packaging Films in the Executive Summary section for more details.
Goodwill of the Aluminum Extrusions operating units are associated with the October 2012 acquisition of AACOA and the February 2017 acquisition of Futura. The estimated fair value of AACOA and Futura exceeded the carrying value of their net assets by approximately 61% and 42%, respectively, at December 1, 2017. Goodwill for AACOA and Futura totaled $13.7 million and $10.4$13.3 million, respectively, at December 31, 2017.2021.


In assessing the recoverability of goodwill and long-lived identifiable assets, the Company primarily estimates fair value using discounted cash flow analysis and comparative enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and amortization) multiples. These calculations require management to make assumptions regarding estimated future cash flows, discount rates and other factors to determine if an impairment exists. If these estimates or their related assumptions change in the future, the Company may be required to record additional impairment charges.
In addition to the impairment of Terphane’s assets, based upon assessments performed as to the recoverability of other long-lived identifiable assets, the Company recorded an asset impairment loss for continuing operations of $1.2 million, $0.6 million and $0.2 million in 2017, 2016 and 2015, respectively.
Investment Accounted for Under the Fair Value Method
In August 2007 and December 2008, Tredegar made an aggregate investment of $7.5 million in kaléo (formerly Intelliject, Inc.), a privately held specialty pharmaceutical company. This investment is accounted for under the fair value method. At the time of the initial investment, the Company elected the fair value option of accounting since its investment objectives were similar to those of venture capitalists, which typically do not have controlling financial interests (venture capital funds generally use the fair value method to account for their investment portfolios). At December 31, 2017, Tredegar’s ownership interest was approximately 20% on a fully diluted basis.
The Company discloses the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). On the dates of its investments, Tredegar believes that the amount it paid for its ownership interest and liquidation preferences was based on Level 2 inputs, including investments by other investors. Subsequent to the last round of financing, and until the next round of financing, the Company believes fair value estimates are based upon Level 3 inputs since there is no secondary market for Tredegar’s ownership interest. Accordingly, after the latest financing and until the next round of financing or any other significant financial transaction, fair value estimates will primarily be based on assumptions relating to meeting cash flow projections and discounting of these factors for the high degree of risk. Adjustments to the estimated fair value of this investment will be made in the period upon which such changes can be quantified.
At December 31, 2017 and 2016, the fair value of the Company’s investment in kaléo (also the carrying value, which is separately stated in the consolidated balance sheets) was estimated at $54.0 million and $20.2 million, respectively. The weighted average cost of capital used in the fair market valuation of the Company’s interest in kaléo was 45% at both December 31, 2017 and 2016. Ultimately, the true value of the Company’s ownership interest in kaléo will be determined if and when a liquidity event occurs, and the ultimate value could be materially different from the $54.0 million estimated fair value at December 31, 2017. The fair market valuation of Tredegar’s interest in kaléo is sensitive to changes in the weighted average cost of capital used to discount cash flow projections for the high degree of risk and wide range of possible outcomes. At December 31, 2017, the effect of a 500 basis point decrease in the weighted average cost of capital assumption would have further increased the fair value of the Company’s interest in kaléo by approximately $11 million, and a 500 basis point increase in the weighted average cost of capital assumption would have decreased the fair value of the Company’s interest by approximately $10 million. See Note 4 of the Notes to Financial Statements for more information.
Pension Benefits
Tredegar sponsors noncontributory defined benefit (pension) plans in its continuing operations that have resulted in varying amounts of net pension income or expense, as developed from actuarial valuations. Inherent in these valuations are key assumptions including discount rates and the expected return on plan assets and rate of future compensation increases.assets. The Company is required to consider current market conditions, including changes in interest rates and plan asset investment returns, in determining these assumptions. Actuarial assumptions may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of participants. These differences may result in a significant impact to the amount of net pension income or expense recorded in future periods.
The discount rate is used to determine the present value of future payments. The discount rate is the single rate that, when applied to expected benefit payments, provides a present value equal to the present value of expected benefit payments determined by using the AA-rated bond yield curve. In general, the pension liability increases as the discount rate decreases and vice versa. The weighted average discount rate utilized was 3.72%2.90%, 4.29%2.57% and 4.55%3.27% at the end of 2017, 20162021, 2020 and 2015,2019, respectively, with changes between periods due to changes in market interest rates. Pay for active participants of the plan was frozen as of December 31, 2007. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan. On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete. As the settlement process occurs, the Company expects to recognize a non-cash reclassification adjustment to net income or loss of other comprehensive net actuarial losses associated with the pension plan currently reflected directly in shareholders’ equity. Other comprehensive net actuarial losses associated with the pension plan were approximately $109 million on a pretax basis as of December 31, 2021.

18



A lower expected return on plan assets increases the amount of expense and vice versa. Decreases in the level of actual plan assets will also serve to increase the amount of pension expense. The total return on plan assets (net of fees and plan expenses), which is primarily affected by the change in fair value of plan assets, current year contributions and current year payments to participants, was approximately 11.6%, 7.9%10.4% in 2021, 10.9% in 2020 and (1.8)%11.8% in 2017, 2016 and 2015, respectively.2019. The expected long-term rate return on plan assets relating to continuing operations, which is estimated byof 3.05%, 5.00% and 6.00% in 2021, 2020 and 2019 was developed through consultation with the Company’s investment advisors. Several factors were considered, including prevailing and planned strategic asset classallocations, current and generally based onexpected future market conditions, inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums, was 6.50%, 7.00% and 7.50% in 2017, 2016 and 2015, respectively.premiums. The Company anticipates that its expected long-term return on plan assets will be 6.50%3.05% for 2018.2022. See Note 13 of8 to the Notes toConsolidated Financial Statements in Item 15 for more information on expected long-term return on plan assets and asset mix.
See the Executive Summary section above for further discussion regarding the financial impact of the Company’s pension plans.
Income Taxes
On a quarterly basis, Tredegar reviews its judgments regarding uncertainCurrent tax positionsliabilities and assets are recognized for the estimated taxes payable or refundable, respectively, on the tax returns for the current year. Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Accordingly, accounting for income taxes represents the Company’s best estimate of various events and transactions. Tax laws are often complex and may be subject to differing interpretations by the taxpayer and the likelihood that the benefits ofrelevant governmental taxing authorities. In establishing a deferred income tax asset will be realized. As circumstances change, the Company reflects in earnings any adjustments to unrecognized benefitsprovision for uncertain tax positions and valuation allowances for deferred income tax assets.
For financial reporting purposes, unrecognized tax benefits on uncertain tax positions were $2.0 million, $3.3 million and $4.0 million as of December 31, 2017, 2016 and 2015, respectively. Tax payments resulting from the successful challenge by the taxing authority on uncertain tax positions taken by Tredegar would possibly result in the payment of interest and penalties. Accordingly, the Company also accrues for possible interest and penalties on uncertain tax positions. The balance of accrued interest and penalties on deductions taken relating to uncertain tax positions was $0.1 million, $0.1 million and $0.4 million at December 31, 2017, 2016 and 2015, respectively ($0.1 million, $0.1 million and $0.2 million, respectively, net of corresponding U.S. federal and state income tax benefits). Accruals for possible interest and penalties on uncertain tax positions are reflected in income tax expense, for financial reporting purposes.
Tredegar or onemust make judgments and interpretations about the application of its subsidiaries, files income tax returnslaws. The Company must also make estimates about when in the U.S. federal jurisdiction,future certain items will affect taxable income in the various states and jurisdictions outsidetaxing jurisdictions.
A valuation allowance is recorded in the U.S. With few exceptions, Tredegarperiod when the Company determines that it is no longer subject to U.S. federal, statemore likely than not that all or non-U.S. income tax examinations by tax authorities for years before 2014.
Asa portion of December 31, 2017 and 2016, valuation allowances relating to deferred income tax assets were $28.5 millionmay not be realized. The establishment and $12.7 million, respectively. For moreremoval of a valuation allowance requires the Company to consider all positive and negative evidence and make a judgmental decision regarding the amount of valuation allowance required as of a reporting date.
Tredegar may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change, or when new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur.
See Note 12 to the Consolidated Financial Statements in Item 15 for additional information on deferred income tax assets and liabilities, see Note 16 of the Notes to Financial Statements.taxes.
Recently Issued Accounting Standards
Refer to the section Recently Issued Accounting Statements in Note 1 of the Notes to Financial Statements for information concerning the effect of recently issued accounting pronouncements.
Results of Continuing Operations
20172021 versus 20162020
Revenues. Sales in 20172021 increased by 16.1%9.4% compared with 2016 due to higher sales in all segments and, in particular, from the acquisition of Futura by Aluminum Extrusions in February 2017.2020. Net sales increased 6.4%18.3% in Aluminum Extrusions primarily due to an increase in average selling prices to cover significantly higher aluminum raw material costs and higher operating costs, partially offset by lower sales volume. Net sales decreased 14.6% in PE Films primarily due to increasedlower volume and favorable salesunfavorable mix for surface protection films, acquisition distribution layer materials and overwrap products.associated with the previously disclosed customer product transitions in Surface Protection, partially offset by higher pricing associated with the pass-through of increased resin costs. Net sales were relatively flatincreased in Flexible Packaging Films (0.3% increase). Net sales increased 29.6% in Aluminum Extrusionsby 4.0% primarily due to higher selling prices from the acquisitionpass-through of Futura, higher sales volume, improvedresin costs and favorable product mix, and an increase in average selling prices primarily due to the pass-through to customers of higher market-driven raw material costs.partially offset by lower sales volume. For more information on changes in net sales and volume, see the Executive Summary.section above.
Operating Costs and Expenses. Consolidated gross profit margin (sales minus cost of goods sold and freightfreight) as a percentage of sales)sales (gross profit margin) was 15.8%18.0% in 20172021 versus 22.6% in 2020. The gross profit margin in Aluminum Extrusions decreased primarily due to higher labor and 15.8% in 2016.employee-related costs and other inflationary operating costs such as higher supply expenses, partially offset by higher pricing. The gross profit margin in PE Films increaseddecreased primarily due to Surface Protection lower sales and unfavorable mix associated with the customer product transitions, lower sales and unfavorable mix for products unrelated to customer product transitions, and margin erosion associated with higher revenue, as discussed above,resin costs that occurred before the realized cost savings of a restructuring completed in 2017, productivity efficiencies in surface protection films and personal care, and a favorable LIFO inventory adjustment.resin index pricing plan was fully implemented. The gross profit margin in Flexible Packaging Films decreased primarily as a result of lower production primarily due to numerous intermittent power outages at Terphane’s Cabo, Brazil plant, during the third quarter,lower sales volume and higher raw material and other costs, related to adverse impact of high inflation in Brazil, partially offset by lower foreign currency transaction losses in 2017 versus 2016. The gross profit margin in Aluminum Extrusions increased slightly due to higher sales volume and improvedfavorable product mix noted above, partially offset by increased operating costs, disruptions to normal plant production associated withand higher selling prices from the startuppass-through of a new press at the Niles, Michigan plant and an unfavorable LIFO adjustment. Consolidated gross profit as a percentage of sales was positively impacted by lower


pension expense in 2017 compared to 2016. Most of the impact related to pension expense is not allocated to the Company’s business segments.
higher resin costs. For more information on changes in operating costs and expenses, see the Executive Summary.section above.
Selling, General and Administrative. As a percentage of sales, selling, general and administrative (“SG&A”) and R&D expenses were 10.8%9.8% in 2017, which decreased from 11.5%2021 compared with 12.3% in 2016. The decrease in selling, general and administrative2020. SG&A and R&D expenses as a percentagewere down year-over-year, while net sales increased. Decreased spending is primarily due to non-recurring corporate costs associated with the divested Personal
19


Care Films business, lower R&D spending in PE Films, lower stock-based compensation, and nonrecurring SG&A expenses related to the Bright View Technologies divestiture at the end of sales can be primarily attributed to higher sales as a result of the acquisition of Futura.2020.
Plant shutdowns, asset impairments, restructurings and other. PlantPre-tax losses associated with plant shutdowns, asset impairments, restructurings and other items for continuing operations in 20172021 detailed below are shown in the statements of net sales and EBITDA from ongoing operations by segment operating profit table in Note 513 to the Consolidated Financial Statements in Item 15 and are describedincluded in detail“Asset impairments and costs associated with exit and disposal activities, net of adjustments” in Note 17the consolidated statements of the Notes to Financial Statements.income, unless otherwise noted. A discussion of unrealized gains and losses on investments can also be found in Note 4 of16 to the NotesFinancial Statements in Item 15 and additional information on restructuring costs can be found in Note 17 to the Consolidated Financial Statements. in Item 15.

20


($ in millions)Q1Q2Q3Q42021
Aluminum Extrusions:
(Gains) losses from sale of assets, investment writedowns and other items:
Consulting expenses for ERP feasibility study1
$— $— $— $0.3 $0.3 
Futura intangible amortization out-of-period adjustment6
— — — (0.9)(0.9)
Vacation accrual policy change5
— — — (2.9)(2.9)
Environmental charges at Newnan, Georgia plant3
— — 0.1 0.1 0.2 
COVID-19-related expenses, net of relief 2
(0.2)0.3 0.1 (0.1)0.1 
Total for Aluminum Extrusions$(0.2)$0.3 $0.2 $(3.5)$(3.2)
PE Films:
(Gains) losses associated with plant shutdowns, asset impairments and restructurings:
Other restructuring costs - severance$— $— $0.1 $0.3 $0.4 
(Gains) losses from sale of assets, investment writedowns and other items:
Vacation accrual policy change5
— — — (0.5)(0.5)
COVID-19-related expenses2
0.2 0.1 0.1 0.1 0.5 
Total for PE Films$0.2 $0.1 $0.2 $(0.1)$0.4 
Flexible Packaging Films:
(Gains) losses from sale of assets, investment writedowns and other items:
One-time tax credit in Brazil for unemployment/social security insurance non-income taxes resulting from a favorable decision by Brazil’s Supreme Court regarding the calculation of such taxes 2,4
$— $(8.5)$— $— $(8.5)
COVID-19-related expenses2
— — — 0.1 0.1 
Total for Flexible Packaging Films$— $(8.5)$— $0.1 $(8.4)
Corporate:
(Gains) losses associated with plant shutdowns, asset impairments and restructurings:
Costs, net of gain associated with the sale of the Lake Zurich manufacturing facility assets$0.2 $0.2 $(0.2)$(0.1)$0.1 
Other restructuring costs - severance— — — 0.2 0.2 
(Gains) losses from sale of assets, investment writedowns and other items:
Professional fees associated with business development activities and other2
0.8 0.8 0.7 1.6 3.9 
Professional fees associated with internal control over financial reporting2
0.20.90.81.23.1 
Write-down of investment in Harbinger Capital Partners Special Situations Fund2
0.1 0.4 — — 0.5 
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 Special Dividend1
0.4 0.1 (0.1)— 0.4 
Transition service fees, net of corporate costs associated with the divested Personal Care Films business2
(0.3)(0.3)0.1 0.2 (0.3)
Vacation accrual policy change5
— — — (0.4)(0.4)
Total for Corporate$1.4 $2.1 $1.3 $2.7 $7.5 
1.Included in “Selling, general and administrative expenses” in the consolidated statements of income.
2. Included in “Other income (expense), net” in the consolidated statements of income.
3. Included in "Costs of goods sold" in the consolidated statements of income.
4. For more information, see Note 9 to the consolidated financial statements in Item 15.
5. For more information, see Note 6 to the consolidated financial statements in Item 15.
6. Included in “Amortization of identifiable intangibles” in the consolidated statements of income.
Interest Income and Expense. Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $0.2 million in 2017 and $0.3 million in 2016.
Interest expense, which is net of amounts capitalized and included in property, plant and equipment ($0.40.1 million and $0.3$0.1 million capitalized in 20172021 and 2016,2020, respectively), was $6.2$3.4 million in 2017,2021, compared to $3.8$2.6 million for 2016. In February 2017, the Company borrowed $87 million under its revolving credit agreement to fund the acquisition of Futura. Interest expense in 2016 included the write-off of $0.2 million in unamortized loan fees from Tredegar’s revolving credit facility that was refinanced in the first quarter of 2016.2020. Average debt outstanding and interest rates were as follows:
21


(In millions, except percentages)2017 2016(In millions, except percentages)20212020
Floating-rate debt with interest charged on a rollover   
basis at one-month LIBOR plus a credit spread:   
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:
Average outstanding debt balance$175.0
 $103.5
Average outstanding debt balance$128.8 $33.5 
Average interest rate3.0% 2.3%Average interest rate1.8 %2.3 %
Fixed-rate and other debt:   
Average outstanding debt balance$
 $
Average interest raten/a
 n/a
Total debt:   
Average outstanding debt balance$175.0
 $103.5
Average interest rate3.0% 2.3%
Identifiable Assets. A summary of identifiable assets for the year ended December 31, 2017 versus 2016 is provided below:
(In thousands)Year Ended
December 31
  
 2017 2016 Variance
PE Films$289,514
 $278,558
 $10,956
Flexible Packaging Films49,915
 156,836
 (106,921)
Aluminum Extrusions268,127
 147,639
 120,488
      Subtotal607,556
 583,033
 24,523
General corporate111,696
 38,618
 73,078
Cash and cash equivalents36,491
 29,511
 6,980
      Total$755,743
 $651,162
 $104,581
Identifiable assets in PE Films increased at December 31, 2017 from December 31, 2016 primarily due to higher property, plantLiquidity and equipment balances as a result of higher current year capital expenditures. Identifiable assets in Flexible Packaging Films decreased at December 31, 2017 from December 31, 2016 due to the impairment of assets recognized during the fourth quarter of 2017. For more information on the impairment, see the Flexible Packaging Films section of the Executive Summary. Identifiable assets in Aluminum Extrusions increased at December 31, 2017 from December 31, 2016 primarily due to the acquisition of Futura and higher property, plant and equipment balances as a result of current year capital expenditures, higher accounts receivable balances due to the timing of collections and higher inventory balances. Identifiable assets in


General corporate increased at December 31, 2017 from December 31, 2016 due to an increase in income taxes recoverable and an increase in the value of the Company’s investment in kaléo.
2016 versus 2015
Revenues. Sales in 2016 decreased by 7.6% compared with 2015 due to lower sales by PE Films and Aluminum Extrusions, partially offset by higher sales by Flexible Packaging Films. Net sales decreased 14.1% in PE Films primarily due to lower volume from lost sales, product transitions and adverse market demand for certain products. Net sales increased 2.6% in Flexible Packaging Films from higher volume partially due to the increase of end-use applications for flexible packaging films in the Latin American market, partially offset by competitive pricing pressures and the pass-through to customers of lower raw material costs. Net sales decreased 4.1% in Aluminum Extrusions primarily due to a decrease in average selling prices driven mainly by lower aluminum costs, partially offset by higher sales volume in the automotive market.
Operating Costs and Expenses. Consolidated gross profit margin (sales minus cost of goods sold and freight as a percentage of sales) was 15.8% in 2016 and 15.7% in 2015. The gross profit margin in PE Films decreased due to lower revenue, as discussed above, an unfavorable lag in the pass-through of average resin costs, productivity inefficiencies in surface protection films and an unfavorable LIFO inventory adjustment. The gross profit margin in Flexible Packaging Films increased primarily as a result of higher sales volume, as discussed above, operating efficiencies and lower other costs and expenses, partially offset by net refunds in 2015 of export duties paid. The gross profit margin in Aluminum Extrusions increased primarily as a result of higher volume, production efficiencies, improved management of freight logistics and lower utility costs. Consolidated gross profit as a percentage of sales was positively impacted by lower pension expenses in 2016 compared to 2015. Most of the impact related to pension expense is not allocated to the Company’s business segments.
Selling, General and Administrative. As a percentage of sales, selling, general and administrative and R&D expenses were 11.5% in 2016, which increased from 9.8% in 2015. The increase in selling, general and administrative and R&D expenses as a percentage of sales can be primarily attributed to the higher R&D expenses.
Plant shutdowns, asset impairments, restructurings and other. Plant shutdowns, asset impairments, restructurings and other items in 2016 are shown in the segment operating profit table in Note 5 and are described in detail in Note 17 of the Notes to Financial Statements. A discussion of unrealized gains and losses on investments can also be found in Note 4 of the Notes to Financial Statements.
Interest Income and Expense. Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $0.3 million in both 2016 and 2015.
Interest expense, which is net of amounts capitalized and included in property, plant and equipment ($0.3 million and $0.4 million capitalized in 2016 and 2015, respectively), was $3.8 million in 2016, compared to $3.5 million for 2015. Interest expense in 2016 included the write-off of $0.2 million in unamortized loan fees from Tredegar’s revolving credit facility that was refinanced, in the first quarter of 2016. Average debt outstanding and interest rates were as follows:
(In millions, except percentages)2016 2015
Floating-rate debt with interest charged on a rollover   
basis at one-month LIBOR plus a credit spread:   
Average outstanding debt balance$103.5
 $135.1
Average interest rate2.3% 2.0%
Fixed-rate and other debt:   
Average outstanding debt balance$
 $
Average interest raten/a
 n/a
Total debt:   
Average outstanding debt balance$103.5
 $135.1
Average interest rate2.3% 2.0%
Identifiable Assets. A summary of identifiable assets for the year ended December 31, 2016 versus 2015 is provided below:


(In thousands)Year Ended
December 31
  
 2016 2015 Variance
PE Films$278,558
 $270,236
 $8,322
Flexible Packaging Films156,836
 146,253
 10,583
Aluminum Extrusions147,639
 136,935
 10,704
      Subtotal583,033
 553,424
 29,609
General corporate38,618
 25,680
 12,938
Cash and cash equivalents29,511
 44,156
 (14,645)
      Total$651,162
 $623,260
 $27,902
Identifiable assets in PE Films increased at December 31, 2016 from December 31, 2015 primarily due to higher property, plant and equipment balances as a result of higher current year capital expenditures. Identifiable assets in Flexible Packaging Films increased at December 31, 2016 from December 31, 2015 primarily due to higher property, plant and equipment balances as a result of changes in the value of the U.S. Dollar relative to foreign currencies, partially offset by depreciation and amortization. Identifiable assets in Aluminum Extrusions increased at December 31, 2016 from December 31, 2015 primarily due to higher property, plant and equipment balances as a result of current year capital expenditures, higher accounts receivable balances due to the timing of collections and higher inventory balances. Identifiable assets in General Corporate increased at December 31, 2016 from December 31, 2015 due to an increase in income taxes recoverable, deferred financing fees from the refinancing of the revolving credit facility, and an increase in the value of the Company’s investment in kaléo.
Segment Analysis. A summary of operating results for 2016 versus 2015 for each of the Company’s reporting segments is shown below.
PE Films
A summary of operating results for PE Films is provided below:
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2016 2015 % Change
Sales volume (pounds)139,020
 160,283
 (13.3)%
Net sales$331,146
 $385,550
 (14.1)%
Operating profit from ongoing operations$26,312
 $48,275
 (45.5)%


Net sales in 2016 decreased by $54.4 million versus 2015 primarily due to:Capital Resources
The loss of business with PE Films’ largest customer related to various products in personal care materials ($22.0 million) and other personal care materials customers ($7.6 million);
Lower volume in personal care materials primarily due to the timing of product transitions and lower customer demand ($10.8 million);
A decline in volume in surface protection films ($6.2 million) that the Company believes is primarily the result of lower consumer demand for products with flat panel display screens; and
Lower volume of low margin overwrap films ($9.1 million) primarily due to the loss of business with a large customer, partially offset by sales growth for components used in LED lighting products ($1.3 million).
Sales volume in 2016 declined in part due to the wind down of shipments for certain personal care materials related to previously announced known lost business, primarily with PE Films’ largest customer. The table below summarizes the pro forma operating profit from ongoing operations for 2016 and 2015, had the impact of the lost business been fully realized:
 Year Ended December 31,
(In thousands)20162015
Operating profit from ongoing operations, as reported$26,312$48,275
Contribution to operating profit from ongoing operations associated with known lost business before restructurings & fixed costs reduction2,995
13,349
Operating profit from ongoing operations net of the impact of known business that will be fully eliminated in future periods23,317
34,926
Estimated future benefit of North American facility consolidation5,200
5,200
Pro forma estimated operating profit from ongoing operations$28,517$40,126
Net sales associated with known lost business that had not been fully eliminated were $8.9 million and $38.5 million in 2016 and 2015, respectively.
Net of the impact of known lost business, pro forma estimated operating profit from ongoing operations in 2016 decreased by $11.6 million versus 2015 primarily due to:
Lower contribution to profits from surface protection films ($5.0 million) primarily due to lower volume and productivity issues;
Lower contribution to profits in personal care materials primarily due to volume declines resulting from the timing of product transitions and lower customer demand ($3.1 million) and lower productivity ($1.8 million) due in part to operational inefficiencies largely related to elastics production for European customers sourced from the Lake Zurich, Illinois facility;
The unfavorable lag in the pass-through of average resin costs of $0.2 million in 2016 versus the favorable lag of $1.3 million in 2015;
A charge for inventories accounted for under the LIFO method of $0.9 million in 2016 versus income of $0.4 million in 2015;
Higher contribution to profits from other products in PE Films ($0.7 million); and
Higher research and development expenses to support new product opportunities ($3.0 million), offset by lower general, sales and administrative expenses ($3.6 million).
Capital Expenditures and Depreciation & Amortization
Capital expenditures in PE Films were $25.8 million in 2016 compared to $21.2 million in 2015. Depreciation expense was $13.5 million in 2016 and $15.4 million in 2015. Amortization expense was $0.1 million in 2016 and $0.1 million in 2015.


Flexible Packaging Films
A summary of operating results for Flexible Packaging Films, which excludes the 2015 goodwill impairment charge, is provided below:
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2016 2015 % Change
Sales volume (pounds)89,706
 82,347
 8.9 %
Net sales$108,028
 $105,332
 2.6 %
Operating profit from ongoing operations$1,774
 $5,453
 (67.5)%

Net sales in 2016 increased 2.6% versus 2015 primarily due to a 8.9% increase in sales volume partially offset by competitive pricing pressures and the pass-through to customers of lower raw material costs. Sales volume improved from 2015 to 2016 partially due to the increase of end-use applications for flexible packaging films in the Latin American market.
Operating profit from ongoing operations decreased by $3.7 million in 2016 versus 2015 primarily due to:
Foreign currency transaction losses of $3.5 million in 2016 versus foreign currency transaction gains of $3.5 million in 2015, associated with U.S. Dollar denominated export sales in Brazil;
Higher volume ($3.0 million) and operating efficiencies ($0.7 million);
Net refunds of $1.6 million in 2015 received as a result of the reinstatement by the U.S. of the Generalized System of Preferences (GSP) program for allowing duty-free shipments of Terphane products into the U.S. (none in 2016);
The favorable settlement of certain loss contingencies of $0.6 million in 2015 (none in 2016);
The estimated lag in the pass through of lower raw material costs of $1.2 million in 2016 versus $1.0 million in 2015; and
Lower depreciation and amortization costs ($0.2 million) and other costs and expenses ($1.4 million).
Capital Expenditures, Depreciation & Amortization and Goodwill Impairment Charge
Capital expenditures were $3.4 million in 2016 compared to $3.5 million in 2015. Depreciation expense was $6.7 million in 2016 and $6.8 million in 2015. Amortization expense was $2.8 million in 2016 and $2.9 million in 2015.
During the third quarter of 2015, the Company performed a goodwill impairment assessment related to Terphane. This review was undertaken as a result of the continued competitive pressures related to ongoing unfavorable economic conditions in Terphane’s primary market of Brazil, and excess global industry capacity. The assessment resulted in a full write-off of the goodwill of $44.5 million associated with the acquisition of Terphane.
Aluminum Extrusions
A summary of operating results for Aluminum Extrusions is provided below:
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2016 2015 % Change
Sales volume (pounds)172,986
 170,045
 1.7 %
Net sales$360,098
 $375,457
 (4.1)%
Operating profit from ongoing operations$37,794
 $30,432
 24.2 %
Net sales in 2016 decreased versus 2015 primarily due to a decrease in average selling prices, partially offset by higher sales volume. Higher sales volume, primarily in the automotive market, had a favorable impact of $4.7 millioncontinuously focuses on sales in 2016 versus 2015. Lower average selling prices, which had an unfavorable impact on net sales of $20.8 million, can be primarily attributed to a decrease in average aluminum market prices.
Operating profit from ongoing operations in 2016 increased in comparison to 2015 by $7.4 million, as a result of:


Higher volume ($0.9 million) and lower materials, supply and other net costs ($2.6 million, including $0.7 million of construction-related costs incurred in 2015 for the anodizing upgrade project); and
Improved management of freight logistics and lower utility costs ($2.2 million) and other efficiencies ($1.8 million).
Cast House Explosion
During 2016, Bonnell Aluminum recognized a gain of $1.9 million for insurance recoveries to-date associated with assets destroyed or damaged in the cast house explosion (included in “Other income (expense), net” in the Consolidated Statements of Income - see Note 17 of the Notes to Financial Statements for additional details). The Company also incurred $5.0 million of additional expenses during 2016, $4.3 million of which had been fully offset by insurance recoveries (netted in “Cost of goods sold” in the Consolidated Statements of Income and in “Plant shutdowns, asset impairments, restructurings and other” in the Operating Profit table in Note 5 of the Notes to Financial Statements). The remaining $0.7 million in 2016 of additional expenses for which recovery from insurance was not assured was included in “Cost of goods sold” in the Consolidated Statements of Income.
Capital Expenditures and Depreciation & Amortization
Capital expenditures for Aluminum Extrusions were $15.9 million in 2016 compared to $8.1 million in 2015. Capital expenditures in 2016 included approximately $5 million for routine capital expenditures required to support operations and $9 million of a total of $18 million to add extrusions capacity at the Niles, Michigan, manufacturing facility.  Depreciation expense was $8.1 million in 2016 compared to $8.7 million in 2015. Amortization expense was $1.0 million in 2016 and $1.0 million in 2015.
Financial Condition
Assets and Liabilities
Tredegar’s management continues to focus on improving working capital management. Measures such as days sales outstanding (“DSO”), days inventory outstanding (“DIO”) and days payables outstanding (“DPO”) are used by the Company to evaluate changes in working capital. Significant changesChanges in operating assets and liabilities from continuing operations from December 31, 20162020 to December 31, 20172021 are summarized below:below. Cash flows for discontinued operations have not been separately disclosed in the consolidated statements of cash flows.
Accounts and other receivables increased $22.7$17.0 million (23.4%)or 19.7%.
Accounts and other receivables in PE FilmsAluminum Extrusions increased by $2.1$17.1 million primarily due mainly to the timing of cash receiptsan increase in average selling prices to cover significantly higher aluminum raw material costs and collections.higher operating costs, partially offset by lower sales volume and improved collection efforts in 2021. DSO (computed using trailing 12 months net sales and a rolling 12-month average of accounts and other receivables balances) was approximately 48.447.6 days in 20172021 and 45.747.5 days in 2016.2020.
Accounts and other receivables in PE Films decreased by $0.6 million primarily due to lower volume and unfavorable mix associated with the previously disclosed customer product transitions in Surface Protection, partially offset by higher pricing associated with the pass-through of increased resin costs. DSO was approximately 28.5 days in 2021 and 30.2 days in 2020.
Accounts and other receivables in Flexible Packaging Films increased by $0.3$1.3 million primarily due to higher selling prices from the impactpass-through of the change in the value of the U.S. Dollar relative to the Brazilian real.higher resin costs and favorable product mix, partially offset by lower sales volume. DSO was approximately 53.240.0 days in 20172021 and 51.841.0 days in 2016.2020.
Accounts and other receivablesInventories increased $22.1 million or 33.3%.
Inventories in Aluminum Extrusions increased by $20.6$17.4 million primarily due to the acquisition of Futura in February 2017, which added $10.0 million, higher salesaverage aluminum prices and the timing of cash receipts. DSO was approximately 43.3 days in 2017COVID-19-related operational and 43.3 days in 2016.
Inventories increased $20.8 million (31.5%).
Inventories in PE Films increased by $3.9 million primarily due to increased production to accommodate higher demand and the timing of raw material purchases.inefficiencies. DIO (computed using trailing 12 months costs of goods sold calculated on a first-in, first-outfirst in, first out basis and a rolling 12-month average of inventory balances calculated on the first-in, first-out basis) was approximately 55.041.4 days in 20172021 and 52.239.3 days in 2016.2020.
Inventories in PE Films decreased by $2.1 million primarily due to lower planned raw material levels as a result of lower sales volume in 2021 compared to 2020. DIO was approximately 62.8 days in 2021 and 59.2 days in 2020.
Inventories in Flexible Packaging Films increased by $1.3$6.8 million primarily related to higher average resin prices, higher finished good levels due to lower than anticipated sales demand and higher planned raw material levels due to resin supply issues. DIO was approximately 93.1 days in 2021 and 89.4 days in 2020.
Net property, plant and equipment increased by $3.8 million (2.3%) primarily due to capital expenditures of $27.8 million, partially offset by depreciation expense of $22.1 million and a reduction from the impacteffect of the changechanges in the valueforeign exchange rates of the U.S. Dollar relative$0.8 million.
Goodwill and identifiable intangible assets, net decreased by $1.8 million (2.0%) primarily due to the Brazilian real. DIO was approximately 70.1 days in 2017 and 77.0 days in 2016.amortization expense.
InventoriesAccounts payable increased by $34.1 million or 38.0%.
Accounts payable in Aluminum Extrusions increased by $15.6$23.7 million, primarily due to the addition of balances from the acquisition of Futura, which added $9.7 million, the restart of the Newnan, Georgia cast househigher average aluminum prices and the timing of purchases. DIO was approximately 32.6 days in 2017 and 26.5 days in 2016.
Net property, plant and equipment decreased $37.6 million (14.4%) due primarily to the property and equipment added from the acquisition of Futura of $32.7 million and capital expenditures of $44.4 million, more than offset by the impairment of assets at Terphane ($83.1 million) and depreciation of $34.1 million.


Identifiable intangible assets increased by $7.0 million (20.7%) primarily due to balances added from the acquisition of Futura of $30.7 million, partially offset by the write-down of identifiable intangibles at Terphane in the amount of $17.5 million and amortization expense of $6.2 million.
Goodwill increased by $10.4 million (8.8%) due to balances added from the acquisition of Futura.
Accounts payable increased by $27.0 million (33.3%).
Accounts payable in PE Films increased by $6.1 million primarily due to the normal volatility associatedfavorable payment terms with the timing of payments at the end of the year.certain vendors. DPO (computed using trailing 12 months costs of goods sold calculated on a first-in, first-outfirst in, first out basis and a rolling 12-month average of accounts payable balances) was approximately 40.660.1 days in 20172021 and 38.553.1 days in 2016.2020.
Accounts payable in PE Films increased by $4.4 million primarily due to higher resin costs related to raw material purchases in 2021. DPO was approximately 44.0 days in 2021 and 36.8 days in 2020.
Accounts payable in Flexible Packaging Films increased by $2.5 million, due to the timing of payments and the impact of the change in the U.S. Dollar value of currencies for operations outside the U.S. DPO was approximately 42.8 days in 2017 and 39.5 days in 2016.
Accounts payable in Aluminum Extrusions increased by $18.3$6.7 million, primarily due to the addition of balances from the acquisition of Futura, which added $4.3 million, negotiation ofhigher resin costs related to raw material purchases in 2021 and favorable payment terms and the normal volatility associated with the timing of payments.certain vendors. DPO was approximately 48.068.2 days in 20172021 and 45.461.7 days in 2016.
Accrued expenses increased by $3.8 million (9.8%) from December 31, 2016 due to the addition of balances from the acquisition of Futura, which added $2.1 million, higher employee benefit accruals, and higher stock-based compensation obligations.2020.
22


Net noncurrent deferred income tax assetscash provided by operating activities was $70.6 million in excess of noncurrent deferred income tax liabilities increased by $35.02021 compared to $74.4 million in 2020. The decrease was primarily due to numerous changes between yearshigher net working capital ($13.8 million), partially offset by lower pension and postretirement benefit plan contributions ($7.0 million) and lower operating lease payments ($1.1 million) in the balance of the components shown in the December 31, 2017 and 2016 schedule of deferred income tax assets and liabilities provided in Note 16 of the Notes to Financial Statements. The Company had a current income tax receivable of $32.1 million at December 31, 20172021 compared to $7.52020.
Net cash provided by investing activities was $24.5 million at December 31, 2016.in 2021 compared to $32.9 million in 2020. The change isdecrease was primarily due to higher capital expenditure spending of $4.0 million in 2021 and cash proceeds from the sale of Personal Care Films ($55.1 million) and Bright View Technologies ($1.1 million) in 2020, partially offset by cash proceeds received in 2021 in connection with the sale of the Company’s investment in kaléo ($47.1 million) and the sale of the Lake Zurich manufacturing facility assets ($4.7 million).
Net cash used in financing activities was $76.8 million in 2021 compared to $125.6 million in 2020. The decrease was primarily due to a special dividend of $200 million paid to shareholders in 2020, partially offset by higher net borrowings ($153.0 million) in 2020 under the Credit Agreement (as defined below).
The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy short term material cash requirements related to working capital, capital expenditure, debt repayments and dividend requirements for at least the next twelve months. In the longer term, liquidity will depend on many factors, including results of operations, the timing and extent of tax payments and anticipated refunds of netcapital expenditures, changes in operating losses and tax credits available for carryback to prior years.
On March 1, 2016,plans, or other events that would cause the Company entered intoto seek additional financing in future periods.
At December 31, 2021, Tredegar had cash and cash equivalents of $30.5 million, including funds held in locations outside the U.S. of $16.4 million.
Tredegar has a new five-year $400 million secured revolving credit agreement that expires on March 1, 2021 (“revolving credit agreement”(the “Credit Agreement”). providing for aggregate borrowings in an amount of $375 million, which matures in June 2024.
Net capitalization and indebtedness as defined under the revolving credit agreementCredit Agreement as of December 31, 20172021 were as follows:
Net Capitalization and Indebtedness as of December 31, 2017
(In thousands)
 
Net capitalization: 
Cash and cash equivalents$36,491
Debt: 
$400 million revolving credit agreement maturing March 1, 2021152,000
Other debt
Total debt152,000
Debt net of cash and cash equivalents115,509
Shareholders’ equity343,780
Net capitalization$459,289
Indebtedness as defined in revolving credit agreement: 
Total debt$152,000
Face value of letters of credit2,685
Capital lease144
Other250
Indebtedness$155,079


Net Capitalization and Indebtedness as of December 31, 2021
(In thousands)
Net capitalization:
Cash and cash equivalents$30,521 
Debt:
Credit Agreement73,000 
Debt, net of cash and cash equivalents42,479 
Shareholders’ equity184,722 
Net capitalization$227,201 
Indebtedness as defined in Credit Agreement:
Total debt$73,000 
Indebtedness$73,000 
The credit spread and commitment fees charged on the unused amount under our revolving credit agreementthe Credit Agreement at various indebtedness-to-adjustedindebtedness-to-Credit EBITDA levels are as follows:
Pricing Under Revolving Credit Agreement (Basis Points)
Indebtedness-to-Adjusted EBITDA Ratio
Credit Spread
Over LIBOR
 
Commitment
Fee
Pricing Under Credit Agreement (Basis Points)Pricing Under Credit Agreement (Basis Points)
Indebtedness-to-Credit EBITDA RatioIndebtedness-to-Credit EBITDA RatioCredit Spread
Over LIBOR
Commitment
Fee
> 3.5x but <= 4.0x250
 45
> 3.5x but <= 4.0x200.0 40 
> 3.0x but <= 3.5x225
 40
> 3.0x but <= 3.5x187.5 35 
> 2.0x but <= 3.0x200
 35
> 2.0x but <= 3.0x175.0 30 
> 1.0x but <= 2.0x175
 30
> 1.0x but <= 2.0x162.5 25 
<= 1.0x150
 25
<= 1.0x150.0 20 
At December 31, 2017,2021, the interest rate on debt under the revolving credit agreementCredit Agreement existing at that date was priced at one-month LIBOR plus the applicable credit spread of 175150.0 basis points. Under
The most restrictive covenants in the revolving credit agreement, borrowings are permitted upCredit Agreement include:
Maximum indebtedness-to-Credit EBITDA (“Leverage Ratio”) of 4.00x;
Minimum Credit EBITDA-to-interest expense of 3.00x; and
23


Maximum aggregate distributions to $400shareholders over the remaining term of the Credit Agreement of $75 million; provided, that if the Leverage Ratio of equal to or greater than 3.00x, a limitation on such payments for the succeeding quarter at the greater of (i) $4.75 million and approximately $248 million was available to borrow at(ii) 50% of consolidated net income for the most recent fiscal quarter.
The Credit Agreement is secured by substantially all of the Company’s and its domestic subsidiaries’ assets, including equity in certain material first-tier foreign subsidiaries. At December 31, 2017,2021, based upon the most restrictive covenant within the revolvingCredit Agreement, available credit agreement.
Asunder the Credit Agreement was approximately $287 million. Total debt outstanding was $73 million and $134 million as of December 31, 2017, Tredegar was in compliance with all financial covenants outlined in its revolving credit agreement. Noncompliance with any of the debt covenants may have a material adverse effect on financial condition or liquidity in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant(s) through an amendment to the revolving credit agreement may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the amended covenant is renegotiated.2021 and 2020, respectively.
The computations of adjustedCredit EBITDA, adjusted EBIT, the leverage ratio and interest coverage ratio as defined in the revolving credit agreementCredit Agreement are presented below along with the related most restrictive covenants. AdjustedCredit EBITDA and adjusted EBIT as defined in the revolving credit agreement areCredit Agreement is not intended to represent net income or cash flow from operations as defined by GAAP and should not be considered as either an alternative to net income or to cash flow.



24


Computations of Adjusted EBITDA, Adjusted EBIT, Leverage Ratio and Interest Coverage Ratio as Defined in the Revolving Credit Agreement Along with Related Most Restrictive Covenants

As of and for the Twelve Months Ended December 31, 2017 (In thousands)
Computations of adjusted EBITDA and adjusted EBIT as defined in revolving credit agreement for the twelve months ended December 31, 2017:
Net income$38,251
Plus: 
After-tax losses related to discontinued operations
Total income tax expense for continuing operations
Interest expense6,170
Depreciation and amortization expense for continuing operations40,277
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $10,000)113,254
Charges related to stock option grants and awards accounted for under the fair value-based method264
Losses related to the application of the equity method of accounting
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting
Minus: 
After-tax income related to discontinued operations
Total income tax benefits for continuing operations(53,163)
Interest income(209)
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings(7,867)
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method
Income related to the application of the equity method of accounting
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting(33,800)
Plus cash dividends declared on investments accounted for under the equity method of accounting
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions547
Adjusted EBITDA as defined in revolving credit agreement103,724
Less: Depreciation and amortization expense for continuing operations (including pro forma for acquisitions and asset dispositions)(40,953)
Adjusted EBIT as defined in revolving credit agreement$62,771
Computations of leverage and interest coverage ratios as defined in revolving credit agreement at December 31, 2017:
Leverage ratio (indebtedness-to-adjusted EBITDA)1.50x
Interest coverage ratio (adjusted EBIT-to-interest expense)10.17x
Most restrictive covenants as defined in revolving credit agreement: 
Maximum permitted aggregate amount of dividends that can be paid by Tredegar during the term of the revolving credit agreement ($100,000 plus 50% of net income generated for each quarter beginning January 1, 2016)$140,323
Maximum leverage ratio permitted4.00x
Minimum interest coverage ratio permitted2.50x



Tredegar is obligated to make future payments under various contracts as set forth below:
 Payments Due by Period
(In millions)2018 2019 2020 2021 2022 Remainder Total
Debt:             
Principal payments$
 $
 $
 $152.0
 $
 $
 $152.0
Estimated interest expense5.2
 5.2
 5.2
 0.9
 
 
 16.5
Estimated contributions required: (1)
             
Defined benefit plans5.3
 5.3
 5.0
 5.3
 5.9
 11.3
 38.1
Other postretirement benefits0.5
 0.5
 0.5
 0.5
 0.5
 2.4
 4.9
Capital expenditure commitments4.6
 
 
 
 
 
 4.6
Leases3.7
 3.5
 3.3
 2.8
 2.0
 3.1
 18.4
Estimated obligations relating to uncertain tax positions (2)

 
 
 
 
 2.0
 2.0
Other (3)
3.0
 2.1
 
 
 
 
 5.1
Total$22.3
 $16.6
 $14.0
 $161.5
 $8.4
 $18.8
 $241.6
(1)Estimated minimum required contributions for defined benefit plansComputations of Credit EBITDA, Leverage Ratio and benefit payments for other postretirement plans are based on actuarial estimates using current assumptions for discount rates, long-term rateInterest Coverage Ratio as Defined in the Credit Agreement Along with Related Most Restrictive Covenants
As of return on plan assets, rate of compensation increases and health care cost trends. The expected defined benefit plan contribution estimates for 2018 through 2027 were determined under provisions of the Pension Protection Act of 2006 using the preliminary assumptions chosen by Tredegar for the 2018 plan year. Tredegar has determined that it is not practicable to presentTwelve Months Ended December 31, 2021 (In thousands)
Computations of Credit EBITDA as defined benefit contributions and other postretirement benefit payments beyond 2027.in Credit Agreement for the twelve months ended December 31, 2021
Net income (loss)$57,826 
(2)Amounts for which reasonable estimates about the timing of payments cannot be made are included in the remainder column.
Plus:
(3)After-tax losses related to discontinued operationsIncludes contractual severance111 
Total income tax expense for continuing operations9,284 
Interest expense3,386 
Depreciation and other miscellaneous contractual arrangements.amortization expense for continuing operations23,784 
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $8,999)9,553 
Charges related to stock option grants and awards accounted for under the fair value-based method2,495 
Losses related to the application of the equity method of accounting— 
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting— 
Minus:
After-tax income related to discontinued operations— 
Total income tax benefits for continuing operations— 
Interest income(73)
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings(3,859)
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method— 
Income related to the application of the equity method of accounting— 
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting(12,780)
Plus cash dividends declared on investments in an amount not to exceed $10,000 for such period318 
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions— 
Plus or minus, as applicable, pro forma EBITDA adjustments to pension expense associated with the early payment of pension obligations— 
Credit EBITDA as defined in Credit Agreement$90,045 
Computations of leverage and interest coverage ratios as defined in Credit Agreement at December 31, 2021:
Leverage ratio (indebtedness-to-Credit EBITDA)0.81x
Interest coverage ratio (Credit EBITDA-to-interest expense)26.59x
Most restrictive covenants as defined in Credit Agreement:
Available balance of maximum permitted aggregate amount of dividends that can be paid by Tredegar during the remaining term of the Credit Agreement ($75,000 minus $20,187 of dividends paid after December 1, 2020)$54,813 
Maximum leverage ratio permitted4.00x
Minimum interest coverage ratio permitted3.00x
Tredegar was in compliance with all of its debt covenants as of December 31, 2021. Noncompliance with any of the debt covenants may have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on its financial condition or liquidity depending upon how the covenant is renegotiated.
25


Material Cash Requirements for Known Contractual and Other Obligations
The Company’s material cash requirements from known contractual and other obligations as of December 31, 2021 were as follows:
Long-term debt and interest payments
As of December 31, 2021, the Company had outstanding debt of $73.0 million with contractual payments due in June 2024. Estimated future interest payments associated with outstanding debt total $3.2 million, with $1.3 million payable within the next 12 months.
Pension and other postretirement obligations
On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete. In connection therewith, on February 9, 2022, the Company borrowed funds under its revolving credit agreement and contributed a $50 million Special Contribution to the pension plan to reduce its underfunding and as part of a program within the pension plan to hedge or fix the expected future contributions that will be needed by the Company through the settlement process. The Company estimates that, with the Special Contribution, there will be no required minimum contributions to the pension plan until final settlement. Tredegar has determined that it is not practicable to estimate additional cash requirements beyond 2022 as the ultimate settlement of the benefit obligation may differ from the projected benefit obligation of $314 million as of December 31, 2021.
In addition to providing pension benefits, the Company provides postretirement life insurance and health care benefits for certain groups of employees. As of December 31, 2021, the aggregate benefit obligation for the Company’s other post retirement plans was $7.4 million, of which the Company expects to pay $0.5 million in the next 12 months.
Capital expenditure commitments
See “Projected Capital Expenditures and Depreciation & Amortization” within “Operations Overview” above in this Item 7 for discussion of the Company’s planned investment in capital expenditures in 2022, a portion of which represents contractual commitments that existed as of December 31, 2021.
Operating Leases
The Company enters into various operating leases primarily for real estate, office equipment and vehicles. See Note 4 to the consolidated financial statements for additional information.
Uncertain Tax Positions
As of December 31, 2021, unrecognized tax benefits on uncertain tax positions were $0.6 million. Tax payments resulting from the successful challenge by the taxing authority on uncertain tax positions taken by Tredegar would possibly result in the payment of estimated interest and penalties of $0.1 million if tax payments were made as a result of a successful challenge by the taxing authority on uncertain tax positions. Due to uncertainties in the timing of potential tax audits, the timing of the resolution of these positions is uncertain. Therefore, the Company is unable to make a reasonably reliable estimate of the timing of payments beyond 12 months. See Note 12 to the Consolidated Financial Statements in Item 15 for additional information.
Off-Balance Sheet Arrangements
The Company has no material off-balance sheet arrangements that have had or are reasonably likely to have a material current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
From time to time, the Company enters into transactions with third parties in connection with the sale of assets or businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or the sellers or third parties involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business. Also, in the ordinary course of business, the Company may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, the Company is unable to estimate the maximum potential amount of the potential future liability under the indemnity provisions of these agreements. Tredegar does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. The Company discloses contingent liabilities if the probability of loss is reasonably possible and material.
At December 31, 2017, Tredegar had cash and cash equivalents of $36.5 million, including funds held in locations outside the U.S. of $32.7 million. Tredegar’s policy is to accrue U.S. federal income taxes on unremitted earnings of all foreign subsidiaries where required. However, due to changes in the taxation of dividends under TCJA, Tredegar will only record U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries. Prior to the second quarter of 2016, deferred U.S. federal income taxes had not been recorded for the undistributed earnings for Terphane Limitada because the Company had intended to permanently reinvest these earnings. Due to concerns about the current political and economic conditions in Brazil, Terphane Limitada began making cash distributions to the Company. During 2016, Terphane Limitada paid dividends totaling $13.3 million to the Company. Because of the accumulation of significant losses related to foreign currency translations at Terphane Limitada, there were no unrecorded deferred income tax liabilities associated with the U.S. federal income taxes and foreign withholding taxes on Terphane Limitada’s undistributed earnings as of December 31, 2017 and December 31, 2016.
26
The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy working capital, capital expenditure and dividend requirements for at least the next twelve months.




Shareholders’ Equity
At December 31, 2017, Tredegar had 33,017,422 shares of common stock outstanding and a total market capitalization of $633.9 million, compared with 32,933,807 shares of common stock outstanding and a total market capitalization of $790.4 million at December 31, 2016.
Tredegar did not repurchase any shares on the open market in 2017, 2016 or 2015 under its approved share repurchase program.
Cash Flows
The discussion in this section supplements the information presented in the Consolidated Statements of Cash Flows.
Cash provided by operating activities was $88.2 million in 2017 compared with $48.9 million in 2016. The increase is due primarily to higher operating profit from ongoing operations ($16.5 million), higher non-cash charges for depreciation and amortization expense included in operating profit ($7.8 million), lower income tax payments ($6.2 million), cash received from a settlement of an escrow agreement associated with the acquisition of Terphane in October 2011 ($11.9 million) and lower contributions to fund pension and postretirement benefit plans ($2.2 million), partially offset by higher interest payments from higher debt levels ($2.7 million).
Cash used in investing activities was $125.6 million in 2017 compared with $42.0 million in 2016. Cash used in investing activities in 2017 primarily represents the acquisition of Futura in 2017 for $87.1 million (which includes the net settlement of post-closing adjustments of $0.1 million) and capital expenditures of $44.4 million, which compares to $45.5 million in 2016.
Net cash flow provided by financing activities was $43.2 million in 2017, which is primarily due to net borrowings under the revolving credit facility to fund the acquisition of Futura and the payment of regular quarterly dividends aggregating for the year to $14.5 million ($0.44 per share annually), partially offset by the proceeds from the exercise of stock options and other financing activities of $0.7 million. Cash used in financing activities was $23.7 million in 2016, primarily used for net debt repayments of $9.0 million, regular quarterly dividends aggregating for the year to $14.5 million ($0.44 per share annually) and debt financing costs related to the refinancing of the credit agreement of $2.6 million, partially offset by the proceeds from the exercise of stock options and other financing activities of $2.3 million.
Quantitative and Qualitative Disclosures about Market Risk
Tredegar has exposure to the volatility of interest rates, polyethylene polypropylene and polyesterpolypropylene resin prices, PTA and MEG prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See the AssetsLiquidity and Liabilities sectionCapital Resources regarding interest rate exposures related to borrowings under the revolving credit agreement.Credit Agreement.
Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate its casting furnaces). Changes in polyethylene resin prices and the timing of those changes could have a significant impact on profit margins in PE Films. Changes in polyester resin, PTA and MEG prices, and the timing of those changes, could have a significant impact on profit margins in Flexible Packaging Films. Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate its casting furnaces). There is no assurance of the Company’s ability to pass through higher raw material and energy costs to its customers.
See the Executive Summary and the Results of Continuing Operations sections for discussion regarding the impact of the lag in the pass-through of resin price changes.


The volatility of average quarterly prices of low density polyethylene resin in the U.S. (a primary raw material for PE Films products) is shown in the chart below:
Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In January 2015, IHS reflected a 21 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2014 average rate of $1.09 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2014.
Polyethylene resin prices in Europe, Asia and South America have exhibited similar long-term trends. The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. To address fluctuating resin prices, PE Films has index-based pass-through raw material cost agreements for the majority of its business. However, under certain agreements, changes in resin prices are not passed through for an average period of 90 days (see the Executive Summary and the Results of Continuing Operations sections for more information). Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within the markets in which the Company operates.
Polyester resins, MEG and PTA used by Flexible Packaging Films in Brazil are primarily purchased domestically, with other sources available, mostly from Asia and the U.S. Given the nature of these products as commodities, pricing is derived from Asian pricing indexes. The volatility of the average quarterly prices for polyester fibers in Asia, which is representative of polyester resin (a primary raw material for polyester film products) prices, is shown in the chart below:
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.



The volatility of average quarterly prices of PTA and MEG in Asia (raw materials used in the production of polyester resins produced by Flexible Packaging Films) is shown in the chart below:


Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge its exposure to aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not more than 12 months, the Company enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. See Note 9 of10 to the Notes toConsolidated Financial Statements in Item 15 for moreadditional information.
The volatility of quarterly average aluminum prices is shown in the chart below:below.
tg-20211231_g2.jpg
Source: Quarterly averages computed by Tredegarthe Company using daily Midwest average prices provided by Platts.
From time-to-time, Aluminum Extrusions hedges a portion of its exposure to natural gas price volatility by entering into fixed-price forward purchase contracts with its natural gas suppliers. The Company estimates that, in an unhedged situation, every $1 per mmBtu per month change in the market price of natural gas has an $102,000 impact on the continuing monthly operating profit for U.S. operations in Aluminum Extrusions. There is an energy surcharge for Aluminum Extrusions in the U.S. that is applied when the previous quarter’s NYMEX natural gas average settlement price is in excess of $8.85 per mmBtu.
27




The volatility of quarterly average natural gas prices is shown in the chart below:below.
tg-20211231_g3.jpg
Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices.

The volatility of average quarterly prices of polyethylene resin in the U.S. (a primary raw material for PE Films products) is shown in the chart below:
tg-20211231_g4.jpg
Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In February 2020, IHS reflected a 32 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2019 average rate of $0.51 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2019.
The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. Selling prices to customers are set considering numerous factors, including the expected volatility of resin prices. In certain situations, PE Films has index-based pass-through raw material cost arrangements with customers. However, under certain agreements, changes in resin prices are not passed through for a period of 90 days or more. In response to unprecedented cost increases and supply issues for polyethylene and polypropylene resin, Tredegar Surface Protection implemented a quarterly resin cost pass-through mechanism, effective July 1, 2021, for all products and customers not previously covered by such arrangements. Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within the markets that the Company competes.
Polyester resins, MEG and PTA used in flexible packaging films produced in Brazil are primarily purchased domestically, with other sources available mostly from Asia and the U.S. Given the nature of these products as commodities, pricing is
28


derived from Asian pricing indexes. The volatility of the average quarterly prices for polyester fibers in Asia, which is representative of polyester resin (a primary raw material for Flexible Packaging Films) pricing trends, is shown in the chart below:
tg-20211231_g5.jpg
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
The volatility of average quarterly prices of PTA and MEG in Asia (raw materials used in the production of polyester resins produced by Flexible Packaging Films) is shown in the chart below:
tg-20211231_g6.jpg
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
29


The Company sells to customers in foreign markets through its foreign operations and through exports from U.S. plants. The percentage of sales and total assets for manufacturing operations related to foreign markets for 2017, 20162021, 2020 and 20152019 are as follows:
Tredegar Corporation—Continuing Operations
Percentage of Net Sales and Total Assets Related to Foreign Markets
 2017 2016 2015
 % of Total 
% Total
Assets -
Foreign
Oper-
ations *
 % of Total 
% Total
Assets -
Foreign
Oper-
ations *
 % of Total 
% Total
Assets -
Foreign
Oper-
ations *
 Net Sales *  Net Sales *  Net Sales * 
 
Exports
From
U.S.
 
Foreign
Oper-
ations
  
Exports
From
U.S.
 
Foreign
Oper-
ations
  
Exports
From
U.S.
 
Foreign
Oper-
ations
 
Canada5
 
 
 6
 
 
 5
 
 
Europe1
 9
 6
 1
 10
 6
 1
 10
 5
Latin America**2
 9
 7
 
 11
 21
 
 10
 20
Asia9
 2
 5
 9
 3
 6
 9
 3
 7
Total % exposure to foreign markets17
 20
 18
 16
 24
 33
 15
 23
 32
Tredegar Corporation
Percentage of Net Sales and Total Assets Related to Foreign Markets*
 202120202019
 % of Total% Total
Assets - Foreign Operations
% of Total% Total
Assets - Foreign
Operations
% of Total% Total
Assets -Foreign
Operations
 Net SalesNet SalesNet Sales
 Exports
From
U.S.
Foreign OperationsExports
From
U.S.
Foreign OperationsExports
From
U.S.
Foreign Operations
Canada2   — — — — 
Europe1   — — — — 
Latin America1 12 10 — 13 10 12 
Asia7  3 11 — 10 — 
Total11 12 13 14 13 14 14 12 10 
*The percentages for foreign markets are relative to Tredegar’s consolidated net sales and total assets from continuing operations.
**
In 2017, Flexible Packaging Films’ recorded a charge for the impairment of assets in the amount of $101 million. See Terphane Asset Impairment Loss and Worthless Stock Deduction in Flexible Packaging Films in the Executive Summary section for more details.
.
Tredegar attempts to match the pricing and cost of its products in the same currency and generally views the volatility of foreign currencies and emerging markets, and the corresponding impact on earnings and cash flow as part of the overall risk of operating in a global environment (for additional information, see trends for the Euro, Brazilian Real and Chinese Yuan in the charts on the following page). Exports from the U.S. are generally denominated in U.S. Dollars. The Company’s foreign currency exposure on income from continuing foreign operations relates to the Euro, the Chinese Yuan the Hungarian Forint,and the Brazilian Real and the Indian Rupee.Real.
PE Films is generally able to match the currency of its sales and costs for its product lines. For flexible packaging films produced in Brazil, selling prices and key raw material costs are principally determined in U.S. Dollars and are impacted by local economic conditions. Competition in Brazil, Terphane’s primary market, has been exacerbated byconditions and local and global overcapacity in the polyester industry generally, and by particularly acute overcapacity in Latin America. Additional PET capacity from a competitor in Latin America came on line in September 2017. These factors have resulted in significant competitive pricing pressures and U.S. Dollar equivalent margin compression. Moreover, variable conversion, fixed conversion and sales, general


and administrative costs for operations in Brazil have been adversely impacted by inflation in Brazil that is higher than in the U.S.dynamics. Flexible Packaging Films is exposed to additional foreign exchange translation risk (its functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films’ Brazilian salesFilms business unit in Brazil (“Terphane Ltda.”) and substantially all of its related raw material costs are quoted or priced in U.S. Dollars while a large majority of its Brazilianvariable conversion, fixed conversion and sales, general and administrative costs before depreciation & amortization (collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively impact operating profitEBITDA from ongoing operations for Flexible Packaging Films.
The Company's earnings are exposed to foreign currency exchange risk primarily through the translation of the financial statements of subsidiaries that have a functional currency other than the U.S. Dollar. The Company estimates thatannual net costs of R$150 million for the net mismatch translation exposure between Terphane’sTerphane Ltda.’s U.S. Dollar quoted or priced sales and raw material costs and underlying Brazilian Real quoted or priced operating costs (excluding depreciation and amortization) is annual net costs of R$95 million (approximately $30 million annually in equivalent U.S. Dollars or $2.5 million per month). On September 29, 2017, the Flexible Packaging Films business unit in Brazil (“Terphane Limitada”) entered into 15 monthlyLtda. Operating Costs. Terphane Ltda. has outstanding foreign exchange average forward rate contracts to purchase Brazilian Real (“R$”) and sell U.S. Dollars coveringto hedge its exposure. See Note 10 to the period from October 2017 through December 2018. These agreements hedge half of the Company’s exposure at monthly average forward rates rangingConsolidated Financial Statements in Item 15 for more information on an approximately linear increasing basis from R$3.164 for each U.S. Dollar in October 2017 to R$3.3148 in December 2018. For example, if in December 2018 the actual average rate was R$3.000 for each U.S. Dollar, then Terphane Limitada would have a settlement gain on its forward contract of R$393,500, which would help offset the estimated translation loss on the net mismatch exposure of R$787,000 for December 2018. The opposite would occur if the actual average rate were greater than the forward rate. These foreign currency exchangeoutstanding hedging contracts have been designated and qualify as cash flow hedges of Terphane Limitada's forecasted sales to customers quoted or priced in U.S. Dollars over that period. By changing the currency risk associated with these U.S. Dollar sales, the derivatives have the effect of offsetting operating costs quoted or priced in Brazilian Real and decreasing the net exposure to Brazilian Real in the consolidated statements of income. The aggregate notional amount of open foreign exchange contracts at December 31, 2017 was $15.0 million (R$48.8 million). The net fair value of the 12 open forward contracts was a negative $0.6 million as of December 31, 2017.this hedging program.
Tredegar estimates that the change in the value of foreign currencies relative to the U.S. Dollar on PE Films had a favorable impact on operating profitEBITDA from ongoing operations in PE Films of $0.3 million in 20172021 compared to 20162020 and an unfavorable impact on operating profitEBITDA from ongoing operations of $0.3$0.7 million in 20162020 compared with 2015.
Trends for the Euro are shown in the chart below:
2019.
30

Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.



Trends for the Brazilian Real and Chinese Yuan are shown in the chart below:
tg-20211231_g7.jpg
Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.


31
Item 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK



Item 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See discussion of Quantitative and Qualitative Disclosures about Market Risk in Management’s DiscussionItem 7.
Item 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The information required by this Item 8 is set forth in Item 15 and Analysis of Financial Conditionis hereby incorporated herein by reference.
Item 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Item 9A.CONTROLS AND PROCEDURES
On November 1, 2018, the Company filed a Current Report on Form 8-K (the “November 2018 Form 8-K”) to disclose deficiencies in internal control over financial reporting. For further information, see the November 2018 Form 8-K and Results of Operations.
Item 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
See the Index to Financial StatementsItem 4. “Controls and Supplementary Data for references to the reportProcedures” of the independent registered public accounting firm,Company’s Quarterly Report on Form 10-Q for the consolidatedquarterly period ended September 30, 2018. See Item 1A. “Risk Factors” of this Form 10-K for risks and uncertainties associated with management’s report on internal control over financial statementsreporting as of and selected quarterly financial data.for the year ended December 31, 2021.
Item 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Item 9A.CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
PursuantIn connection with the preparation of this Form 10-K, pursuant to Rule 13a-15(b) under the Securities Exchange Act Tredegarof 1934, as amended (the “Exchange Act”), the Company carried out an evaluation with the participation of its management, including its principalChief Executive Officer (principal executive officerofficer) and principalChief Financial Officer (principal financial officer,officer), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2021.
Based on this evaluation, the endCompany’s Chief Executive Officer and Chief Financial Officer concluded that, because of the period covered by this report. Based upon that evaluation, the principal executive officer and principalmaterial weaknesses in internal control over financial officer concluded thatreporting discussed below, the Company’s disclosure controls and procedures arewere not effective as of December 31, 2021, to ensureensure: (i) that information required to be disclosed by Tredegarthe Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and (ii) that such information is accumulated and communicated to management, including the principal executive officerChief Executive Officer and principal financial officer,Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.


Management’s Report on Internal Control Over Financial Reporting
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in RuleRules 13a-15(f) and 15d-15(f) under the Exchange Act. Tredegar’sThe Company’s internal control over financial reporting is a process designed by or under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, and overseen by the Board of Directors, to provide reasonable assurance regarding the reliability of financial reporting and the preparation and fair presentation of published financial statements for external purposes in accordance with U.S. generally accepted accounting principlesGAAP and includes policies and procedures that:
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of ourthe Company’s assets;
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles,GAAP, and that ourthe Company’s receipts and expenditures are being made only in accordance with the authorization of ourits management and directors; and
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of ourthe Company’s assets that could have a material effect on the consolidated financial statements.
Internal control over financial reporting includes the controls themselves, monitoring (including internal auditing practices) and actions taken to correct deficiencies as identified.
Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of the Company’s consolidated financial statements would be prevented or detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

32


Management conducted an evaluation of the effectiveness of ourthe Company’s internal control over financial reporting based onusing the frameworkcriteria in Internal Control - Integrated Framework 2013issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”(the “2013 COSO Framework”). In conducting its assessmentAs a result of the effectiveness of our internal controls over financial reporting, management excluded its acquisition of Futura Industries Corporation, which was acquired by Tredegar on
February 15, 2017, and is included in Tredegar’s 2017 consolidated financial statements and constituted 7% of consolidated total assets and 8% of consolidated total sales for the year then ended. Based on this evaluation, under the framework in Internal Control — Integrated Framework 2013, Tredegar’s management concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2017.2021, because of the material weaknesses in internal control over financial reporting discussed below.
Control Environment: The Company did not have a sufficient number of trained resources with assigned responsibility and accountability for the design, operation and documentation of internal control over financial reporting in accordance with the 2013 COSO Framework.
Risk Assessment:The Company did not have an effective risk assessment process to identify and evaluate at a sufficient level of detail all relevant risks of material misstatement, including fraud risks.
Information and Communication: The Company did not have an effective information and communication process that identified and assessed the source of and controls necessary to ensure the reliability of information used in financial reporting and that communicates relevant information about roles and responsibilities for internal control over financial reporting.
Monitoring Activities: The Company did not have effective monitoring activities to assess the operation of internal control over financial reporting, including the continued appropriateness of control design and level of documentation maintained to support control effectiveness.
Control Activities: As a consequence of the material weaknesses described above, internal control deficiencies related to the design and operation of process-level controls and general information technology controls were determined to be pervasive throughout the Company’s financial reporting processes.
While these material weaknesses did not result in material misstatements of the Company’s consolidated financial statements as of and for the year ended December 31, 2021, these material weaknesses create a reasonable possibility that a material misstatement of account balances or disclosures in annual or interim consolidated financial statements may not be prevented or detected in a timely manner. Accordingly, the Company concluded that the deficiencies represent material weaknesses in its internal control over financial reporting and its internal control over financial reporting was not effective as of December 31, 2021.
The Company’s independent registered public accounting firm, KPMG LLP, which audited the 2021 consolidated financial statements included in this Form 10-K, has expressed an adverse opinion on the operating effectiveness of the Company's internal control over financial reporting. KPMG LLP’s report appears on page 40 of this Form 10-K.
Remediation Plan and Efforts to Address the Previously Identified Material Weaknesses
To remediate the material weaknesses described above, the Company, with the oversight of the Audit Committee of the Board of Directors (the “Audit Committee”), has been pursuing the six remediation steps as originally identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The Company’s remediation plan was designed with the assistance of management’s outside consultant, an internationally recognized accounting firm. The Company continues to work with its outside consultant to assist in completing the remediation plan and believes that its remediation plan will be sufficient to remediate the identified material weaknesses and strengthen its internal control over financial reporting. As the Company continues to evaluate, and works to improve, its internal control over financial reporting, management may determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary.
Through the fourth quarter of 2021, the Company has completed certain steps in its remediation plan, including:
for certain processes, developed new and revised existing process narratives and identified risks of material misstatement inherent to those processes;
developed new controls and revised the design of existing controls for a significant number of relevant key controls to mitigate the aforementioned risks, inclusive of general information technology controls and entity-level controls;
conducted initial organization-wide training sessions with all control owners;
increased resources in the Company’s internal audit function and created and staffed a controls compliance group charged with monitoring and facilitating compliance with the Company’s responsibilities under the Sarbanes Oxley Act of 2002 (“SOX”); and
implemented a software solution to assist in monitoring and documenting compliance with SOX.
The effectivenessfollowing remaining activities are scheduled for completion in the first half of Tredegar’s2022 in anticipation of conducting management’s testing that will begin in the first half of 2022 in support of issuing management’s assessment of internal control over financial reporting as of December 31, 20172022:
completion of the identification of risks arising from inappropriate segregation of duties and fraud risks;
33


completion of risk assessment and control design for the remaining populations of processes and controls;
implementation of controls across all financial reporting processes and information technology environments;
ongoing training with control owners, as necessary; and
ongoing migration of certain components of a legacy information technology system onto a common information technology environment, including risk assessment, control design and implementation of new and revised controls.
The Company continues to monitor the impact of employee turnover, the COVID-19 pandemic and other external factors on its remediation plan and its assessment of internal control over financial reporting. The material weaknesses cannot be considered remediated until the applicable controls have operated for a sufficient period of time and management has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as statedconcluded, through testing, that these controls are operating effectively. The Company cannot assure you when it will remediate the identified material weaknesses, nor can it be certain whether additional actions will be required. Moreover, the Company cannot assure you that additional material weaknesses will not arise in their report which is included in Item 15.the future.
Changes in Internal Control Over Financial Reporting
ThereThe Company is in the process of making certain changes in its internal controls to remediate the material weaknesses as described above. The execution of the material aspects of this plan began in the second quarter of 2019. Except as noted above with respect to the completion of certain steps in the remediation plan, there has been no change in Tredegar’sthe Company’s internal control over financial reporting during the quarter ended December 31, 2017,2021, that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act).
Item 9B.OTHER INFORMATION
Item 9B.    OTHER INFORMATION
None.


Item 9C.    DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None.

34


PART III
Item 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Item 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information concerning directors and persons nominated to become directors of Tredegar to be included in the Proxy Statement under the headings “Proposal 1: Election of Directors” and “Tredegar’s Board of Directors” is incorporated herein by reference.
The information concerning corporate governance to be included in the Proxy Statement under the headings “Board Meetings, Meetings of Non-Management Directors and the Board Committees” and “Corporate Governance” is incorporated herein by reference.
The information to be included in the Proxy Statement under the heading “Section 16(a) Beneficial Ownership Reporting Compliance” is incorporated herein by reference.
Set forth below are the names, ages and titles of the Company’s executive officers:
NameAgeTitle
John D. GottwaldM. Steitz63
President and Chief Executive Officer
D. Andrew Edwards5963 
Executive Vice President and Chief Financial Officer
Michael J. SchewelKevin C. Donnelly6447 
Vice President, General Counsel and Corporate Secretary
John D. Gottwald. M. Steitz. Mr. GottwaldSteitz was elected President and Chief Executive Officer on August 18, 2015. From June 26, 2015 until August 17, 2015, he served as interim President and Chief Executive Officer.effective March 19, 2019.  He previously served as the Company’s President and Chief Executive Officer of Addivant Corporation, a leading global supplier of antioxidants, intermediates, inhibitors, modifiers, UV stabilizers and other additives to the plastic and rubber industries, from March 1, 20062015 until January 31, 2010,2019, as President and as the Company’s ChairmanChief Operating Officer of the BoardPQ Corporation, a leading worldwide producer of specialty inorganic performance chemicals and catalysts, from September 2001October 2013 until February 2008. Mr. Gottwald also servedMarch 2015, as the Company’s President and Chief Executive Officer of Avantor Performance Materials, a global supplier of ultra-high-purity life sciences materials with strict regulatory and performance specifications, from July 1989September 2012 until September 2001.2013, as President and Chief Operating Officer of Albemarle Corporation, a global specialty chemicals company, from March 2012 until August 2012, and as Chief Operating Officer and Executive Vice President of Albemarle from April 2007 until March 2012.
D. Andrew Edwards.Mr. Edwards was electednamed Executive Vice President and Chief Financial Officer effective August 6, 2020. Mr. Edwards served as Vice President and Chief Financial Officer from July 20, 2015.2015 until August 2020. He previously served as the Chief Financial Officer of United Sporting Companies, Inc., a wholesale distributor of outdoor sporting goods, from February 2013 until July 2015 and as Vice President, Controller and Chief Accounting Officer of Owens & Minor, Inc., a distributor of acute medical products, from April 2010 to February 2013 and as Acting Chief Financial Officer of Owens & Minor, Inc. from March 2012 to February 2013. Mr. Edwards also served as Vice President, Finance, of Owens & Minor, Inc. from December 2009 until April 2010.  Mr. Edwards previously served as the Company’s Vice President, Chief Financial Officer and Treasurer from August 2003 to December 2009 and as the Company’s Vice President, Finance from November 1998 to August 2003. Mr. Edwards also served as the Company’s Treasurer from May 1997 to December 2009 and as the Company’s Controller from October 1992 until July 2000.
Michael J. SchewelKevin C. Donnelly.  Mr. SchewelDonnelly was elected Vice President, General Counsel and Corporate Secretary effective May 9, 2016.January 1, 2021. He was previously partner with the law firm of McGuire Woods, LLP from 1986 until May 2016, except for four years from 2002 until 2006 when hejoined Tredegar in 2010 and served as Secretaryits Associate General Counsel from 2013 to 2020. Prior to joining Tredegar, Mr. Donnelly was an associate at Hunton & Williams LLP (now Hunton Andrews Kurth LLP). He received a B.A. degree from the University of CommerceRichmond and Trade fora J.D. from the CommonwealthUniversity of Virginia.
Tredegar has adopted a Code of Conduct that applies to all of its directors, officers and employees (including its chief executive officer, chief financial officer and principal accounting officer) and has posted the Code of Conduct on its website. All amendments to or waivers from any provision of the Company’s Code of Conduct applicable to the chief executive officer, chief financial officer and principal accounting officer will be disclosed on the Company’s website. The Company’s internet address is www.tredegar.com.
Item 11.EXECUTIVE COMPENSATION
Item 11.    EXECUTIVE COMPENSATION
The information to be included in the Proxy Statement under the headings “Compensation of Directors,” “Board Meetings, Meetings of Non-Management Directors and Board Committees—Committees - Executive Compensation Committee Interlocks and Insider Participation,” “Compensation Discussion and Analysis,” “Executive Compensation Committee Report” and “Compensation of Executive Officers” is incorporated herein by reference.


Item 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ANDRELATED STOCKHOLDER MATTERS
Item 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ANDRELATED STOCKHOLDER MATTERS
The information to be included in the Proxy Statement under the heading “Stock Ownership”“Equity Compensation Plan Information” is incorporated herein by reference. The following table summarizes information with respect to equity compensation plans under which securities are authorized for issuance as of December 31, 2017.
35
  Column (a) Column (b) Column (c)
Plan Category
Number of Securities
to be Issued Upon
Exercise of
Outstanding Options,
Warrants and Rights*
 Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights 
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans,
Excluding Securities
Reflected in Column (a)**
Equity compensation plans approved by security holders987,329
 $19.75
 1,704,554
Equity compensation plans not approved by security holders
 
 
Total987,329
 $19.75
 1,704,554
*Includes performance stock units that give the holder the right to receive shares of Tredegar common stock upon the satisfaction of certain performance criteria.

** Due to an administrative error, the number of securities remaining available for future issuance under equity compensation plans, excluding securities reflected in column (a), was overstated in

Item 12 of Tredegar’s Annual Report on Form 10-K for the years ended December 31, 2014, 2015 and 2016. The correct amounts as of December 31, 2014, 2015 and 2016 were 2,099,239; 2,025,091; and 1,898,592, respectively.13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Item 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information to be included in the Proxy Statement under the headings “Certain Relationships and Related Transactions”,Transactions,” “Tredegar’s Board of Directors” and “Board Meetings, Meetings of Non-Management Directors and Board Committees” is incorporated herein by reference.
Item 14.PRINCIPAL ACCOUNTING FEES AND SERVICES
Item 14.    PRINCIPAL ACCOUNTING FEES AND SERVICES
Our independent registered public accounting firm is KPMG LLP, Richmond, Virginia, Audit Firm ID: 185.
The following is incorporated herein by reference:
Information on accounting fees and services to be included in the Proxy Statement under the heading “Audit and Non-Audit Fees;” and
Information on the Audit Committee’s procedures for pre-approving certain audit and non-audit services to be included in the Proxy Statement under the heading “Board Meetings, Meetings of Non-Management Directors and Board Committees—Audit Committee Matters.”


36



PART IV

Item 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a)List of documents filed as a part of the report:
(1)Financial statements:
Tredegar Corporation
Index to Financial Statements and Supplementary DataItem 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
37


Page
Report of Independent Registered Public Accounting Firm
48-49
Financial Statements:
Consolidated Balance Sheets as of December 31, 2017 and 2016
Consolidated Statements of Income for the Years Ended December 31, 2017, 2016 and 2015
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2017, 2016 and 2015
Consolidated Statements of Cash Flows for the Years Ended December 31, 2017, 2016 and 2015
Consolidated Statements of Shareholders' Equity for the Years Ended December 31, 2017, 2016 and 2015
Notes to Financial Statements
55-94
(2)Financial statement schedules:
None.
(3)Exhibits:
See Exhibit Index on pages 95-97.




Report of Independent Registered Public Accounting Firm


To the Shareholders and Board of Directors and Shareholders of
Tredegar Corporation:


OpinionsOpinion on the Consolidated Financial Statements and Internal Control over Financial Reporting


We have audited the accompanying consolidated balance sheets of Tredegar Corporation and its subsidiaries (the Company) as of December 31, 20172021 and 2016, and2020, the related consolidated statements of income, comprehensive income (loss), shareholders’ equity, and cash flows and shareholders’ equity for each of the three years in the three-year period ended December 31, 2017, including2021, and the related notes (collectively, referred to as the “consolidatedconsolidated financial statements”)statements). We also have audited the Company's internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework(2013)issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 20172021 and 2016,2020, and the results of its operations and its cash flows for each of the three years in the three-year period ended December 31, 20172021, in conformity with accounting principlesU.S. generally accepted accounting principles.

We also have audited, in accordance with the United Statesstandards of America. Also in our opinion, the Public Company maintained, in all material respects, effectiveAccounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2017,2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effectiveCommittee of Sponsoring Organizations of the Treadway Commission, and our report dated March 11, 2022 expressed an adverse opinion on the effectiveness of the Company’s internal control over financial reporting, andreporting.

Basis for its assessmentOpinion

These consolidated financial statements are the responsibility of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control Over Financial Reporting under Item 9A.Company’s management. Our responsibility is to express opinionsan opinion on the Company’sthese consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB")PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.


We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the auditsaudit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

fraud. Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Fair value of investments measured at net asset value

As discussed in Note 8 to the consolidated financial statements, the fair value of pension plan assets at December 31, 2021 was $244.6 million. Of this amount, $49.0 million represents the fair value of private equity, hedge funds and certain international equity securities measured at net asset value (NAV).

We identified the assessment of the fair value of investments measured at NAV as a critical audit matter. Subjective auditor judgment was required in the application and performance of procedures to assess the fair value of the investments measured at NAV because the determination involved the use of unobservable inputs. Additionally, specialized skills and
38


knowledge were required to assess the fair value of the investments measured at NAV and to assess the sufficiency of audit evidence obtained.

The following are the primary procedures we performed to address this critical audit matter. For a selection of the investments measured at NAV, we compared:

the Company’s previous estimates of fair value to the NAVs subsequently audited by third parties
the rates of return to relevant, publicly available market indices
the estimated fair values to external confirmations received directly from the third-party investment managers.

We involved valuation professionals with specialized skills and knowledge, who assisted in our risk assessment and the design of procedures performed for the investments measured at NAV. With respect to the selection of investments tested, the valuation professionals assisted in assessing the sufficiency of audit evidence obtained by assessing the results of the procedures performed.

/s/ KPMG LLP

We have served as the Company’s auditor since 2018.

Richmond, Virginia
March 11, 2022
39


Report of Independent Registered Public Accounting Firm


To the Shareholders and Board of Directors
Tredegar Corporation:

Opinion on Internal Control Over Financial Reporting

We have audited Tredegar Corporation and subsidiaries' (the Company) internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weaknesses, described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income (loss), shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements), and our report dated March 11, 2022 expressed an unqualified opinion on those consolidated financial statements.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses related to an ineffective control environment resulting from an insufficient number of trained resources, ineffective risk assessment, ineffective information and communication, and ineffective monitoring activities resulting in ineffective control activities related to the design and operation of process-level controls and general information technology controls across all financial reporting processes have been identified and included in management’s assessment. The material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2021 consolidated financial statements, and this report does not affect our report on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our auditsaudit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provideaudit provides a reasonable basis for our opinions.opinion.

As described in Management’s Report on Internal Control over Financial Reporting, management has excluded Futura Industries Corporation (“Futura”) from its assessment of internal control over financial reporting as of December 31, 2017 because it was acquired by the Company in a purchase business combination during 2017. We have also excluded Futura from our audit of internal control over financial reporting. Futura is a wholly-owned subsidiary whose total assets and total sales excluded from management’s assessment and our audit of internal control over financial reporting represent 7% and 8%, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2017.


Definition and Limitations of Internal Control overOver Financial Reporting


A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i)(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)(2) provide reasonable assurance that transactions are recorded as necessary to


permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)(3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.


40


Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.



/s/ PricewaterhouseCoopersKPMG LLP

Richmond, Virginia
February 21, 2018March 11, 2022

41
We have served as the Company’s auditor since 1989.






CONSOLIDATED BALANCE SHEETS
Tredegar Corporation and Subsidiaries
December 31
December 31 2017 2016
20212020
(In thousands, except share data)(In thousands, except share data)   (In thousands, except share data)
AssetsAssets   Assets
Current assets:Current assets:   Current assets:
Cash and cash equivalentsCash and cash equivalents$36,491
 $29,511
Cash and cash equivalents$30,521 $11,846 
Accounts and other receivables, net of allowance for doubtful accounts and sales returns of $3,304 in 2017 and $3,102 in 2016120,135
 97,388
Accounts and other receivables, netAccounts and other receivables, net103,312 86,327 
Income taxes recoverableIncome taxes recoverable32,080
 7,518
Income taxes recoverable2,558 2,807 
InventoriesInventories86,907
 66,069
Inventories88,569 66,437 
Prepaid expenses and otherPrepaid expenses and other8,224
 7,738
Prepaid expenses and other11,275 19,679 
Current assets of discontinued operationsCurrent assets of discontinued operations178 1,339 
Total current assetsTotal current assets283,837
 208,224
Total current assets236,413 188,435 
Property, plant and equipment, at cost:Property, plant and equipment, at cost:   Property, plant and equipment, at cost:
Land and land improvementsLand and land improvements8,723
 11,294
Land and land improvements4,537 4,544 
BuildingsBuildings101,271
 126,064
Buildings69,406 66,406 
Machinery and equipmentMachinery and equipment660,898
 660,272
Machinery and equipment424,368 404,669 
Total property, plant and equipmentTotal property, plant and equipment770,892
 797,630
Total property, plant and equipment498,311 475,619 
Less accumulated depreciationLess accumulated depreciation(547,801) (536,905)Less accumulated depreciation(327,930)(309,074)
Net property, plant and equipmentNet property, plant and equipment223,091
 260,725
Net property, plant and equipment170,381 166,545 
Right-of-use leased assetsRight-of-use leased assets13,847 16,037 
Investment in kaléo (cost basis of $7,500)Investment in kaléo (cost basis of $7,500)54,000
 20,200
Investment in kaléo (cost basis of $7,500) 34,600 
Identifiable intangible assets, netIdentifiable intangible assets, net40,552
 33,601
Identifiable intangible assets, net14,152 18,820 
GoodwillGoodwill128,208
 117,822
Goodwill70,608 67,708 
Deferred income tax assetsDeferred income tax assets16,636
 584
Deferred income tax assets15,723 19,068 
Other assetsOther assets9,419
 10,006
Other assets2,460 3,506 
Non-current assets of discontinued operationsNon-current assets of discontinued operations 151 
Total assetsTotal assets$755,743
 $651,162
Total assets$523,584 $514,870 
Liabilities and Shareholders’ EquityLiabilities and Shareholders’ Equity   Liabilities and Shareholders’ Equity
Current liabilities:Current liabilities:   Current liabilities:
Accounts payableAccounts payable$108,391
 $81,342
Accounts payable$123,760 $89,702 
Accrued expensesAccrued expenses42,433
 38,647
Accrued expenses33,104 40,741 
Lease liability, short-termLease liability, short-term2,158 2,082 
Income taxes payableIncome taxes payable9,333 706 
Current liabilities of discontinued operationsCurrent liabilities of discontinued operations193 7,521 
Total current liabilitiesTotal current liabilities150,824
 119,989
Total current liabilities168,548 140,752 
Lease liability, long-termLease liability, long-term12,831 14,949 
Long-term debtLong-term debt152,000
 95,000
Long-term debt73,000 134,000 
Pension and other postretirement benefit obligations, net

Pension and other postretirement benefit obligations, net

98,837
 95,370
Pension and other postretirement benefit obligations, net78,265 110,585 
Deferred income tax liabilities2,123
 21,110
Other noncurrent liabilities8,179
 8,910
Other non-current liabilitiesOther non-current liabilities6,218 5,529 
Total liabilitiesTotal liabilities411,963
 340,379
Total liabilities338,862 405,815 
Commitments and contingencies (Notes 15 and 18)
 
Shareholders’ equity:Shareholders’ equity:   Shareholders’ equity:
Common stock (no par value):Common stock (no par value):   Common stock (no par value):
Authorized 150,000,000 shares;Authorized 150,000,000 shares;   Authorized 150,000,000 shares;
Issued and outstanding—33,017,422 shares in 2017 and 32,933,807 in 2016 (including restricted stock)34,747
 32,007
Common stock held in trust for savings restoration plan (71,309 shares in 2017 and 69,622 in 2016)(1,528) (1,497)
Issued and outstanding— 33,736,629 shares in 2021 and 33,457,176 in 2020 (including restricted stock)Issued and outstanding— 33,736,629 shares in 2021 and 33,457,176 in 2020 (including restricted stock)55,174 50,066 
Common stock held in trust for savings restoration plan (108,433 shares in 2021 and 105,067 in 2020)Common stock held in trust for savings restoration plan (108,433 shares in 2021 and 105,067 in 2020)(2,135)(2,087)
Accumulated other comprehensive income (loss):Accumulated other comprehensive income (loss):   Accumulated other comprehensive income (loss):
Foreign currency translation adjustmentForeign currency translation adjustment(86,178) (93,970)Foreign currency translation adjustment(85,792)(84,149)
Gain (loss) on derivative financial instrumentsGain (loss) on derivative financial instruments459
 863
Gain (loss) on derivative financial instruments901 2,264 
Pension and other postretirement benefit adjustmentsPension and other postretirement benefit adjustments(90,950) (90,127)Pension and other postretirement benefit adjustments(64,613)(96,519)
Retained earningsRetained earnings487,230
 463,507
Retained earnings281,187 239,480 
Total shareholders’ equityTotal shareholders’ equity343,780
 310,783
Total shareholders’ equity184,722 109,055 
Total liabilities and shareholders’ equityTotal liabilities and shareholders’ equity$755,743
 $651,162
Total liabilities and shareholders’ equity$523,584 $514,870 
    
See accompanying notes to financial statements.

42



CONSOLIDATED STATEMENTS OF INCOME
Tredegar Corporation and Subsidiaries
Years Ended December 31
Years Ended December 31 2017 2016 2015
202120202019
(In thousands, except per-share data)(In thousands, except per-share data)     (In thousands, except per-share data)
Revenues and other:Revenues and other:     Revenues and other:
SalesSales$961,330
 $828,341
 $896,177
Sales$826,455 $755,290 $826,324 
Other income (expense), netOther income (expense), net51,713
 2,381
 (20,113)Other income (expense), net20,376 (67,294)28,371 
1,013,043
 830,722
 876,064
846,831 687,996 854,695 
Costs and expenses:Costs and expenses:     Costs and expenses:
Cost of goods soldCost of goods sold775,628
 668,626
 725,459
Cost of goods sold649,690 558,967 641,140 
FreightFreight33,683
 29,069
 29,838
Freight28,232 25,686 28,980 
Selling, general and administrativeSelling, general and administrative85,501
 75,754
 71,911
Selling, general and administrative74,964 84,246 76,598 
Research and developmentResearch and development18,287
 19,122
 16,173
Research and development6,347 8,398 7,893 
Amortization of identifiable intangiblesAmortization of identifiable intangibles6,198
 3,978
 4,073
Amortization of identifiable intangibles1,704 3,017 13,601 
Pension and postretirement benefitsPension and postretirement benefits14,160 14,720 9,642 
Interest expenseInterest expense6,170
 3,806
 3,502
Interest expense3,386 2,587 4,051 
Asset impairments and costs associated with exit and disposal activities102,488
 2,684
 3,850
Goodwill impairment charge
 
 44,465
Asset impairments and costs associated with exit and disposal activities, net of adjustmentsAsset impairments and costs associated with exit and disposal activities, net of adjustments1,127 1,725 784 
Goodwill impairmentGoodwill impairment 13,696 — 
TotalTotal1,027,955
 803,039
 899,271
Total779,610 713,042 782,689 
Income (loss) before income taxes(14,912) 27,683
 (23,207)
Income (loss) from continuing operations before income taxesIncome (loss) from continuing operations before income taxes67,221 (25,046)72,006 
Income tax expense (benefit)Income tax expense (benefit)(53,163) 3,217
 8,928
Income tax expense (benefit)9,284 (8,213)13,545 
Net income (loss) from continuing operationsNet income (loss) from continuing operations57,937 (16,833)58,461 
Income (loss) from discontinued operations, net of taxIncome (loss) from discontinued operations, net of tax(111)(58,611)(10,202)
Net income (loss)Net income (loss)$38,251
 $24,466
 $(32,135)Net income (loss)$57,826 $(75,444)$48,259 
     
Earnings (loss) per share:Earnings (loss) per share:     Earnings (loss) per share:
Basic:Basic:
Continuing operationsContinuing operations$1.72 $(0.51)$1.76 
Discontinued operationsDiscontinued operations (1.75)(0.31)
Basic earnings (loss) per shareBasic earnings (loss) per share$1.72 $(2.26)$1.45 
Diluted:Diluted:
Continuing operationsContinuing operations$1.72 $(0.51)$1.76 
Discontinued operationsDiscontinued operations (1.75)(0.31)
Diluted earnings (loss) per shareDiluted earnings (loss) per share$1.72 $(2.26)$1.45 
Shares used to compute earnings (loss) per share:Shares used to compute earnings (loss) per share:
BasicBasic$1.16
 $0.75
 $(0.99)Basic33,56333,40233,236
DilutedDiluted$1.16
 $0.75
 $(0.99)Diluted33,67033,40233,258
See accompanying notes to financial statements.

43



CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Tredegar Corporation and Subsidiaries
Years Ended December 31 2017 2016 2015
(In thousands, except per-share data)     
Net income (loss)$38,251
 $24,466
 $(32,135)
Other comprehensive income (loss):     
Unrealized foreign currency translation adjustment (net of tax benefit of $371 in 2017, tax benefit of $729 in 2016 and tax benefit of $890 in 2015)7,792
 18,837
 (65,537)
Derivative financial instruments adjustment (net of tax of $111 in 2017, net of tax of $727 in 2016 and tax benefit of $550 in 2015)(404) 1,236
 (1,029)
Pension & other postretirement benefit adjustments:     
Net gains (losses) and prior service costs (net of tax benefit of $2,518 in 2017, tax benefit of $1,874 in 2016 and tax benefit of $226 in 2015)(8,634) (3,288) (2,176)
Amortization of prior service costs and net gains or losses (net of tax of $4,234 in 2017, tax of $4,398 in 2016 and tax of $5,823 in 2015)7,811
 8,700
 10,218
Other comprehensive income (loss)6,565
 25,485
 (58,524)
Comprehensive income (loss)$44,816
 $49,951
 $(90,659)
Years Ended December 31
202120202019
(In thousands)
Net income (loss)$57,826 $(75,444)$48,259 
Other comprehensive income (loss):
Unrealized foreign currency translation adjustment (net of tax benefit of $365 in 2021, net of tax benefit of $897 in 2020 and net of tax benefit of $623 in 2019)(1,643)(8,781)(3,723)
Reclassification of foreign currency translation loss realized on the sale of Personal Care Films 25,295 — 
Derivative financial instruments adjustment (net of tax benefit of $351 in 2021, net of tax of $790 in 2020 and net of tax of $71 in 2019)(1,363)3,571 294 
Pension & other postretirement benefit adjustments:
Net gains (losses) and prior service costs (net of tax of $5,212 in 2021, net of tax benefit of $4,228 in 2020 and net of tax benefit of $6,417 in 2019)18,720 (12,197)(22,508)
Amortization of prior service costs and net gains or losses (net of tax of $3,676 in 2021, net of tax of $3,937 in 2020 and net of tax of $2,359 in 2019)13,186 11,359 8,273 
Other comprehensive income (loss)28,900 19,247 (17,664)
Comprehensive income (loss)$86,726 $(56,197)$30,595 
See accompanying notes to financial statements.

44



CONSOLIDATED STATEMENTS OF CASH FLOWS
Tredegar Corporation and Subsidiaries
Years Ended December 31
Years Ended December 31 2017 2016 2015
(In thousands)     
202120202019
(In thousands)
Cash flows from operating activities:Cash flows from operating activities:     Cash flows from operating activities:
Net income (loss)Net income (loss)$38,251
 $24,466
 $(32,135)Net income (loss)$57,826 $(75,444)$48,259 
Adjustments for noncash items:Adjustments for noncash items:     Adjustments for noncash items:
DepreciationDepreciation34,079
 28,494
 30,909
Depreciation22,080 28,940 30,683 
Amortization of identifiable intangiblesAmortization of identifiable intangibles6,198
 3,978
 4,073
Amortization of identifiable intangibles1,704 3,017 13,601 
Goodwill impairment charge
 
 44,465
Goodwill impairmentGoodwill impairment 13,696 — 
Reduction of right-of-use lease assetReduction of right-of-use lease asset2,086 2,753 2,588 
Deferred income taxesDeferred income taxes(36,414) (3,689) (10,523)Deferred income taxes(4,944)(16,892)5,856 
Accrued pension and postretirement benefitsAccrued pension and postretirement benefits10,193
 11,047
 12,521
Accrued pension and postretirement benefits14,160 14,720 9,642 
(Gain) loss on investment in kaléo accounted for under the fair value method(33,800) (1,600) 20,500
Loss on asset impairments101,282
 1,436
 403
(Gain) loss on sale of assets553
 (220) (11)
Gain from insurance recoveries(5,261) (1,634) 
Stock-based compensation expenseStock-based compensation expense5,167 5,402 7,293 
(Gain) loss on investment in kaléo(Gain) loss on investment in kaléo(12,462)60,900 (10,900)
Loss on sale of divested businessesLoss on sale of divested businesses 52,326 — 
Net gain on disposal of assetsNet gain on disposal of assets — (6,334)
Changes in assets and liabilities:Changes in assets and liabilities:     Changes in assets and liabilities:
Accounts and other receivablesAccounts and other receivables(10,566) 92
 9,180
Accounts and other receivables(16,993)(335)16,471 
InventoriesInventories(9,128) 1,127
 1,137
Inventories(23,132)(4,366)11,315 
Income taxes recoverable/payableIncome taxes recoverable/payable(24,449) (7,061) (1,849)Income taxes recoverable/payable8,956 1,617 2,644 
Prepaid expenses and otherPrepaid expenses and other(784) (1,914) (1,256)Prepaid expenses and other3,612 (2,203)795 
Accounts payable and accrued expensesAccounts payable and accrued expenses21,123
 161
 (2,455)Accounts payable and accrued expenses19,835 4,045 (2,937)
Lease liabilityLease liability(1,935)(3,049)(2,723)
Pension and postretirement benefit plan contributionsPension and postretirement benefit plan contributions(5,829) (8,061) (2,709)Pension and postretirement benefit plan contributions(5,687)(12,681)(8,614)
Other, netOther, net2,767
 2,250
 2,006
Other, net310 1,927 (1,776)
Net cash provided by operating activitiesNet cash provided by operating activities88,215
 48,872
 74,256
Net cash provided by operating activities70,583 74,373 115,863 
Cash flows from investing activities:Cash flows from investing activities:     Cash flows from investing activities:
Capital expendituresCapital expenditures(44,362) (45,457) (32,831)Capital expenditures(27,361)(23,355)(50,864)
Acquisitions, net of cash acquired(87,110) 
 
Insurance proceeds from cast house explosion5,739
 1,156
 
Proceeds from the sale of kaléoProceeds from the sale of kaléo47,062 — — 
Net proceeds on sale of divested businessesNet proceeds on sale of divested businesses 56,236 — 
Proceeds from the sale of assets and otherProceeds from the sale of assets and other129
 2,308
 1,416
Proceeds from the sale of assets and other4,749 — 10,936 
Net cash used in investing activities(125,604) (41,993) (31,415)
Net cash provided by (used in) investing activitiesNet cash provided by (used in) investing activities24,450 32,881 (39,928)
Cash flows from financing activities:Cash flows from financing activities:     Cash flows from financing activities:
BorrowingsBorrowings190,750
 96,750
 107,000
Borrowings75,500 162,250 65,500 
Debt principal paymentsDebt principal payments(133,750) (105,750) (140,250)Debt principal payments(136,500)(70,250)(125,000)
Dividends paidDividends paid(14,532) (14,456) (13,725)Dividends paid(16,167)(216,049)(15,325)
Debt financing costsDebt financing costs
 (2,606) (78)Debt financing costs0(693)(1,817)
Proceeds from exercise of stock options and other695
 2,313
 2,858
Net cash provided by (used) in financing activities43,163
 (23,749) (44,195)
OtherOther325 (850)(670)
Net cash used in financing activities:Net cash used in financing activities:(76,842)(125,592)(77,312)
Effect of exchange rate changes on cashEffect of exchange rate changes on cash1,206
 2,225
 (4,546)Effect of exchange rate changes on cash484 (1,238)(1,598)
Increase (decrease) in cash and cash equivalentsIncrease (decrease) in cash and cash equivalents6,980
 (14,645) (5,900)Increase (decrease) in cash and cash equivalents18,675 (19,576)(2,975)
Cash and cash equivalents at beginning of periodCash and cash equivalents at beginning of period29,511
 44,156
 50,056
Cash and cash equivalents at beginning of period11,846 31,422 34,397 
Cash and cash equivalents at end of periodCash and cash equivalents at end of period$36,491
 $29,511
 $44,156
Cash and cash equivalents at end of period$30,521 $11,846 $31,422 
Supplemental cash flow information:Supplemental cash flow information:     Supplemental cash flow information:
Interest paymentsInterest payments$5,808
 $3,074
 $3,508
Interest payments$2,923 $1,679 $4,358 
Income tax payments (refunds), netIncome tax payments (refunds), net$9,193
 $15,406
 $20,118
Income tax payments (refunds), net$4,706 $1,670 $2,595 
See accompanying notes to financial statements.


45


CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
Tredegar Corporation and Subsidiaries
         Accumulated Other Comprehensive Income (Loss)  
 Common Stock 
Retained
Earnings
 Trust for Savings Restora-tion Plan 
Foreign
Currency
Trans-lation
 
Gain
(Loss) on
Derivative
Financial Instruments
 
Pension & Other Post-
retirement Benefit Adjust.
 
Total
Share-
holders’ Equity
(In thousands, except share and per-share data)Shares Amount      
Balance at January 1, 201532,422,082
 $24,364
 $499,300
 $(1,440) $(47,270) $656
 $(103,581) $372,029
Net loss
 
 (32,135) 
 
 
 
 (32,135)
Foreign currency translation adjustment (net of tax benefit of $890)
 
 
 
 (65,537) 
 
 (65,537)
Derivative financial instruments adjustment (net of tax benefit of $550)
 
 
 
 
 (1,029) 
 (1,029)
Net gains or losses and prior service costs (net of tax benefit of $226)
 
 
 
 
 
 (2,176) (2,176)
Amortization of prior service costs and net gains or losses (net of tax of $5,823)
 
 
 
 
 
 10,218
 10,218
Cash dividends declared ($0.42 per share)
 
 (13,725) 
 
 
 
 (13,725)
Stock-based compensation expense118,440
 3,435
 
 
 
 
 
 3,435
Issued upon exercise of stock options (including related income tax of $302) & other141,640
 1,668
 
 
 
 
 
 1,668
Shareholder Rights Plan redemption
 
 
 
 
 
 
 
Tredegar common stock purchased by trust for savings restoration plan
 
 27
 (27) 
 
 
 
Balance at December 31, 201532,682,162
 29,467
 453,467
 (1,467) (112,807) (373) (95,539) 272,748
Net income
 
 24,466
 
 
 
 
 24,466
Foreign currency translation adjustment (net of tax benefit of $729)
 
 
 
 18,837
 
 
 18,837
Derivative financial instruments adjustment (net of tax of $727)
 
 
 
 
 1,236
 
 1,236
Net gains or losses and prior service costs (net of tax benefit of $1,874)
 
 
 
 
 
 (3,288) (3,288)
Amortization of prior service costs and net gains or losses (net of tax of $4,398)
 
 
 
 
 
 8,700
 8,700
Cash dividends declared ($0.44 per share)
 
 (14,456)         (14,456)
Stock-based compensation expense127,169
 1,461
 
 
 
 
 
 1,461
Issued upon exercise of stock options (including related income tax of $1,109) & other124,476
 1,079
 
 
 
 
 
 1,079
Tredegar common stock purchased by trust for savings restoration plan
 
 30
 (30) 
 
 
 
Balance at December 31, 201632,933,807
 32,007
 463,507
 (1,497) (93,970) 863
 (90,127) 310,783
Net income
 
 38,251
 
 
 
 
 38,251
Foreign currency translation adjustment (net of tax benefit of $371)
 
 
 
 7,792
 
 
 7,792
Derivative financial instruments adjustment (net of tax of $111)
 
 
 
 
 (404) 
 (404)
Net gains or losses and prior service costs (net of tax benefit of $2,518)
 
 
 
 
 
 (8,634) (8,634)
Amortization of prior service costs and net gains or losses (net of tax of $4,234)
 
 
 
 
 
 7,811
 7,811
Cash dividends declared ($0.44 per share)
 
 (14,532) 
 
 
 
 (14,532)
Stock-based compensation expense49,475
 2,018
 
 
 
 
 
 2,018
Issued upon exercise of stock options & other34,140
 695
 
 
 
 
 
 695
Cumulative effect adjustment for adoption of stock-based compensation accounting guidance
 27
 (27) 
 
 
 
 
Tredegar common stock purchased by trust for savings restoration plan
 
 31
 (31) 
 
 
 
Balance at December 31, 201733,017,422
 $34,747
 $487,230
 $(1,528) $(86,178) $459
 $(90,950) $343,780
    Accumulated Other Comprehensive Income (Loss)
 Common StockRetained
Earnings
Trust for Savings Restoration PlanForeign Currency TranslationGain (Loss) on Derivative Financial InstrumentsPension & Other 
Postretirement Benefit Adjust
Total Shareholders’ Equity
(In thousands, except share and per-share data)SharesAmount
Balance at January 1, 201933,176,024 $38,892 $497,511 $(1,559)$(96,940)$(1,601)$(81,446)$354,857 
Net income (loss)— — 48,259 — — — — 48,259 
Foreign currency translation adjustment— — — — (3,723)— — (3,723)
Derivative financial instruments adjustment— — — — — 294 — 294 
Net gains or (losses) and prior service costs— — — — — — (22,508)(22,508)
Amortization of prior service costs and net gains or losses— — — — — — 8,273 8,273 
Cash dividends declared ($0.46 per share)— — (15,325)— — — — (15,325)
Stock-based compensation expense228,959 7,292 — — — — — 7,292 
Repurchase of employee common stock for tax withholdings(49,444)(854)— — — — — (854)
Issued upon exercise of stock options9,500 184 — — — — — 184 
Tredegar common stock purchased by trust for savings restoration plan— — 33 (33)— — — — 
Balance at December 31, 201933,365,039 45,514 530,478 (1,592)(100,663)(1,307)(95,681)376,749 
Net income (loss)— — (75,444)— — — — (75,444)
Foreign currency translation adjustment— — — — (8,781)— — (8,781)
Foreign currency translation loss realized on the sale of Personal Care Films— — — — 25,295 — — 25,295 
Derivative financial instruments adjustment— — — — — 3,571 — 3,571 
Net gains or (losses) and prior service costs— — — — — — (12,197)(12,197)
Amortization of prior service costs and net gains or losses— — — — — — 11,359 11,359 
Cash dividends declared ($6.45 per share)— — (216,049)— — — — (216,049)
Stock-based compensation expense131,354 5,402 — — — — — 5,402 
Repurchase of employee common stock for tax withholdings(39,217)(850)— — — — — (850)
Tredegar common stock purchased by trust for savings restoration plan— — 495 (495)— — — — 
Balance at December 31, 202033,457,176 50,066 239,480 (2,087)(84,149)2,264 (96,519)109,055 
Net income (loss)  57,826     57,826 
Foreign currency translation adjustment    (1,643)  (1,643)
Derivative financial instruments adjustment     (1,363) (1,363)
Net gains or (losses) and prior service costs      18,720 18,720 
Amortization of prior service costs and net gains or losses      13,186 13,186 
Cash dividends declared ($0.48 per share)  (16,167)    (16,167)
Stock-based compensation expense229,014 4,783      4,783 
Issued upon exercise of stock options67,705 915      915 
Repurchase of employee common stock for tax withholdings(17,266)(590)     (590)
Tredegar common stock purchased by trust for savings restoration plan  48 (48)    
Balance at December 31, 202133,736,629 $55,174 $281,187 $(2,135)$(85,792)$901 $(64,613)$184,722 
See accompanying notes to financial statements.

46



NOTES TO FINANCIAL STATEMENTS
Tredegar Corporation and Subsidiaries
1SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization and 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations. Tredegar Corporation and subsidiaries (collectively “Tredegar,” “the Company,” “we,” “us” or “our”) are primarily engagedis an industrial manufacturer with three primary businesses: custom aluminum extrusions for the North American building & construction, automotive and specialty end-use markets; surface protection films for high-technology applications in the manufacture ofglobal electronics industry and polyethylene overwrap films polyesterused in bathroom tissue and paper towels; and polyester-based films for use in packaging applications that have specialized properties primarily for the Latin American and aluminum extrusions, whichthe United States (“U.S.”) flexible packaging markets. The Company’s business segments are reported for business segment purposes under PE Films, Flexible Packaging Films (also referred to as Terphane) and Aluminum Extrusions (also referred to as Bonnell Aluminum), respectively.PE Films, and Flexible Packaging Films (also referred to as Terphane). More information on the Company’s business segments is provided in Note 5. See13.
On October 30, 2020, the Company completed the sale of its personal care films business (“Personal Care Films”), which was part of its PE Films segment. The transaction excluded the packaging film lines and related operations located at the Pottsville, Pennsylvania manufacturing site (“Pottsville Packaging”), which are now being reported within the Surface Protection component of PE Films. Commencing in the third quarter of 2020, all historical results for Personal Care Films have been presented as discontinued operations.
In December 2020, the Company entered into a definitive agreement to sell Bright View Technologies (“Bright View”). The sale did not represent a strategic shift nor did it have a major effect on the Company’s historical and ongoing operations, thus all financial information for Bright View has been presented as continuing operations in the PE Films segment.
For more information on these transactions, see Note 15 in the Notes 10 and 17 regarding restructurings.to Financial Statements
Basis of Presentation.Presentation and Principles of Consolidation. The consolidated financial statements include the accounts and operations of Tredegarthe Company and all of its majority-owned subsidiaries.have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Intercompany accountsbalances and transactions have been eliminated in consolidation.
The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires Tredegar to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.
Certain amounts for the prior years have been reclassified to conform to current year presentation.
Fiscal Year End. The Company operates on a calendar fiscal year except for the Aluminum Extrusions segment, which operates on a 52/53-week fiscal year basis. References to Aluminum Extrusions for 2017, 20162021, 2020 and 20152019 relate to the 52-week fiscal yearsyear ended December 24, 2017, December 26, 2016 and2021, the 52-week fiscal year ended December 27, 2015,2020 and the 52-week fiscal year ended December 29, 2019, respectively. The Company does not believe the impact of reporting the results of this segment as stated abovein this manner is material to the consolidated financial results. The Company may fund or receive cash from the Aluminum Extrusions segment based on Aluminum Extrusion’s cash flows from operations during the intervening period from Aluminum Extrusion’s fiscal year end to the Company’s calendar year end. There was no intercompany funding with Aluminum Extrusions between December 27, 2021 and December 31, 2021. As of December 31, 2020, the Company’s cash and cash equivalents declined by $3.8 million since the Company made payments to the Aluminum Extrusions segment to fund its working capital during the intervening period.
Use of Estimates. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and disclosure of contingent assets and liabilities (if any). On an ongoing basis, the Company evaluates its estimates, including those related to provisions for transaction and credit losses, income taxes, pension, and the valuation of goodwill and intangible assets, among others. Tredegar bases its estimates on historical experience and various other assumptions which the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.
Risk and Uncertainties. While it is not possible to estimate the impact that the coronavirus pandemic (“COVID-19”) may have on the Company’s business, estimates related to the accounting for impairment of long-lived assets and goodwill, pension benefits and income taxes could be materially adversely affected in future periods. Due to the uncertainty with respect to the magnitude of the impact and duration of COVID-19, future developments associated with COVID-19 may adversely affect the Company's financial condition, results of operations and cash flows. The Company continues to monitor the impact of COVID-19 on the business and its effect on the consolidated financial statements.
Foreign Currency Translation. The financial statements of subsidiaries located outside the U.S., where the local currency is the functional currency, are translated into U.S. Dollars using exchange rates in effect at the period end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from the translation of these financial statements are reflected as a separate component of shareholders’ equity. There are no operating subsidiaries located outside the U.S. where the U.S. Dollar is the functional currency.
Transaction and remeasurement gains or losses included in income were losses of $0.8$0.5 million, $3.6gains of $0.6 million and $4.0losses of $0.6 million in 2017, 20162021, 2020 and 2015,2019, respectively. These amounts do not include the effects between reporting periods that exchange rate changes have on income of the locations outside the U.S. that result from translation into U.S. Dollars.
47


Cash and Cash Equivalents. Cash and cash equivalents consist of cash on hand in excess of daily operating requirements and highly liquid investments with original maturities of three months or less. At December 31, 20172021 and 2016,2020, Tredegar had cash and cash equivalents of $36.5$30.5 million and $29.5$11.8 million, respectively, including funds held in locations outside the U.S. of $32.7$16.4 million and $23.8$9.4 million, respectively.
The Company’s policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year. The primary objectives of the policy are safety of principal and liquidity.
Accounts and Other Receivables.Receivables, net. Accounts receivable are stated at the amount invoiced to customers less allowances for doubtful accounts and sales returns.accounts. Accounts receivable are non-interest bearing and arise from the sale of product to customers under typical industry trade terms. Notes receivable are not significant.immaterial. Past due amounts are determined based on established terms and charged-off when deemed uncollectible. The allowance for doubtful accounts is determined based on an assessment of probable losses taking into account past due amounts, customer credit profile, historical experience and current economic conditions. For receivables that do not have a specific allowance, the loss rate is computed by segment to apply to the remaining receivables balance, using each segment’s historic loss rate. Other receivables include value-added taxes related to certain foreign subsidiaries and other miscellaneous receivables due within one year. For certain customers, the Company has arrangements in place with financial institutions whereby certain customer receivables are sold to the financial institution at a discount and without recourse. Upon sale, the associated receivable is unrecognized and the discount is recognized as a reduction of sales. For more information on accounts receivable and other receivables, net, see Note 2.
Inventories. Inventories are stated at the lower of cost or market, with cost determined onusing the last-in, first-outlast in, first out (“LIFO”) basis,, the weighted average cost or the first-in, first-out basis.first in, first out method. Cost elements included in work-in-process and finished goods inventories are raw materials, direct labor and manufacturing overhead. Finished goods, work-in-process, raw materials and supplies, stores and other inventory are reviewed to determine if inventory quantities are in excess of forecasted usage or if they have become obsolete.
Property, Plant and Equipment. Accounts include costs of assets constructed or purchased, related delivery and installation costs and interest incurred on significant capital projects during their construction periods. Expenditures for renewals and betterments also are capitalized, but expenditures for repairs and maintenance are expensed as incurred. The cost and


accumulated depreciation applicable to assets retired or sold are removed from the respective accounts, and gains or losses thereon are included in income.
Capital expenditures for property, plant and equipment include capitalized interest. Capitalized interest included in capital expenditures for property, plant and equipment was $0.4$0.1 million, $0.1 million and $0.3 million in 2021, 2020 and $0.4 million in 2017, 2016 and 2015,2019, respectively.
Depreciation is computed primarily by the straight-line method based on the estimated useful lives of the assets that except for isolated exceptions,generally range from 5 to 40 years for buildings and land improvements and 2 to 20 years for machinery and equipment.
Investments in Private Entities with Less Than or Equal to 50% Voting Ownership Interest. The Company accounts for its investments in private entities where its voting ownership is less than or equal to 50% based on the facts and circumstances surrounding the investment.
For those investments measured at fair value, GAAP requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
Goodwill and Identifiable Intangibles. The excess of the purchase price over the fair value of identifiable net assets of acquired companies is allocated to goodwill. The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable or, at a minimum, on an annual basis (December 1st of each year). When assessing goodwill for impairment, accounting guidance allows the Company to first perform a qualitative assessment about the likelihood of the carrying value of a reporting unit exceeding its fair value, referred to as the "Step 0" assessment. The Step 0 assessment requires the evaluation of certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well as company and reporting unit factors. If the Company's Step 0 analysis indicates that it is more likely than not that the fair value of a reporting unit is less than the carrying amount, then the Company would perform a quantitative impairment test that estimates the fair value of its reporting units using discounted cash flow analyses and comparative enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and amortization) multiples.
During the first three months of 2020, the Company performed goodwill impairment tests and recognized a goodwill impairment charge of $13.7 million ($10.5 million after taxes), which represented the entire amount of goodwill associated with Aluminum Extrusions’ AACOA reporting unit. The operations of the AACOA reporting unit, which includes the Niles, Michigan and Elkhart, Indiana facilities, were expected to be severely impacted by COVID-19, with over 80% of the aluminum extrusions manufactured at these facilities sold to customers that make consumer durable products, such as recreational boating and power sports vehicles, and to customers serving the building and construction and automotive markets.
As of December 1, 2021, the Company’s significant operatingreporting units with goodwill were Surface Protection in PE Films include Personal Care and Surface Protection. There are three operating unitsFutura in Aluminum Extrusions: Bonnell Aluminum, AACOA and Futura. EachExtrusions. Both of these reporting units hashave separately identifiable operating net assets (operating assets including goodwill and identifiable intangible assets net of operating liabilities).
In addition, the Company applied the Step 0 goodwill assessment to Surface Protection and Futura; both had fair values significantly in excess of their carrying amounts when last tested using the quantitative impairment test. The Company recorded aCompany's Step 0 analyses in 2021 of these reporting units concluded that it is not more likely than not that the fair values of each reporting unit was less than its carrying amount. Therefore, the quantitative goodwill impairment charge of $44.5 million ($44.5 million after taxes) to write off the goodwill associated with Flexible Packaging Films in the third quarter of 2015. See Note 8tests for additional details.
The Company estimates the fair value of itsthese reporting units using discounted cash flow analysiswere not necessary in 2021. The Surface
48


Protection and comparative enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and amortization) multiples. Goodwill of the PE Films operatingFutura reporting units Personal Care and Surface Protection,had goodwill in the amounts of $46.8$57.3 million and $57.3 million, respectively, was tested for impairment at the annual testing date, with the estimated fair value of these reporting units exceeding the carrying value of their net assets by approximately 15% and +100%, respectively, at December 1, 2017. The goodwill of the Aluminum Extrusions reporting unit was tested for impairment at the annual testing date. The goodwill in Aluminum Extrusions is associated with the October 2012 acquisition of AACOA, Inc. (“AACOA”) and the February 2017 acquisition of Futura Industries Corporation (“Futura”). The estimated fair value of AACOA and Futura exceeded the carrying value of their net assets by approximately 61% and 42%, respectively, at December 1, 2017. Goodwill for AACOA and Futura totaled $13.7 million and $10.4$13.3 million, respectively, at December 31, 2017.
Indefinite-lived identifiable intangible assets are assessed for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum,2021. For more information on an annual basis (December 1st of each year). The Company estimates the fair value of its trade names using a relief-from-royalty method that relies upon a corresponding discounted cash flow analysis.
For AACOA and Futura, the indefinite-lived identifiable intangible assets for each were tested for impairment at the annual testing date, with the estimated fair value substantially exceeding the carrying value of the net assets for each.
Based on a valuation analysis conducted in the fourth quarter of 2017, Terphane recorded an impairment of its assets. Indefinite-lived trade names for Terphane were written down by $4.0 million to $2.4 million and were assigned estimated useful lives of 5 to 13 years. Also, Terphane recorded a reduction of the carrying value of definite-lived identifiable intangible assets in the amount of $14.0 million.
Additional disclosure of Tredegar goodwill and identifiable intangible assets and the impairments recorded in 2017 are included inintangibles, see Note 8.5.
Impairment of Long-Lived Assets. The Company reviews long-lived assets for possible impairment when events indicate that an impairment may exist. For assets that are held and used in operations, if events indicate that an asset may be impaired, the Company estimates the future unlevered pre-tax cash flows expected to result from the use of the asset and its eventual disposition. Assets are grouped for this purpose at the lowest level for which there are identifiable and independent cash flows.


If the sum of these undiscounted pre-tax cash flows is less than the carrying amount of the asset group, an impairment loss is calculated. Measurement of the impairment loss is the amount by which the carrying amount exceeds the estimated fair value of the asset group.
During the fourth quarter As of 2017, in conjunction with annual business planning as well as valuation activities (including the use of discounted cash flowDecember 31, 2021 and comparative enterprise value-to-EBITDA multiple methods) and other efforts, the Company determined2020, no events were identified that the carrying value of Terphane’s remainingindicated long-lived assets weremay be impaired.  Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million. This write-down resulted in a non-cash asset impairment loss recognized during the fourth quarter of 2017 of $101 million ($87 million after non-cash tax benefits). See Note 17 for more information on this impairment.
Assets that are held for sale are reported at the lower of their carrying amount or estimated fair value less cost to sell, with an impairment loss recognized for any write-down required.
Pension Costs and Postretirement Benefit Costs Other than Pensions. Pension costs and postretirement benefit costs other than pensions arehave been accrued over the period employees provideprovided service to Tredegar. Liabilities and expenses for pension plans and other postretirement benefits are determined using actuarial methodologies and incorporate significant assumptions, including the rate used to discount the future estimated liability, the long-term rate of return on plan assets, and several assumptions relating to the employee workforce. The Company recognizes the funded status of its pension and other postretirement plans in the accompanying consolidated balance sheets. Tredegar’s policy is to fund its pension plans at amounts not less than the minimum requirements of the Employee Retirement Income Security Act (“ERISA”) of 1974 and to fund postretirement benefits other than pensions when claims are incurred.
On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete. In connection therewith, on February 9, 2022, the Company contributed $50 million to the pension plan (the “Special Contribution”). The Company estimates that, with the Special Contribution, there will be no required minimum contributions to the pension plan until final settlement. As of December 31, 2021, no adjustment to the consolidated financial statements has been recognized as a result of this announcement and Special Contribution made in 2022. As the settlement process occurs, the Company expects to recognize a non-cash reclassification adjustment to net income or loss of other comprehensive net actuarial losses associated with the pension plan currently reflected directly in shareholders’ equity. Other comprehensive net actuarial losses associated with the pension plan were approximately $109 million on a pretax basis as of December 31, 2021.
Additional disclosure regarding Tredegar’s pension costs and postretirement benefit costs other than pensions is included in Note 8.
Revenue Recognition. Revenue The Company’s revenue is primarily generated from the sale of finished products which is shown net of estimatedto customers. Those sales returnspredominantly contain a single performance obligation and allowances,revenue is recognized at the point in time when title has passed to the customer, the pricecontrol of the product is transferred to customers, along with the title, risk of loss and rewards of ownership. Depending on the arrangement with the customer, these criteria are met either at the time the product is shipped or when the product is made available or delivered at the destination specified in the agreement with the customer.
Sales revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange for that finished product. The Company offers various discounts, rebates and allowances to customers, (collectively, “allowances”), all of which are considered when determining the transaction price. Certain allowances are fixed and determinable at the time of sale and collectability is reasonably assured. are recorded at the time of sale as a reduction to revenues. Other allowances can vary depending on future outcomes such as sales returns and customer sales volume, thus represents variable consideration.
Amounts billed to customers related to freight have beenare classified as sales inrevenue and the accompanying consolidated statements of income. The cost of freight has beenis classified as a separate line in the accompanying consolidated statements of income. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction between Tredegar and its customers (such as value-added taxes) are accounted for on a net basis and therefore excluded from revenues. See Note 13 for disaggregation of revenue by segment and type. See Note 2 for a table showing accounts and other receivables, net of allowance for bad debts.
Revenue expected to be recognized in any future period related to remaining performance obligations, excluding i) revenue pertaining to contracts that have an original expected duration of one year or less, ii) contracts where revenue is recognized as invoiced and iii) variable consideration related to unsatisfied performance obligations, is not expected to materially impact the Company’s financial results. 
Research & Development (“R&D”) Costs. R&D costs are expensed as incurred and include primarily salaries, wages, employee benefits, equipment depreciation, facility costs and the cost of materials consumed relating to R&D efforts. R&D costs include a reasonable allocation of indirect costs.
49


Leases. At inception, the Company determines if an arrangement contains a lease and whether that lease meets the classification criteria of a finance or operating lease. The Company has elected to not record short-term leases with an original lease term of one year or less in the consolidated balance sheet. To the extent such leases contain renewal options that the Company intends to exercise, the related Right-of-Use (“ROU”) asset and lease liability are included in the consolidated balance sheet. Some of the Company’s lease arrangements contain lease components (e.g., minimum rent payments) and non-lease components (e.g., maintenance, labor charges, etc.). The Company generally accounts for the lease and non-lease components as a single lease component.
Certain of the Company’s lease agreements include rental payments that are adjusted periodically for an index or rate. The leases are initially measured using the projected payments adjusted for the index or rate in effect at the commencement date. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
Operating leases are included in “Right-of-use lease assets”, “Lease liabilities - short-term” and “Lease liabilities - long-term” on the consolidated balance sheets. These assets and liabilities are recognized at the commencement date based on the present value of remaining lease payments over the lease term using the Company’s secured incremental borrowing rates, adjusted for term and geographic location using country-based swap rates. As a result of the Company’s review of new and existing lease contracts, there were no instances where the Company could readily determine a rate implicit in the lease.
Lease expense for operating leases is recognized on a straight-line basis over the lease term. Variable lease expense is recognized in the period in which the obligation for those payments is incurred. Depending upon the specific use of the ROU asset, lease expense is included in the “Cost of goods sold”, “Freight”, “Selling, general and administrative”, and “Research and development” line items on the consolidated statements of income. Lease income is not material to the results of operations for the years ended December 31, 2021 and 2020, respectively. Additional disclosure regarding Tredegar’s leases is included in Note 4.
Income Taxes. Income taxes are recognized during the period in which transactions enter into the determination of income for financial reporting purposes, with deferred income taxes being provided at enacted statutory tax rates on the differences between the financial reporting and tax bases of assets and liabilities (see Note 16)12). Tredegar’s policy is to accrue U.S. federal income taxes to the extent required under GAAP on unremitted earnings of all foreign subsidiaries where required. However, due to changes in the taxation of dividends under the Tax Cuts and Jobs Act (the “TCJA”) enacted by the U.S. government onin December 22, 2017, Tredegar will only recordrecords U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries. Prior to the second quarter of 2016, deferred U.S. federal income taxes had not been recorded for the undistributed earnings for Terphane Limitada because the Company had intended to permanently reinvest these earnings. Due to concerns about the current political and economic conditions in Brazil, Terphane Limitada began making cash distributions to the Company. During 2016, Terphane Limitada paid dividends totaling $13.3 million to the Company. Because of the accumulation of significant losses related to foreign currency translations at Terphane Limitada, there were no unrecorded deferred income tax liabilities associated with the U.S. federal income taxes and foreign withholding taxes on Terphane Limitada’s undistributed earnings as of December 31, 20172021 and December 31, 2016.2020.
A valuation allowance is recorded in the period when the Company determines that it is more likely than not that all or a portion of deferred income tax assets may not be realized. The establishment and removal of a valuation allowance requires the Company to consider all positive and negative evidence and make a judgmental decision regarding the amount of valuation allowance required as of a reporting date. The benefit of an uncertain tax position is included in the accompanying financial statements when the Company determines that it is more likely than not that the position will be sustained, based on the technical merits of the position, if the taxing authority examines the position and the dispute is litigated. This determination is made on the basis of all the facts, circumstances and information available as of the reporting date.
Earnings Per Share. Basic earnings per share is computed using the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed using the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:


2017 2016 2015202120202019
Weighted average shares outstanding used to compute basic earnings per share32,945,961
 32,761,793
 32,578,116
Weighted average shares outstanding used to compute basic earnings per share33,562,684 33,402,147 33,236,115 
Incremental shares attributable to stock options and restricted stock5,327
 13,279
 
Incremental shares attributable to stock options and restricted stock107,566 — 22,022 
Shares used to compute diluted earnings per share32,951,288
 32,775,072
 32,578,116
Shares used to compute diluted earnings per share33,670,250 33,402,147 33,258,137 
Incremental shares attributable to stock options and restricted stock are computed using the average market price during the related period. The Company had a net loss in 2015, so there is no dilutive impact for such shares. IfFor the Company had reported net income in 2015, average out-of-the-money options to purchase shares that would have been excluded from the calculation of incremental shares attributable to stock options and restricted stock were 881,513. Theyear ended December 31, 2021, average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 397,669 in 20171,582,222. The Company had a net loss from continuing operations for the year ended December 31, 2020, so there is no dilutive impact for such shares. If the Company had reported net income from continuing operations for the year ended December 31, 2020, average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and 128,200 in 2016.restricted stock were 1,212,375. For the year ended December 31, 2019, average out-of-the-money options
50


to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 209,592.
Stock-Based Employee Compensation Plans. Compensation expense is recorded onThe cost of all share-based awards based upon itspayments is recognized using the calculated fair value at the grant date, or the date of any later modification, over the requisite service period usingunder the graded-vesting method. The fair value of stock option awards was estimated as of the grant date using the Black-Scholes options-pricing model. The fair value of restricted stock awards was estimated as of the grant date using the closing stock price on that date.See Note 11 for additional information.
The assumptions used in this model for valuing Tredegar stock options granted in 2017 (no grants in 2015 and 2016) were as follows:
 2017
Dividend yield1.9%
Weighted average volatility percentage38.3%
Weighted average risk-free interest rate1.8%
Holding period (years): 
Officers5
Management5
Weighted average exercise price at date of grant (also weighted average market price at date of grant): 
Officers$15.65
Management15.65
The dividend yield is the actual dividend yield on Tredegar’s common stock at the date of grant, which the Company believes is a reasonable estimate of the expected yield during the holding period. The expected volatility is based on the historical volatility of Tredegar’s common stock using a sequential period of historical data equal to the expected holding period of the option. The Company has no reason to believe that future volatility for this period is likely to differ from the past. The assumed risk-free interest rate is based on observed interest rates (zero coupon U.S. Treasury debt securities) appropriate for the expected holding period.
In March 2016, the FASB issued amended guidance (ASU 2016-09) to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The Company adopted the new guidance in the first quarter of 2017. Under the new guidance, excess tax benefits related to equity compensation were recognized in income tax expense (benefit) in the consolidated statements of income rather than in accumulated other comprehensive income in the consolidated balance sheets and were applied on a prospective basis. If these amounts had been included in the consolidated statements of income in previous years, net income would have been reduced by $1.1 million in 2016, and the net loss would have increased $0.3 million in 2015. Changes to the statements of cash flows related to the classification of excess tax benefits and employee taxes paid for share-based payment arrangements were implemented on a retrospective basis. In addition, the updated guidance allows the Company to make an accounting policy election to account for forfeitures as they occur. Previously, the Company was required to estimate forfeitures at the grant date, accounting for estimated forfeitures over the requisite service period.
Tredegar stock options granted during 2017 (no grants in 2015 and 2016), and related estimated fair value at the date of grant, are as follows:


 2017
Stock options granted (number of shares): 
Officers151,992
Management57,559
Total209,551
Estimated weighted average fair value of options per share at date of grant: 
Officers$4.69
Management4.69
Total estimated fair value of stock options granted (in thousands)$983
Additional disclosure of Tredegar stock options is included in Note 12.
Financial Instruments. Tredegar uses derivative financial instruments for the purpose of hedging aluminum price volatility and currency exchange rate exposures that exist as part of transactions associated with ongoing business operations. The Company’s derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the accompanying balance sheet at fair value. A change in the fair value of the derivative that is highly effective and that is designated and qualifies as a cash flow hedge is recorded in other comprehensive income. Gains and losses reported in other comprehensive income (loss) are reclassified to earnings in the periods in which earnings are affected by the variability of cash flows of the hedged transaction. Such gains and losses are reported onin the same line as the underlying hedged item, and the cash flows related to financial instruments are classified in the consolidated statements of cash flows in a manner consistent with those of the transactions being hedged. Any hedge ineffectiveness (which represents the amount by which the changes in the fair value of the derivative exceed the variability in the cash flows of the forecasted transaction) is recorded in current period earnings. The amount of gains and losses recognized for hedge ineffectiveness were not material in 2017, 2016 and 2015.
The Company’s policy requires that it formally document all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions. The Company also uses regression analysis, unless the hedge qualifies for other methods of assessing effectiveness, to formally assessesassess (both at the hedge’s inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, the Company discontinues hedge accounting prospectively.
As a policy, Tredegar does not engage in speculative or leveraged transactions, nor does it hold or issue financial instruments for trading purposes. Additional disclosure of the utilization of derivative hedging instruments is included in Note 9.10.
Comprehensive Income (Loss). Comprehensive income (loss) is defined as net income or loss as adjusted by other comprehensive income or loss items. Other comprehensive income (loss) includes changes in foreign currency translation adjustments, unrealized gains and losses on derivative financial instruments, prior service costs and net gains or losses from pension and other postretirement benefit plans arising during the period and amortization of these prior service costs and net gain or loss adjustments, all recorded net of deferred income taxes.

51




The following table summarizes the after-tax changes in accumulated other comprehensive income (loss) for the year ended December 31, 2017:by component are summarized as follows:

(In thousands)Foreign currency translation adjustment Gain (loss) on derivative financial instruments Pension and other post-retirement benefit adjustments Total
Beginning balance, January 1, 2017$(93,970) $863
 $(90,127) $(183,234)
Other comprehensive income (loss) before reclassifications7,792
 538
 (8,634) (304)
Amounts reclassified from accumulated other comprehensive income (loss)
 (942) 7,811
 6,869
Net other comprehensive income (loss) - current period7,792
 (404) (823) 6,565
Ending balance, December 31, 2017$(86,178) $459
 $(90,950) $(176,669)

Foreign Currency TranslationGain (Loss) on Derivative Financial InstrumentsPension & Other Postretirement Benefit AdjustTotal Accumulated Other Comprehensive Income (Loss)
Balance at January 1, 2019$(96,940)$(1,601)$(81,446)$(179,987)
Other comprehensive income (loss)(4,346)(3,214)(28,925)(36,485)
Income tax (expense) benefit623 528 6,417 7,568 
Other comprehensive income (loss), net of tax(3,723)(2,686)(22,508)(28,917)
Reclassification adjustment to net income (loss)— 3,578 10,632 14,210 
Income tax (expense) benefit— (598)(2,359)(2,957)
Reclassification adjustment to net income (loss), net of tax— 2,980 8,273 11,253 
Other comprehensive income (loss), net of tax(3,723)294 (14,235)(17,664)
Balance at December 31, 2019(100,663)(1,307)(95,681)(197,651)
Other comprehensive income (loss)(9,678)(4,362)(16,425)(30,465)
Income tax (expense) benefit897 1,077 4,228 6,202 
Other comprehensive income (loss), net of tax(8,781)(3,285)(12,197)(24,263)
Reclassification adjustment to net income (loss)25,295 8,724 15,296 49,315 
Income tax (expense) benefit— (1,868)(3,937)(5,805)
Reclassification adjustment to net income (loss), net of tax25,295 6,856 11,359 43,510 
Other comprehensive income (loss), net of tax16,514 3,571 (838)19,247 
Balance at December 31, 2020(84,149)2,264 (96,519)(178,404)
Other comprehensive income (loss)(2,008)3,800 23,932 25,724 
Income tax (expense) benefit365 (842)(5,212)(5,689)
Other comprehensive income (loss), net of tax(1,643)2,958 18,720 20,035 
Reclassification adjustment to net income (loss) (5,513)16,862 11,349 
Income tax (expense) benefit 1,192 (3,676)(2,484)
Reclassification adjustment to net income (loss), net of tax (4,321)13,186 8,865 
Other comprehensive income (loss), net of tax(1,643)(1,363)31,906 28,900 
Balance at December 31, 2021$(85,792)$901 $(64,613)$(149,504)
The following table summarizes the after-tax changes in accumulated other comprehensive income (loss) for the year ended December 31, 2016:
(In thousands)Foreign currency translation adjustment Gain (loss) on derivative financial instruments Pension and other post-retirement benefit adjustments Total
Beginning balance, January 1, 2016$(112,807) $(373) $(95,539) $(208,719)
Other comprehensive income (loss) before reclassifications18,837
 247
 (3,288) 15,796
Amounts reclassified from accumulated other comprehensive income (loss)
 989
 8,700
 9,689
Net other comprehensive income (loss) - current period18,837
 1,236
 5,412
 25,485
Ending balance, December 31, 2016$(93,970) $863
 $(90,127) $(183,234)



Reclassifications of balancesamounts reclassified out of accumulated other comprehensive income (loss) intorelated to pension and other postretirement benefits is included in the computation of net income during 2017 are summarized as follows:periodic pension costs, see Note 8 for additional details.
0
52


(In thousands)Amount reclassified from other comprehensive income (loss) Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (loss)
Gain (loss) on derivative financial instruments:   
Aluminum future contracts, before taxes$1,210
 Cost of goods sold
Foreign currency forward contracts, before taxes62
 Cost of goods sold
Foreign currency forward contracts, before taxes(43) Selling, general and administrative
Total, before taxes1,229
  
Income tax expense (benefit)287
 Income taxes
Total, net of tax$942
  
Amortization of pension and other post-retirement benefits:   
Actuarial gain (loss) and prior service costs, before taxes$(12,045) (a)
Income tax expense (benefit)(4,234) Income taxes
Total, net of tax$(7,811)  
    
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).

Reclassifications of balances out of accumulated other comprehensive income (loss) into net income during 2016 are summarized as follows:
(In thousands)Amount reclassified from other comprehensive income (loss) Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income
Gain (loss) on derivative financial instruments:   
Aluminum future contracts, before taxes$(1,630) Cost of goods sold
Foreign currency forward contracts, before taxes62
 Cost of goods sold
Total, before taxes(1,568)  
Income tax expense (benefit)(579) Income taxes
Total, net of tax$(989)  
Amortization of pension and other post-retirement benefits:   
Actuarial gain (loss) and prior service costs, before taxes$(13,098) (a)
Income tax expense (benefit)(4,398) Income taxes
Total, net of tax$(8,700)  
    
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).

Reclassifications of balances out of accumulated other comprehensive income (loss) into net income during 2015 are summarized as follows:


(In thousands)Amount reclassified from other comprehensive income (loss) Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income
Gain (loss) on derivative financial instruments:   
Aluminum future contracts, before taxes$(3,538) Cost of goods sold
Foreign currency forward contracts, before taxes62
 Cost of goods sold
Total, before taxes(3,476)  
Income tax expense (benefit)(1,284) Income taxes
Total, net of tax$(2,192)  
Amortization of pension and other post-retirement benefits:   
Actuarial gain (loss) and prior service costs, before taxes$(16,041) (a)
Income tax expense (benefit)(5,823) Income taxes
Total, net of tax$(10,218)  
    
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).

Recently Issued Accounting Standards Adopted.
In May 2014,December 2019, the Financial Accounting Standards Board (“FASB”) and Internationalissued Accounting Standards BoardUpdate (“IASB”ASU”) issued their converged standard on revenue recognition. The revised revenue standard contains principles that2019-12, which simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an entity will apply to direct the measurement of revenueinterim period, hybrid taxes and timing of when it is recognized. The core principle of the guidance is that the recognition of revenue should depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchangedeferred tax liabilities for those goodsoutside basis differences. It also clarifies and services. To achieve that core principle, an entity will utilize a principle-based five-step approach model. The converged standard also includes more robust disclosure requirements which will require entities to provide sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. In March 2016, amended guidance was issued regarding clarifying the implementation guidance on principal versus agent considerations and in April 2016, clarifying guidance was issued relating to identifying performance obligations and licensing implementation. The effective date of this revised standard is for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The converged standard can be adopted using a full retrospective method or a modified retrospective method, which applies the new guidance to contracts that are not completed at the adoption date without adjusting prior reporting periods. The Company has completed its assessmentsimplifies other aspects of the impact of this standard. The Company used a team to analyze the impact of the standard, and the related guidance issued, across all revenue streams and to evaluate the impact of the new standard on revenue contracts. This team reviewed current accounting policies and practices, identifying potential differences that would result from applying the requirements under the new standard. The Company will adopt this new standard infor income taxes. In the first quarter of 2018 using2021, the modified retrospective method of adoption, and the adoption will not have a material impact on the timing or amount of revenue recognized in the Company’s consolidated financial statements, although there will be expanded disclosures.
In July 2015, the FASB issued new guidance for the measurement of inventories. Inventories within the scope of the revised guidance should be measured at the lower of cost or net realizable value. The previous guidance dictated that inventory should be measured at the lower of cost or market, with market being either replacement cost, net realizable value or net realizable value less an approximation of normal profit margin. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Subsequent measurement is unchanged for inventories measured using LIFO or the retail inventory method. The Company adopted the new guidance prospectively in the first quarter of 2017, and the adoption of this guidanceASU 2019-12, which did not have a material impact on the Company’s consolidated financial statements.
Accounting Standards Not Yet Adopted.
In January 2016,March 2020, the FASB issued amended guidance associated with accountingASU 2020-04, which provides optional expedients and exceptions for equity investments measured at fair value. The amended guidance requires all equity investmentsapplying GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate or by another reference rate expected to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under equity methoddiscontinued because of accounting or those that result in consolidation of the investee or those without a readily determinable fair value).reference rate reform. The amended guidance also requires an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. In addition, the amendments in this update eliminate the requirement to disclose the fair value of financial instruments measured at amortized cost for entities that are not public business entitieswas effective beginning March 12, 2020 and


the requirement to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. The amended guidance is effective for fiscal years beginning after December 31, 2017, including the interim periods within those fiscal years. The amendments should be applied by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) should can be applied prospectively to equity investments that exist asthrough December 31, 2022. In January 2021, the FASB issued ASU 2021-01, which clarified the scope and application of the dateoriginal guidance. The Company is currently evaluating the potential impact of adoption of the update. Early adoption is permitted under limited, specific circumstances. The adoption of the amendedadopting this guidance, isbut does not expectedexpect it to have a material impact on the Company’s consolidated financial statements.
In February 2016, the FASB issued a revised standard on lease accounting. Lessees will need to recognize virtually all
2. ACCOUNTS AND OTHER RECEIVABLES
As of their leases on the balance sheet, by recording a right-of-use asset and lease liability. The revised standard requires additional analysis of the components of a transaction to determine if a right-of-use asset is embedded in the transaction that needs to be treated as a lease. Substantial additional disclosures are also required by the revised standard. The revised standard is effective for fiscal years beginning after December 31, 2018, including the interim periods within those fiscal years. The revised standard should be adopted using a modified retrospective approach, with early adoption permitted. The Company has a process in place to analyze the impact of the standard,2021 and the related guidance issued, on all leases throughout the Company. This process includes reviewing all active leases with terms greater than 12 months, which are currently being identified. The Company has also started evaluating the new requirements for tracking and cost recovery of these leases. The Company expects to complete its evaluations of the impacts of the accounting and disclosure requirements on its business processes, controls and systems by the second half of 2018.
In October 2016, the FASB issued guidance that requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings at the beginning of the period of adoption. Early adoption is permitted in the first interim period of an annual reporting period for which financial statements have not been issued. The Company has evaluated the impact of adopting this guidance and does not expect there to be a material impact on the Company’s consolidated financial statements.
In January 2017, the FASB issued guidance to assist with evaluating when a set of transferred assets and activities (collectively, the "set") is a business and provides a screen to determine when a set is not a business. Under the new guidance, when substantially all of the fair value of gross assets acquired (or disposed of) is concentrated in a single identifiable asset, or group of similar assets, the assets acquired would not represent a business. Also, to be considered a business, an acquisition would have to include an input and a substantive process that together significantly contribute to the ability to produce outputs. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and should be applied on a prospective basis to any transactions occurring within the period of adoption. Early adoption is permitted for interim or annual periods for which the financial statements have not been issued. The Company has not elected early adoption of this guidance and will apply the new guidance beginning in the first quarter of 2018.
In January 2017, the FASB issued amended guidance that eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new guidance, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The new standard is effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for annual or interim goodwill impairment testing performed after January 1, 2017. The Company has not elected early adoption and does not expect any impact on the Company’s consolidated financial statements.
In March 2017, the FASB issued final guidance on the presentation of net periodic pension and postretirement benefit cost (net benefit cost). Currently, net benefit cost is reported as an employee cost within operating income. This new guidance requires the bifurcation of net periodic pension and postretirement benefit costs. Service cost will be part of operating income (and is the only piece eligible to be capitalized). All other components will be shown outside of operations. The new standard is effective for annual and interim periods in fiscal years beginning after December 15, 2017, and should be applied on a retrospective basis, except for the amendments related to capitalization of benefit cost, which should be applied on a prospective basis. The Company is currently evaluating the amended guidance but does not expect there to be an impact of adopting this guidance on the Company’s consolidated financial statements.
In August 2017, the FASB issued amended guidance on the accounting for hedging activities. The amended guidance makes more hedging strategies qualify for hedge accounting. After initial qualification, the amended guidance permits a qualitative effectiveness assessment for certain hedges instead of a quantitative test, if the company can reasonably support an


expectation of effectiveness throughout the term of the hedge. The amended guidance is effective for annual and interim periods beginning after January 1, 2019, but may be adopted immediately. The adoption should be on a cumulative effect basis and applied prospectively. The Company is currently evaluating the amended guidance but does not expect there to be an impact of adopting this guidance on the Company’s consolidated financial statements.
2ACQUISITIONS
On February 15, 2017, Bonnell Aluminum acquired 100% of the stock of Futura on a net debt-free basis for approximately $92 million (the “Initial Purchase Price”). The amount actually funded in cash at the transaction date was approximately $87.0 million (the “Initial Cash Funding”), which was the Initial Purchase Price net of preliminary closing adjustments for working capital and seller transaction-related obligations assumed and subsequently paid by Bonnell Aluminum. The acquisition, which was funded using Tredegar’s revolving credit facility, was treated as an asset purchase for U.S. federal income tax purposes. Tredegar expects to receive a $5 million refund in 2018 from an earnout price adjustment mechanism discussed further below.

Futura, headquartered in Clearfield, Utah, with a national sales presence and particular strength in the western U.S., designs and manufactures a wide range of extruded aluminum products, including branded flooring trims and TSLOTSTM, as well as OEM (original equipment manufacturer) components for truck grills, solar panels, fitness equipment2020, accounts receivable and other applications. As a result of this transaction, Futura is now a wholly-owned subsidiary of the William L. Bonnell Company, Inc. (which is a wholly-owned subsidiary of Tredegar) and operates as a division of Bonnell Aluminum, and its results of operations are included in Tredegar’s consolidated financial statements from the date of acquisition.

Under the terms of the transaction, $5 million of the Initial Cash Funding was placed in escrow (the “Earnout Escrow”) and will be returned to Bonnell Aluminum because Futura did not achieve a targeted EBITDA level (as defined in the Stock Purchase Agreement) for the last eleven months of the fiscal year ended December 2017. At the acquisition date, the Company performed a probability weighted assessment in order to determine the fair value of this contingent asset. The assessment estimated a fair value of $4.3 million, which would be returned to Bonnell Aluminum in early 2018, and accordingly, a receivable of $4.3 million (“Initial Earnout Receivable”) was recorded by Bonnell Aluminum. In the second quarter of 2017, the Company updated its valuation of this contingent asset, which resulted in a fair value of $5.0 million. The receivable was increased to $5.0receivables, net, were $103.3 million and $0.7$86.3 million, was recognized as income in the second quarter of 2017 in Other income (expense), net in the Consolidated Statements of Income.

The net purchase price for financial reporting purposes was set at approximately $82.9 million (the “Adjusted Net Purchase Price”), which was the Initial Cash Funding less the Initial Earnout Receivable and the net settlement of certain post-closing adjustments of $0.1 million paid to the seller during the second quarter of 2017. Adjustments to the purchase price wererespectively, made retrospectively as if the accounting had been completed on the acquisition date. Based upon management’s valuation of the fair value of tangible and identifiable intangible assets acquired (net of cash acquired) and liabilities assumed, the allocation of the Adjusted Net Purchase Price is as follows:
(In thousands) 
Accounts receivable$6,680
Inventories10,342
Prepaid expenses and other current assets240
Property, plant & equipment32,662
Identifiable intangible assets: 
      Customer relationships24,000
      Trade names6,700
Trade payables & accrued expenses(8,135)
      Total identifiable net assets72,489
      Adjusted Net Purchase Price82,860
Goodwill$10,371

The goodwill and identifiable intangible asset balances associated with this acquisition will be deductible for tax purposes on a straight-line basis over a period of approximately 15 years. For financial reporting purposes, customer relationships are being amortized over 12 years and trade names are being amortized over 13 years. Goodwill is not subject to amortization for financial reporting purposes. Customer relationships were valued using the excess earnings approach. Trade


names were valued using a relief-from-royalty approach. The Company does not anticipate marketing Futura’s products under a different brand in light of its strong name recognition and competitive advantage in its target markets.

For 2017, Tredegar’s consolidated results of operations and its Aluminum Extrusions business segment included the following Futura results for the 10.5 months owned: sales of $71.0 million, operating profit from ongoing operations of $8.2 million, depreciation and amortization of $5.0 million, and capital expenditures of $2.5 million.

The following unaudited supplemental pro forma data presents Tredegar’s consolidated sales, net income and related earnings per share as if the acquisition of Futura had been consummated at the beginning of 2016, and is not necessarily indicative of the Company’s financial performance if the acquisition had actually been consummated as of that date, or of future performance. The supplemental unaudited pro forma measures for the years ended December 31, 2017 and 2016 are presented below:

Tredegar Pro Forma Results with Futura Acquisition 
(In thousands, except per-share data)2017 2016
Sales$968,340
 $904,877
Net income$37,974
 $27,805
Earnings per share:   
    Basic$1.15
 $0.85
    Diluted$1.15
 $0.85

Futura’s pre-acquisition results for the period from January 1 to February 14, 2017, and therefore the pro forma information for 2017 presented above, were adversely impacted by significant disruptions to manufacturing operations and sales caused by the renovation of its anodizing line. The actual accretion to Tredegar’s diluted earnings per share from Futura since the acquisition date was 12 cents per share for 2017.

The Company’s pro forma net income was computed for the periods shown as: (i) the Company’s reported net income, plus (ii) Futura’s historical pre-acquisition period earnings before interest, taxes, depreciation and amortization and excluding one-time purchase accounting and transaction-related expenses, minus (iii) the pro forma pre-acquisition period depreciation and amortization for Futura under purchase accounting for the Company, minus (iv) the pro forma pre-acquisition period interest expense for the Company applied at an annual rate of 3.0% to the $87.0 million Initial Cash Funding, minus (v) the pro forma pre-acquisition period income taxes applied at a rate of 39.1% to the pro forma pre-acquisition earnings before income taxes computed from items (ii) through (iv).
3OTHER INCOME (EXPENSE), NET
Other income (expense), net consistsup of the following:
(In thousands)2017 2016 2015
Gain (loss) on investment in kaléo accounted for under fair value method$33,800
 $1,600
 $(20,500)
Gain associated with the settlement of an escrow agreement related to Terphane, acquired in October 201111,856
 
 
Gain from insurance recoveries5,261
 1,902
 
Unrealized loss on investment property
 (1,032) 
Other796
 (89) 387
Total$51,713
 $2,381
 $(20,113)
See Note 17 for more details on the items broken out separately in the table above.



4INVESTMENTS
In August 2007 and December 2008, Tredegar made an aggregate investment of $7.5 million in kaleo, Inc. (“kaléo”), a privately held specialty pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. The mission of kaléo is to provide products that empower patients to confidently take control of their medical conditions. Tredegar owns Series A-3 Preferred Stock and Series B Preferred Stock in kaléo that, taken together, represents on a fully-diluted basis an approximate 20% interest in kaléo. Tredegar accounts for its investment in kaléo under the fair value method. At the time of the initial investment, the Company elected the fair value option of accounting since its investment objectives were similar to those of venture capitalists, which typically do not have controlling financial interests.
At December 31, 2017 and 2016, the estimated fair value of the Company’s investment (also the carrying value, which is separately stated in the consolidated balance sheets) was $54.0 million and $20.2 million, respectively. The Company recognized an unrealized gain on its investment in kaléo of $33.8 million ($24.0 million after taxes) and $1.6 million ($1.2 million after taxes) in 2017 and 2016, respectively.
The change in the estimated fair value of the Company’s holding in kaléo in 2017 primarily related to recent favorable operating results and projections. Kaléo’s stock is not publicly traded. In addition, kaléo had not completed a full year of operations since the re-launch of its Auvi-Q® product which occurred during the first quarter of 2017. The valuation estimate in this situation is based on projection assumptions or Level 3 inputs that have a wide range of possible outcomes. Consequently, the present value of kaléo’s projected future cash flows is determined at a discount rate of 45% for their high degree of risk. Ultimately, the true value of the Company’s ownership interest in kaléo will be determined if and when a liquidity event occurs, and the ultimate value could be materially different from the $54.0 million estimated fair value reflected in the Company’s financial statements at December 31, 2017.
The Company recognized an unrealized loss of $20.5 million ($15.7 million after taxes) in 2015 that primarily related to a voluntary recall of the epinephrine auto-injectors that were on the market which was announced on October 28, 2015 by sanofi-aventis U.S. LLC to whom kaléo had licensed exclusive rights to commercialize the epinephrine auto-injectors at that time.  Kaléo relaunched the epinephrine auto-injector in the U.S. in the first quarter of 2017.
Unrealized gains (losses) associated with this investment are included in “Other income (expense), net” in the consolidated statements of income and separately stated in the segment operating profit table in Note 5. Subsequent to its most recent investment (December 15, 2008), and until the next round of financing, the Company believes fair value estimates are based upon Level 3 inputs since there is no secondary market for its ownership interest. Accordingly, until the next round of financing or any other significant financial transaction, value estimates will primarily be based on assumptions related to meeting cash flow projections and discounting of these factors for their high degree of risk. If kaléo does not meet its projected cash flows or related risks are unfavorable versus the most recent valuation, or a new round of financing or other significant financial transaction indicates a lower enterprise value, then the Company’s estimate of the fair value of its ownership interest in kaléo is likely to decline. Adjustments to the estimated fair value of this investment will be made in the period upon which such changes can be quantified.
In addition to the impact on valuation of the possible changes in assumptions, Level 3 inputs and projections from changes in business conditions, the fair market valuation of Tredegar’s interest in kaléo is sensitive to changes in the weighted average cost of capital used to discount cash flow projections for the high degree of risk associated with a wide range of possible outcomes. The weighted average cost of capital used in the fair market valuation of the Company’s interest in kaléo was 45% at both December 31, 2017 and 2016. At December 31, 2017, the effect of a 500 basis point decrease in the weighted average cost of capital assumption would have further increased the fair value of Tredegar’s interest in kaléo by approximately $11 million, and a 500 basis point increase in the weighted average cost of capital assumption would have decreased the fair value of the Company’s interest by approximately $10 million.
On April 2, 2007, Tredegar invested $10.0 million in Harbinger Capital Partners Special Situations Fund, L.P. (the “Harbinger Fund”), a private investment fund that is subject to limitations on withdrawal. There is no secondary market for interests in the fund. The Company’s investment in the Harbinger Fund, which represents less than 1% of its total partnership capital, is accounted for under the cost method. There were no unrealized gains or losses on the Company’s investment in the Harbinger Fund in 2017, 2016 and 2015. The December 31, 2017 and 2016 carrying values in the consolidated balance sheets (included in “Other assets and deferred charges”) were $1.7 million and $1.7 million, respectively. The carrying value at December 31, 2017 reflected Tredegar’s cost basis in its investment in Harbinger, net of total withdrawal proceeds received and unrealized losses. Withdrawal proceeds were $0.1 million in 2015 (none in 2017 and 2016). The timing and amount of future installments of withdrawal proceeds was not known as of December 31, 2017. There were no realized gains or losses associated with the investment in the Harbinger Fund in 2017, 2016 and 2015. Gains on the Company’s investment in the Harbinger Fund, if any, will be recognized when the amounts expected to be collected from withdrawal from the investment are known, which will likely be when cash in excess of the remaining carrying value is received. Losses will be recognized if management believes it is probable that future withdrawal proceeds will not exceed the remaining carrying value.


Tredegar has investment property in Alleghany and Bath counties, Virginia. In 2016, the Company recorded an unrealized loss on this investment property of $1.0 million ($0.7 million after taxes) as a reduction in the estimated fair value of the investment that is not expected to be temporary. The Company’s carrying value in this investment property (included in “Other assets and deferred charges” on the consolidated balance sheets) was $1.6 million at December 31, 2017 and $1.6 million at December 31, 2016.
5BUSINESS SEGMENTS
The Company's business segments are PE Films, Flexible Packaging Films and Aluminum Extrusions. PE Films is comprised of the following operating segments: personal care materials, surface protection films, and LED lighting products. Flexible Packaging Films is comprised of the Company’s polyester films business, Terphane Holdings LLC (“Terphane”), which was acquired by Tredegar in October 2011. Aluminum Extrusions, which includes Bonnell Aluminum and its operating divisions, AACOA and Futura, produces high-quality, soft-alloy and medium-strength aluminum extrusions primarily for the following markets: building and construction, automotive, and specialty, which consists of consumer durables, machinery and equipment, electrical and distribution end-use products.
Information by business segment and geographic area for the last three years is provided below. There were no accounting transactions between segments and no allocations to segments. Net sales (sales less freight) and operating profit from ongoing operations are the measures of sales and operating profit used by the chief operating decision maker (Tredegar’s President and Chief Executive Officer) for purposes of assessing performance. PE Films’ net sales to The Procter & Gamble Company (“P&G”) totaled $122.4 million in 2017, $129.1 million in 2016 and $163.9 million in 2015. These amounts include plastic film sold to others that convert the film into materials used with products manufactured by P&G.
Net Sales
(In thousands) 2017 2016 2015
PE Films$352,459
 $331,146
 $385,550
Flexible Packaging Films108,355
 108,028
 105,332
Aluminum Extrusions466,833
 360,098
 375,457
Total net sales927,647
 799,272
 866,339
Add back freight33,683
 29,069
 29,838
Sales as shown in consolidated statements of income$961,330
 $828,341
 $896,177


Operating Profit
(In thousands) 2017 2016 2015
PE Films:     
Ongoing operations$41,546
 $26,312
 $48,275
Plant shutdowns, asset impairments, restructurings and other (a)(4,905) (4,602) (4,180)
Flexible Packaging Films:     
Ongoing operations(2,626) 1,774
 5,453
Plant shutdowns, asset impairments, restructurings and other (a)(89,398) (214) (185)
Goodwill impairment charge
 
 (44,465)
Aluminum Extrusions:     
Ongoing operations43,454
 37,794
 30,432
Plant shutdowns, asset impairments, restructurings and other (a)321
 (741) (708)
Total(11,608) 60,323
 34,622
Interest income209
 261
 294
Interest expense6,170
 3,806
 3,502
Gain (loss) on investment in kaléo accounted for under the fair value method (a)33,800
 1,600
 (20,500)
Unrealized loss on investment property (a)
 1,032
 
Stock option-based compensation expense264
 56
 483
Corporate expenses, net (a)30,879
 29,607
 33,638
Income (loss) before income taxes(14,912) 27,683
 (23,207)
Income tax expense (benefit) (a)(53,163) 3,217
 8,928
Net income (loss)$38,251
 $24,466
 $(32,135)
Identifiable Assets
(In thousands) 2017 2016
PE Films$289,514
 $278,558
Flexible Packaging Films49,915
 156,836
Aluminum Extrusions268,127
 147,639
Subtotal607,556
 583,033
General corporate (b)111,696
 38,618
Cash and cash equivalents (d)36,491
 29,511
Total$755,743
 $651,162
  Depreciation and Amortization Capital Expenditures
(In thousands) 2017 2016 2015 2017 2016 2015
PE Films$14,609
 $13,653
 $15,480
 $15,029
 $25,759
 $21,218
Flexible Packaging Films10,443
 9,505
 9,697
 3,619
 3,391
 3,489
Aluminum Extrusions15,070
 9,173
 9,698
 25,653
 15,918
 8,124
Subtotal40,122
 32,331
 34,875
 44,301
 45,068
 32,831
General corporate155
 141
 107
 61
 389
 
Total$40,277
 $32,472
 $34,982
 $44,362
 $45,457
 $32,831

See footnotes following the tables.



Net Sales by Geographic Area (d)
(In thousands) 2017 2016 2015
United States$584,066
 $475,734
 $528,881
Exports from the United States to:     
Asia84,846
 73,220
 75,383
Canada46,505
 45,683
 45,290
Europe8,505
 7,348
 9,809
Latin America15,199
 5,561
 3,464
Operations outside the United States:     
Brazil87,155
 90,571
 89,829
The Netherlands54,380
 54,352
 53,211
Hungary24,727
 24,207
 32,612
China12,199
 14,390
 18,919
India10,065
 8,206
 8,941
Total (c)$927,647
 $799,272
 $866,339
  
Identifiable Assets
by Geographic Area (d)
 
Property, Plant & Equipment,
Net by Geographic Area (d)
(In thousands) 2017 2016 2017 2016
United States (b)$475,844
 $367,406
 $156,054
 $118,661
Operations outside the United States:       
Brazil49,536
 139,163
 13,396
 91,553
China28,833
 29,751
 23,273
 23,759
Hungary28,573
 20,610
 18,230
 15,117
The Netherlands17,423
 19,484
 6,423
 5,784
India7,347
 6,619
 4,628
 4,670
General corporate (b)111,696
 38,618
 1,087
 1,181
Cash and cash equivalents (d)36,491
 29,511
 n/a
 n/a
Total$755,743
 $651,162
 $223,091
 $260,725
Net Sales by Product Group
(In thousands) 2017 2016 2015
PE Films:     
Personal care materials$246,416
 $238,213
 $287,768
Surface protection films99,079
 84,013
 90,197
LED lighting products & other films6,964
 8,920
 7,585
Subtotal352,459
 331,146
 385,550
Flexible Packaging Films108,355
 108,028
 105,332
Aluminum Extrusions:     
Nonresidential building & construction239,713
 212,863
 221,363
Consumer durables54,126
 39,293
 41,835
Automotive38,261
 34,700
 30,250
Machinery & equipment33,450
 20,872
 18,102
Distribution30,202
 20,506
 18,659
Residential building & construction40,354
 20,252
 22,737
Electrical30,727
 11,612
 22,511
Subtotal466,833
 360,098
 375,457
Total$927,647
 $799,272
 $866,339
See footnotes following the tables and a reconciliation of net sales to sales as shown in the Consolidated Statements of Income in the first table of this Note 5.



(a)See Notes 1, 3, 4 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.
(b)The balance sheets include the funded status of each of the Company’s defined benefit pension and other postretirement plans. The funded status of the Company’s defined benefit pension plan was a net liability of $91.8 million and $88.6 million as of December 31, 2017 and 2016, respectively. See Note 13 for more information on the Company’s pension and other postretirement plans.
(c)The difference between total consolidated sales as reported in the consolidated statements of income and segment, geographic and product group net sales reported in this note is freight of $33.7 million in 2017, $29.1 million in 2016 and $29.8 million in 2015.
(d)Information on exports and foreign operations are provided on the previous page. Cash and cash equivalents includes funds held in locations outside the U.S. of $32.7 million and $23.8 million at December 31, 2017 and 2016, respectively. Export sales relate almost entirely to PE Films. Operations outside the U.S. in The Netherlands, Hungary, China and India also relate to PE Films. Operations in Brazil are primarily related to Flexible Packaging Films, but also include PE Films operations. Sales from locations in The Netherlands and Hungary are primarily to customers located in Europe. Sales from locations in China (Guangzhou and Shanghai) are primarily to customers located in China, but also include other customers in Asia.
6ACCOUNTS AND OTHER RECEIVABLES
Accounts and other receivables consist of the following:
(In thousands) 2017 2016
Trade, less allowance for doubtful accounts and sales returns of $3,304 in 2017 and $3,102 in 2016$110,252
 $91,109
Other9,883
 6,279
Total$120,135
 $97,388
(In thousands)20212020
Customer receivables$102,090 $85,274 
Other accounts and notes receivable2,958 3,850 
Total accounts and other receivables105,048 89,124 
Less: Allowance for bad debts(a)
(1,736)(2,797)
Total accounts and other receivables, net$103,312 $86,327 
(a) As of December 31, 2021, the Company recorded a reclassification of $0.8 million from accounts receivable, net to accrued expenses to account for the Company’s estimated obligation to customers for product returns that may result in either a customer credit or refund. Prior to December 31, 2021, the Company presented estimated sales returns as a reduction to accounts receivable.
A reconciliation of the beginning and ending balances of the allowance for doubtful accounts and sales returns for the three years ended December 31, 20172021 is as follows:
(In thousands)202120202019
Balance, beginning of year$2,797 $1,904 $2,054 
Charges to expense1,440 1,901 715 
Recoveries35 (90)(38)
Write-offs and settlements(1,246)(709)(756)
Foreign exchange and other(515)(209)(71)
Reclassification to accrued expenses for estimated sales returns(775)— — 
Balance, end of year$1,736 $2,797 $1,904 

53
(In thousands) 2017 2016 2015
Balance, beginning of year$3,102
 $3,746
 $2,610
Charges to expense2,369
 1,410
 3,387
Recoveries(857) (32) (7)
Write-offs and settlements(1,322) (2,167) (1,970)
Foreign exchange and other12
 145
 (274)
Balance, end of year$3,304
 $3,102
 $3,746


3. INVENTORIES
7INVENTORIES
Inventories consist of the following:
(In thousands) 2017 2016(In thousands)20212020
Finished goodsFinished goods$20,281
 $16,215
Finished goods$25,199 $15,251 
Work-in-processWork-in-process11,958
 8,590
Work-in-process11,955 9,098 
Raw materialsRaw materials35,909
 23,733
Raw materials32,958 25,913 
Stores, supplies and otherStores, supplies and other18,759
 17,531
Stores, supplies and other18,457 16,175 
TotalTotal$86,907
 $66,069
Total$88,569 $66,437 
Inventories stated on the LIFO basis amounted to $21.9$18.8 million at December 31, 20172021 and $16.4$14.4 million at December 31, 2016,2020, which were below replacement costs by $15.9$27.5 million at December 31, 20172021 and $15.3$12.1 million at December 31, 2016. During 2017,2020. Inventories stated on the weighted average cost basis were $30.9 million and $33.6 million at December 31, 2021 and 2020, respectively, while inventories stated on the first in, first out method amounted to $38.9 million and $18.4 million at December 31, 2021 and 2020, respectively.
4. LEASES
Tredegar has various operating lease agreements with remaining terms up to 9 years, including leases of real estate, office equipment and vehicles. As of December 31, 2021 and 2020, the Company had no finance lease agreements. Some leases include options to purchase the leased asset, terminate the agreement or extend the term of the agreement for one or more years. These options are included in the lease term when it is reasonably certain PE Films inventories accountedthat the option will be exercised.
The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of December 31, 2021:
(In thousands)
Future Lease Payments
2022$2,594 
20232,478 
20242,417 
20252,417 
20262,079 
Thereafter5,326 
Total undiscounted operating lease payments17,311 
Less: Imputed interest2,322 
Present value of operating lease liabilities$14,989 
The following table summarizes lease costs, related cash flow and other information for on a LIFO basis declined, which resulted in cost of goods sold being stated at below currentthe years ended December 31, 2021 and 2020. These costs by $1.5 million.

are primarily related to long-term operating leases, but also include amounts for variable leases and short-term leases.

(In thousands)20212020
Operating lease expense$2,752 $3,260 
Right-of-use assets recognized as non-cash additions from the execution of new operating leases$ $529 
Other Information:
Weighted-average remaining lease term for operating leases7 years8 years
Weighted-average discount rate for operating leases4.22 %4.21 %
8GOODWILL AND IDENTIFIABLE INTANGIBLE ASSETS

54


5. GOODWILL AND IDENTIFIABLE INTANGIBLE ASSETS
The components of goodwill and identifiable intangibles at December 31, 20172021 and 2016,2020, and related amortization periods for continuing operations are as follows:
(In thousands) 2017 2016 Amortization Periods
Goodwill$128,208
 $117,822
 Not amortized
Identifiable intangible assets:(a)
     
Customer relationships (cost basis of $29,647 in 2017 and $26,021 in 2016)25,444
 14,844
 10-12 years
Proprietary technology (cost basis of $6,203 in 2017 and $17,366 in 2016)1,700
 7,582
 Not more than 15 years
Trade names (cost basis of $13,887 in 2017 and $11,175 in 2016)13,408
 11,175
 
5 - 13 years(b)
Total carrying value of identifiable intangibles40,552
 33,601
  
Total carrying value of goodwill and identifiable intangible assets$168,760
 $151,423
  
(a) Identifiable intangibles also includes non-compete agreements, which have been fully amortized. These identifiable intangible assets, which have a cost basis of $1.9 million, were previously amortized over 2 years.
(b) Includes $4.8 million of trade names with an indefinite life.
(In thousands)20212020Amortization Periods
Goodwill$70,608 $67,708 Not amortized
Identifiable intangible assets, net:
Customer relationships (cost basis of $26,526 in 2021 and $29,450 in 2020)13,259 17,551 10-12 years
Proprietary technology (cost basis of $3,721 in 2021 and $3,726 in 2020)118 194 Not more than 15 years
Trade names (cost basis of $13,338 in 2021 and $13,397 in 2020)775 1,075 5 - 13 years
Total carrying value of identifiable intangibles14,152 18,820 
Total carrying value of goodwill and identifiable intangible assets$84,760 $86,528 
A reconciliation of the beginning and ending balance of goodwill for each of the two years in the period endedat December 31, 20172021 and 2020 is as follows:
(In thousands) PE Films Aluminum Extrusions Total
Net carrying value of goodwill at January 1, 2016$104,143
 $13,696
 $117,839
Increase (decrease) due to foreign currency translation(17) 
 (17)
Net carrying value of goodwill at December 31, 2016104,126
 13,696
 117,822
Acquisitions
 10,370
 10,370
Increase (decrease) due to foreign currency translation16
 
 16
Net carrying value of goodwill at December 31, 2017$104,142
 $24,066
 $128,208
The goodwill at PE Films is carried by the personal care division and the surface protection division in the amounts of $46.8 million and $57.3 million, respectively, as of December 31, 2017. The goodwill at Aluminum Extrusions is carried by its AACOA division and Futura division (which was acquired on February 15, 2017) in the amounts of $13.7 million and $10.4 million, respectively, as of December 31, 2017.


A reconciliation of the beginning and ending balance of identifiable intangibles for each of the two years in the period ended December 31, 2017 is as follows:
(In thousands) Customer Relationships  Proprietary Technology  Trade Names  Total
PE Films:       
 Net carrying value at January 1, 2016$
 $1,073
 $
 $1,073
  Amortization expense
 (114) 
 (114)
 Net carrying value at December 31, 2016
 959
 
 959
  Amortization expense
 (114) 
 (114)
 Net carrying value at December 31, 2017$
 $845
 $
 $845
          
Flexible Packaging Films:       
 Net carrying value at January 1, 2016$12,380
 $6,362
 $5,776
 $24,518
  Amortization expense(1,700) (1,131) 
 (2,831)
  Increase (decrease) due to foreign currency translation1,404
 343
 599
 2,346
 Net carrying value at December 31, 201612,084
 5,574
 6,375
 24,033
  Amortization expense(1,793) (1,161) 
 (2,954)
  Increase (decrease) due to foreign currency translation(16) (2) (33) (51)
  Impairment loss(9,444) (4,051) (4,005) (17,500)
 Net carrying value at December 31, 2017$831
 $360
 $2,337
 $3,528
          
Aluminum Extrusions:       
 Net carrying value at January 1, 2016$3,240
 $1,602
 $4,800
 $9,642
  Amortization expense(480) (553) 
 (1,033)
 Net carrying value at December 31, 20162,760
 1,049
 4,800
 8,609
  Additions related to acquisition of Futura24,000
 
 6,700
 30,700
  Amortization expense(2,147) (554) (429) (3,130)
 Net carrying value at December 31, 2017$24,613
 $495
 $11,071
 $36,179
          
Total net carrying value of identifiable intangibles at December 31, 2017$25,444
 $1,700
 $13,408
 $40,552
(In thousands)
Aluminum Extrusions(a)
PE Films(a)
Total
Net carrying value of goodwill at December 31, 2019$24,066 $57,338 $81,404 
Goodwill impairment charge(13,696)— (13,696)
Net carrying value of goodwill at December 31, 202010,370 57,338 67,708 
Out-of-period adjustment2,900  2,900 
Net carrying value of goodwill at December 31, 2021$13,270 $57,338 $70,608 
(a) The goodwill of Aluminum Extrusions and PE Films is carried by the Futura and Surface Protection reporting units, respectively.
During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts,2021, the Company determined thatrecorded an out-of-period adjustment in connection with the carrying valueoriginal valuation of Terphane’s remaining long-livedintangible assets were impaired (Terphane’sand goodwill was written offrelated to the acquisition of Futura in 2015).  Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million.February 2017. This write-downadjustment resulted in a non-cash asset impairment loss recognized duringreclassification of $2.9 million from acquired customer relationship intangible assets to goodwill and a $0.9 million decrease to accumulated amortization and amortization expense as of and for the fourth quarterperiod ended December 31, 2021.
55


A reconciliation of 2017 of $101 million ($87 million after non-cash tax benefits). As part of this write-down, customer relationships, proprietary technologyidentifiable intangibles at December 31, 2021 and trade names were impaired by $9.4 million, $4.1 million and $4.0 million, respectively, reducing their values to $0.8 million, $0.4 million and $2.4 million, respectively. The remaining part of this write-down was related to property, plant and equipment. Also, Terphane’s trade names were assigned estimated useful lives of 5 to 13 years, a change from the previous designation of an indefinite life.2020 is as follows:
(In thousands) Customer Relationships Proprietary Technology Trade Names Total
Aluminum Extrusions:
Net carrying value at December 31, 2019$19,644 $55 $— $19,699 
Amortization expense(2,480)(20)— (2,500)
Net carrying value at December 31, 202017,164 35 — 17,199 
Amortization expense(a)
(2,239)(20) (2,259)
Out-of-period Adjustment(b)
(1,953)  (1,953)
Net carrying value at December 31, 2021$12,972 $15 $ $12,987 
PE Films:
Net carrying value at December 31, 2019$— $610 $— $610 
Amortization expense— (120)— (120)
Bright View disposal— (490)— (490)
Net carrying value at December 31, 2020— — — — 
Amortization expense    
Net carrying value at December 31, 2021$ $ $ $ 
Flexible Packaging Films:
Net carrying value at December 31, 2019$554 $230 $1,543 $2,327 
Amortization expense(84)(53)(260)(397)
Increase (decrease) due to foreign currency translation(83)(18)(208)(309)
Net carrying value at December 31, 2020387 159 1,075 1,621 
Amortization expense(82)(53)(257)(392)
Increase (decrease) due to foreign currency translation(18)(3)(43)(64)
Net carrying value at December 31, 2021$287 $103 $775 $1,165 
Total net carrying value of identifiable intangibles at December 31, 2021$13,259 $118 $775 $14,152 
(a) Excludes a reduction of $0.9 million to amortization expense related to the out-of-period adjustment.
(b) Represents a $2.9 million gross reclassification from customer relationship intangible assets to goodwill offset by a $0.9 million decrease to accumulated amortization as a result of the out-of-period adjustment.
Amortization expense for continuing operations over the next five years is expected to be as follows:
YearAmount
(In thousands)
2022$2,579 
20231,953 
20241,913 
20251,913 
20261,913 
56
Year
Amount
(In thousands)
2018$3,985
20193,585
20203,585
20213,585
20223,460




6. ACCRUED EXPENSES
9FINANCIAL INSTRUMENTS
Accrued expenses consist of the following:
(In thousands)20212020
Incentive compensation$7,016 $8,138 
Payrolls, related taxes and medical and other benefits6,903 9,571 
Vacation3,452 7,283 
Workers’ compensation and disabilities2,422 2,986 
Accrued freight2,337 1,397 
Accrued utilities1,938 1,460 
Customer rebates1,857 1,398 
Environmental liabilities (current)1,634 2,066 
Derivative contract liability1,254 487 
Accrued severance445 1,894 
Other3,846 4,061 
Total$33,104 $40,741 
In the fourth quarter of 2021, the Company changed its vacation policy such that effective January 1, 2022 substantially all U.S. employees earn their vacation for the current year on a monthly basis throughout the year and forfeit any unused vacation at the end of the year, with the exception of a partial rollover allowance subject to a cap or where forfeiture is prohibited by applicable state or local law or a collective bargaining agreement. Under the previous policy, vacation was granted at the beginning of the year in advance of work being performed for the subsequent year. As a result of this policy change, the Company recorded in the fourth quarter of 2021 a reduction of $3.9 million to accrued expenses and a decrease to selling, general, and administrative expense ($1.3 million) and cost of goods sold ($2.6 million) within the consolidated statements of income.
7. DEBT AND CREDIT AGREEMENTS
Tredegar has a five-year secured revolving credit agreement (the “Credit Agreement”) providing for aggregate borrowings in an amount of $375 million, which matures in June 2024.
Borrowings under the Credit Agreement bear an interest rate of LIBOR plus a credit spread and commitment fees charged on the unused amount under the Credit Agreement at various indebtedness-to-Credit EBITDA levels as follows:
Pricing Under Credit Agreement (Basis Points)
Indebtedness-to-Credit EBITDA RatioCredit Spread
Over LIBOR
Commitment
Fee
> 3.5x but <= 4.0x200.0 40 
> 3.0x but <= 3.5x187.5 35 
> 2.0x but <= 3.0x175.0 30 
> 1.0x but <= 2.0x162.5 25 
<= 1.0x150.0 20 
At December 31, 2021, the interest cost on debt borrowed under the Credit Agreement was priced at one-month LIBOR plus the applicable credit spread of 150.0 basis points.
The most restrictive covenants in the Credit Agreement include:
Maximum indebtedness-to-Credit EBITDA (“Leverage Ratio”) of 4.00x;
Minimum Credit EBITDA-to-interest expense of 3.00x; and
Maximum aggregate distributions to shareholders over the remaining term of the Credit Agreement of $75 million; provided, that if the Leverage Ratio of equal to or greater than 3.00x, a limitation on such payments for the succeeding quarter at the greater of (i) $4.75 million and (ii) 50% of consolidated net income for the most recent fiscal quarter.
The Credit Agreement is secured by substantially all of the Company’s and its domestic subsidiaries’ assets, including equity in certain material first-tier foreign subsidiaries. At December 31, 2021, based upon the most restrictive covenant within the Credit Agreement, available credit under the Credit Agreement was approximately $287 million. Total debt outstanding was $73 million and $134 million as of December 31, 2021 and 2020, respectively.
57


Tredegar was in compliance with all of its debt covenants as of December 31, 2021. Noncompliance with any of the debt covenants may have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on its financial condition or liquidity depending upon how the covenant is renegotiated.
8. RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS
Tredegar sponsors a noncontributory defined benefit (pension) plan covering certain current and former U.S. employees. The plan for salaried and hourly employees currently in effect is based on a formula using the participant’s years of service and compensation or using the participant’s years of service and a dollar amount. The plan is closed to new participants and pay for active plan participants for benefit calculations was frozen as of December 31, 2007. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan.
Tredegar also has a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. The plan was designed to restore all or a part of the pension benefits that would have been payable to designated participants from the principal pension plans if it were not for limitations imposed by income tax regulations. The projected benefit obligation relating to this unfunded plan was $2.1 million and $2.2 million at December 31, 2021 and December 31, 2020, respectively. Pension expense recognized for this plan was $0.1 million in 2021, 2020, and 2019. This information has been included in the pension benefit tables below.
In addition to providing pension benefits, the Company provides postretirement life insurance and health care benefits for certain groups of employees. Tredegar and retirees share in the cost of postretirement health care benefits, with employees hired on or before January 1, 1993, receiving a fixed subsidy to cover a portion of their health care premiums. The Company eliminated prescription drug coverage for Medicare-eligible retirees as of January 1, 2006. Consequently, Tredegar is not eligible for any federal subsidies.
Pension and other postretirement benefit liabilities related to Personal Care Films have been retained by the Company. Pension expense recognized for participation by these former employees in the Company’s plans is not material for the years ended December 31, 2021, 2020, and 2019.
58


The following tables reconcile the changes in benefit obligations and plan assets in 2021 and 2020, and reconcile the funded status to prepaid or accrued cost at December 31, 2021 and 2020:
 Pension BenefitsOther Post-
Retirement Benefits
(In thousands)2021202020212020
Change in benefit obligation:
Benefit obligation, beginning of year$336,159 $318,763 $8,164 $7,650 
Service cost — 21 29 
Interest cost8,398 10,156 195 243 
Effect of actuarial (gains) losses related to the following:
Discount rate change(12,512)26,887 (272)644 
Retirement rate assumptions and mortality table adjustments1,028 (3,446)(1)13 
Other(101)69 (274)55 
Plan participant contributions — 613 606 
Benefits paid(16,803)(16,270)(1,076)(1,076)
Benefit obligation, end of year$316,169 $336,159 $7,370 $8,164 
Change in plan assets:
Plan assets at fair value, beginning of year$233,075 $218,329 $ $— 
Actual return on plan assets23,131 18,800  — 
Employer contributions5,209 12,216 463 470 
Plan participant contributions — 613 606 
Benefits paid(16,803)(16,270)(1,076)(1,076)
Plan assets at fair value, end of year$244,612 $233,075 $ $— 
Funded status of the plans$(71,557)$(103,084)$(7,370)$(8,164)
Amounts recognized in the consolidated balance sheets:
Accrued expenses (current)$181 $181 $478 $481 
Pension and other postretirement benefit obligations, net71,376 102,903 6,892 7,683 
Net amount recognized$71,557 $103,084 $7,370 $8,164 
The following table sets forth the assumptions used in accounting for the pension and other post-retirement benefits, and the components of net periodic benefit cost:
 Pension BenefitsOther Post-
Retirement Benefits
(In thousands, except percentages)202120202019202120202019
Weighted-average assumptions used to determine benefit obligations:
Discount rate2.90 %2.57 %3.27 %2.86 %2.54 %3.25 %
Expected long-term return on plan assets3.05 %5.00 %5.00 %n/an/an/a
Weighted-average assumptions used to determine net periodic benefit cost:
Discount rate2.57 %3.27 %4.40 %2.54 %3.25 %4.37 %
Expected long-term return on plan assets5.00 %5.00 %6.00 %n/an/an/a
Components of net periodic benefit cost:
Service cost$ $— $— $21 $29 $26 
Interest cost8,398 10,156 12,222 195 243 290 
Expected return on plan assets(11,316)(11,004)(13,528) — — 
Amortization of prior service costs and gains or losses17,003 15,494 10,891 (141)(198)(258)
Net periodic benefit cost$14,085 $14,646 $9,585 $75 $74 $58 
59


Net periodic benefit cost is determined using assumptions at the beginning of each year. Funded status is determined using assumptions at the end of each year. The amount of the accumulated benefit obligation is the same as the projected benefit obligation. At December 31, 2021, the effect of a 1% change in the health care cost trend rate assumptions would not impact the post-retirement obligation.
Expected benefit payments over the next five years and in the aggregate for 2027—2031 are as follows:
(In thousands)Pension
Benefits
Other Post-
Retirement
Benefits
2022$18,256 $478 
202318,380 472 
202418,591 465 
202518,615 456 
202618,574 447 
2027—203189,722 2,081 
The average remaining duration of benefit payments for the pension plan is about 11.1 years.
The pre-tax amounts recorded in 2021, 2020 and 2019 in accumulated other comprehensive income consist of:
 PensionOther Post-Retirement
(In thousands)202120202019202120202019
Net actuarial (gain) loss$109,893 $150,267 $150,047 $(320)$86 $(824)
Pension expense is expected to be $13.9 million in 2022. The amounts in accumulated other comprehensive income, before related deferred income taxes, that are expected to be recognized as components of net periodic cost during 2022 are $13.2 million of cost for the pension plan and $0.1 million of benefit for other post-retirement plans.
The percentage composition of assets held by pension plans at December 31, 2021, 2020 and 2019 are as follows:
 % Composition of Plan Assets
at December 31,
 202120202019
Pension plans:
Fixed income securities25.3 %7.7 %8.7 %
Large/mid-capitalization equity securities28.1 27.1 21.3 
Small-capitalization equity securities6.8 8.6 7.8 
International and emerging market equity securities19.9 20.6 19.7 
Total equity securities54.8 56.3 48.8 
Private equity and hedge funds10.4 12.1 35.0 
Cash and cash equivalents2.8 17.5 1.4 
Other assets6.7 6.4 6.1 
Total100.0 %100.0 %100.0 %
Prior to commencing plans to terminate and settle the frozen defined benefit pension plan, the Company’s primary investment objective was to maximize total return with a strong emphasis on the preservation of capital, which it expected to achieve through a diversified portfolio with both a higher risk profile and anticipated long-term returns via fixed income securities, equity securities, hedge funds and private equity funds. Concurrent with the Company’s decision to commence the termination and settlement of the plan, the Company began transitioning to a liability-driven investment strategy aimed at reducing funded status volatility. The new strategy contemplates an increase of the fixed income securities allocation from 25.3% as of December 31, 2021 to an ultimate target of 100% and decreases to the asset allocations currently invested in equity securities, commodity funds, private equity and hedge funds, from 71.9% to zero over the next 18 months.
The expected long-term rate of return developed through consultation with the Company’s investment advisors as of December 31, 2021 contemplates the impact of this strategy which included consideration of several factors, including prevailing and planned strategic asset allocations, current and expected future market conditions, inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums.
60


Estimates of the fair value of assets held by the Company’s pension plan are provided by unaffiliated third parties. Investments in private equity, hedge funds and certain international equity securities are measured at net asset value, which is a practical expedient for measuring fair value. These assets are therefore excluded from the fair value hierarchy for each of the years presented. At December 31, 2021 and 2020, the pension plan assets are categorized by level within the fair value measurement hierarchy as follows:
(In thousands)TotalQuoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Balances at December 31, 2021
Cash and cash equivalents$6,943 $6,943 $ $ 
Large/mid-capitalization equity securities68,739 68,739   
Small-capitalization equity securities16,588 16,588   
International and emerging market equity securities25,174 25,174   
Fixed income securities61,845 9,306 52,539  
Contracts with insurance companies9,438   9,438 
Other assets(a)
6,868 6,868   
Total plan assets at fair value$195,595 $133,618 $52,539 $9,438 
Investments measured at net asset value49,017 
Total plan assets, December 31, 2021$244,612 
Balances at December 31, 2020
Cash and cash equivalents$40,890 $40,890 $— $— 
Large/mid-capitalization equity securities63,146 63,146 — — 
Small-capitalization equity securities19,932 19,932 — — 
International and emerging market equity securities24,325 24,325 — — 
Fixed income securities18,008 6,690 11,318 — 
Contracts with insurance companies9,118 — — 9,118 
Other assets(a)
5,629 5,629 — — 
Total plan assets at fair value$181,048 $160,612 $11,318 $9,118 
Investments measured at net asset value52,027 
Total plan assets, December 31, 2020$233,075 
(a) Represents investments in certain commodity funds measured using quoted market prices.
61


9. OTHER INCOME (EXPENSE), NET
Other income (expense), net consists of the following:
(In thousands)202120202019
Gain (loss) on investment in kaléo(a)
$12,780 $(60,900)$28,482 
One-time tax credit in Brazil for unemployment/social security insurance non-income taxes resulting from a favorable decision by Brazil’s Supreme Court regarding the calculation of such tax8,486 — — 
Transition service fees, net of corporate costs associated with the divested Personal Care business297 (851)— 
COVID-19-related expenses(b)
(624)(2,231)— 
Loss on sale of Bright View Technologies (2,299)— 
Write-down of investment in Harbinger Capital Partners Special Situations Fund(c)
(517)— — 
Gain associated with the sale of Lake Zurich manufacturing facility assets378 — — 
Other(424)(1,013)(111)
Total$20,376 $(67,294)$28,371 
(a) The gain in 2021 includes a $0.3 million dividend received from kaléo in the first quarter of 2021. The gain in 2019 includes a $17.6 million dividend received from kaléo.
(b) Costs associated with operating under COVID-19 conditions include employee overtime expenses associated with absenteeism, personal protective equipment supplies and facility maintenance.
(c) Represents the unrealized loss on the Company’s investment in Harbinger Capital Partners Special Situations Funds L.P. that had a fair value of $0.2 million, $0.7 million and $1.1 million as of December 31, 2021, 2020 and 2019, respectively, reported in “Other assets” in the consolidated balance sheet.
In May 2021, the Brazil Supreme Court ruled in a leading case related to the amount of Brazilian value-added tax to exclude from the calculation of unemployment/social security insurance non-income taxes (“PIS/COFINS”). As a result, in the second quarter of 2021, the Company recorded a pre-tax gain of $8.5 million for certain excess PIS/COFINS paid from 2003 to 2021, that included applicable interest, which the Company applied to required Brazilian federal tax payments during 2021. The pre-tax gain was recorded in “Other income (expense), net” in the consolidated statements of income.
10. DERIVATIVES
Tredegar uses derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales contracts in Aluminum Extrusions and exposure from currency volatility that exist as part of ongoing business operations (primarily in Flexible Packaging Films). These derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the consolidated balance sheet at fair value. The fair value of derivative instruments recorded on the consolidated balance sheets are based upon Level 2 inputs. If individual derivative instruments with the same counterparty can be settled on a net basis, the Company records the corresponding derivative fair values as a net asset or net liability.
In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the future sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge margin exposure created from the fixing of future sales prices relative to volatile raw material (aluminum) costs, Aluminum Extrusions enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled purchases for the firm sales commitments. The fixed-price firm sales commitments and related hedging instruments generally have durations of not more than 12 months, and the notional amount of aluminum futures contracts that hedged future purchases of aluminum to meet fixed-price forward sales contract obligations was $8.2$22.1 million (8.0(14.9 million pounds of aluminum) at December 31, 20172021 and $8.0$12.1 million (9.6(13.0 million pounds of aluminum) at December 31, 2016.2020.
62


The table below summarizes the location and gross amounts of aluminum derivative contract fair values (Level 2) in the consolidated balance sheets as of December 31, 20172021 and 2016:2020:
December 31, 2017 December 31, 2016 December 31, 2021December 31, 2020
(In thousands)
Balance Sheet
Account
 
Fair
Value
 
Balance Sheet
Account
 
Fair
Value
(In thousands)Balance Sheet
Account
Fair
Value
Balance Sheet
Account
Fair
Value
Derivatives Designated as Hedging Instruments    Derivatives Designated as Hedging Instruments
Asset derivatives:
Aluminum futures contracts
Prepaid expenses and other $578
 Prepaid expenses and other $308
Asset derivatives:
Aluminum futures contracts
Prepaid expenses & other$2,085 Prepaid expenses & other$1,560 
Liability derivatives:
    Liability derivatives:

Aluminum futures contracts
Prepaid expenses and other (16) Prepaid expenses and other (37)
    
Derivatives Not Designated as Hedging Instruments    
Asset derivatives:
Aluminum futures contracts
Prepaid expenses and other $
 Prepaid expenses and other $
Liability derivatives:
Aluminum futures contracts
Prepaid expenses and other 
 Prepaid expenses and other 
Liability derivatives:
Aluminum futures contracts
Accrued expenses(119)Accrued expenses(22)
Net asset (liability) $562
 $271
Net asset (liability)$1,966 $1,538 
In the event that a counterparty to an aluminum fixed-price forward sales contract chooses not to take delivery of its aluminum extrusions, the customer is contractually obligated to compensate Aluminum Extrusions for any losses on the related aluminum futures and/or forward contracts through the date of cancellation.


The table below summarizes the location and gross amounts of foreign currency forward contract fair values (Level 2) in the consolidated balance sheets as of December 31, 2017 and 2016:
 December 31, 2017 December 31, 2016
(In thousands)
Balance Sheet
Account
 
Fair
Value
 
Balance Sheet
Account
 
Fair
Value
Derivatives Designated as Hedging Instruments       
Asset derivatives:
Foreign currency forward contracts
Accrued Expenses $
 Accrued Expenses $
Liability derivatives:
Foreign currency forward contracts
Accrued Expenses (558) Accrued Expenses 
        
Derivatives Not Designated as Hedging Instruments       
Asset derivatives:
Foreign currency forward contracts
Accrued Expenses $
 Accrued Expenses $
Liability derivatives:
Foreign currency forward contracts
Accrued Expenses 
 Accrued Expenses 
Net asset (liability)  $(558)   $
The Company's earnings reported in U.S. Dollars are exposed to foreign currency translationexchange risk primarily through the translation of the financial statements of subsidiaries that have a functional currency other than the U.S. Dollar. On September 29, 2017,The Company estimates that the net mismatch translation exposure for the Flexible Packaging FilmsFilm's business unit in Brazil (“Terphane Limitada”Ltda.”) entered into 15 monthlyof its sales and raw materials quoted or priced in U.S. Dollars and its variable conversion, fixed conversion and sales, general and administrative costs (before depreciation and amortization) quoted or priced in Brazilian Real is annual net costs of R$150 million Brazilian Real ("R$").
Terphane Ltda. has the following outstanding foreign exchange average forward rate contracts to purchase Brazilian Real (“R$”) and sell U.S. Dollars covering the period from October 2017 through December 2018. Dollars:
USD Notional Amount (000s)Average Forward Rate Contracted on USD/BRLR$ Equivalent Amount (000s)Applicable MonthEstimated % of Terphane Ltda. R$ Operating Cost Exposure Hedged
$1,6775.3360R$8,948Jan-2272%
$1,7515.3631R$9,391Feb-2275%
$1,6625.3905R$8,959Mar-2272%
$1,6155.4247R$8,761Apr-2270%
$1,6475.4545R$8,984May-2272%
$1,5965.4890R$8,760Jun-2270%
$1,7195.5200R$9,489Jul-2276%
$1,7085.5560R$9,490Aug-2276%
$1,7805.5915R$9,953Sep-2280%
$1,7935.6264R$10,088Oct-2281%
$1,7845.6597R$10,097Nov-2281%
$1,6595.6962R$9,450Dec-2276%
$20,3915.5108R$112,37075%
These foreign currency exchange contracts have been designated as and qualify as cash flow hedges of Terphane Limitada'sLtda.’s forecasted sales to customers quoted or priced in U.S. Dollars over that period. By changing the currency risk associated with these U.S. Dollar sales, the derivatives have the effect of offsetting operating costs quoted or priced in Brazilian Real and decreasing the net exposure to Brazilian Real in the Company’s consolidated statements of income.
63


The aggregate notional amounttable below summarizes the location and gross amounts of open foreign exchange contracts atcurrency forward contract fair values (Level 2) in the consolidated balance sheets as of December 31, 2017 was $15.0 million (R$48.8 million).2021 and 2020:
 December 31, 2021December 31, 2020
(In thousands)Balance Sheet
Account
Fair
Value
Balance Sheet
Account
Fair
Value
Derivatives Designated as Hedging Instruments
Asset derivatives:
Foreign currency forward contracts
Prepaid expenses and other$ Prepaid expenses and other$853 
Liability derivatives:
Foreign currency forward contracts
Accrued expenses(1,255)Accrued expenses(466)
Net asset (liability)$(1,255)$387 
These derivative contracts involve elements of market risk that are not reflected on the consolidated balance sheet, including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to the Company’sany forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to any aluminum futures contracts are major financial institutions. Fixed-price forward sales contracts are only made available to the best and most credit-worthy customers. The counterparties to Tredegar’sthe Company’s foreign currency forwardcash flow hedge contracts are major financial institutions.
The pretax effect on net income (loss) from continuing operations and other comprehensive income (loss) of derivative instruments classified as cash flow hedges and described in the previous paragraphs for years ended December 31, 2017, 2016,2021, 2020, and 20152019 is summarized in the tables below:
(In thousands)Cash Flow Derivative Hedges
 Aluminum Futures Contracts
Years Ended December 31,202120202019
Amount of pre-tax gain (loss) recognized in other comprehensive income$6,215 $74 $(2,359)
Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)Cost of
goods sold
Cost of
goods sold
Cost of
goods sold
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$5,787 $(2,717)$(2,736)
(In thousands)Cash Flow Derivative Hedges(In thousands)Cash Flow Derivative Hedges
Aluminum Futures Contracts Foreign Currency Forward Contracts
Years Ended December 31,2017 2016 2015Years Ended December 31,202120202019
Amount of pre-tax gain (loss) recognized in other comprehensive income$1,501
 $394
 $(5,055)Amount of pre-tax gain (loss) recognized in other comprehensive income$ $(2,415)$— $(4,437)$— $(856)
Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)
Cost of
goods sold

 Cost of
goods sold

 Cost of
goods sold

Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)Cost of
goods sold
Selling, general & adminCost of
goods sold
Selling, general & adminCost of
goods sold
Selling, general & admin
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$1,210
 $(1,630) $(3,538)Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$63 $(337)$62 $(6,069)$62 $(904)


(In thousands)Cash Flow Derivative Hedges
 Foreign Currency Forward Contracts
Years Ended December 31,2017 2016 2015
Amount of pre-tax gain (loss) recognized in other comprehensive income$
$(561) $
 $
Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)Cost of
goods sold
Selling, general & admin Cost of
goods sold
 Cost of
goods sold
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$62
$(43) $62
 $62

Gains and losses on the ineffective portion of derivative instruments or derivative instruments that were not designated as hedging instruments were not material in 2017, 2016 and 2015. For the years ended December 31, 2017, 2016 and 2015, unrealized net losses from hedges that were discontinued were not material. As of December 31, 2017,2021, the Company expected $0.4expects $0.7 million of unrealized after-tax net gains on aluminum and foreign currency derivative instrumentscontracts reported in accumulated other comprehensive income (loss) to be reclassified to earnings within the next 12 months.
10ACCRUED EXPENSES
Accrued expenses consist of For the following:
(In thousands)2017 2016
Vacation$8,575
 $8,254
Incentive compensation7,958
 5,530
Payrolls, related taxes and medical and other benefits6,034
 5,519
Workers’ compensation and disabilities3,746
 3,732
Environmental liabilities (current)3,110
 2,100
Accrued utilities2,177
 2,126
Customer rebates1,929
 842
Accrued freight1,581
 1,612
Accrued severance783
 1,976
Derivative contract liability558
 
Other5,982
 6,956
Total$42,433
 $38,647


A reconciliation of the beginning and ending balances of accrued expenses associated with asset impairments and costs related to exit and disposal activities for each of the three years in the period ended December 31, 2017 is as follows:2021, 2020 and 2019, net gains or losses realized, from previously unrealized net gains or losses on hedges that had been discontinued, were not material.
(In thousands)
Severance(a)
 
Asset Impairments(b)
 
Other(c)
 Total
Balance at January 1, 2015$246
 $
 $201
 $447
For the year ended December 31, 2015:       
Charges2,568
 403
 879
 3,850
Cash spend(1,352) 
 (675) (2,027)
Charges against assets
 (403) 
 (403)
Balance at December 31, 20151,462
 
 405
 1,867
For the year ended December 31, 2016:       
Charges1,535
 603
 546
 2,684
Cash spend(1,143) 
 (397) (1,540)
Charges against assets
 (603) 
 (603)
Balance at December 31, 20161,854
 
 554
 2,408
For the year ended December 31, 2017:       
Charges589
 101,595
 304
 102,488
Cash spend(1,816) 
 (382) (2,198)
Charges against assets
 (101,595) 
 (101,595)
Balance at December 31, 2017$627
 $
 $476
 $1,103
(a) Severance primarily includes severance payments associated with the consolidation of North American PE Films manufacturing facilities.
(b) Asset impairments in 2017 primarily related to the Flexible Packaging Films’ impairment of $101 million.
(c) Other primarily includes other shutdown-related costs associated with the shutdown and sale of the Company’s aluminum extrusions manufacturing facility in Kentland, Indiana.
11. STOCK OPTION AND STOCK AWARD PLANS
See Note 17 for more information on plant shutdowns, asset impairments and restructuringsAs of continuing operations.
11DEBT AND CREDIT AGREEMENTS
On March 1, 2016, Tredegar entered into a $400 million five-year, secured revolving credit facility (“Credit Agreement”), with an option to increase that amount by $50 million. The Credit Agreement replaced the Company’s previous $350 million five-year, unsecured revolving credit facility that was due to expire on April 17, 2017. In connection with the refinancing,December 31, 2021, the Company borrowed $107 million underhad one stock-based compensation plan that permits the Credit Agreement, which was used, together withgrants of stock options, stock appreciation rights (“SARs”), stock, restricted stock, and stock unit awards. Awards available cash on hand, to repay all indebtedness under the previous revolving credit facility.
Borrowings under the Credit Agreement bear an interest rate of LIBOR plus a credit spread and commitment fees charged on the unused amount under the Credit Agreement at various indebtedness-to-adjusted EBITDA levels as follows:
Pricing Under Credit Revolving Agreement (Basis Points)
Indebtedness-to-Adjusted EBITDA Ratio
Credit Spread
Over LIBOR
 
Commitment
Fee
> 3.5x but <= 4.0x250
 45
> 3.0x but <= 3.5x225
 40
> 2.0x but <= 3.0x200
 35
> 1.0x but <= 2.0x175
 30
<= 1.0x150
 25

At December 31, 2017, the interest cost on debt borrowed under the Credit Agreement was priced at one-month LIBOR plus the applicable credit spread of 175 basis points.
The most restrictive covenants in the Credit Agreement include:


Maximum indebtedness-to-adjusted EBITDA (“Leverage Ratio:) of 4.00x;
Minimum adjusted EBIT-to-interest expense of 2.50x; and
Maximum aggregate distributions to shareholders over the term of the Credit Agreement of $100 million plus, beginning with the fiscal quarter ended March 31, 2016, 50% of net income and, at a Leverage Ratio of equal to or greater than 3.00x, a limitation on such payments for the succeeding quarter at the greater of (i) $4 million and (ii) 50% of consolidated net income for the most recent fiscal quarter, and, at a Leverage Ratio of equal to or greater than 3.50x, the prevention of such payments for the succeeding quarter unless the fixed charge coverage ratio is equal to or greater than 1.20x.
The Credit Agreement is secured by substantially all of the Company’s and its domestic subsidiaries’ assets, including equity in certain material first-tier foreign subsidiaries. 
At December 31, 2017, based upon the most restrictive covenant within the Credit Agreement, available credit under the Credit Agreement was approximately $248 million. Total debt due and outstandinggrant totaled 910,420 shares at December 31, 2017 is summarized below:
Debt Due and Outstanding at December 31, 2017
(In thousands)
Year Due
Credit
Agreement
 Other 
Total Debt
Due
2018$
 $
 $
2019
 
 
2020
 
 
2021152,000
 
 152,000
2022
 
 
Total$152,000
 $
 $152,000
Tredegar believes that it was in compliance with all of its debt covenants as of December 31, 2017. Noncompliance with any of the debt covenants may have a material adverse effect on financial condition or liquidity in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the covenant is renegotiated.
12STOCK OPTION AND STOCK AWARD PLANS
Tredegar has one equity incentive plan under which stock2021. Stock options may be granted to purchase a specified number of shares of common stock at a price no lower than the fair market value on the date of grant and for a term not to exceed 10 years. EmployeeStock options granted from 2012 to 2014 vested overby the Company in 2021, 2020 and 2019 vest after 2 years and have a four-year period, with7-year life or vest after 3 years and have a quarter5-year life. Stock options exercisable totaled 1,762,190 and 1,287,792 shares at December 31, 2021 and 2020, respectively.
On December 1, 2020, Tredegar’s Board of Directors declared a special cash dividend of $200 million, or $5.97 per share, on the Company’s common stock (the “Special Dividend”). The Special Dividend was payable on December 18, 2020 and had
64


an ex-dividend date of December 21, 2020. All stock option awards that were outstanding at the time of the Special Dividend were modified pursuant to the nondiscretionary anti-dilution provisions in the related stock-based compensation plan. SARs that were outstanding at the time of the Special Dividend were also modified pursuant to the nondiscretionary anti-dilution provisions in the related SARs grant agreements. The modifications included increasing the number of outstanding stock options and SARs as well as reducing the exercise prices of all outstanding stock options and SARS. The modification did not result in additional stock-based compensation expense. No other terms or conditions of outstanding awards were modified.
A summary of stock options outstanding at December 31, 2021, 2020 and 2019, and changes during those years, is presented below:
  Option Exercise Price/Share
  Number of
Options
RangeWeighted
Average
Outstanding at January 1, 2019890,116 $15.65 to$24.84 $19.69 
Granted758,287 18.48 to18.48 18.48 
Forfeited and expired(10,000)19.40 to19.40 19.40 
Exercised(9,500)19.40 to19.40 19.40 
Outstanding at December 31, 20191,628,903 15.65 to24.84 19.13 
Granted638,074 10.75 to14.62 11.90 
Modification for special cash dividend(a)
701,535 10.75 to14.62 11.90 
Forfeited and expired(a)
(141,074)10.75 to24.84 11.87 
Outstanding at December 31, 2020(a)
2,827,438 10.75 to22.49 13.55 
Granted388,822 16.37 to16.37 16.37 
Forfeited and expired(22,611)14.47 to19.64 18.14 
Exercised(67,705)10.75 to17.29 13.51 
Outstanding at December 31, 20213,125,944 $10.75 to$22.49 $13.82 
(a) The option exercise price per share reflects the reduction to the exercise prices of outstanding stock options impacted by the modification due to the anti-dilution provisions in the stock-based compensation plan.
The assumptions used in the Black-Scholes options-pricing model for valuing Tredegar stock options originally granted vestingin 2021, 2020 and 2019, and the related estimated fair values at the date of grant, were as follows:
202120202019
Dividend yield2.6 %2.5 %2.4 %
Weighted average volatility percentage48.3 %43.8 %38.3 %
Weighted average risk-free interest rate0.9 %0.8 %2.4 %
Holding period (years)555
Weighted average exercise price at date of grant (also weighted average market price at date of grant)(a)
$16.37 $14.41 $18.48 
Estimated weighted average fair value of options per share at date of grant$5.57 $4.44 $5.43 
Total estimated fair value of stock options granted (in thousands)$2,165 $2,833 $4,117 
(a) In December 2020, the weighted average exercise price for outstanding stock option awards granted in 2020 and 2019 were modified to $10.75 and $13.78, respectively. As the anti-dilution provisions in the stock-based compensation plan were structured to equitably adjust the award’s fair value before and after the modification, there is no resulting incremental fair value.
The dividend yield is the actual dividend yield on each yearTredegar’s common stock at the date of grant, which the Company believes is a reasonable estimate of the expected yield during the holding period. The expected volatility is based on the grant date anniversary. Twohistorical volatility of Tredegar’s common stock using a sequential period of historical data equal to the expected holding period of the option. The Company has no reason to believe that future volatility for this period is likely to differ from the past. The assumed risk-free interest rate is based on observed interest rates for U.S. Treasury debt securities appropriate for the expected holding period.
65


The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2021:
 Options Outstanding at December 31, 2021Options Exercisable at December 31, 2021
  Weighted AverageAggregate Intrinsic Value  Aggregate Intrinsic Value
Range of
Exercise Prices
SharesRemaining Contractual LifeExercise
Price
SharesWeighted Average Exercise Price
$10.75 to$16.37 2,953,052 4.4 years$13.48 $792,082 1,589,298 $13.78 $41,076 
17.29 to25.94 172,892 1.6 years19.71 — 172,892 19.71 — 
Total3,125,944 4.2 years$13.82 $792,082 1,762,190 $14.36 $41,076 
The total intrinsic value of stock options exercised is $0.2 million in 2021 and $0.1 million in 2019. There were no stock options exercised in 2020. The grant-date fair value of stock option-based awards vested was $3.5 million, $3.0 million, and $0.5 million in 2021, 2020, and 2019, respectively. As of December 31, 2021, the unrecognized compensation cost for continuing operations related to stock option-based awards was $1.7 million. This cost is expected to be recognized over the remaining weighted average period of 0.6 years. Commencing in 2019, stock option award grants were madeinclude a retirement provision that allow for the immediate vesting of options held by a participant that ceases to provide service, including service as a member of the board of directors, with the Company, subsequent to reaching the age of 65.  As a result of this provision, the Company recognized accelerated stock compensation expense for continuing operations of $0.1 million and $1.3 million in 2017, with one cliff vesting after two years2020 and the other cliff vesting after three years. No2019, respectively. There was no accelerated stock options were grantedcompensation expense in 2015 and 2016. The option plan also permits the grant of stock appreciation rights (“SARs”), stock, restricted stock, stock unit awards and incentive awards. 2021. 
Restricted stock grants ordinarily vest three years from the date of grant based upon continued employment. The fair value of restricted stock awards is estimated as of the grant date using the closing stock price on that date. Stock unit awards vest upon the achievement of certain performance targets. No SARs have been granted since 1992 and none are currently outstanding.


A summary of stock options outstanding at December 31, 2017, 2016 and 2015, and changes during those years, is presented below:
   Option Exercise Price/Share
  
Number of
Options
 Range 
Weighted
Average
Outstanding at January 1, 20151,164,120
 $14.06
 to $30.01
 $19.59
Granted
 
 to 
 
Forfeited and expired(60,207) 17.13
 to 30.01
 22.30
Exercised(222,400) 14.06
 to 19.84
 16.34
Outstanding at December 31, 2015881,513
 17.13
 to 30.01
 20.22
Granted
 
 to 
 
Forfeited and expired(246,394) 17.13
 to 30.01
 18.90
Exercised(134,200) 17.13
 to 19.84
 17.23
Outstanding at December 31, 2016500,919
 17.13
 to 30.01
 21.67
Granted209,551
 15.65
 to 15.65
 15.65
Forfeited and expired(60,685) 17.13
 to 30.01
 21.42
Exercised(41,265) 19.84
 to 19.84
 19.84
Outstanding at December 31, 2017608,520
 $15.65
 to $24.84
 $19.75
The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2017:
      Options Outstanding at December 31, 2017 Options Exercisable at December 31, 2017
        Weighted Average 
Aggregate Intrinsic Value
(In thousands)
     Aggregate Intrinsic Value
(In thousands)
Range of
Exercise Prices
 Shares Remaining Contractual Life (Years) 
Exercise
Price
  Shares 
Weighted
Average
Exercise
Price
 
$
 to $15.00
 
 0.0 $
 $
 
 $
 $
15.01
 to 17.50
 209,551
 6.4 15.65
 743,906
 
 
 
17.51
 to 20.00
 171,460
 2.2 19.58
 429
 171,460
 19.58
 429
20.01
 to 25.00
 227,509
 5.6 23.64
 
 214,198
 23.71
 
Total 608,520
 4.9 $19.75
 $744,335
 385,658
 $21.88
 $429
During 2015, the Board of Directors approved the accelerated vesting of stock options and restricted stock for several Tredegar executives who left the Company. Compensation expense recognized in 2015 for accelerated stock option vestings (0.4 million shares) and accelerated restricted stock vestings (0.1 million shares) totaled $0.4 million and $1.0 million, respectively.


The following table summarizes additional information about unvested restricted stock outstanding at December 31, 2017, 20162021, 2020 and 2015:2019:
 Unvested Restricted StockMaximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria
 Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Outstanding at January 1, 2019244,736 $16.20 $3,965 184,709 $16.97 $3,134 
Granted185,422 18.46 3,423 57,442 18.34 1,053 
Vested(117,834)14.76 (1,739)(69,926)10.96 (766)
Forfeited(26,389)16.11 (425)(24,562)11.51 (283)
Outstanding at December 31, 2019285,935 18.27 5,224 147,663 21.25 3,138 
Granted155,138 14.55 2,257 34,275 15.25 523 
Vested(148,709)17.39 (2,586)(37,370)17.38 (649)
Forfeited(57,385)17.00 (976)(32,066)17.36 (557)
Outstanding at December 31, 2020234,979 16.68 3,919 112,502 21.82 2,455 
Granted200,073 15.63 3,127 14,669 15.24 224 
Vested(87,636)15.78 (1,383)(73,930)17.17 (1,269)
Forfeited(11,616)16.38 (190)(2,523)17.63 (44)
Outstanding at December 31, 2021335,800 $16.30 $5,473 50,718 $17.63 $1,366 
 Unvested Restricted Stock Maximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria
 
Number
of Shares
 Weighted Avg. Grant Date Fair Value/Share 
Grant Date
Fair Value
(In thousands)
 
Number
of Shares
 Weighted Avg. Grant Date Fair Value/Share 
Grant Date
Fair Value
(In thousands)
Outstanding at January 1, 2015188,058
 $22.48
 $4,227
 129,713
 $24.99
 $3,241
Granted147,666
 18.87
 2,786
 144,582
 18.47
 2,670
Vested(174,145) 20.57
 (3,582) 
 
 
Forfeited(29,226) 21.42
 (626) (107,167) 20.78
 (2,227)
Outstanding at December 31, 2015132,353
 21.19
 2,805
 167,128
 22.04
 3,684
Granted144,546
 13.47
 1,947
 136,986
 11.34
 1,553
Vested(52,167) 21.56
 (1,125) 
 
 
Forfeited(17,377) 18.97
 (330) (65,685) 20.24
 (1,329)
Outstanding at December 31, 2016207,355
 15.90
 3,297
 238,429
 16.39
 3,908
Granted107,362
 18.29
 1,964
 46,205
 17.38
 803
Vested(50,154) 19.72
 (989) 
 
 
Forfeited(57,887) 16.16
 (935) (112,501) 17.73
 (1,995)
Outstanding at December 31, 2017206,676
 $16.15
 $3,337
 172,133
 $15.78
 $2,716
The total intrinsic value of stock options exercised was $0.2 million in 2017, $0.2 million in 2016 and $1.0 million in 2015. The grant-date fair value of stock option-based awards vested was $0.4 million in 2017, $0.4 million in 2016 and $1.9 million in 2015. As of December 31, 2017, there was2021, the unrecognized compensation cost of $0.6 million related to stock option-based awards and $2.2 millionfor continuing operations related to non-vested restricted stock and other stock-based awards.awards was $2.6 million. This cost is expected to be recognized over the remaining weighted average period of 1.651.5 years.
SARs granted by the Company in 2021 and 2020 vest after 2 years and have a 7-year life. No SARs were granted prior to January 1, 2020 since 1992. SARs may be settled in cash upon exercise and therefore are classified as liabilities and included in accrued expenses in the consolidated balance sheet. The fair value of these liability awards is remeasured at each reporting period until the date of settlement. Increases and decreases in stock-based compensation expense is recognized over the vesting period, or immediately, for stock option-based awards and 1.3 years for non-vested restricted stock and other stock-basedvested awards.
Stock options exercisable totaled 385,658
66


A summary of SARs outstanding at December 31, 20172021 and 453,067 shares at December 31, 2016. Stock options available for grant totaled 1,704,554 shares at December 31, 2017.

2020, and changes during those years, is presented below:

  Exercise Price/Share
  Number of
SARs
RangeWeighted
Average
Outstanding at January 1, 2020— $— to$— $— 
Granted(a)
387,252 10.75 to19.64 11.60 
Modification for special cash dividend71,402 10.75 to19.64 11.60 
Forfeited and expired(82,214)10.75 to19.64 11.39 
Outstanding at December 31, 2020376,440 10.75 to19.64 11.64 
Granted164,464 16.37 to16.37 16.37 
Forfeited and expired(10,043)10.75 to16.37 13.01 
Exercised(9,260)10.75 to15.25 13.87 
Outstanding at December 31, 2021521,601 $10.75 to$16.37 $13.55 
(a) The SARs exercise price per share reflects the reduction to the exercise prices of outstanding SARs as a results of the modification to the awards pursuant to the nondiscretionary anti-dilution provisions in the related SARs grant agreements.
13RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS
Tredegar sponsors noncontributory defined benefit (pension) plans covering certain currentThe grant-date fair value of SARs awards vested was $0.1 million and former employees. The plans for salaried$0.6 million in 2021 and hourly employees currently in effect are based on a formula using the participant’s years of service and compensation or using the participant’s years of service and a dollar amount. The plan is closed to new participants, and pay for active participants of the plan was frozen as2020, respectively. As of December 31, 2007. As of January 31, 2018,2021, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan.
In addition to providing pension benefits, the Company provides postretirement life insurance and health care benefits for certain groups of employees. Tredegar and retirees share in the cost of postretirement health care benefits, with employees hired on or before January 1, 1993, receiving a fixed subsidy to cover a portion of their health care premiums. The Company eliminated prescription drug coverage for Medicare-eligible retirees as of January 1, 2006. Consequently, Tredegar is not eligible for any federal subsidies.
The following tables reconcile the changes in benefit obligations and plan assets in 2017 and 2016, and reconcile the funded status to prepaid or accrued cost at December 31, 2017 and 2016:
 Pension Benefits  
Other Post-
Retirement Benefits
(In thousands)2017 2016  2017 2016
Change in benefit obligation:        
Benefit obligation, beginning of year$303,126
 $303,852
  $7,436
 $7,745
Service cost194
 231
  33
 38
Interest cost12,575
 13,323
  301
 337
Effect of actuarial (gains) losses related to the following:        
Discount rate change21,055
 9,296
  471
 210
Retirement rate assumptions and mortality table adjustments(2,145) (5,537)  15
 (433)
Other(1,921) (3,025)  (245) (131)
Plan participant contributions
 
  646
 634
Benefits paid(14,761) (15,014)  (953) (964)
Benefit obligation, end of year$318,123
 $303,126
  $7,704
 $7,436
Change in plan assets:        
Plan assets at fair value, beginning of year$214,559
 $210,642
  $
 $
Actual return on plan assets21,034
 11,199
  
 
Employer contributions5,522
 7,732
  307
 330
Plan participant contributions
 
  646
 634
Benefits paid(14,761) (15,014)  (953) (964)
Plan assets at fair value, end of year$226,354
 $214,559
  $
 $
Funded status of the plans$(91,769) $(88,567)  $(7,704) $(7,436)
Amounts recognized in the consolidated balance sheets:        
Accrued expenses (current)$182
 $182
  $457
 $453
Pension and other postretirement benefit obligations, net91,587
 88,385
  7,247
 6,983
Net amount recognized$91,769
 $88,567
  $7,704
 $7,436


Assumptions used for financial reporting purposes to compute net benefit income or cost and benefit obligations for continuing operations, and the components of net periodic benefit income orunrecognized compensation cost for continuing operations are as follows:
  Pension Benefits  
Other Post-
Retirement Benefits
(In thousands, except percentages)2017 2016 2015  2017 2016 2015
Weighted-average assumptions used to determine benefit obligations:            
Discount rate3.72% 4.29% 4.55%  3.69% 4.24% 4.49%
Expected long-term return on plan assets6.50% 6.50% 7.00%  n/a
 n/a
 n/a
Weighted-average assumptions used to determine net periodic benefit cost:            
Discount rate4.29% 4.55% 4.17%  4.24% 4.49% 4.11%
Expected long-term return on plan assets6.50% 7.00% 7.50%  n/a
 n/a
 n/a
Components of net periodic benefit cost:            
Service cost$194
 $231
 $530
  $33
 $38
 $44
Interest cost12,575
 13,323
 13,217
  301
 337
 325
Expected return on plan assets(14,955) (15,980) (17,636)  
 
 
Amortization of prior service costs and gains or losses12,320
 13,312
 16,190
  (275) (214) (194)
Settlement/curtailment
 
 45
  
 
 
Net periodic benefit cost$10,134
 $10,886
 $12,346
  $59
 $161
 $175
Net benefit income orwas $0.4 million. This cost is determined using assumptions at the beginning of each year. Funded status is determined using assumptions at the end of each year. The amount of the accumulated benefit obligation is the same as the projected benefit obligation. At December 31, 2017, the effect of a 1% change in the health care cost trend rate assumptions would not impact the post-retirement obligation.
Expected benefit payments for continuing operations over the next five years and in the aggregate for 2023-2027 are as follows:
(In thousands)
Pension
Benefits
 
Other Post-
Retirement
Benefits
2018$16,378
 $457
201916,916
 461
202017,403
 462
202117,762
 466
202218,075
 469
2023—202792,799
 2,299
Amounts recorded in 2017, 2016 and 2015 in accumulated other comprehensive income, before related deferred income taxes, consist of:
 Pension Other Post-Retirement
(In thousands)2017 2016 2015 2017 2016 2015
Prior service cost (benefit)$5
 $10
 $18
 $
 $
 $
Net actuarial (gain) loss144,377
 145,782
 153,570
 (1,238) (1,756) (1,616)


Pension expense is expected to be $10.2 million in 2018. The amounts in accumulated other comprehensive income, before related deferred income taxes, that are expected to be recognized as components of net periodic benefit or cost during 2018 are as follows:
(In thousands)Pension 
Other Post-
Retirement
Prior service cost (benefit)$5
 $
Net actuarial (gain) loss13,706
 (218)
The percentage composition of assets held by pension plans for continuing operations at December 31, 2017, 2016 and 2015 are as follows:
 
% Composition of Plan Assets
at December 31,
 2017 2016 2015
Pension plans related to continuing operations:     
Fixed income securities7.7% 8.0% 12.8%
Large/mid-capitalization equity securities19.0
 14.7
 13.8
Small-capitalization equity securities6.4
 5.3
 4.0
International and emerging market equity securities15.1
 11.5
 10.9
Total equity securities40.5
 31.5
 28.7
Private equity and hedge funds44.6
 48.4
 52.4
Other assets7.2
 12.1
 6.1
Total for continuing operations100.0% 100.0% 100.0%
Tredegar’s targeted allocation percentage for pension plan assets and the expected long-term rate of return on assets used to determine its benefit obligation at December 31, 2017, are as follows:
 Target % Composition of Plan Assets * Expected Long-term Return %
Pension plans related to continuing operations:   
Fixed income securities12.0% 2.1%
Large/mid-capitalization equity securities19.0
 8.3
Small-capitalization equity securities6.0
 9.6
International and emerging market equity securities15.0
 8.6
Total equity securities40.0
 8.6
Private equity and hedge funds48.0
 5.9
Total for continuing operations100.0% 6.5%
*    Target percentages for the composition of plan assets represents a neutral position within the approved range of allocations for such assets.

Expected long-term returns are estimated by asset class and generally are based on inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums. The portfolio of fixed income securities is structured with maturities that generally match estimated benefit payments over the next 1-2remaining weighted average period of 0.6 years. The other assets category is primarily comprised of cash and contracts with insurance companies. The Company’s primary investment objective is to maximize total return with a strong emphasis on the preservation of capital, and it believes that over the long-term a diversified portfolio of fixed income securities, equity securities, hedge funds and private equity funds has a better risk-return profile than fixed income securities alone. The average remaining duration of benefit payments for the pension plans is about 11.3 years. The Company expects its required contributions to be approximately $5.3 million in 2018.


Estimates of the fair value of assets held by the Company’s pension plan are provided by unaffiliated third parties. Investments in private equity and hedge funds and certain fixed income securities by the Company’s pension plan are measured at NAV, which is a practical expedient for measuring fair value. These assets are therefore excluded from the fair value hierarchy for each of the years presented. At December 31, 2017 and 2016, the pension plan assets are categorized by level within the fair value measurement hierarchy as follows:
(In thousands)Total 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Balances at December 31, 2017       
Large/mid-capitalization equity securities$42,920
 $42,920
 $
 $
Small-capitalization equity securities14,477
 14,477
 
 
International and emerging market equity securities34,153
 16,409
 17,744
 
Fixed income securities17,513
 5,374
 12,139
 
Other assets5,822
 5,822
 
 
Total plan assets at fair value$114,885
 $85,002
 $29,883
 $
Private equity and hedge funds100,974
      
Contracts with insurance companies10,495
      
Total plan assets, December 31, 2017$226,354
      
Balances at December 31, 2016       
Large/mid-capitalization equity securities$31,549
 $31,549
 $
 $
Small-capitalization equity securities11,389
 11,389
 
 
International and emerging market equity securities24,710
 11,410
 13,300
 
Fixed income securities17,213
 4,441
 12,772
 
Other assets15,853
 15,853
 
 
Total plan assets at fair value$100,714
 $74,642
 $26,072
 $
Private equity and hedge funds103,686
      
Contracts with insurance companies10,158
      
Total plan assets, December 31, 2016$214,558
      
Tredegar also has a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. The plan was designed to restore all or a part of the pension benefits that would have been payable to designated participants from the principal pension plans if it were not for limitations imposed by income tax regulations. The projected benefit obligation relating to this unfunded plan was $2.2 million at December 31, 2017 and $2.2 million at December 31, 2016. Pension expense recognized for this plan was $0.1 million in 2017, $0.1 million in 2016 and $0.1 million in 2015. This information has been included in the preceding pension benefit tables.
Approximately 70 employees at the Company’s film products manufacturing facility in Kerkrade, The Netherlands are covered by a collective bargaining agreement that includes participation in a multi-employer pension plan. Pension expense recognized for participation in this plan, which is equal to required contributions, was $0.4 million in 2017, $0.4 million in 2016 and $0.4 million in 2015. This information has been excluded from the preceding pension benefit tables.
14SAVINGS PLAN
Tredegar has a savings plan that allows eligible employees to voluntarily contribute a percentage of their compensation, up to Internal Revenue Service (“IRS”) limitations. The provisions of the savings plan provided the following benefits for salaried and certain hourly employees:
The Company makes matching contributions to the savings plan of $1 for every $1 an employee contributes per pay period up to a maximum of 5% of eligible compensation.
The savings plan includes immediate vesting of matching contributions and automatic enrollment at 3% of eligible compensation unless the employee opts out or elects a different percentage.


The Company also has a non-qualified plan that restores matching benefits for employees suspended from the savings plan due to certain limitations imposed by income tax regulations (“restoration plan”). Charges recognized for these plans were $3.5 million in 2017, $3.2 million in 2016 and $3.0 million in 2015. The Company’s liability under the restoration plan was $1.3 million at December 31, 2017 (consisting of 65,548 phantom shares of common stock) and $1.6 million at December 31, 2016 (consisting of 67,013 phantom shares of common stock) and valued at the closing market price on those dates.
The Tredegar Corporation Benefits Plan Trust (the “Trust”) purchased 7,200 shares of the Company’s common stock in 1998 for $0.2 million and 46,671 shares of its common stock in 1997 for $1.0 million, as a partial hedge against the phantom shares held in the restoration plan. There have been no shares purchased since 1998 except for re-invested dividends. The cost of the shares held by the Trust is shown as a reduction to shareholders’ equity in the consolidated balance sheets.
15RENTAL EXPENSE AND CONTRACTUAL COMMITMENTS
Rental expense for continuing operations was $4.4 million in 2017, $2.9 million in 2016 and $3.6 million in 2015. Rental commitments under all noncancellable leases (including $0.1 million for capital leases) for continuing operations as of December 31, 2017, are as follows:
(In thousands) 
2018$3,657
20193,532
20203,314
20212,826
20221,991
Remainder3,109
Total minimum lease payments$18,429
Contractual obligations for plant construction and purchases of real property and equipment amounted to $4.6 million at December 31, 2017.
1612. INCOME TAXES
The TCJA makes broad and complex changes to the U.S. tax code, including, but not limited to: (i) reducing the U.S. federal corporate income tax rate from 35 percent to 21 percent; (ii) requiring companies to pay a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries; (iii) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries; (iv) creating new taxes on certain foreign earnings; (v) eliminating certain deductions; and (vi) providing the option to full expensing of qualified property.
The SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the TCJA. SAB 118 provides a measurement period that should not extend beyond one year from the TCJA enactment date for companies to complete the accounting under Accounting Standards Codification No. 740 (“ASC 740”). In accordance with SAB 118, a company must reflect the income tax effects of a company’s accounting for those tax effects of the TCJA for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain tax effects of the TCJA is incomplete, but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements. If a company cannot determine a reasonable estimate to be included in the financial statements, it should continue to apply ASC 740 on the basis of the provisions of the tax law that were in effect immediately before the enactment of the TCJA.
The TCJA is complex and its impact may materially differ from the Company’s estimates, due to, among other things, changes in the Company’s assumptions, implementation guidance that may be issued from the IRS and related interpretations and clarifications of tax law relevant for the completion of the Company’s 2017 tax return filings. The Company expects to complete its assessment of these items during 2018, and any adjustments to the provisional amounts initially recorded, will be included as an adjustment to income tax expense or benefit in the period the amounts are determined, in accordance with SAB 118.
Item (i) above has been completed and resulted in a non-cash deferred income tax benefit in the fourth quarter of 2017 of $3.9 million to adjust applicable deferred income tax assets and liabilities for the change in the U.S. federal corporate income tax rate. Income tax accruals on U.S. income in future periods will apply the new 21% rate. While item (ii) has not been completed, the Company has not accrued any deemed repatriation taxes on unrepatriated earnings of its foreign subsidiaries,


since its preliminary assessment indicates that such foreign subsidiaries have no net cumulative unremitted earnings due to historical repatriation. The remaining TCJA summary items (iii through vi) relate to 2018 and beyond.
The application of the new Global Intangible Low Taxed Income (“GILTI”) tax rules to the Company, which is part of item (iv), is not complete. The rules are complex, and under GAAP the Company is allowed to make a policy choice of either: (a) treating taxes due on future U.S. inclusions in taxable income related to GILTI as current period expense when incurred (the “period cost method”), or (b) factoring such amounts into a company’s measurement of its deferred income taxes (the “deferred method”). The selection of an accounting policy with respect to the new GILTI tax rules will depend, in part, on the Company’s analysis of its global income to determine whether it expects to have future U.S. inclusions in taxable income related to GILTI, and, if so, what the impact is expected to be. Consequently, the Company has not been able to complete this analysis at this time and is not able to reasonably estimate the effect of this provision of the TCJA. Accordingly, the Company has not made any adjustments related to potential GILTI tax in its financial statements and has not made a policy decision regarding whether to record deferred income taxes on GILTI.
Income (loss) from continuing operations before income taxes and income tax expense (benefit) for continuing operations are as follows:
(In thousands)202120202019
Income (loss) from continuing operations before income taxes:
Domestic$22,885 $(58,033)$52,536 
Foreign44,336 32,987 19,470 
Total$67,221 $(25,046)$72,006 
Current income tax expense (benefit):
Federal$1,232 $4,777 $7,551 
State764 136 1,558 
Foreign13,521 2,374 579 
Total15,517 7,287 9,688 
Deferred income tax expense (benefit):
Federal(7,862)(18,191)15,298 
State125 (640)187 
Foreign1,504 3,331 (11,628)
Total(6,233)(15,500)3,857 
Total income tax expense (benefit)$9,284 $(8,213)$13,545 
67

(In thousands) 2017 2016 2015
Income (loss) before income taxes:     
Domestic$67,549
 $26,284
 $(9,116)
Foreign(82,461) 1,399
 (14,091)
Total$(14,912) $27,683
 $(23,207)
Current income tax expense (benefit):     
Federal$(20,560) $4,302
 $12,693
State800
 (709) 973
Foreign3,247
 3,255
 6,064
Total(16,513) 6,848
 19,730
Deferred income tax expense (benefit):     
Federal(23,302) (2,505) (9,419)
State(949) 1,396
 (1,035)
Foreign(12,399) (2,522) (348)
Total(36,650) (3,631) (10,802)
Total income tax expense (benefit)$(53,163) $3,217
 $8,928




The significant differences between the U.S. federal statutory rate and the effective income tax rate forrelated to continuing operations are as follows:
202120202019
(In thousands, except percentages)Amount%Amount%Amount%
Income tax expense (benefit) at federal statutory rate$14,116 21.0 $(5,260)21.0 $15,121 21.0 
Foreign rate differences8,269 12.3 4,554 (18.2)2,247 2.9 
Tax on Prodepe tax incentive2,858 4.3 (801)3.2 (714)(1.0)
Foreign currency translation variation on intercompany loans1,374 2.0 — — — — 
Non-deductible other1,053 1.6 208 (0.8)637 0.9 
State taxes, net of federal income tax benefit933 1.4 (373)1.5 1,050 1.5 
Tax contingency accruals and tax settlements202 0.3 (58)0.2 (2,543)(3.5)
Foreign derived intangible income deduction  — — (319)(0.4)
Valuation allowance due to foreign losses and impairments  — — (14,350)(19.9)
Dividend received deduction net of foreign withholding tax(109)(0.2)(52)0.2 (1,016)(1.4)
Changes in estimates related to prior year tax provision(383)(0.6)(2,472)9.9 (135)(0.2)
Research and development tax credit(928)(1.4)(633)2.5 (523)(0.7)
Valuation allowance for capital loss carryforwards(5,415)(8.1)52 (0.2)60 0.1 
U.S. tax on foreign branch income(5,667)(8.4)1,409 (5.6)16,029 22.3 
Brazilian tax incentive(7,019)(10.4)(4,787)19.1 (1,999)(2.8)
    Income tax expense (benefit) at effective income tax rate$9,284 13.8 $(8,213)32.8 $13,545 18.8 
 2017 2016 2015
(In thousands, except percentages)Amount
%
 Amount
%
 Amount
%
Income tax expense (benefit) at federal statutory rate$(5,219)35.0
 $9,689
35.0
 $(8,122)35.0
Worthless stock deductions(61,413)411.9
 

 

Impact of U.S. Tax Cuts and Jobs Act(4,433)29.7
 

 

Settlement of Terphane acquisition escrow(4,200)28.2
 

 

Increase in value of kaléo investment held abroad(2,326)15.6
 (197)(0.7) 2,523
(10.9)
Tax contingency accruals and tax settlements(420)2.8
 104
0.4
 716
(3.1)
Research and development tax credit(375)2.5
 (550)(2.0) (350)1.5
Brazilian tax incentive

 

 (120)0.5
Unremitted earnings from foreign operations

 (256)(0.9) (502)2.2
Domestic Production Activities Deduction

 (735)(2.7) (840)3.6
Remitted earnings from foreign operations

 (6,574)(23.7) (18)0.1
Valuation allowance for capital loss carryforwards83
(0.6) 267
1.0
 (311)1.3
Non-deductible goodwill and asset impairment loss228
(1.5) 13

 15,798
(68.1)
Changes in estimates related to prior year tax provision320
(2.1) 330
1.2
 489
(2.1)
Non-deductible expenses633
(4.2) 396
1.4
 448
(1.9)
State taxes, net of federal income tax benefit656
(4.4) 647
2.3
 (67)0.3
Foreign rate differences2,546
(17.1) 499
1.8
 (719)3.1
Valuation allowance due to foreign losses and impairments20,757
(139.3) (416)(1.5) 3

    Income tax expense (benefit) at effective income tax rate$(53,163)356.5
 $3,217
11.6
 $8,928
(38.5)

During 2017, the Company completed a plan to liquidate for tax purposes one of its domestic subsidiaries, which allowed it to claim an income tax benefit on the write-off of the stock basis of Terphane, Inc. (Terphane’s U.S. affiliate) on its 2017 U.S. federal income tax return. The Company recorded an income tax benefit during the second quarter of 2017 of $8.1 million related to this worthless stock deduction, net of valuation allowances and accrual for uncertain tax positions. Also, during the fourth quarter of 2017, as a result of valuation activities and other efforts, the Company claimed an ordinary loss for U.S. federal and state income tax purposes of $153 million for the write-off of the stock basis of Terphane Limitada (Terphane’s Brazilian entity). The full tax benefit accrued for the Terphane Limitada worthless stock deduction at the 35% U.S. corporate income tax rate applicable for 2017 was approximately $54 million. This benefit was reduced by $4.8 millionIncome taxes in conjunction with the TCJA for the portion of the deduction that is expected to be applied to income generated after 2017 where the new U.S. federal corporate income tax rate of 21% is applicable. The significant foreign rate difference for 2017 is2021 are primarily due to the difference between Hungary’s incomestrong earnings of Terphane Ltda, which are included in Tredegar’s U.S. consolidated tax return and, the tax impact of the local statutory tax rates of Tredegar’s foreign subsidiaries being higher than the current U.S. tax rate of 9%21%, the benefit of tax incentives in Brazil and the release of the valuation allowance for capital loss carryforwards.
Income taxes in 2020 were primarily impacted by the tax impact of Terphane Ltda. being included in Tredegar’s U.S. federal corporate incomeconsolidated tax return as a foreign branch, the tax impact of the local statutory tax rates of Tredegar’s foreign subsidiaries being higher than the current US tax rate of 35%.21%, the benefit of tax incentives in Brazil, and by claims for prior years’ U.S. research and development tax credits.
During 2019, due to favorable earnings trends, the Company released a $12.4 million valuation allowance on the net deferred tax assets of its Brazilian subsidiary Terphane Ltda. Because Terphane Ltda. is taxed as a foreign branch for U.S. tax purposes, Tredegar also recorded a related deferred tax liability of $12.4 million for the reduction in foreign tax credits that would result from Terphane Ltda. realizing this net deferred tax asset.
Tredegar accrues U.S. federal income taxes on unremitted earnings of all foreign subsidiaries where required. However, due to changes in the taxation of dividends under TCJA, Tredegar will only record U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries. Prior to the second quarter of 2016, deferred U.S. federal income taxes had not been recorded for the undistributed earnings for Terphane Limitada. because the Company had intended to permanently reinvest these earnings. Due to concerns about the political and economic conditions in Brazil, Terphane Limitada began making cash distributions to the Company in 2016. During the second quarter of 2016, Terphane Limitada paid a dividend of $10.7 million to the Company. During the second quarter of 2017, the Company recognized a net tax benefit of $0.4 million associated with additional U.S. tax related to this repatriation of cash from Brazil offset by the reversal of related tax contingencies. Because of the accumulation of significant losses related to foreign currency translations at Terphane Limitada,Ltda., there were no deferred income tax liabilities associated with the U.S. federal income taxes and foreign withholding taxes on Terphane Limitada’sLtda.’s undistributed earnings as of and December 31, 20172021 and 2016.
Income taxes in 2016 included the recognition of an additional valuation allowance of $0.3 million related to expected limitations on the utilization of assumed capital losses on certain investments. In 2016, the difference between the federal statutory rate and the effective tax rate is primarily driven by the $6.4 million tax benefit from excess foreign tax credits related to the repatriation of cash from Brazil discussed above.


2020.
The Brazilian federal statutory income tax rate is a composite of 34.0% (25.0% of income tax and 9.0% of social contribution on income). Terphane’s manufacturing facility in Brazil is the beneficiary of certain income tax incentives that allow for a reduction in the statutory Brazilian federal income tax rate levied on the operating profit of its products. These incentives produce a current tax rate of 15.25% for Terphane (6.25% of income tax and 9.0% social contribution on income). The incentives have beenwere originally granted for a 10-year period which has a commencement date ofcommencing January 1, 2015 and will expireexpiring at the end of 2024. Terphane Brazil has been granted an additional three years of tax incentives through the end of 2027. The benefit from the tax incentives was immaterial$7.0 million, $4.8 million and $2.0 million in 2017, 20162021, 2020 and 2015.2019, respectively.
68


Deferred income tax liabilities and deferred income tax assets at December 31, 20172021 and 2016,2020, are as follows:
(In thousands)2017 2016(In thousands)20212020
Deferred income tax liabilities:   Deferred income tax liabilities:
Amortization of goodwill and identifiable intangibles$22,739
 $43,546
Amortization of goodwill and identifiable intangibles$10,215 $9,520 
Depreciation
 24,178
Depreciation12,902 10,844 
Foreign currency translation gain adjustment433
 1,424
Foregone tax credits on foreign branch incomeForegone tax credits on foreign branch income4,796 5,714 
Excess of carrying value over tax basis of investment in kaléo8,602
 4,131
Excess of carrying value over tax basis of investment in kaléo 4,905 
Derivative financial instruments167
 493
Right-of-use leased assetsRight-of-use leased assets2,767 2,979 
OtherOther520 944 
Total deferred income tax liabilities31,941
 73,772
Total deferred income tax liabilities31,200 34,906 
Deferred income tax assets:   Deferred income tax assets:
Depreciation4,917
 
Pensions19,626
 30,733
Pensions5,632 25,576 
Employee benefits6,842
 10,262
Employee benefits7,791 9,757 
Excess capital losses4,695
 11,726
Excess capital losses1,097 7,462 
Inventory2,884
 3,622
Inventory3,775 2,613 
Asset write-offs, divestitures and environmental accruals1,754
 2,515
Asset write-offs, divestitures and environmental accruals1,173 2,904 
Tax benefit on U.S. federal, state and foreign NOL and credit carryforwards33,384
 4,921
Tax benefit on U.S. federal, state and foreign NOL and credit carryforwards33,922 18,305 
Timing adjustment for unrecognized tax benefits on uncertain tax positions, including portion relating to interest and penalties184
 395
Allowance for doubtful accounts406
 198
Other261
 1,568
Other146 275 
Lease liabilitiesLease liabilities2,977 3,144 
Tax basis remaining for installment sale - kaléoTax basis remaining for installment sale - kaléo1,092 — 
Foreign currency translation gain adjustmentForeign currency translation gain adjustment1,970 1,423 
Deferred income tax assets before valuation allowance74,953
 65,940
Deferred income tax assets before valuation allowance59,575 71,459 
Less: Valuation allowance28,499
 12,694
Less: Valuation allowance12,652 17,485 
Total deferred income tax assets46,454
 53,246
Total deferred income tax assets46,923 53,974 
Net deferred income tax (assets) liabilities$(14,513) $20,526
Net deferred income tax (assets) liabilities$(15,723)$(19,068)
Amounts recognized in the consolidated balance sheets:   Amounts recognized in the consolidated balance sheets:
Deferred income tax assets (noncurrent)$16,636
 $584
Deferred income tax assets (noncurrent)$15,723 $19,068 
Deferred income tax liabilities (noncurrent)2,123
 21,110
Deferred income tax liabilities (noncurrent) — 
Net deferred income tax assets (liabilities)$14,513
 $(20,526)Net deferred income tax assets (liabilities)$15,723 $19,068 
Except as noted below, the Company believes that it is more likely than not that future taxable income will exceed future tax-deductible amounts thereby resulting in the realization of deferred income tax assets. The Company has estimated gross federal, state and foreign tax credits and net operating loss carryforwards of $33.4$33.9 million and $4.9$18.3 million at December 31, 20172021 and 2016,2020, respectively. The U.S. federal foreign tax credits will expire in between 20262027-2031 and 2037. Thethe U.S. federal net operating loss carryforwardsresearch and development tax credits will expire in 2037. The majority of the foreign net operating loss carryforwards do not expire.by 2041. The U.S. state carryforwards expire at different points over the next 10 to 20 years.
Valuation allowances of $8.5$9.4 million, $1.5$5.5 million and $1.5$2.5 million at December 31, 2017, 20162021, 2020 and 2015,2019, respectively, are recorded against the tax benefit on U.S. federal, state and foreign tax credits and net operating loss carryforwards generated by certain foreign and domestic subsidiaries that may not be recoverable in the carryforward period. The valuation allowance for excess capital losses from investments and other related items was $4.4$0.7 million, $11.2$7.1 million and $10.9$1.3 million at December 31, 2017, 20162021, 2020 and 2015.2019, respectively. The current year2021 balance decreased primarily due to the expirationutilization of capital losses as a portionresult of the capital loss carryforwards andsale of the enacted reductionCompany’s investment in the U.S. federal corporate income tax rate.kaléo. The amount of the deferred income tax asset considered realizable, however, could be adjusted in the near term if estimates of the fair value of certain investments during the carryforward period change. Tredegar continues to evaluate opportunities to utilize capital loss carryforwards prior to their expiration at various dates in the future.


As circumstances and events warrant, allowances will be reversed when it is more likely than not that future taxable income will exceed deductible amounts, thereby resulting in the realization of deferred income tax assets. The valuation allowance for asset impairments in foreign jurisdictions where the Company believes it is more likely than not that the deferred income tax asset will not be realized was $15.6Valuation allowances of $2.5 million, $4.9 million and $0 million at December 31, 20172021, 2020 and $0.92019, respectively, were recorded against certain deferred state tax assets. In 2019, the Company reversed a $12.4 million at December 31, 2015 (nonevaluation allowance on the net deferred tax assets of its Brazilian subsidiary Terphane Ltda due to favorable earnings trends. Since Terphane Ltda. is taxed as a foreign branch for US tax purposes, Tredegar also recorded a related deferred tax liability of $12.4 million for the reduction in 2016).foreign tax credits that would result from Terphane Ltda. realizing this net deferred tax asset.
69


A reconciliation of the Company’s unrecognized uncertain tax positions since January 1, 2015,2019, is shown below:
  Years Ended December 31,
(In thousands) 2017 2016 2015
Balance at beginning of period$3,315
 $4,049
 $3,255
Increase (decrease) due to tax positions taken in:     
Current period27
 1,151
 518
Prior period(532) 43
 326
Increase (decrease) due to settlements with taxing authorities(51) (1,706) 
Reductions due to lapse of statute of limitations(797) (222) (50)
Balance at end of period$1,962
 $3,315
 $4,049
 Years Ended December 31,
(In thousands)202120202019
Balance at beginning of period$628 $881 $3,361 
Increase (decrease) due to tax positions taken in:
Current period 12 12 
Prior period40 — 49 
Increase (decrease) due to settlements with taxing authorities — (151)
Reductions due to lapse of statute of limitations(20)(265)(2,390)
Balance at end of period$648 $628 $881 
Additional information related to unrecognized uncertain tax positions since January 1, 20152019 is summarized below:
 Years Ended December 31, Years Ended December 31,
(In thousands) 2017 2016 2015(In thousands)202120202019
Gross unrecognized tax benefits on uncertain tax positions (reflected in current income tax and other noncurrent liability accounts in the balance sheet)$1,962
 $3,315
 $4,049
Gross unrecognized tax benefits on uncertain tax positions (reflected in
current income tax, other noncurrent liability accounts, or deferred tax assets in the balance sheet)
Gross unrecognized tax benefits on uncertain tax positions (reflected in
current income tax, other noncurrent liability accounts, or deferred tax assets in the balance sheet)
$648 $628 $881 
Deferred income tax assets related to unrecognized tax benefits on uncertain tax positions (reflected in deferred income tax accounts in the balance sheet)Deferred income tax assets related to unrecognized tax benefits on uncertain tax positions (reflected in deferred income tax accounts in the balance sheet)(153) (345) (858)Deferred income tax assets related to unrecognized tax benefits on uncertain tax positions (reflected in deferred income tax accounts in the balance sheet)48 (110)(163)
Net unrecognized tax benefits on uncertain tax positions, which would impact the effective tax rate if recognizedNet unrecognized tax benefits on uncertain tax positions, which would impact the effective tax rate if recognized1,809
 2,970
 3,191
Net unrecognized tax benefits on uncertain tax positions, which would impact the effective tax rate if recognized696 518 718 
Interest and penalties accrued on deductions taken relating to uncertain tax positions (approximately $(1), $(262) and $90 reflected in income tax expense in the income statement in 2017, 2016 and 2015, respectively, with the balance shown in current income tax and other noncurrent liability accounts in the balance sheet)136
 135
 397
Interest and penalties accrued on deductions taken relating to uncertain tax positions (approximately $26, $2 and $(144) reflected in income tax expense in the income statement in 2021, 2020 and 2019, respectively, with the balance shown in current income tax and other noncurrent liability accounts in the balance sheet)Interest and penalties accrued on deductions taken relating to uncertain tax positions (approximately $26, $2 and $(144) reflected in income tax expense in the income statement in 2021, 2020 and 2019, respectively, with the balance shown in current income tax and other noncurrent liability accounts in the balance sheet)133 102 100 
Related deferred income tax assets recognized on interest and penaltiesRelated deferred income tax assets recognized on interest and penalties(32) (49) (148)Related deferred income tax assets recognized on interest and penalties(31)(24)(23)
Interest and penalties accrued on uncertain tax positions net of related deferred income tax benefits, which would impact the effective tax rate if recognizedInterest and penalties accrued on uncertain tax positions net of related deferred income tax benefits, which would impact the effective tax rate if recognized104
 86
 249
Interest and penalties accrued on uncertain tax positions net of related deferred income tax benefits, which would impact the effective tax rate if recognized102 78 77 
Total net unrecognized tax benefits on uncertain tax positions reflected in the balance sheet, which would impact the effective tax rate if recognizedTotal net unrecognized tax benefits on uncertain tax positions reflected in the balance sheet, which would impact the effective tax rate if recognized$1,913
 $3,056
 $3,440
Total net unrecognized tax benefits on uncertain tax positions reflected in the balance sheet, which would impact the effective tax rate if recognized$798 $596 $795 
Tredegar, or one of its subsidiaries, files income tax returns in the U.S. federal jurisdiction, various states and jurisdictions outside the U.S. With few exceptions, Tredegar is no longer subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years before 2014.2018. The Company anticipates that it is reasonably possible that Federal and state income tax audits or statutes may settle or close within the next 12 months, which could result in the recognition of up to approximately $0.8$0.5 million of the balance of unrecognized tax positions, including any payments that may be made.
17LOSSES ASSOCIATED WITH PLANT SHUTDOWNS, ASSET IMPAIRMENTS AND RESTRUCTURINGS, UNUSUAL ITEMS, GAINS FROM SALE OF ASSETS AND OTHER ITEMS
Losses13. BUSINESS SEGMENTS
The Company's business segments are Aluminum Extrusions, PE Films and Flexible Packaging Films. Aluminum Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft-alloy and medium-strength custom fabricated and finished aluminum extrusions for the building and construction, automotive and transportation, consumer durables, machinery and equipment, electrical and renewable energy, and distribution markets. PE Films is composed of surface protection films, polyethylene overwrap films and films for other markets. Flexible Packaging Films is comprised of the Company’s polyester films business, Terphane Holdings LLC (“Terphane”).
The Company’s reportable segments are based on its method of internal reporting, which is generally segregated by differences in products. Accounting standards for presentation of segments require an approach based on the way the Company organizes the segments for making operating decisions and how the chief operating decision maker (“CODM”) assesses performance. EBITDA from ongoing operations is the key profitability measure used by the CODM (Tredegar’s President and Chief Executive Officer) for purposes of assessing financial performance. The Company uses sales less freight (“net sales”) from continuing operations as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
70


Information by business segment and geographic area for the last three years is provided in the segment tables below. There were no accounting transactions between segments and no allocations to segments.
Net Sales
(In thousands)202120202019
Aluminum Extrusions$539,325 $455,711 $529,602 
PE Films118,920 139,288 133,807 
Flexible Packaging Films139,978 134,605 133,935 
Total net sales798,223 729,604 797,344 
Add back freight28,232 25,686 28,980 
Sales as shown in consolidated statements of income$826,455 $755,290 $826,324 
Refer to Notes to Financial Tables that follow these tables.

EBITDA from Ongoing Operations
(In thousands)202120202019
Aluminum Extrusions:
Ongoing operations:
EBITDA$55,948 $55,137 $65,683 
Depreciation & amortization (d)(16,272)(17,403)(16,719)
EBIT39,676 37,734 48,964 
Plant shutdowns, asset impairments, restructurings and other (a)3,237 (3,506)(561)
Goodwill impairment charge (13,696)— 
Trade name accelerated amortization (d) — (10,040)
PE Films:
Ongoing operations:
EBITDA27,694 45,107 41,133 
Depreciation & amortization(6,263)(6,762)(5,860)
EBIT21,431 38,345 35,273 
Plant shutdowns, asset impairments, restructurings and other (a)(371)(1,974)(733)
Flexible Packaging Films:
Ongoing operations:
EBITDA31,684 30,645 14,737 
Depreciation & amortization(1,988)(1,761)(1,517)
EBIT29,696 28,884 13,220 
Plant shutdowns, asset impairments, restructurings and other (a)8,439 (18)— 
Total102,108 85,769 86,123 
Interest income73 44 66 
Interest expense3,386 2,587 4,051 
Gain (loss) on investment in kaléo (a)12,780 (60,900)28,482 
Loss on sale of Bright View (f) (2,299)— 
Stock option-based compensation expense2,495 2,161 4,132 
Corporate expenses, net (a)41,859 42,912 34,482 
Income (loss) from continuing operations before income taxes67,221 (25,046)72,006 
Income tax expense (benefit) (a)9,284 (8,213)13,545 
Income (loss) from continuing operations57,937 (16,833)58,461 
Income (loss) from discontinued operations, net of tax (a)(111)(58,611)(10,202)
Net income (loss)$57,826 $(75,444)$48,259 
Refer to Notes to Financial Tables that follow these tables.
71





Identifiable Assets
(In thousands)20212020
Aluminum Extrusions$280,521 $244,560 
PE Films113,613 119,013 
Flexible Packaging Films75,269 66,453 
Subtotal469,403 430,026 
General corporate23,482 71,508 
Cash and cash equivalents (b)30,521 11,846 
Discontinued operations178 1,490 
Total$523,584 $514,870 
 Depreciation and AmortizationCapital Expenditures
(In thousands)202120202019202120202019
Aluminum Extrusions$15,326 $17,403 $26,759 $18,914 $10,260 $17,855 
PE Films6,263 6,762 5,860 2,997 6,024 8,567 
Flexible Packaging Films1,988 1,761 1,517 5,603 4,959 8,866 
Subtotal23,577 25,926 34,136 27,514 21,243 35,288 
General corporate (e)207 520 186 (153)200 223 
Discontinued operations 5,511 9,962  1,912 15,353 
Total$23,784 $31,957 $44,284 $27,361 $23,355 $50,864 
Net Sales by Geographic Area (c)
(In thousands)202120202019
United States$614,987 $530,243 $593,599 
Exports from the United States to:
Asia59,242 80,217 82,342 
Canada17,776 18,024 15,022 
Europe4,489 5,440 5,752 
Latin America4,937 2,169 4,135 
Operations outside the United States:
Brazil96,792 93,511 96,274 
China — 220 
Total$798,223 $729,604 $797,344 
 Identifiable Assets
by Geographic Area (c)
Property, Plant & Equipment,
Net by Geographic Area (c)
(In thousands)2021202020212020
United States$398,749 $363,106 $135,310 $132,268 
Operations outside the United States:
Brazil54,299 49,157 18,615 15,588 
China16,355 17,763 14,889 16,245 
General corporate23,482 71,508 1,567 2,444 
Cash and cash equivalents (b)30,521 11,846 n/an/a
Discontinued operations178 1,490  — 
Total$523,584 $514,870 $170,381 $166,545 
Refer to Notes to Financial Tables that follow these tables.
72


The Company’s facilities in Pottsville, PA (“PV”) and Guangzhou, China (“GZ”) have a tolling arrangement whereby certain surface protection films are manufactured in GZ for a fee with raw materials supplied from PV that are then shipped by GZ directly to customers principally in the Asian market but paid by customers directly to PV.Amounts associated with this intercompany tolling arrangement are reported in the table above as export sales from the U.S. to Asia, and include net sales of $32.7 million in 2021, $35.1 million in 2020 and $32.1 million in 2019.
Net Sales by Product Group
(In thousands)202120202019
Aluminum Extrusions:
Nonresidential building & construction$269,252 $253,126 $272,729 
Consumer durables53,578 44,167 57,607 
Automotive43,256 35,895 46,461 
Machinery & equipment42,721 30,649 38,657 
Distribution45,639 28,339 34,753 
Residential building & construction52,236 40,049 43,554 
Electrical32,643 23,486 35,841 
Subtotal539,325 455,711 529,602 
PE Films:
Surface protection films88,436 109,097 103,893 
Packaging30,484 22,700 22,542 
LED-based products 7,491 7,372 
Subtotal118,920 139,288 133,807 
Flexible Packaging Films139,978 134,605 133,935 
Total$798,223 $729,604 $797,344 
(a)See Notes 1, 9, 15, 16 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other chargesitems.
(b)Cash and cash equivalents includes funds held in 2017 (as shownlocations outside the U.S. of $16.4 million and $9.4 million at December 31, 2021 and 2020, respectively.
(c)Information on exports and foreign operations are provided on the previous page. Export sales relate almost entirely to PE Films. Operations in China relate to PE Films. Operations in Brazil relate to Flexible Packaging Films.
(d)Depreciation and amortization for Aluminum Extrusions in 2019 excludes $10.0 million for accelerated amortization of trade names as a result of a rebranding initiative (see Note 5 for more information)
(e)Corporate depreciation and amortization are included in Corporate expenses, net, on the EBITDA from ongoing operations table above.
(f)In December 2020, the Company completed the sale of Bright View. See Note 15 for more details. 
14. SAVINGS PLAN
Tredegar has a savings plan that allows eligible employees to voluntarily contribute a percentage of their compensation, up to Internal Revenue Service (“IRS”) limitations. The provisions of the savings plan provided the following benefits for salaried and certain hourly employees:
The Company makes matching contributions to the savings plan of $1 for every $1 an employee contributes per pay period up to a maximum of 5% of eligible compensation.
The savings plan includes immediate vesting of matching contributions and automatic enrollment at 3% of eligible compensation unless the employee opts out or elects a different percentage.
The Company also has a non-qualified plan that restores matching benefits for employees suspended from the savings plan due to certain limitations imposed by income tax regulations (“restoration plan”). Charges recognized for these plans were $3.3 million in 2021, $4.0 million in 2020 and $3.9 million in 2019. The Company’s liability under the restoration plan was $0.7 million at December 31, 2021 (consisting of 56,570 phantom shares of common stock) and $1.0 million at December 31, 2020 (consisting of 61,394 phantom shares of common stock) and valued at the closing market price on those dates.
The Tredegar Corporation Benefits Plan Trust (the “Trust”) purchased 7,200 shares of the Company’s common stock in 1998 for $0.2 million and 46,671 shares of its common stock in 1997 for $1.0 million, which were intended as a hedge against the phantom shares held in the segment operating profit table in Note 5) totaled $94.0 million ($79.2 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities”restoration plan. There have been no shares purchased since 1998 except for re-invested dividends. The cost of the shares held by the Trust is shown as a reduction to shareholders’ equity in the consolidated statementsbalance sheets.

73


15. DIVESTITURES AND ASSETS HELD FOR SALE
Divestitures
Personal Care Films
In 2020, the Company completed the sale of income. Results in 2017 included:


A fourth quarter chargePersonal Care Films for an aggregate purchase price of $101.3$60.5 million, ($87.2 million after taxes)subject to customary adjustments. The Company agreed to provide certain transition services related to the impairment of assets at Flexible Packaging Films. During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activitiesfinance, human resources and other efforts, the Company determinedinformation technology (“IT”) that the carrying value of Terphane’s remaining long-lived assets were impaired (Terphane’s goodwill was written off in 2015).  Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million;
Second quarter income of $11.9 million ($11.9 million after taxes) related to the settlement of an escrow arrangement established upon the acquisition of Terphane Holdings, LLC in 2011 (included in “Other income (expense), net” in the consolidated statements of income). In settling the escrow arrangement, the Company assumed the risk of the claims (and associated legal fees) against which the escrow previously secured the Company.  While the ultimate amount of such claims is unknown, the Company believes that it is reasonably possible that it could be liable for some portion of these claims, and currently estimates the amount of such future claims at approximately $3.5 million;
First quarter charges of $3.3 million ($2.0 million after taxes) related to the acquisition of Futura, i) associated with accounting adjustments of $1.7 million made to the value of inventory sold by Aluminum Extrusions after its acquisition of Futura (included in “Cost of goods sold” in the consolidated statements of income), ii) acquisition costs of $1.5 million and, iii) integration costs of $0.1 million (included in “Selling, general and administrative expenses” in the consolidated statements of income), offset in the second quarter by pretax income of $0.7 million ($0.5 million after taxes) related to the fair valuation of an earnout provision (included in “Other income (expense), net” in the consolidated statements of income);
Quarterly charges related to estimated excess costs associated with the ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects by PE Films of $1.4 million ($1.3 million after taxes), $0.9 million ($0.8 million after taxes), $0.6 million ($0.5 million after taxes) and $0.6 million ($0.6 million after taxes) for the first, second, third and fourth quarter, respectively, and by Aluminum Extrusions of $0.3 million ($0.2 million after taxes), $0.1 million (less than $0.1 million after taxes) and $0.1 million (less than $0.1 million after taxes) for the first, second, and third quarters, respectively (included in “Cost of goods sold” in the consolidated statements of income);
A third quarter charge of $0.2 million ($0.1 million after taxes) associated with the consolidation of domestic PE Films’ manufacturing facilities for other facility consolidation-related expenses, a second quarter charge of $0.3 million ($0.2 million after taxes), which includes accelerated depreciation of $0.1 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.2 million ($0.1 million is included in “Cost of goods sold” in the consolidated statements of income), offset by a reversal of severance and other employee-related costs of $0.3 million ($0.2 million after taxes) and a first quarter charge of $0.7 million ($0.4 million after taxes), which includes severance and other employee-related costs of $0.2 million, asset impairments of $0.1 million, accelerated depreciation of $0.1 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.3 million ($0.2 million is included in “Cost of goods sold” in the consolidated statements of income);
Fourth quarter net gain of $5.1 million ($3.2 million after taxes), related to the explosion that occurred inended during the second quarter of 2016 at2021, resulting in final cash proceeds of $64.1 million. Personal Care Films was previously reported in the aluminum extrusions manufacturing facilityPE Films segment.
The following table summarizes the financial results of discontinued operations reflected in Newnan, Georgia,the Consolidated Statements of Income for the year ended December 31, 2021, 2020 and 2019:
Years Ended December 31
(In thousands)202120202019
Revenues and other items:
Sales$ $110,246 $146,034 
Other income (expense), net (333)6,424 
 109,913 152,458 
Costs and expenses:
Cost of goods sold 92,079 126,371 
Freight 5,229 7,083 
Selling, general and administrative739 16,824 17,754 
Research and development 8,863 11,743 
Asset impairments and costs associated with exit and disposal activities, net of adjustments 1,529 3,341 
Adjustment to the fair value estimates used in the disposal of Personal Care Films (a)
(1,118)— — 
Loss on sale of business 50,027 — 
Total(379)174,551 166,292 
Income (loss) from discontinued operations before income taxes379 (64,638)(13,834)
Income tax expense (benefit)490 (6,027)(3,632)
Income (loss) from discontinued operations, net of tax$(111)$(58,611)$(10,202)
(a) Represents a net increase to the estimated fair value of Personal Care Films primarily due to lower costs associated with IT transition-related services to provide the seller developed assets, which did not exist at the time of the sale, to support the seller’s IT infrastructure.
The assets and liabilities of the discontinued operations reflected in the Consolidated Balance Sheets as of December 31, 2021 and 2020, respectively were as follows:
December 31
(In thousands)20212020
Assets
Prepaid expenses and other (a)
$178 $1,339 
Other assets 151 
Total assets of discontinued operations$178 $1,490 
Liabilities
Accrued expenses (a)
$193 $7,521 
(a) The consolidated balance sheet of discontinued operations as of December 31, 2021 includes $0.2 million of other receivables related to the settlement of customary post-closing adjustments and other miscellaneous accrued expenses of $0.2 million. The consolidated balance sheet of discontinued operations as of December 31, 2020 includes $0.4 million of other receivables related to the settlement of customary post-closing adjustments, deferred assets of $0.9 million and deferred obligations of $5.3 million related to transition services, accrued severance of $2.1 million, and other miscellaneous accrued expenses of $0.2 million.
74


The following table provides significant operating and investing cash flow information for discontinued operations:
Year Ended December 31,
(In thousands)202120202019
Operating activities:
Depreciation and amortization$ $5,511 $9,962 
Gain from the sale of the Shanghai manufacturing facility assets — (6,316)
Loss on sale of Personal Care Films 50,027 — 
Other(1,118)— — 
Total(1,118)55,538 3,646 
Investing activities:
Net proceeds on sale of Personal Care Films$ $55,115 $— 
Proceeds from the sale of the Shanghai manufacturing facility assets — 10,936 
Capital expenditures (1,912)(15,353)
Total$ $53,203 $(4,417)
Bright View
In December 2020, the Company entered into a definitive agreement and completed the sale of Bright View, which includesresulted in the recognition of a gain on the involuntary conversion of an asset of $5.3 million for insurance proceeds used for the replacement of capital equipment (included in “Other income (expense), net” in the consolidated statements of income), partially offset by excess production costs of $0.2 million ($0.1 million after taxes) (included in “Cost of goods sold” in the consolidated statements of income); a second quarter net gain on the expected recovery of excess production costs of $0.9 million ($0.6 million after taxes) incurred in prior periods for which recovery from insurance carriers was not previously considered to be reasonably assured (included in “Cost of goods sold” in the consolidated statements of income); and a first quarter netpre-tax loss of $0.4$2.3 million ($0.21.8 million after taxes), which includes $0.3 million for other costs for which recovery from insurance carriers was not considered to be reasonably assured (reversed in the second quarter) and legal and consulting fees of $0.1 million (included in “Selling, general and administrative expenses” in the consolidated statements of income);
A fourth quarter charge of $1.5 million ($1.0 million after taxes) and a first quarter charge of $0.4 million ($0.2 million after taxes) related to expected future environmental costs at the aluminum extrusions manufacturing facilities in Carthage, Tennessee and Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income);
A fourth quarter charge of $0.8 million ($0.5 million after taxes) at Corporate related to expected future environmental costs at various shutdown facilities (included in “Cost of goods sold” in the consolidated statements of income);


A fourth quarter charge of $1.3 million ($0.8 million after taxes), a third quarter charge of $0.2 million ($0.1 million after taxes), a second quarter charge of $0.6 million ($0.4 million after taxes), and a first quarter charge of $0.3 million ($0.2 million after taxes), associated with business development projects (included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A fourth quarter charge of $0.1 million (less than $0.1 million after taxes) and a third quarter charge of $0.1 million (less than $0.1 million after taxes) for severance and other employee-related costs associated with restructurings in PE Films, and a fourth quarter charge of $0.1 million ($0.1 million after taxes) for severance and other employee-related costs associated with restructurings in Aluminum Extrusions and a fourth quarter charge of $0.1 million ($0.1 million after taxes) and a first quarter charge of $0.3 million ($0.2 million after taxes) for severance and other employee-related costs associated with restructurings in Corporate (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment);
Fourth quarter charges of $0.4 million ($0.2 million after taxes) for professional fees associated with the Terphane Limitada worthless stock deduction and impairment of assets of Flexible Packaging Films;
A fourth quarter charge of $0.3 million ($0.3 million after taxes) associated with asset impairments at PE Films’ Hungary facility; and
A third quarter charge of $0.2 million ($0.1 million after taxes) associated with the settlement of customer claims and other costs related to the previously shutdown aluminum extrusions manufacturing facility in Kentland, Indiana.
Results in 2017 include a net unrealized gain on the Company’s investment in kaléo (included in “Other income (expense), net” in the consolidated statements of income) of $33.8 million ($24.0 million after taxes). See Note 4 for additional information on investments.
Total expenses associated with the North American facility consolidation project were $0.8 million ($0.5 million after taxes) in 2017 (included in “Cost of goods sold” in the consolidated statements of income) and the total expenses for the project since inception were $7.3 million. Cash expenditures for the restructuring were $1.9 million in 2017, which includes capital expenditures of $0.1 million. Total cash expenditures since project inception were $16.0 million, which includes $11.2 million for capital expenditures. Additional cash payments for remaining accrued costs of approximately $0.5 million are expected to be paid within the next 12 months.    
Losses associated with plant shutdowns, asset impairments, restructurings and other charges for continuing operations in 2016 (as shown in the segment operating profit table in Note 5) totaled $6.1 million ($3.9 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” in the consolidated statements of income. Results in 2016 included:
Fourth quarter net loss $0.7 million ($0.4 million after taxes), related to the explosion that occurred in the second quarter of 2016 at the aluminum extrusions manufacturing facility in Newnan, Georgia, which consists of excess production costs for which recovery from insurance is not assured of $0.6 million ($0.4 million after taxes) (included in “Cost of goods sold” in the consolidated statements of income) and legal and consulting fees of $0.1 million ($0.1 million after taxes) (included in “Selling, general and administrative expenses” in the consolidated statements of income), third quarter net income of $1.7 million ($1.1 million after taxes), which includes the recognition of a gain of $1.9 million ($1.2 million after taxes) for a portion of the insurance recoveries approved by the insurer to begin the replacement of capital equipment, offset by the impairment of equipment damaged by the explosion of $0.3 million ($0.2 million after taxes) (net amountafter-tax) included in “Other income (expense), net” in the consolidated statements of income),income for the year ended December 31, 2020. The sale did not represent a strategic shift nor did it have a major effect on the Company’s historical and ongoing operations, thus all financial information for Bright View has been presented as continuing operations within the reversalPE Films segment.
Assets Held For Sale
In July 2019, the Company committed to a plan to close its manufacturing facility in Lake Zurich, Illinois, which historically was reported within the personal care component of an accrual for other costs related toits PE Films segment. As of December 31, 2020, the explosion not recoverable from insurancedisposal group carrying value of $0.1$4.6 million ($0.0 million after taxes) (includedwas reported in “Selling, general"Prepaid expenses and administrative expenses”other" in the consolidated statementsbalance sheet as the held for sale criteria was met. During the third quarter of income)2021, the Company completed the sale of the remaining assets in Lake Zurich, Illinois resulting in total cash proceeds of $4.7 million.
16. INVESTMENTS
In August 2007 and December 2008, the Company made an aggregate investment of $7.5 million in kaleo, Inc. (“kaléo”), a privately held specialty pharmaceutical company dedicated to building innovative solutions for serious and second quarter netlife-threatening medical conditions. Tredegar historically accounted for its investment in kaléo under the fair value option. At the time of the initial investment, the Company elected the fair value option of accounting since its investment objectives were similar to those of venture capitalists, which typically do not have controlling financial interests. kaléo’s stock is not publicly traded.
On December 27, 2021, the Company completed the sale of its investment interests in kaléo (Series A-3 Preferred Stock, Series B Preferred Stock and common stock) that, taken together, represented on a fully-diluted basis an approximate 18% interest in kaléo. Tredegar received closing cash proceeds of $47.1 million. A pre-tax gain of $12.8 million on the Company’s investment in kaléo was recognized in the full year ended December 31, 2021 compared to a pre-tax loss of $0.6$60.9 million ($0.4and pre-tax gain of $28.5 million after taxes) for other costs related to the explosion not recoverable from insurance (included in “Selling, general and administrative expenses” in the consolidated statements of income);


Quarterly charges associated with the consolidation of domestic PE Films’ manufacturing facilities,full years ended December 31, 2020 and 2019, respectively, which includes categories of expenses shown in the table below (Accelerated depreciation and a portion of Other facility consolidation-related costs as noted in the table below are included in “Cost of goods sold” in the consolidated statements of income):
 1st Quarter2nd Quarter3rd Quarter4th Quarter2016
($ in millions)BTATBTATBTATBTATBTAT
Severance0.3
0.2
0.4
0.2
0.3
0.2
0.3
0.2
1.2
0.8
Asset impairments0.3
0.2
0.1
0.1
0.1



0.4
0.3
Accelerated depreciation0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.2
0.6
0.4
Other facility consolidation-related costs0.5
0.3
0.8
0.5
0.6
0.4
0.2
0.1
2.0
1.3
   Total1.1
0.7
1.3
0.9
1.1
0.7
0.8
0.5
4.3
2.8
           
Other facility consolidation-related costs included in “Cost of goods sold” in the consolidated statements of income0.4
0.2
0.7
0.4
0.4
0.2
0.2
0.1
1.6
1.0
Note: BT = before taxes; AT = after taxes
A fourth quarter charge of $0.6 million ($0.4 million after taxes) associated with the acquisition of Futura by Bonnell Aluminum (included in “Selling, general and administrative expenses” in the consolidated statements of income);
A fourth quarter charge of $0.5 million ($0.3 million after taxes) related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income);
A first quarter charge of $0.4 million ($0.2 million after taxes) associated with a non-recurring business development project (included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A third quarter charge of $0.3 million ($0.2 million after taxes) for severance and other employee-related costs associated with restructurings in PE Films ($0.1 million) ($0.1 million after taxes) and Corporate ($0.2 million) ($0.1 million after taxes) (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A fourth quarter charge of $0.3 million ($0.2 million after taxes) related to contingencies associated with the application of prior period Brazilian value-added tax credits in Flexible Packaging Films (included in “Cost of goods sold” in the consolidated statements of income);
A fourth quarter charge of $0.2 million ($0.1 million after taxes) associated with asset impairments in PE Films;
A fourth quarter gain of $0.1 million ($0.0 million after taxes) related to contractual indemnifications associated with the anticipated settlement of a Terphane pre-acquisition contingency (includedreported in “Other income (expense), net” in the consolidated statements of income);income. The gain in 2021 includes a $0.3 million dividend received from kaléo in the first quarter of 2021 and the gain in 2019 includes a $17.6 million dividend received from kaléo.
A fourth quarter gain of $0.1 million ($0.1 million after taxes) associated
17. ASSET IMPAIRMENTS AND COSTS ASSOCIATED WITH EXIT AND DISPOSAL ACTIVITIES
In connection with the shutdown ofanticipated customer product transitions in Surface Protection, the aluminum extrusions manufacturing facility in Kentland, Indiana, which includes a pretax gain of $0.2 million ($0.1 million after taxes) related to the sale of the property, partially offset by pretax charges of $0.1 million ($0.0 million after taxes) associated with the shutdown of this facilityCompany recognized severance and a third quarter charge of $0.3 million ($0.2 million after taxes) associated with shutdown costs.
Results in 2016 include a net unrealized gain on the Company’s investment in kaléo (included in “Other income (expense), net” in the consolidated statements of income)other employee-related expenses of $1.6 million ($1.2 million after taxes). The Company recorded an unrealized loss on its investment property in Alleghany and Bath Counties, Virginia (included in “Other income (expense), net” in the consolidated statements of income) of $1.0 million ($0.7 million after taxes) in the fourth quarter of 2016. See Note 4 for additional information on investments.    
Losses associated with plant shutdowns,2020. The Company recognizes termination benefits that are covered by a contract or an ongoing benefit arrangement when it is probable that employees will be entitled to benefits and the amount can be reasonably estimated. Other accrued expenses and losses related to asset impairments, restructurings and other charges for continuing operations in 2015 (as shown in the segment operating profit table in Note 5) totaled $10.1 million ($6.4 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” inactivities for continuing operations were not material for the consolidated statements of income. Results in 2015 included:years ended December 31, 2021, 2020 and 2019, respectively.


18. CONTINGENCIES
A second quarter charge of $3.9 million ($2.5 million after taxes) for severance and other employee-related costs associated with the resignation of the Company’s former chief executive and chief financial officers (included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A fourth quarter charge of $1.0 million ($0.6 million after taxes) and a third quarter charge of $1.2 million ($0.7 million) associated with the consolidation of domestic PE Films’ manufacturing facilities, which includes severance and other employee-related costs of $0.8 million, asset impairments of $0.4 million, accelerated depreciation of $0.4 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.6 million ($0.1 million is included in “Cost of goods sold” in the consolidated statements of income);
A fourth quarter charge of $1.1 million ($0.7 million after taxes) in PE Films ($0.4 million included in “Selling, general and administrative expense” in the consolidated statement of income), a third quarter charge of $0.9 million ($0.6 million after taxes) in PE Films ($0.9 million), Aluminum Extrusions ($35,000) and Corporate ($26,000, included in “Corporate expenses, net” in the statement of net sales and operating profit by segment), and a second quarter charge of $0.3 million ($0.2 million taxes) in Flexible Packaging Films ($0.3 million) and PE Films ($7,000) for severance and other employee-related costs, and a first quarter reversal of previously accrued severance and other employee related costs of $67,000 ($43,000 after taxes) in Flexible Packaging Films, all associated with restructurings;
A fourth quarter charge of $1.0 million ($0.6 million after taxes) associated with a business development project (included in “Selling, general and administrative expense” in the consolidated statement of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A fourth quarter charge of $31,000 ($19,000 after taxes), a third quarter charge of $0.3 million ($0.2 million after taxes), a second quarter charge of $18,000 ($11,000 after taxes) and a first quarter charge of $15,000 ($9,000 after taxes) associated with the previously shutdown aluminum extrusions manufacturing facility in Kentland, Indiana; and
A fourth quarter charge of $0.3 million ($0.2 million after taxes) related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income).
Results in 2015 include a net unrealized gain on the Company’s investment in kaléo (included in “Other income (expense), net” in the consolidated statements of income) of $20.5 million ($15.7 million after taxes). See Note 4 for additional information on investments.
18CONTINGENCIES
Tredegar is involved in various stages of investigation and remediation relating to environmental matters at certain current and former plant locations. Where the Company has determined the nature and scope of any required environmental
75


remediation activity, estimates of cleanup costs have been obtained and accrued. As efforts continue to maintain compliance with applicable environmental laws and regulations, additional contingencies may be identified. If additional contingencies are identified in the future, the Company’s practice is to determine at that time the nature and scope of those contingencies, obtain and accrue estimates of the cost of remediation, and perform remediation. TheWhile the Company does not believebelieves it is currently adequately accrued for known environmental issues, it is possible that additionalunexpected future costs that could arise from those activities will have a material adverse effect on its financial position. However, those costsfor known or unknown environmental issues could have a material adverse effect on its financial condition, results of operations and cash flows at that time.
The Company is involved in various other legal actions arising in the normal course of business. After taking into consideration the relevant information, the Company believes that it has sufficiently accrued for probable losses and that the actions will not have a material adverse effect on its financial position. However, the resolution of the actions in a future period could have a material adverse effect on quarterly or annual operating results at that time.
From time to time, the Company enters into transactions with third parties in connection with the sale of assets or businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or in which the sellers or third parties involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business. Also, in the ordinary course of its business, the Company may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, Tredegar is unable to estimate the maximum amount of the potential future liability under the indemnity provisions of these agreements. The Company does, however, accrue for losses for any known contingent


liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. The Company discloses contingent liabilities if the probability of loss is reasonably possible and material.
In 2011, Tredegar was notified by U.S. Customs and Border Protection (“U.S. Customs”) that certain film products exported by Terphane Limitada to the U.S. since November 6, 2008 could be subject to duties associated with an anti-dumping duty order on imported polyester films from Brazil.  The Company contested the applicability of these anti-dumping duties to the films exported by Terphane Limitada, and a request was filed with the U.S. Department of Commerce (“Commerce”) for clarification about whether the film products at issue are within the scope of the anti-dumping duty order.  On January 8, 2013, Commerce issued a scope ruling confirming that the films are not subject to the order, provided that Terphane Limitada can establish to the satisfaction of U.S. Customs that the performance enhancing layer on those films is greater than 0.00001 inches thick.  The films at issue are manufactured to specifications that exceed that threshold.  On February 6, 2013, certain U.S. producers of PET film filed a summons with the U.S. Court of International Trade to appeal the scope ruling from Commerce.  In December 2014, the U.S. International Trade Commission voted to revoke the anti-dumping duty order on imported PET films from Brazil. The revocation, as a result of the vote by the U.S. International Trade Commission, was effective as of November 2013. On February 20, 2015, certain U.S. producers of PET films filed a summons with the U.S. Court of International Trade to appeal the determination by the U.S. International Trade Commission. The Court granted a motion by the plaintiffs to stay the appeal of the revocation decision pending the resolution of the scope appeal.  On June 8, 2017, the U.S. Court of International Trade remanded the scope determination to Commerce for re-consideration of certain scope issues. On October 20, 2017, Commerce filed its Remand Redetermination Results with the U.S. Court of International Trade, and again found that Terphane Limitada’s films are outside of the scope of the anti-dumping duty order. Commerce’s decision will now be reviewed by the U.S. Court of International Trade.
76


19SELECTED QUARTERLY FINANCIAL DATA


19. SELECTED QUARTERLY FINANCIAL DATA
Tredegar Corporation and Subsidiaries
(In Thousands, Except Per-Share Amounts)
(Unaudited)
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
For the year ended December 31, 2021
Sales$184,822 $211,129 $209,517 $220,986 
Gross profit37,313 45,394 31,497 34,328 
Income (loss) from continuing operations, net of tax9,618 20,728 6,229 21,358 
Income (loss) from discontinued operations, net of tax(587)508 (26)(6)
Net income (loss)$9,031 $21,236 $6,203 $21,352 
Earnings (loss) per share:
Basic:
Continuing operations$0.29 $0.62 $0.19 $0.64 
Discontinued operations(0.02)0.02   
Basic$0.27 $0.64 $0.19 $0.64 
Diluted:
Continuing operations$0.29 $0.61 $0.19 $0.63 
Discontinued operations(0.02)0.02   
Diluted$0.27 $0.63 $0.19 $0.63 
For the year ended December 31, 2020
Sales$192,136 $186,260 $184,370 $192,524 
Gross profit40,092 46,331 41,909 42,305 
Income (loss) from continuing operations, net of tax(20,663)14,332 (16,976)6,475 
Income (loss) from discontinued operations, net of tax(1,658)(3,136)(48,237)(5,580)
Net income$(22,321)$11,196 $(65,213)$895 
Earnings per share:
Basic:
Continuing operations$(0.62)$0.43 $(0.51)$0.19 
Discontinued operations(0.05)(0.10)(1.44)(0.17)
Basic$(0.67)$0.33 $(1.95)$0.02 
Diluted:
Continuing operations$(0.62)$0.43 $(0.51)$0.19 
Discontinued operations(0.05)(0.10)(1.44)(0.17)
Diluted$(0.67)$0.33 $(1.95)$0.02 
Due to rounding, the sum of quarterly amounts presented in the table above may not add up precisely to the corresponding full year amounts.
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
For the year ended December 31, 2017       
Sales$221,026
 $247,347
 $247,121
 $245,836
Gross profit30,872
 42,063
 42,107
 36,979
Net income (loss)$3,703
 $44,204
 $8,274
 $(17,929)
Earnings (loss) per share:       
Basic$0.11
 $1.34
 $0.25
 $(0.54)
Diluted$0.11
 $1.34
 $0.25
 $(0.54)
Shares used to compute earnings (loss) per share:       
Basic32,920
 32,961
 32,954
 32,948
Diluted32,957
 33,051
 32,954
 32,948
For the year ended December 31, 2016       
Sales$207,333
 $208,533
 $207,702
 $204,772
Gross profit37,279
 31,637
 33,927
 27,801
Net income$7,281
 $3,408
 $12,048
 $1,728
Earnings per share:       
Basic$0.22
 $0.10
 $0.37
 $0.05
Diluted$0.22
 $0.10
 $0.37
 $0.05
Shares used to compute earnings per share:       
Basic32,654
 32,716
 32,818
 32,856
Diluted32,654
 32,716
 32,818
 32,900



Item 16. FORM 10-K SUMMARY
Not Applicable.




77


EXHIBIT INDEX
 

2.13.1Stock Purchase Agreement, made as of October 1, 2012, by and among The William L. Bonnell Company, Inc., AACOA, Inc., the shareholders of AACOA, Inc., and Daniel G. Formsma, as the representative of the shareholders of AACOA, Inc. (filed as Exhibit 2.1 to Tredegar Corporation’s (“Tredegar’s”) Current Report on Form 8-K (File No. 1-10258), filed on October 3, 2012, and incorporated herein by reference). (Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Tredegar agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted exhibit or schedule upon request)
2.2Membership Interest Purchase Agreement, dated as of October 14, 2011, by and among TAC Holdings, LLC, Gaucho Holdings B.V. and Tredegar Film Products Corporation (filed as Exhibit 2.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on October 19, 2011, and incorporated herein by reference). (Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Tredegar agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted exhibit or schedule upon request)
2.3Stock Purchase Agreement, dated as of February 1, 2017, by and among Futura Industries Corporation, Futura Corporation, Susan D. Johnson, The Susan D. Johnson Trust, Ken Wells, The William L. Bonnell Company, Inc., and, in his capacity as Sellers’ Representative, Brent F. Lloyd (filed as Exhibit 2.1 of Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on February 2, 2017, and incorporated herein by reference). (Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Tredegar agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted exhibit or schedule upon request.)
3.1
3.1.1
3.1.1
3.1.2
3.1.2
3.1.3
3.1.3
3.2
3.2
4.1
4.1Form
4.210.1

4.2.110.1.1

4.2.210.1.2

10.1.3
10.110.1.4
10.2
*10.3


*10.2Employee Benefits Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.2 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)
10.4
10.3
10.5
10.4
*10.6
*10.5
*10.6.1
*10.5.1
*10.7
*10.6
78


*10.7.1
*10.6.1
*10.8
*10.7
*10.9
*10.8
*10.10
*10.9
*10.11
*10.10
*10.12
10.11*10.13Agreement, dated
*10.14
*10.15
*10.16
*10.17
*10.12
*10.13Form of Notice of Stock Award and Stock Terms and Conditions (filed as Exhibit 10.2 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on March 3, 2015, and incorporated herein by reference)
*10.14Severance Agreement with D. Andrew Edwards, dated June 25, 2015 (filed as Exhibit 10.3 to Tredegar’s Current Report on Form 8-K (file No. 1-10258) filed on June 29, 2015, and incorporated herein by reference)
*10.14.1First Amendment to Severance Agreement with D. Andrew Edwards, dated February 25, 2016 (filed as Exhibit 10.3 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on March 1, 2016, and incorporated herein by reference)
*10.15Severance Agreement with Michael J. Schewel, dated May 9, 2016 (filed as Exhibit 10.16 to Tredegar’s Annual Report on Form 10-K/A (File No. 1-10258) for the year ended December 31, 2016, and incorporated herein by reference)
+21
+23.123
+31.1


+31.2
+32.1
+32.2
+101
+101XBRL Instance Document and Related Items
+104Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101)
*Denotes compensatory plans or arrangements or management contracts.
+Filed herewith
79



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TREDEGAR CORPORATION
(Registrant)
Dated:March 11, 2022
TREDEGAR CORPORATION
(Registrant)
By
Dated:February 21, 2018By/s/ John D. GottwaldM. Steitz
John D. GottwaldM. Steitz
President and Chief Executive Officer


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 21, 2018.
March 11, 2022.
SignatureTitle
/s/John M. SteitzPresident, Chief Executive Officer and Director
(John M. Steitz)(Principal Executive Officer)
/s/D. Andrew EdwardsExecutive Vice President and Chief Financial Officer
(D. Andrew Edwards)(Principal Financial Officer)
/s/Frasier W. Brickhouse, IICorporate Treasurer and Controller
(Frasier W. Brickhouse, II)(Principal Accounting Officer)
/s/John D. GottwaldChairman of the Board of Directors
(John D. Gottwald)
/s/Gregory A. PrattLead Director
Signature(Gregory A. Pratt)Title
/s/John D. Gottwald    President, Chief Executive Officer and Director
(John D. Gottwald)(Principal Executive Officer)
/s/D. Andrew EdwardsVice President and Chief Financial Officer
(D. Andrew Edwards)(Principal Financial Officer)
/s/Frasier W. Brickhouse, IICorporate Treasurer and Controller
(Frasier W. Brickhouse, II)(Principal Accounting Officer)
/s/William M. GottwaldChairman of the Board of Directors
(William M. Gottwald)
/s/George C. Freeman, IIIDirector
(George C. Freeman, III)
/s/William M. GottwaldDirector
(William M. Gottwald)
/s/Kenneth R. NewsomeDirector
(Kenneth R. Newsome)
/s/Gregory A. PrattDirector
(Gregory A. Pratt)
/s/Thomas G. Snead, Jr.Director
(Thomas G. Snead, Jr.)
/s/John M. SteitzDirector
(John M. Steitz)
/s/Carl E. Tack, IIIDirector
(Carl E. Tack, III)
/s/Anne G. WaleskiDirector
(Anne G. Waleski)


98
80